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Abstract 
 
 
This thesis comprises both a natural product investigation and a synthetic component.  The 
natural product investigations are presented in Chapters Two and Three. In Chapter Two  the 
isolation and spectroscopic identification of the new isocopalane diterpene 12S,13R,14S-
isocopalan-13-ol-12,14-diacetate (2.1) and two known 3-(14S)-isocopal-12-ene-15-oyl-1-
acetyl-sn-glycerol (2.2) and 3-(14S)-isocopal-12-ene-15-oyl-2-acetyl-sn-glycerol (2.3) from a 
single, large, unidentified sub-Antarctic nudibranch, collected near Marion Island, 
approximately 2000 km south of Cape Town are described. Chapter Three  discusses the 
isolation, spectroscopic structure elucidation and anti-oesophageal cancer activity (3.1-3.4 
only) of two known labdane diterpenes 6β,7α-diacetoxylabda-8,13E-dien-15-ol (3.1) and 
2α,6β,7α-triacetoxylabda-8,13E-dien-15-ol (3.2) and one new 6β,7α,15-triacetoxylabda-
8,13E-diene (3.3), as well as new 3α,11-dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.4) 
and cholest-7-en-3,5,7-triol (3.5) from the endemic pulmonate mollusc, Trimusculus costatus. 
The absolute configuration of 3.2, and hence 3.1 and 3.3 (from biogenetic arguments) was 
determined through X-ray diffraction of a single crystal of the camphanate ester of 3.2. The 
absolute configuration of the secondary hydroxyl at C-3 of 3.4 was established using the 
Modified Mosher’s method. 
 
The synthetic component of the thesis commences in Chapter Four with the semi-synthesis of 
labdane diterpene nitriles 9α-cyano-15,16-epoxy-7β-hydroxylabda-13(16),14-dien-6-one (4.1), 
9α-cyano-15,16-epoxy-7-hydroxylabda-7,13(16),14-trien-6-one (4.2) and 9α-cyano-15,16-
epoxy-6β,7β-dihydroxylabda-13(16),14-diene (4.3) from the terrestrial labdane diterpene, 
hispanolone (4.4). This work is an extension of previous synthetic studies directed towards 
the synthesis of T. costatus metabolites. Diterpenes 4.1-4.3 exhibited in planta activity against 
the economically important crop pathogens, Magnaporthea grisea and Puccinia recondita. 
Chapter Five describes the successful semi-synthesis of two isomeric marine molluscan 
labdane diterpene aldehyde metabolites, labd-13E-ene-8β-ol-15-al (5.1) and labd-13Z-ene-
8β-ol-15-al (5.2) from the commercially available, terrestrial plant derived, labdane diterpene 
manool (5.3). Diterpenes 5.1 and 5.2, originally isolated from the Mediterranean nudibranch, 
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Pleurobranchaea meckelii and selected diterpenes arising from this synthesis were evaluated 
for their activity against an oesophageal cancer cell line (WHCO1). Chapter Six further 
develops the research discussed in Chapter Five, where ethyl 17-norabiet-13(15)-E-en-8β-ol-
16-oate (5.49) and ethyl 17-norabiet-13(15)-Z-en-8β-ol-16-oate (5.50) were first semi-
synthesized serendipitously. Based on their structural relationship to naturally occurring 
tricyclic diterpenes with anti-plasmodial activity, tricyclic diterpenes, 17-norpimaran-13α-
ethoxy-8,16-olactone (6.6), 17-norisopimar-15-ene-8β,13β-diol (6.7), 17-norisopimarane-
8β,16-diol (6.8) and 17-norabiet-13(15)-ene-8β,16-diol (6.9) were semi-synthesized from the 
terrestrial labdane diterpene, 5.3, and critically evaluated for their antimalarial potential from 
parasite inhibition and haemolytic studies. 
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1.1 Marine gastropod molluscs as a source of biomolecular diversity 
 
1.1.1 The classification of opisthobranch and pulmonate molluscs 
 
Class Gastropoda is the second most species diverse class of animals after class Insecta and 
includes over half of all molluscan species.1;2  Traditionally, gastropods have been classified 
into the three sub-classes Prosobranchia, Opisthobranchia and Pulmonata, and although the 
higher classification of gastropods is still a matter of dispute amongst taxonomists,2;3 this 
classification is generally maintained in the marine natural products literature,2 and will 
accordingly be used in this chapter. This thesis deals primarily with diterpene compounds 
isolated from marine opisthobranch and pulmonate molluscs and thus an overview of the 
diterpene secondary metabolites from these two sub-classes will be the subject of this 
introductory chapter. 
 
Opisthobranchs are marine gastropod molluscs and have recently been divided into nine 
Orders (Figure 1.1).4 The shell in opisthobranch molluscs, e.g. nudibranchs (sea slugs), is 
either reduced or completely absent,2-5 rendering them vulnerable to predation. Faulkner and 
Ghiselin (1983) first recognized that an evolutionary trend in opisthobranch molluscs towards 
the loss of the shell could possibly be linked to a parallel evolutionary trend towards the 
adoption of a natural product based chemical defence mechanism to deter predation.6;7  The 
evolutionary advantage of a chemically mediated defensive strategy is centred around the 
minimal energy costs of acquiring defensive chemicals from the diet when compared to the 
energy costs of transporting a shell as a form of physical defence. A major disadvantage of 
the former defensive strategy, however, is the limitation it poses on dietary selection by a 
mollusc species, which becomes dependent on selected invertebrate species for its chemical 
defence. If the dietary source of the chemical defence metabolites is removed from the 
ecosystem, the shell-less mollusc is again vulnerable to predation. To overcome the 
restrictive dietary dependence on defence metabolites, a less common defence strategy, and 
one that predominates in some cold water nudibranchs, is de novo biosynthesis.8;9 The need 
for de novo biosynthesis in cold waters is presumably driven by the reduced biodiversity in 
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these regions, which in turn possibly reduces the potential for chemical defence metabolites 
being ingested and sequestered by these nudibranchs. Defence metabolites, whether of 
dietary or de novo biosynthetic origin, are stored in specialized glands in the nudibranch’s 
skin for release as feeding deterrents in the presence of a predator. The diverse array of 
sequestered secondary metabolites isolated from opisthobranch molluscs includes 
polyketides, alkaloids, peptides and terpenes.4  Diterpenes comprise the greater part of all 
metabolites isolated from the opisthobranchs and an excellent review of the diterpene 
metabolites of opisthobranch molluscs by Gavagnin and Fontana covers the literature up until 
1999.4  
             
PHYLUM:  Mollusca  
CLASS:  Gastropoda  
SUBCLASS:  Opisthobranchia  
ORDERS:  Cephalaspidea Acochlidea Rhodopemorpha 
 Sacoglossa Anaspidea Notaspidea 
 Gymnosomata Thecosomata Nudibranchia 
 
Figure 1.1  Opisthobranch classification,4 with Orders from which diterpenes have been 
isolated printed in bold.  
 
Unlike the opisthobranch gastropods, the majority of pulmonate gastropods (classification 
shown in Figure 1.2) are terrestrial or freshwater species and as a result rely on a pulmonary 
cavity, which serves as a lung, rather than gills for respiration.1-3  The relatively few marine 
species of pulmonate gastropods are found in the intertidal zone of rocky shores.1;2 As a 
result of the harsh environment in which they live, being battered by waves and debris at high 
tide while facing desiccation at low tide, they have retained their shell to survive these 
environmental constraints, but employ a chemical defence mechanism while foraging to deter 
predation.1;2;6;7;10;11 Although various secondary metabolites have been isolated from 
pulmonates belonging to the families Siphonariidae, Onchidiidae and Trimusculidae, 
diterpenes are confined to the family Trimusculidae (Order Eupulmonata).1  A detailed review 
of the metabolites isolated from Trimusculus species is provided in Chapter Three.  
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PHYLUM:  Mollusca  
CLASS:  Gastropoda  
SUBCLASS:  Pulmonata  
ORDERS:  Systellommatophora Basommatophora Eupulmonata 
 
Figure 1.2  Pulmonate classification.1 
 
1.1.2 Structural diversity of diterpenes from marine opisthobranch gastropods 
 
In Gavagnin and Fontana’s recent review of diterpenes from marine opisthobranch molluscs,4 
35 different structural classes of diterpene were recognized. While rearranged skeletons were 
included in these 35 classes, diterpenes in which oxygen insertion had occurred into any of 
the rings were omitted. Selected examples of all non-rearranged diterpene frameworks 
presented in Gavagnin and Fontana’s review are presented in Tables 1.1-1.5. In instances 
where two different enantiomeric series exist they have been counted together, while the total 
number of diterpenes with rearranged skeletons has been provided for comparative purposes. 
The plethora of rearranged skeletons precludes a detailed discussion of their diversity in this 
brief synopsis of Gavagnin and Fontana’s seminal review. 
 
Table 1.1  Acyclic diterpenes. 
Diterpene class 
No. of 
examples 
Example 
Example isolated 
from 
 
 
Phytane 
7 
 
OAc CHO
AcO
OAcOAc
 
 
Elysia 
halimedae12 
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 Table 1.2  Monocyclic diterpenes. 
Diterpene class 
No. of 
examples 
Example Example isolated from 
 
 
Dactylomelol† 
1 
HO
ClO
Br
 
1.3 
Aplysia dactylomela13 
 
 
Cyclophytane 
1 O
O
O
O
OAc
AcO
 
Thuridilla hopei14 
 
 
Dictyolactone† 
1 
HO
O
 
Aplysia depilans15 
 
 
Cembrane 
8 
OH
H
 
Phyllodesmium 
longicirra16 
Rearranged (e.g. 
degraded ent-labdane) 
2 
 
O
O
O
O
OH
OAc
 
Austrodoris 
kerguelenensis17 
† No class name exists. 
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Table 1.3  Bicyclic diterpenes. 
Diterpene class 
No. of 
examples 
Example 
Example isolated 
from 
 
Labdane 
13 
Br
OH
CH2OH
 
Aplysia kurodai18 
 
Briarane 
9 
O
AcO
O H
 
Armina maculata19 
 
Eudesmane 
2 
Br
OH OH
 
Aplysia kurodai20 
 
Obtustane 
1 
OH OH
Br
H H
 
Aplysia 
dactylomela21 
 
Dolabellane 
16 
AcO
AcO
 
Dolabella 
californica22 
 
Guaiane 
5 
O
HH
OH
H
 
Aplysia kurodai23 
 
Crenulide† 
4 
OH
O
O
HO
HH
 
Aplysia vaccaria24 
Rearranged 
(e.g. 4,5-seco-spongians) 
29 
Cl
OH
O
OH
 
Chromodoris 
hamiltoni25 
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Table 1.4  Tricyclic diterpenes. 
Diterpene class 
No. of 
examples 
Example Example isolated from 
 
 
Spongian/isocopalane 
Spongian: 43 
Isocopalane: 17 
O
O
O
OAc
 
Cadlina 
luteomarginata26 
 
 
Irieol 
2 
Br
O
O
OH
Br
 
Aplysia angasi27 
 
 
Dolastane 
3 
HO
HO
OH
 
Aplysia dactylomela28 
 
 
Marginatane 
2 O
O
AcO
 
Cadlina 
luteomarginata26 
Rearranged 14 
 
H
O
OAc
HH
AcO
HO
O
O
 
Chromodoris cavae29 
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Table 1.5  Tetracyclic diterpenes. 
Diterpene class 
No. of 
examples 
Example 
Example isolated 
from 
 
 
Isoparguerane 
(modified pimarane) 
2 
AcO
OH
H OH
H
Br
OH
 
1.10 
Aplysia 
dactylomela30 
 
 
Parguerane 
(modified pimarane) 
3 
AcO
H OH
H
OHBr
OH
 
1.9 
Aplysia 
dactylomela30 
 
 
From the data in Tables 1.1-1.5 (summarized in Figure 1.3), it is clear that the majority of 
diterpenes reported from opisthobranch gastropods prior to 1999 were either bicyclic or 
tricyclic.  Further analysis of the bicyclic diterpenes (Figure 1.4) revealed that the dolabellane 
(20%), labdane (16%) and briarane diterpenes (11%) predominated.  The tricyclic diterpenes 
isolated from molluscs are strongly dominated (54%) by spongian diterpenes (Figure 1.5). 
The structures of 154 spongian diterpenes from marine sponges of the Orders Dictyoceratida 
and Dendroceratida have recently been reviewed by Keyzers et al.31 This review, however, 
discussed only the spongian diterpenes isolated from marine sponges, while spongian 
diterpenes, isolated from the plethora of nudibranchs that prey on these sponges, were 
omitted. Interestingly, dictyoceratid and dendroceratid sponges are characterized by the 
absence of a spicule skeleton and are composed almost entirely of spongin fibres.31 The 
absence of the physical defence associated with a spicule skeleton would make this group of 
sponges a particularly attractive component in a nudibranch’s diet and may explain why 
spongian diterpenes dominate the tricyclic diterpenes isolated from marine molluscs. The 
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rare, and uniquely marine,32 isocopalane diterpenes (and their ent-isocopalane counterparts) 
are reviewed in Chapter Two. Although the two tetracyclic diterpene classes illustrated in 
Table 1.5 are, strictly speaking, rearranged pimarane diterpenes, they are the only tetracyclic 
diterpenes to have been isolated from opisthobranchs and were thus included.4  
Acyclic 
4% Monocyclic7%
Tricyclic
43%
Tetracyclic
3%
Bicyclic
43%
Acyclic 
Monocyclic
Bicyclic
Tricyclic
Tetracyclic
 
Figure 1.3  Graphical representation of the relative proportion of acyclic, monocyclic, bicyclic, 
tricyclic and tetracyclic diterpenes isolated from marine opisthobranch molluscs up until 
1999.4 
Labdane 
16%
Briarane
11%
Eudesmane
3%
Obtustane
1%
Dolabellane
20%
Guaiane
6%
Crenulide
5%
Rearranged
38%
Labdane 
Briarane
Eudesmane
Obtustane
Dolabellane
Guaiane
Crenulide
Rearranged
 
 
Figure 1.4  Graphical representation of the relative proportions of seven (plus rearranged) 
bicyclic diterpene classes isolated from opisthobranch molluscs up until 1999.4 
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Spongian
54%
Isocopalane
21%
Irieol
2%
Dolastane
4%
Marginatane
2%
Rearranged
17%
Spongian
Isocopalane
Irieol
Dolastane
Marginatane
Rearranged
 
Figure 1.5 Graphical representation of the relative proportions of five (plus rearranged) 
tricyclic diterpene classes isolated from opisthobranch molluscs up until 1999.4 
 
1.1.3 Diterpenes isolated from marine opisthobranch molluscs since 2000 
 
In order to update Gavagnin and Fontana’s review, the isolation and identification of 
diterpenes from marine opisthobranchs reported in the marine natural product literature 2000-
2007 is described here. 
 
1.1.3.1 Order Anaspidea 
 
Molluscs of the Order Anaspidea are most commonly referred to as sea hares.  They are 
known for their herbivorous diet and have been documented to feed exclusively on either red 
or brown algae.4;7 Two papers describing the isolation of diterpenes from sea hares have 
been published since Gavagnin and Fontana’s review. The first was by Wessels et al.33 who 
reported the isolation of two new diterpenes (1.1 and 1.2), as well as the known metabolite 
(1.3, Table 1.2),13 in addition to a host of known algal metabolites from Aplysia dactylomela, 
collected from Tenerife. The structures and relative configuration of 1.1 and 1.2 were 
determined spectroscopically, while that of 1.3 was determined through comparison of NMR 
data acquired with those previously published. Compounds 1.1 and 1.2 were structurally 
related to compounds previously isolated from the red alga Laurencia sp. and dactylomelol 
has also subsequently been isolated from a Laurencia sp.,34 suggesting that 1.1-1.3 are of 
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algal origin. Analysis of the metabolites of three distinct samples of A. dactylomela in this 
study also revealed that the secondary metabolite content was dependent on site of location, 
again suggesting a dietary source for the secondary metabolites isolated from sea hares. 
 
In 2002, Findlay and Li reported the isolation of four new diterpenes from Aplysia punctata 
(1.4-1.7), the structures of which were determined spectroscopically.35 Two known diterpenes 
isoconcinndiol (1.8) and parguerol (1.9, Table 1.5) were also reisolated in this study and 
identified by comparison of spectroscopic and specific rotation data with previously published 
data.  Three new sequiterpenes and fourteen other known non-diterpene compounds were 
also isolated. Many of the terpenes isolated from this sea hare were similar to those 
previously isolated from the Laurencia algal species, providing confirmation of the dietary 
source of these metabolites. 
 
O
Br O
Br
OH
1.1 1.2
 
OHO
O
H OH
H
OH
Br
HO
HO
H OH
H
OH
Br
O
Br
OH
Br
1715
10
1
1.4 1.5 1.6
1.7
Br
OH
HO
1.8
17
AcO
O H
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The relative configuration of 1.4 was deduced by NOE experiments and supported by 
comparison of the interatomic distances of the most stable conformation (obtained by 
computer modelling) with those determined from NOE data. A possible biogenetic pathway 
(Scheme 1.1) for the formation of 1.4 from isoparguerol (1.10) provided the authors with the 
name neoparguerane for compound 1.10. 
 
OH
Br
H
HO
O
H
OH
H
B:
H+ Br
OH
H
O
OH
1.4
1.10
 
 
Scheme 1.1 Possible biogenetic pathway for the formation of 1.4 from 1.10.35 
 
Although compound 1.5 had previously been reported as a hydrolysis product of 1.9, it had 
never been isolated from a natural source.  The relative configuration of the bromine group at 
C-17 was assigned by determining the orientation of H-17 using NOESY data. The instability 
of both 1.1 and 1.5, particularly in deuterated chloroform, prevented the acquisition of 
HREIMS data for these compounds. Punctatene acetate, 1.6, was the second dacylomelol 
diterpene to be isolated from a sea hare and shared the same relative configuration in its 
bicyclic system as dactylomelol, 1.3, isolated from Aplysia dactylomela,13 the absolute 
stereochemistry of which was determined by single crystal X-ray diffraction. Punctatol (1.7) 
was found to have the same skeleton as laurencianol, also an algal diterpene, whose 
stereochemistry had also been determined by X-ray diffraction.36 
 
1.1.3.2 Order Notaspidea 
 
Fu et al.37 reported the isolation of lissoclimide-type diterpenes 1.11-1.18 from 
Pleurobranchus albiguttatus and compounds 1.11-1.16 from P. forskalii, both collected in the 
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Philippines. Although related chlorinated compounds had previously been isolated from an 
ascidian, Lissoclinum sp., this was the first report of Lissoclinum metabolites from an 
opisthobranch predator.37 Compounds 1.11-1.12 had previously been isolated from 
Lissoclinum voeltzkowi,38-40 while 1.11-1.13 had been isolated from an unidentified 
Lissoclinum sp.41-43 The relative configurations of 1.11-1.18 were determined from analysis of 
proton coupling constants and from NOE data.37 
 
Cl
H
N
OH
O O
X
H
N
OH
O O
H
Cl
OH
H
X
H
N
OH
O O
Cl
O
H
Cl
H
N
OH
O O
X
O
H
O
H
1.11  X = H
1.12 X = Cl
1.18 X = OH
1.13 X = Cl
1.14 X = H
1.15 X = Cl
1.17 X = H
1.16
 
1.1.3.2 Order Nudibranchia 
 
Molluscs of the Order Nudibranchia continue to be the source of many of the new compounds 
isolated from marine molluscs. This is not surprising as nudibranchs are the most diverse and 
widespread of the opisthobranchs molluscs.4 They are slow moving invertebrates without any 
visible means of physical protection against predation e.g. a shell or sharp spines, creating 
the need for a chemical defence mechanism.44 Nudibranchs are carnivorous and their diet 
can encompass almost all marine animal phyla, from which many nudibranchs sequester their 
chemical defence allomones.4 The bright colours that many nudibranchs display are 
aposomatic and provide a visual warning to potential predators. Since Gavagnin and 
Fontana’s review,4 four papers have been published outlining the isolation of new diterpene 
compounds from nudibranchs. The first of these was an anatomically guided study of the 
compounds found in Glossodoris atromarginata, collected along with a sample of the sponge 
being preyed upon at Gneerings Reef, South-East Queensland.45 Seven furano-spongian 
diterpenes (1.19-1.28) were isolated, of which 1.19 and 1.20 were first time isolates from a 
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natural source (previously synthesized)46 and 1.21 had never before been isolated from G. 
atromarginata.  Five of the nudibranchs were dissected to establish the distribution of the 
metabolites in the various internal organs (1.19-1.22), mantle tissue (1.19, 1.23 and 1.24) and 
mantle glands (1.25).  Compounds of the C-3 α-epimeric series were found in the digestive 
tissue and mantle dermal formations while those of the C-3 β-epimeric series were noted 
exclusively in the mantle tissue.  Somerville et al.45 commented that these differences might 
be due to the compounds in the digestive tract being those of the host prey, while those in the 
mantle were either sequestered by the nudibranch or modified by selective enzyme 
transformations. They also cautioned that the axial orientation of the hydroxyl species at C-3 
might result from keto-enol tautomerism leading to the more stable equatorial position being 
assumed during storage in the mantle.45  
 
O
O
OO
R2O
R1O
OO
HO
HO R1
1.19 1.20 R1 = Ac; R2 = H
1.21 R1 = H; R2 = Ac
1.22 R1 = H; R2`= H
1.25 R1 = Ac; R2 = Ac
1.23 R1 = H
1.24 R1 = OH
333
 
 
A chemical study on Austrodoris kerguelenensis, collected in Terra Nova Bay, Antarctica, led 
to a revision of the structure of the 1'-acylglycerols (1.26 and 1.27) to their respective 2'-
acylglycerols (1.28 and 1.29).47 This structural revision was made after careful structural 
analyses of correlations in the HMBC NMR spectra of 1.28 and 1.29. Two new acylgylcerol 
diterpenes (1.30 and 1.31) were also isolated. Comparison of the 1H and 13C NMR spectra of 
compounds 1.31 and 1.29 revealed them to be closely related, except that 1.31 lacked an 
acetyl group, allowing them to conclude that 1.31 was the deactyl derivative of 1.29.  Analysis 
of the 2D NMR data of 1.30 quickly allowed the authors to determine the structure as being 
very similar to known diterpene (1.32)48 and limited the differences between 1.30 and 1.32 to 
the substitution pattern of the glyceryl moiety, where an acetyl functionality was linked instead 
of the tiglic acyl residue in 1.32.  
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O OH
O
OAc
O OH
O
OAc
1.26 1.27
O
O
O
O
OR
OH
OAc
OH
1'
2'
3'
2' 1'
3'
1.28 1.29 R = Ac
1.31 R = H
H O
O
O
OH
1.32
O
H O
O
OAc
OH
1.30
 
 
A Chinese collection of the nudibranch Phyllidiella pustulosa afforded four known nitrile-
containing diterpenes (1.33-1.36).49 All four compounds had previously been isolated from 
sponges,50-57 suggesting that they were derived from the nudibranch’s prey. Structural 
elucidations were made by comparison of acquired NMR data with those in the chemical 
literature. 
HO
NC
H O
Cl
NCH
H O NC
H NC
CN
NC
1.33 1.34
1.35 β-Cl
1.36 α-Cl
CO2Me
HO
OH
H
2 1
1.37
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The final diterpene metabolite to have been isolated since Gavagnin’s review is the ent-
isocopalane diterpene (1.37), isolated from the Spanish dancer nudibranch, Hexabranchus 
sanguineus, collected in the Red Sea.58  The large variety of structural features in the 
secondary metabolites isolated from this nudibranch was seen to support recent phylogenetic 
studies suggesting a close phylogenetic relationship between the Spanish dancer nudibranch 
and dorid nudibranchs.58 Since 1.37 is included in the review in Chapter Two, no further 
discussion will be entered into here, apart from mentioning that this compound had previously 
been isolated from an Indonesian collection of the sponge, Coelocarteria cfr. singaporensis.59  
 
This concludes the review of diterpenes isolated from opisthobranch molluscs since Gavagnin 
and Fontana’s recent review.4 Chapter Two provides details of the isolation of one new and 
two known isocopalane diterpenes from a sub-Antarctic nudibranch. Labdane diterpene 
chemistry is a common thread that runs through the remainder of this thesis from the isolation 
of a new labdane diterpene from the pulmonate mollusc, Trimusculus costatus (Chapter 
Three) to the synthesis of the labdane metabolites from the opisthobranchs mollusc, 
Pleurobranchaea meckelii (Chapter Five). Modifications of the labdane skeleton to explore the 
agrochemical and biomedicinal potential of semi-synthetic diterpene analogues are described 
in Chapters Four and Six. 
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Chapter Two 
Isocopalane Diterpenes from a sub-Antarctic Nudibranch  
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2.1 Introduction 
 
This Chapter describes the isolation and identification of new 12S,13R,14S-isocopalan-13-ol-
12,14-diacetate (2.1) and the known 3-(14S)-isocopal-12-ene-15-oyl-1-acetyl-sn-glycerol (2.2) 
and  3-(14S)-isocopal-12-ene-15-oyl-2-acetyl-sn-glycerol (2.3) isocopalane diterpenes from a 
single, large, unidentified sub-Antarctic nudibranch.  The nudibranch was collected at a depth 
of 115 m near Marion Island (approximately 2000 km south of Cape Town) and the research 
described in this Chapter represents the first natural products investigation of a marine 
organism from this region of the Southern Ocean.  A review of the structures and the selected 
syntheses of isocopalane and ent-isocopalane diterpenes isolated from marine organisms 
provides the necessary background to this chapter. 
 
O OR2
OR1
O
2.2 R1 = H; R2 = Ac
2.3 R1 = Ac; R2 = H
H
OAc
OH
H
OAc
2.1
OH
OH
HBr
2.4
13
 
 
Isocopalane diterpenes (vide infra) and their enantiomeric series (the ent-isocopalane 
diterpenes) appear to be unique to the marine environment.32 Isocopalane diterpenes are rare 
compared to the more common spongian diterpenes, (15,16-epoxy-ent-isocopalanes).31 The 
name isocopalane was first proposed by de Miranda et al.60 with an absolute configuration for 
this series defined by an earlier synthesis of (2.4) although the configuration at C-13 had not 
yet been determined.61  
 
1
53
19
20
15
17
14
13
18
16
10
11
isocopalane
1
53
19
20
15
17
14
13
18
16
10
11
ent-isocopalane
1
53
19
20
15
17
14
13
18
16
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11 O
spongian
 
                                                                                                                            Chapter Two 
 
                                                                                                                                    19                                                                                                                
Examples of both the enantiomeric series of isocopalane diterpenes have been isolated from 
nudibranchs, while only one example from sponges has been an isocopalane diterpene. One 
example of a bromine containing isocopalane diterpene has been recorded from a sea hare.  
The most extensively studied examples of isocopalane and ent-isocopalane diterpenes have 
been those containing a glyceride substituent at C-15.  Two numbering systems for the 
carbon atoms of the glycerol moiety are evident in the literature, either C-1'- C-3', or C-21- C-
24. For reasons of simplicity the former glycerol numbering sequence will be used in this 
Chapter. 
 
2.2 Chemical studies of isocopalanes and ent-isocopalanes 
 
2.2.1 Isocopalane and ent-isocopalane diterpenes from marine molluscs 
 
The first isocopalane diterpene isolated from a marine mollusc was isoaplysin-20, 2.4.62  The 
source of 2.4 was the sea hare Aplysia kurodai, collected off the coast of Japan.  The 
structure and relative configuration of 2.4 (with the exception of the configuration at C-13) 
were proposed through comparison of 1H and 13C NMR data with those of co-occurring 
aplysin-20 (2.5). 
 
The relative configuration at C-13 of 2.4 was later established synthetically by Imamura and 
Rúveda61 through a synthesis of the debrominated analogue of 2.4 from methyl isocopalate 
(2.6). Methyl isocopalate was treated with formic acid to yield the tricyclic ester (2.7).  The C-
13 epimers (2.8 and 2.9) were synthesized via expoxidation and subsequent opening of the 
epoxide of the ∆12 olefin of 2.7. The hydroxyl group at C-13 in 2.4 was consequently reported 
to have the relative configuration as shown in 2.9. However, when Nishizawa et al.63;64 
introduced a β-equatorial bromine at C-3 of 2.9, they found that the 1H NMR spectra for the 
supposed synthetic and naturally occurring isoaplysin-20 were different.63;64 The 1H NMR 
spectrum of a minor product of the synthesis, once brominated at C-3 to yield (2.10), proved 
identical to that of naturally occurring isoplysin-2063 when the 1H NMR spectra of the two 
compounds were compared. Subsequent X-ray diffraction experiments on a single crystal of 
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the C-15 acetate of 2.10 established the relative configuration of isoaplysin-20 to be as 
indicated in 2.10, rather than as in 2.4. 
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Gustafson et al.65;66 isolated the first ent-isocopalane metabolites from the dorid nudibranch 
Archidoris montereyensis collected both in British Columbia and California.  In their initial 
investigation,65 they isolated (2.11) and established the relative configuration by X-ray 
analysis and the absolute configuration through hydrolysis of 2.11 to yield the known synthetic 
carboxylic acid (2.12).67 Gustafson et al.66 later reported the isolation of the related 
monoacetates, (2.13 and 2.14). Compound 2.11 has also been isolated from A. odhneri,66 
while 2.11, 2.13 and 2.14 have been isolated from A. tuberculata.68 
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Interestingly, 2.2 and 2.3, the diastereomers of 2.13 and 2.14, have also been isolated from 
the nudibranchs Anisodoris fontaini (initially incorrectly identified as Archidoris carvi)68;69 and 
Doris verrucosa.70 A. fontaini was also the source of a further five isocopalane diterpenes 
(2.15-2.19).70 The absolute configuration of these compounds, known as anisodorins 1-5, was 
established through the synthesis of the enantiomer of 2.15 (2.20) from optically active 
sclareol (2.21).69 Synthetic 2.20 had an opposite CD curve (details not provided) and specific 
rotation to 2.15, confirming that anisodorins 1-5 had an isocopalane skeleton. The absolute 
configuration of 2.19 was later conclusively provided by the synthesis of its enantiomer from 
2.21.71 
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2.18 = Ac; R2 = H
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OAc
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In addition to 2.2 and 2.3, the Mediterranean nudibranch, Doris verrucosa,70 also afforded 
verrucosin A (2.22) and verrucosin B (2.23).72 Cimino et al.72 had erroneously assigned 
verrucosins A and B to the (rearranged) ent-isocopalane series. This error was subsequently 
corrected by the same research group once the configuration at C-2' was unambiguously 
determined to be S by chemical methods.70  The method (Scheme 2.1) involved the initial 
formation of an acetonide (2.24) from the acylglycerol (2.25), reduction and urethane 
formation (2.26). The configuration of 2.26 was determined from HPLC where the retention 
time of 2.26 was compared with the retention times of standard compounds with known 
absolute configuration.70 
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Scheme 2.1 The method used to prepare compound 2.26.70 Reagents and conditions: (a) 
2,2-dimethoxypropane, p-TsOH, RT, 18 h; (b) (i) LAH, THF, ∆, 3.5 h, (ii) in situ treatment with 
(R)-(-)-1-(1-napthyl)ethyl isocyanate. 
 
Verrucosins A and B are unusual in that the C-20 methyl moiety has migrated from C-10 to C-
9 and they have a ∆5 olefin previously not encountered in this diterpene series. Additional 
isocopalane diterpenes isolated from D. verrucosa included (2.27-2.30)70 and the rearranged 
isocopalane diterpenes (2.31)70 and (2.32 and 2.33)72 Compounds 2.29 and 2.30 are the only 
chlorinated isocopalane diterpenes reported in the chemical literature. Diterpene 2.31 is 
unusual in that it is the product of two methyl migrations (C-20 from C-10 to C-9 and C-18 
from C-4 to C-5) and is also the only rearranged isocopalane possessing a ∆4 olefin.  
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Of the non-isocopalane metabolites isolated from D. verrucosa, (2.34) is the most significant, 
as it appears to be the biosynthetic precursor to all the verrucosins.  The absolute 
configuration at C-2' of 2.34 was proven synthetically70 and consequently allowed the 
researchers to make use of biogenetic considerations when proposing the absolute 
configuration of the verrucosins.70   
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Although all the acylglyceride isocopalane and ent-isocopalane diterpenes discussed thus far 
have been linked to their glycerol substituents through esterification at C-1', austrodorins A 
and B (2.35 and 2.36), isolated from Austrodoris kerguelenensis, collected near the Shetland 
Islands, Antarctica, are exceptions to this rule and are 2'-monoglyceryl esters.73 Austrodorins 
A and B have additional oxidation at C-18 and at either C-2 or C-3 respectively and were 
assigned to the isocopalane diterpene series by comparison of CD data with those of related 
isocopalane diterpenes. 
 
2.2.2 Isocopalanes and ent-isocopalanes from marine sponges 
 
Cimino et al.74 isolated three new ent-isocopalanes (2.37-2.39) from Spongia officianalis. 
These metabolites were assigned to the ent-isocopalane series after reduction of 2.37 yielded 
(2.40) with known absolute configuration.67  Further confirmation of the absolute configuration 
of 2.37 and 2.38 was provided by the semi-synthesis of these compounds from copalic acid.75 
The X-ray structure of 2.37 has also subsequently been published.76 
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Six ent-isocopalane diterpenoids, the new saponified analogue of 2.39, (2.41) and new 
metabolites (2.42 and 2.43) plus three known diterpenes, 2.37-2.39, were isolated from the 
Mediterranean sponge, S. zimocca.77 Comparison of the CD spectra of 2.38, 2.39 and 2.42 
with that of polygodial (2.44) confirmed the absolute stereochemistry of 2.37-2.39, 2.41 and 
2.42. Surprisingly, the relative stereochemistry proposed for 2.43 was based solely on 2.43 
having a similar C-7 13C NMR chemical shift to 2.39. No explanation as to the significance of 
this particular single shift to the assignment of the relative stereochemistry of 2.43 was 
provided. 
 
H
CHO
2.42
H
O OAc
OAc
OAc
OAc
OAc
2.442.43
OAc
7
 
 
Mycgranol (2.45) isolated from the Kenyan sponge Mycale aff. graveleyi by Rudi et al.32 is the 
only example of an isocopalane diterpene isolated from a marine sponge. The relative 
configuration of this compound was determined from ROESY data, while the absolute 
configuration was established from the Cotton effect observed in the CD spectrum of 2.45, in 
which an S configuration at C-1 was implied from application of the octant rule to this 
compound.78  
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The most recent ent-isocopalane diterpenes to have been isolated from sponges are 
coelodiol (1.37) and coeloic acid (2.46) from the Indonesian sponge Coelocarteria cfr. 
singaporensis.59 Coelodiol shows the same oxygenation pattern at C-1 and C-2 as previously 
noted in 2.45 but with the opposite configuration at C-1.  Of further interest is that 2.46 is the 
first reported diterpene with a seco-norisocopalane type skeleton, in which oxidative cleavage 
of the C-1-C-2 bond in the ent-isocopalane skeleton has occurred.  In order to determine the 
absolute configuration of 1.37, the 1,2-dibenzoate derivative of the compound was prepared 
and the non-empirical exciton chirality CD method applied.79 The negative sign of the Cotton 
effect at 236 nm was linked to the chirality at C-1 and C-2.59 Compound 1.37 was accordingly 
assigned to the ent-isocopalane series, which is commonly found in sponges (and has 
recently been isolated from the nudibranch Hexabranchus sanguineus).58  Although a paucity 
of 2.46 precluded the use of the exciton chirality effect to determine the absolute configuration 
of this compound, biogenetic arguments suggested that 2.46 also belonged to the ent-
isocopalane series. 
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A further ent-norisocopalane (2.47) was isolated from the Micronesian sponge, Coscinoderma 
mathewsi in addition to four spongian metabolites.80  The absolute configuration for 2.47 was 
based on the co-occurrence of this compound with related spongian diterpenes of known 
absolute configuration.  
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2.3 Selected syntheses of isocopalane and ent-isocopalane diterpenes 
 
A number of different synthetic routes have been used to synthesize isocopalane and ent-
isocopalane diterpenes.e.g.60;61;63;64;70;75;81-83 As mentioned previously, the first synthesis of a 
naturally occurring isocopalane was by Imamura and Rúveda.60 Other syntheses include that 
of Herz and Prasad81 who synthesized ent-isocopalane compounds for use as standards to 
evaluate the presence of these compounds in crude oils.  Although isocopalane-like 
compounds are routinely found in sediments and crude oilse.g.84-86 they are thought to be 
either degradation products of naturally occurring resins or generated from kerogens.85 
Interestingly, the proportions of these tricyclic diterpenes are indicative of the conditions (e.g. 
temperature, pressure) to which the sedimentary rocks have been subjected and as a 
consequence they are regularly used as biomarkers.81 
 
Since we report here the isolation of 2.2 and 2.3 from a Southern Ocean nudibranch and 
diterpene synthesis forms a major component of the research described in this thesis, we 
have decided to focus on the syntheses reported in the chemical literature for these two 
known compounds. Ungur et al.83 first attempted a synthesis of 2.2 and 2.3 from cyclization of 
geranylgeranoic acid, (2.46, Scheme 2.2). From this superacid mediated cyclization they 
obtained racemic mixture of acids (2.47 and 2.48), which they converted in situ to the 
corresponding acid chlorides (2.49 and 2.50). The crude reaction mixture of 2.49 and 2.50 
was then coupled with (–)-2,3-O-isopropylidene-sn-glycerol to yield a mixture of glycerides 
(2.51 and 2.52). Acid catalyzed hydrolysis of the acetonide protecting group afforded the diols 
(2.53) and 2.11. The method for the coupling and deprotection steps had already been well-
established.87 Unfortunately, it was found that 2.53 and 2.11 were chromatographically 
inseparable (no details of attempted chromatographies were provided)83 and an alternative 
route to 2.53 and 2.11 was required.  
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Scheme 2.2 Ungur et al.’s first attempt at the synthesis of acylglycerols 2.11 and 2.53 from 
geranylgeranoic acid, 2.46.83 Reagents and conditions: (a) FSO3H, i-PrNO2, -78 °C, 40 min, 
then Et3N; (b) (COCl)2, C6H6, RT, 2 h, then 45 °C, 0.5 h; (c) (–)-2,3- O-isopropylidene-sn-
glycerol, NaH, dry CH2Cl2, 0 °C, 20 min, then RT, 10 min h; (d) H 2SO4, MeOH, RT, 4 h. 
 
Since Ungur et al.83 had failed to separate 2.53 and 2.11, they required optically active 
precursors in their synthesis.  To this end, they synthesized 2.47 (Scheme 2.3) from naturally 
occurring isocopalic acid (2.54), isolated from Copaiva Balsam.70 Thereafter the same method 
as described in Scheme 2.2 (steps b-d) was followed to obtain (2.53).83 Once 2.53  had been 
obtained, they used the established protocol of Fontana et al.87 for the regioselective 
synthesis of diacylglycerides 2.2 and 2.3 (Scheme 2.4).  Compound 2.2 was readily 
synthesized by preferentially acetylating the terminal primary alcohol of 2.53 with N-
acetylimidazole, while 2.3 could be produced by selectively protecting the primary alcohol, 
acetylating the secondary alcohol and then removing the tertiary butyldimethylsilyl (TBDMS) 
protecting group.  
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Scheme 2.3 Synthesis of isocopalic acid, 2.47, from optically active 2.54.83  Reagents and 
conditions: (a) FSO3H, i-PrNO2, -78 °C, 0.7 h, then Et 3N. 
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Scheme 2.4 Method for the selective preparation of 2.2 and 2.3 from 2.53.83 Reagents and 
conditions: (a) N-acetylimidazole, DBU, C6H6, RT, 1 h; (b) TBDMSCl, dry pyridine, RT, 12 h; 
(c) Ac2O, dry pyridine, RT, 12 h; (d) PdCl2(MeCN)2, RT, 1h. 
 
2.4 Chemical ecology and bioactivity studies 
 
Of all the isocopalane-type diterpenes isolated, the acylglycerides from nudibranchs have 
been the most extensively studied.  While some nudibranchs sequester toxic compounds 
from their invertebrate prey (for example sponges or bryozoans),88 and store these toxic 
metabolites in their mantle tissue as a feeding deterrent to predators, others have been 
shown to synthesize their allomones de novo.89;90 The de novo biosynthesis of diterpene 
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diacylglycerides has been reviewed.89  The general consensus is that the known 1'- and 2'- 
acylglycerols discussed in this chapter are synthesized de novo by the nudibranchs from 
which they have been isolated.65;66;69;70;89;90   
 
In common with a general trend observed in diterpene acylglycerides,17 many isocopalane 
acylglycerides (2.2-2.3, 2.13-2.14, 2.22-2.23, 2.27, 2.29-2.30 and 2.32) have ichthyotoxic 
properties.4;66;68;72 The first report that isocopalane acylglycerols were toxic to fish was 
published by Cimino et al.72 who reported that 2.22 and 2.23 were toxic to the mosquito fish 
(Gambusia affinis) at concentrations between 1.0 and 0.1 µg/mL respectively. Metabolites 
2.13 and 2.14, amongst the earliest isocopalanes isolated, were also found to be toxic to G. 
affinis at similar concentrations. Many of the verrucosins have been screened in a Hydra 
tentacle regeneration assay and have been shown to possess protein kinase C (PKC) 
stimulatory effects.4;70;91 
 
Of all the isocopalanes isolated from sponges, only coelodiol and coeloic acid have any 
reported biological activity.59 Both these compounds, 1.35 and 2.44, were assayed against 
the MKN-45 cell line (human gastric adenocarcinoma) and were found to have moderate in 
vivo cell growth inhibition properties (20 µg/mL and 40 µg/mL) respectively.59   
 
2.5 Known isocopalane diterpenes from an unidentified sub-Antarctic nudibranch 
 
As part of an ongoing interdepartmental collaboration between the Southern Oceans 
Research Group and the Marine Natural Products Research Group at Rhodes University, we 
were fortunate enough to participate in the 2005 Marion Island re-supply expedition on board 
the SA Agulhas in April 2005 (Figure 2.1).  The primary reason for this voyage was to 
transport a relief team of scientists to Marion Island, situated at 46°52'34" S, 37°51'32" E in 
the Southern Ocean (Figure 2.2), where South Africa maintains a base for meteorological and 
ecological research.  During the re-supply of the South African base on Marion Island, the SA 
Agulhas was used for oceanographic research and we were permitted to dredge around the 
islands. Our interest in dredging around Marion Island lay in the fact that this island lies on the 
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border of the Polar Antarctic Convergence Zone and no marine natural product studies had 
previously been carried out around this island.  Although we were specifically targeting 
sponge material as part of an ongoing anti-oesophageal cancer study, we were gratified to 
collect one large pale yellow nudibranch (Figure 2.1) from a dredge at a depth of ca. 115 m 
(Figure 2.3). The specimen was immediately frozen and stored at -20 °C until it could be 
extracted with acetone.  The specimen was subsequently steeped in acetone for a period of 
four months, sonicated and the solvent removed, before again being steeped in acetone for a 
further week.  The two acetone extracts were then combined and adsorbed onto a column of 
polystyrene-divinylbenzene stationary phase (HP-20), manufactured by Diaion and supplied 
by Supelco.  
 
 
 
 
Figure 2.1 The SA Agulhas under anchor off the coast of Marion Island (top) and the 
unidentified nudibranch collected off the Marion Island coast (bottom). 
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Figure 2.2  The position of Marion Island in the Southern Ocean. 
 
 
 
Figure 2.3  Collection site for the unidentified Marion Island nudibranch. 
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HP-20 chromatography is a reversed phase technique, in which the compounds being 
separated from one other are first adsorbed onto a polystyrene-divinylbenzene stationary 
phase before being sequentially stripped from the column with eluting solvents of decreasing 
polarity.92 As a general rule, loading of an HP-20 column should not exceed 25 mg of crude 
extract per mL of HP-20 resin.92  For our purposes, the marine organisms and terrestrial plant 
material (See Chapter Four) investigated were extracted with a water-miscible solvent (we 
used acetone for extraction and elution purposes in the research described in this thesis but 
methanol may also be used).   The non-polar organic metabolites in the acetone extract were 
adsorbed onto the HP-20 resin beads by passing it through the column.  The eluent was 
collected and diluted to approximately 50% of the original acetone concentration with water 
before being passed through the column a second time. Aqueous dilution of the acetone 
eluent facilitated the adsorption of semi-polar and polar organic metabolites onto the HP-20 
beads.92  This procedure was repeated until the final concentration of the acetone in the 
eluent passing through the column was deemed to be approximately 12.5%. At each stage, 
care was taken that no precipitate formed in the solution and if precipitation occurred, acetone 
would be added until the precipitate re-dissolved and this extract would then be passed 
through the column before continuing with the dilution as described above.  Once the extract 
had reached a final concentration of 12.5% acetone and had been passed through the 
column, the HP-20 was washed with three column volumes of water to remove any salts 
remaining on the column and was then eluted with aliquots of aqueous acetone of decreasing 
polarity, beginning with 20% aqueous acetone and ending with 100% acetone, thus affording 
crude fractionation of the original acetone extract.92 Details of the concentration of the eluting 
solvents used in all extractions are clearly indicated in the isolation scheme presented in this 
chapter (Scheme 2.5).  Generally, any water-containing fractions once collected were diluted 
to about 30% of their original concentration with water and respectively passed through a 
second, smaller, HP-20 column to be re-adsorbed.92  Once loaded, the second column was 
stripped with 100% acetone, thus avoiding the difficulty of in vacuo removal of an aqueous 
acetone solvent mixture using a rotary evaporator.  
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As the isolation procedures used in this thesis are described here for the first time, more 
detail will be presented.  After stripping the HP-20 column sequentially with 20%, 40%, 60% 
and 80% aqueous acetone and, finally, with 100% acetone, the 1H NMR spectra of each of 
these fractions were scrutinized for methyl singlets in the range 0.7-2.2 ppm.  Of these five 
fractions, only the 80% aqueous acetone and 100% acetone fractions showed the methyl 
NMR resonances characteristic of diterpenes. These fractions were consequentially loaded 
onto a Diol column (transferred in 5% ethyl acetate in hexane) and were eluted with the eight 
increasingly polar aqueous acetone solvent combinations as indicated by Scheme 2.5.  
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Scheme 2.5 Isolation scheme of compounds 2.2, 2.3 and 2.1 from an acetone extract of the 
nudibranch (SAF05-018). 
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Diol is a derivatised silica based stationary phase that is suitable for elution with both polar 
and non-polar solvents. Dipole-dipole interactions between the solute and stationary phase in 
Diol chromatography are reduced (leading to fewer irreversible bindings between compounds 
and the stationary phase)93 when compared with ordinary silica stationary phase making Diol 
superior to silica for many natural product isolations.  The 1H NMR spectra of each of the Diol 
chromatography fractions were analyzed again and two fractions, both originally from the 80% 
aqueous acetone fraction, 328-A (5% ethyl acetate, 95% hexane fraction) and 328-B (10% 
ethyl acetate, 90% hexane fraction) contained methyl singlet resonances characteristic of 
diterpenoid metabolites.  Fraction 328-A was then subjected to normal phased semi-
preparative HPLC (25% ethyl acetate, 75% hexane).  Of the eight fractions collected, 329-D 
(19 mg, [α]D = +10) and 329-F (10 mg, [α]D = +21) were pure compounds and standard 1D 
and 2D data sets of each of these compounds were obtained. Through analysis of the 1H and 
13C NMR spectra it was immediately apparent that the two isolates were closely related C-25 
compounds, each containing two acetyl functionalities. This information, coupled with the 
presence of four methyl singlets and characteristic oxymethine and oxymethylene glycerides 
resonances (δH 4.23-4.35) allowed us to conclude that the compounds were either the 
isocopalane glycerides 2.2 and 2.3 or the ent-isocopalanes 2.13 and 2.14.  Since the 1H NMR 
data for diastereomers 2.3 and 2.14 and both 1H and 13C NMR data for diastereomers 2.13 
and 2.2 were available,68 we were able to compare our NMR chemical shift and multiplicity 
data directly with the published data (Table 2.1 and Table 2.2) but were unable to draw any 
conclusions from the NMR data as to which enantiomeric series 329-D and 329-F belonged. 
Since only the S configuration at C-2' in the glyceryl side-chain has been found in marine 
acylglyceride diterpenes (reports of acylglycerols with an R configuration at C-2' have been 
erroneous),2;4;47 application of the modified Mosher’s method to determine the configuration at 
C-2' was not deemed necessary. 
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Table 2.1  1H and 13C NMR data for compounds 2.268, 2.1368 and 329-D.  
  
2.2† 
 
 2.13†  329-D‡ 
 
Position 
δC 
(mult.) 
 
δH
§
 
 
 
δC 
(mult.) 
 
δH
§
 
 
 
δC 
(mult.) 
 
δH  
(int.,mult., J/ Hz) 
 
1 39.9 (t) 0.80 
1.62 
 39.8 (t) 0.80 
1.61 
 39.9 (t) 0.79 (1H, m) 
1.62 (1H, m) 
2 18.6 (t) 1.38 
1.57 
 18.6 (t) 1.38 
1.58 
 18.6 (t) 1.36 (1H, m) 
1.57 (1H, m) 
3 41.8 (t) 1.14 
1.38 
 41.8 (t) 1.14 
1.38 
 41.8 (t) 1.11 (1H, m) 
1.36 (1H, m) 
4 33.0 (s) -  33.1 (s) -  33.2 (s) - 
5 56.4 (d) 0.85  56.4 (d) 0.84  56.4 (d) 0.83 (1H, m) 
6 18.5 (t) 1.38 
1.57 
 18.4 (t) 1.38 
1.58 
 18.5 (t) 1.35 (1H, m) 
1.57 (1H, m) 
7 41.8 (t) 1.38 
1.70 
 41.8 (t) 1.38 
1.70 
 41.8 (t) 1.36 (1H, m) 
1.70 (1H, m) 
8 37.5 (s) -  37.4 (s) -  37.4 (s) - 
9 54.2 (d) 1.16  54.2 (d) 1.16  54.3 (d) 1.14 (1H, dd,  
11.1, 6.0) 
10 36.5 (s) -  36.6 (s) -  36.6 (s) - 
11 22.7 (t) 1.95  22.6 (t) 1.95  22.7 (t) 1.94 (2H, m) 
12 124.4 (d) 5.53  124.3 (d) 5.53  124.3 (d) 5.51 (1H, m) 
13 128.5 (s) -  128.5 (s) -  128.5 (s) - 
14 62.5 (d) 2.96  62.5 (d) 2.96  62.5 (d) 2.95 (1H, m) 
15 ┴ -  173.0 -  173.0 (s) - 
16 21.2 (q) 1.60  21.2 (q) 1.60  21.2 (q) 1.59 (3H, br s) 
17 15.6 (q) 0.95  15.6 (q) 0.94  15.6 (q) 0.94 (3H, s) 
18 21.6 (q) 0.81  21.6 (q) 0.81  21.7 (q) 0.80 (3H, s) 
19 33.4 (q) 0.86  33.4 (q) 0.86  33.4 (q) 0.85 (3H, s) 
20 15.7 (q) 0.90  15.7 (q) 0.90  15.7 (q) 0.90 (3H, s) 
21 64.9 (t) 4.12 
4.24 
 64.8 (t) 4.12 
4.22 
 64.9 (t) 4.14 (2H, m) 
22 68.4 (d) 4.12  68.4 (d) 4.10  68.4 (d) 4.08 (1H, m) 
23 65.3 (t) 4.12 
4.24 
 65.3 (t) 4.12 
4.22 
 65.3 (t) 4.11 (1H, m) 
4.19 (1H, m) 
OAc ┴ -  ┴ -  171.0 (s) - 
 20.8 (q) 2.11  20.8 (q) 2.11  20.8 (q) 2.09 (3H, s) 
 
† 1H NMR (500 MHz, CDCl3, referenced to CHCl3 at 7.26 ppm); 13C NMR (125 MHz, CDCl3, 
referenced to CDCl3 at 77.0 ppm). ‡ 1H NMR (400 MHz, CDCl3, referenced to CHCl3 at 7.25 
ppm); 13C NMR (100 MHz, CDCl3, referenced to CDCl3 at 77.0 ppm); § Multiplicities not 
reported; ┴ Not detected. 
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Table 2.2  1H NMR data for compounds 2.368 and 2.1468 and 1H and 13C NMR data for 329-F. 
  
2.3† 
 
 2.14†  329-F‡ 
Position δH§  δH§  
 
δC 
(mult.) 
 
δH 
(int., mult., J/ Hz) 
1 0.80 
1.62 
 0.80 
1.61 
 39.9 (t) 0.80 (1H, m) 
1.62 (1H, m) 
2 1.38 
1.57 
 1.38 
1.58 
 18.7 (t) 1.37 (1H, m) 
1.55 (1H, m) 
3 1.13 
1.38 
 1.14 
1.38 
 41.9 (t) 1.13 (1H, m) 
1.37 (1H, m) 
4 -  -  33.2 (s) - 
5 0.85  0.84  56.4 (d) 0.84 (1H, dd, 11.1, 6.0) 
6 1.38 
1.57 
 1.38 
1.58 
 18.5 (t) 1.37 (1H, m) 
1.55 (1H, m) 
7 1.38 
1.68 
 1.38 
1.68 
 41.8 (t) 1.37 (1H, m) 
1.69 (1H, m) 
8 -  -  37.4 (s) - 
9 1.15  1.15  54.3 (d) 1.16 (1H, m) 
10 -  -  36.6 (s) - 
11 1.95  1.95  22.7 (t) 1.94 (2H, m) 
12 5.52  5.53  124.3 (d) 5.51 (1H, m) 
13 -  -  128.5 (s) - 
14 2.94  2.95  62.5 (d) 2.93 (1H, m) 
15 -  -  172.8 (s) - 
16 1.60  1.60  21.2 (q) 1.59 (3H, br s) 
17 0.93  0.93  15.6 (q) 0.93 (3H, s) 
18 0.81  0.83  21.7 (q) 0.81 (3H, s) 
19 0.86  0.86  33.4 (q) 0.85 (3H, s) 
20 0.90  0.90  15.7 (q) 0.90 (3H, s) 
21 4.23 
4.35 
 4.27 
4.34 
 61.7 (t) 4.21 (dd, 12.0, 5.8) 
4.34 (1H, dd, 12.0, 4.4) 
22 5.10  5.07  72.4 (d) 5.08 (1H, apparent quintet, J = 5.1 Hz) 
23 3.76  3.76  61.8 (t) 3.76 (2H, m) 
OAc -  -  170.6 (s) - 
 2.10  2.11  21.0 (q) 2.09 (3H, s) 
 
†
 
1H NMR (500 MHz, CDCl3, referenced to CHCl3 at 7.26 ppm); ‡ 1H NMR (400 MHz, CDCl3, 
referenced to CHCl3 at 7.25 ppm); 13C NMR (100 MHz, CDCl3, referenced to CDCl3 at 77.0 
ppm); § Multiplicities not reported.  
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Table 2.3  Specific rotations reported for previously isolated and synthesized 2.13, 2.14, 2.2 
and 2.3 as well as 329-D and 329-F. 
 Source 
Compound Archidoris 
montereyensis 
Anisodoris 
fontaini 
Synthesis Unidentified 
nudibranch 
329-D - -  +10 
329-F - -  +21 
2.2 - +21.968 +13.983 - 
2.3 - +66.968 +10.287 - 
2.13 -53.766 - -47.783 - 
2.14 -33.066 - -41.883 - 
 
Zubia et al.68 had ultimately made their determinations of whether their compounds were 
isocopalanes or ent-isocopalanes by comparison of the sign of the Cotton effect at 214 nm 
obtained from the circular dichroism spectra of 2.2, 2.3, 2.13 and 2.14. Since circular 
dichroism (CD) facilities were unavailable in South Africa at the time this research was carried 
out, our first recourse to confirm the absolute configuration of the metabolites we had isolated 
was by comparison of the specific rotations of our compounds with those in the literature.  A 
summary of comparative specific rotation data is given in Table 2.3. Fontana et al.87 attributed 
the variation between the magnitude of the specific rotation of the synthetically produced 2.3 
and the equivalent metabolite isolated from a natural source to the difficulties in accurately 
determining specific rotations of diminishing amounts (<3 mg) of a marine natural product. A 
general trend can nonetheless be inferred from the data presented in Table 2.3: the sign of 
the specific rotations of compounds 2.13 and 2.14 is always negative, while the sign of the 
specific rotation of 2.2 and 2.3 is always positive.
 
 We thus tentatively proposed that 329-D 
and 329-F belonged to the isocopalane series based on the positive sign of their specific 
rotations. Fortuitously, we were subsequently able to access CD facilities in the United States, 
and although we found that both 329-D and 329-F were unstable, we were able to reisolate a 
small amount of 329-D, sufficient to acquire the CD spectrum of this compound (Figure 2.4), 
from the original extract of SAF05-018. The positive CD curve at 216 nm was in accordance 
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with that reported for 2.2 and opposite to that recorded for 2.13, and 329-D (and from 
biogenetic considerations 329-F) were thus allocated to the isocopalane series. 
 
 
 
 
 
 
 
Figure  2.4 The CD curves of 2.2 (left),68 2.13 (middle)68 and 329-D (=2.2, right).  
 
2.6 Identification of a new isocopalane diterpene from an unidentified sub-Antarctic 
nudibranch 
 
A second diterpene-containing fraction from the Diol column (10% ethyl acetate, 90% hexane 
fraction) was subjected to normal phase semi-preparative HPLC (35% ethyl acetate, 65% 
hexane) and yielded two fractions of interest.  The first of these was identified to be identical 
to 329-D, now determined to be 2.2, but the second, minor fraction (2.1, 3 mg, [α]D = +3) 
appeared to contain a new diterpene from analysis of its 600 MHz 1H NMR spectrum.   
 
H
OAc
OH
2.1
13
5
8
12
1517
1620
OAcC
 
 
The molecular formula of 2.1 (C24H40O5) was confirmed from HRFABMS data and implied five 
degrees of unsaturation.  Analysis of the 13C NMR data revealed the presence of two acetyl 
carbonyls (δC 169.3 and δC 169.7), which accounted for two of the degrees of unsaturation. 
Comparison of the 1H and 13C NMR data of 2.1 with those of 2.2 and 2.3 revealed that 2.1 
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shared the same tricyclic skeleton as the former two compounds, which in turn accounted for 
the remaining three degrees of unsaturation. Further comparison of the NMR data for 2.1 with 
those of 2.2 and 2.3 indicated that the differences between 2.1 and 2.2 and 2.3 were limited 
to changes in the substitution pattern around ring C.  The chemical shift assignments for rings 
A and B were thus initially made by analogy with those established for 2.2 and 2.3, and 
further supported by extensive gCOSY and gHMBC correlations (Table 2.4). The most 
obvious difference in the NMR spectra of 2.1 when compared with those of 2.2 and 2.3 was 
the absence of the oxymethine and oxymethylene glyceride signals in addition to the loss of 
the ∆12 olefinic resonances in the 1H and 13C NMR spectra of the former compound. A three 
bond gHMBC correlation from H3-17 (δH 1.41) to a methine carbon (δC 58.0) enabled 
assignment of the methine carbon as C-14 and hence the assignment of H-14 (δH 1.44) 
followed from gHSQC data.  A gCOSY correlation between H-14 and two deshielded 
oxymethylene resonances (δH 4.15 and 4.27) allowed assignment of the oxymethylene carbon 
(δC 62.8) as C-15 from gHSQC data. Further confirmation of the assignment of C-15 was 
provided by three bond gHMBC correlations (Figure 2.5) between the oxymethylene protons 
H-15a (δH 4.15) and H-15b (δH 4.27) and both C-8 (δC 38.7) and an acetyl carbonyl (δC 169.7).  
A further three bond gHMBC correlation from the two C-15 oxymethylene proton resonances 
allowed placement of the deshielded quaternary carbon, C-13 (δC 74.6), the chemical shift of 
which was characteristic of an oxygenated quaternary carbon.  A two bond gHMBC 
correlation from H3-16 (δH 1.12 ppm) to C-13 confirmed the presence of the methyl group at 
this position, while a further three bond correlation from these methyl protons to C-14 further 
confirmed this assignment. An additional gHMBC correlation from H3-16 to an oxymethine 
carbon (δC 78.3) led to the assignment of this carbon as C-12. The presence of the acetyl 
functionality at C-12 was provided by a three bond gHMBC correlation from H-12 (δH 5.01) to 
the remaining acetate carbonyl (δC 169.3).   
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Table 2.4 1H (600 MHz, C6D6), 13C (150 MHz, C6D6) and 2D NMR data obtained for 2.1. 
Position δC (mult.) 
δH  
(int., mult., J/Hz) 
 
gHMBC 
 
 
gCOSY 
 
1a 
1b 
40.5 (t) 0.69 (1H, m) 
1.57 (1H, m)  
20 
 
1b, 2 
1a, 2 
2  18.9 (t) 1.32  (2H, m) - 1a, 1b, 3a  
3a 
3b 
42.3 (t)  1.09  (1H, m) 
1.34 (1H, m) 
2, 4 
-  
2, 3b 
3a 
4  33.5 (s)  - - - 
5  57.2 (d)  0.73 (1H, dd, 12.0, 2.2) 6, 7, 9, 10, 20, 18, 19  6a, 6b  
6a 
6b  
18.7 (t) 1.48 (1H, m) 
1.50 (1H, m) 
8, 7, 10, 17 
-  
5, 7a, 7b 
5, 7a, 7b  
7a 
7b  
39.1 (t) 1.30 (1H, m) 
1.53 (1H, m) 
17  
- 
6 
6  
8  38.7 (s)  - - - 
9  52.6 (d)  1.35 (1H, m)  8, 10, 11, 12, 20, 17  11  
10  38.0 (s)  - - - 
11β  
 
11α 
23.7 (t)  1.76 (1H, m)  
 
1.80 (1H, m) 
8, 9, 12, 13,  
14, 12-OAc 
 8, 10, 11, 12, 20, 17 
9, 12  
 
9, 12  
12  78.3 (d)  5.01(1H, dd, 11.2, 5.0) 11, 12-OAc  11a, 11b  
13  74.6 (s)  - - - 
14  58.0 (d)  1.44 (1H, m) 8, 9, 12, 13, 15, 20  15a, 15b  
15a 
15b  
62.8 (t)  4.15 (1H, dd, 12.8, 3.8) 
4.27 (1H, dd, 12.8, 2.5) 
8, 13, 14, 15-OAc 
8, 13, 14, 15-OAc 
14  
14  
16  27.2 (q)  1.12 (s, 3H)   12, 13, 14  - 
17  26.1 (q)  1.41 (s, 3H) 8, 9, 14  - 
18  21.7 (q)  0.80 (s, 3H) 3, 4, 5, 19  - 
19  33.6 (q)  0.83 (s, 3H) 3, 4, 5, 18  - 
20  16.6 (q)  0.82 (s, 3H) 1,  9, 10  - 
12-OAc 169.3 (s)  - - - 
  20.6 (q)  1.65 (s, 3H) 12-OAc - 
15-OAc   169.7 (s)  - - - 
 20.6 (q)  1.72 (s, 3H) 15-OAc - 
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Figure 2.5  Downfield section (F1 = δC 10 – 180, F2 = δH 3.8 – 5.4) of the gHMBC spectrum 
(C6D6, 600 MHz) of 2.1.   
  
 
 
C-11 
12-OAc 
C-14 
C-13 
15-OAc 
C-8 
H-12 H-15b H-15a 
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The relative configuration of 2.1 was determined from analysis of NOE data. Figure 2.6 
indicates the key NOESY correlations used to determine the relative configuration of the 
molecule, while Figure 2.7 shows a section of the NOESY spectrum highlighting the 
correlations used to establish the relative configuration at C-12 and C-13 of 2.1. 
 
Vicinal coupling constants and NOESY correlations were used to assign the relative 
configuration of 2.1. Of most importance were the NOESY correlations between H-5 (δH 0.73) 
and H-9 (δH 1.35), which in turn correlated to H-11β (δH 1.76).  H-9 also correlated to both H-
12 (δH 5.01) and H-14 (δH 1.44) while H-12 correlated with H-14 and H3-16 (δH 1.12) implying 
a cis relationship between these three axial methine protons and Me-16. Further confirmation 
of the β-axial orientation of H-12 was derived from the large (axial-axial coupling to H-11α) 
and small (axial-equatorial coupling to H-11β) coupling values observed for H-12. A zero 
quantum coherence correlation between both H-11β (δH 1.76) and H-11α (δH 1.80) and H-12, 
was also present. These gCOSY-like peaks occasionally appear in NOESY spectra between 
J-coupled spin systems in small to mid-sized molecules.94  The substituents at C-12 and C-14 
were accordingly placed in α-equatorial positions while the hydroxyl functionality at C-13 
could be assigned an α-axial position. An NOE correlation between axial H-11α (δH 1.80) and 
Me-17 (δH 1.41) and Me-20 (δH 0.82) in turn placed these methyl moieties in α-axial positions. 
Since 2.2 and 2.3 were isolated from the same organism they were determined to have an 
isocopalane tricyclic skeleton from CD data and biogenetic considerations. We have thus 
opted to show 2.1 as belonging to the same enantiomeric series as 2.2 and 2.3. 
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Figure 2.6  Key NOESY correlations in compound 2.1. 
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Figure 2.7  A section (F1 = δH 4.8 – 5.3, F2 = δH = 1.0 –  2.0) of the NOESY spectrum (C6D6, 
600 MHz)
 
of 2.1. Red contours indicate positive peaks, blue contours indicate negative peaks. 
The accompanying figure shows the NOESY correlations to H-12 indicated in the spectrum.† 
Zero quantum coherences.94  
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2.7 Conclusions 
 
Three rare isocopalane diterpenes, 2.2, 2.3 and 2.1 were isolated from an unidentified sub-
Antarctic nudibranch.  The structures of the major components of the acetone extract of the 
nudibranch, 2.2 and 2.3, were determined by comparison of 1H and 13C NMR data with those 
of known compounds. The absolute configuration of 2.2 was determined from the sign of the 
Cotton effect at 216 nm in comparison with the CD curves for known compounds 2.13 and 
2.2, allowing us to conclude that 2.2 was an isocopalane diterpene and 2.3 was hence 
assigned to the same series from biogenetic considerations.  The minor component of the 
acetone extract of the nudibranch, 2.1, was a new compound and was fully characterized 
spectroscopically.  The relative configuration of 2.1 was determined from NOESY data and 
this compound was also proposed to have an isocopalane skeleton for biogenetic reasons.   
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Chapter Three 
Labdane Diterpenes and Sterols from the South African 
Marine Pulmonate Mollusc, Trimusculus costatus  
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3.1 Introduction 
 
Trimusculus costatus is an endemic, South African, intertidal, shell-less mollusc and the only 
known representative of the genus in Africa. Prompted by the successful reinvestigation of 
other Trimusculus species,95-97 a reinvestigation of the secondary metabolites of T. costatus is 
presented in this chapter. The isolation, structure elucidation and antiproliferativer activity of 
two known 6β,7α-diacetoxylabda-8,13E-dien-15-ol (3.1) and 2α,6β,7α-triacetoxylabda-8,13E-
dien-15-ol (3.2) and new 6β,7α,15-triacetoxylabda-8,13E-diene (3.3) labdane diterpenes, as 
well as new 3α,11-dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.4) and cholest-7-en-
3,5,7-triol (3.5) from T. costatus are described. The sterol, 3.5, has never previously been 
isolated from a natural source. The introduction to this chapter provides an historical 
perspective of the chemistry, ecology and bioactivity studies of Trimusculus metabolites. The 
chiral derivatization strategies adopted to determine the relative and absolute configurations 
of the diterpenes isolated from T. costatus are also discussed. 
R1
R2
OAc
OAc
3.1 ∆13 E  R1 = H; R2= CH2OH
3.2 ∆13 E  R1 = OAc; R2= CH2OH
3.3 ∆13 E  R1 = H; R2 = CH2OAc
3.6 ∆13 Z  R1 = H; R2 = CH2OAc
13
O
HO
HO
O
H
H
3.4
HO OH
OH
3.5
20
6
1819
1
16
11
17
10
4
13
21
6
18
19
1 15
11 22
20
3
26
25 27
89
13
21
6
18
19
1 15
11
20
3
26
25
27
8
 
Diterpene 3.3 was determined to be the geometric isomer of the known diterpene (3.6), 
isolated from the Chilean T. peruvianus. The formation of the camphanate ester of 3.2 using 
(-)-camphanic acid and subsequent crystallization of this ester enabled the determination of 
the absolute configuration of 3.2 by X-ray crystallography. The structures of the steroidal 
metabolites 3.4 and 3.5 were determined using standard spectroscopic techniques, and the 
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relative configuration of these compounds was determined, where possible, from NOESY 
data. This chapter concludes with a discussion of the cytotoxicity of compounds 3.1-3.4 to 
oesophageal cancer cells. 
    
3.1.1 Biology of Trimusculid molluscs 
 
Members of the mollusc family Trimusculidae enjoy a global distribution and are generally 
found in the intertidal zone of rocky shores. As an adaptation to their intertidal habitat, 
trimusculids lack gills, instead relying on a modified mantle cavity to act as a lung.98 They 
congregate in large colonies,98 often living so closely together that their shells, with 
characteristically serrated edges, interlock like the pieces of a jigsaw puzzle. Trimusculids are 
prolific where they occur and, where population densities are high, they are often found living 
in layers on top of one another. Since the limpets live in shady rocky overhangs, algal growth 
is slow, reducing the significance of algae as a primary food source, typically exploited by 
other intertidal limpets.11;98;99 Trimusculus species have, however, evolved a unique feeding 
method and use a mucous net, secreted by the mantle glands, to filter phytoplankton out of 
the water column.98  The mucous net and trapped particles are ingested once the oral lobes 
detect the presence of food in the mucous net.  A second form of mucous, distinct from that 
used for filter feeding has also been reported.10;11;99-101 This milky white mucous, produced by 
numerous subepithelial glands situated in the mantle and sides of the foot,98 is used as a 
chemical defence mechanism to deter predation and has developed as a direct consequence 
of the sessile, colonial lifestyle of these organisms.10;11;99-101 
 
3.1.2 The natural products chemistry of Trimusculus species 
 
Possibly prompted by Rice’s101 findings that the mucous secretions of T. reticulatus acted as 
a feeding deterrent for certain seastar species, Manker and Faulkner99 performed the first 
investigation of the chemistry of the metabolites secreted by these pulmonates. Starting with 
115 freeze-dried specimens of T. reticulatus, collected off the coast near San Diego, they 
were the first to isolate diterpene metabolites (3.7 and 3.8) from marine pulmonate molluscs.  
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The relative configuration of the B ring of 3.7 was determined through the reduction of 3.7 to 
the corresponding triol, followed by analysis of the J5,6 and J6,7 coupling constants. The E 
geometry of the ∆13 olefin in the alkenol side chain was presumably assigned from the 13C 
NMR chemical shift of methyl C-16 (δC 16.2) and methylene C-12 (δC 39.1) in both 3.7 and 
3.8. An E configuration in similar olefins requires δC ca. 16 and ca. 39,10;102 while a Z 
configuration requires δC ca. 24 and ca. 32).97;100 The relative configuration of the B ring in 3.8 
was assigned through comparison of the 1H and 13C NMR data of this compound with those of 
3.7, while the determination that H-2 was axial (from limited spectroscopic data) prompted the 
α-equatorial assignment of the acetyl functionality at C-2.  The relative configuration of 3.7, 
including the geometry of the exocyclic double bond was established via a synthesis of this 
compound by Gao et al.102 A recent stereoselective synthesis of 3.7 (from T. reticulatus) by 
Pathak et al.103 confirmed the absolute configuration of 3.7 and suggested that the 
metabolites secreted by Trimusculus species belong to the labdane, rather than the ent-
labdane series of diterpenes.  The respective syntheses of Gao and Pathak will be discussed 
later in this chapter. 
 
R1
R4
OR2
OR3
3.7 R1 = R3 = H; R2 = COCH2CH(CH3)2; R4 = CH2OH
3.8 R1= OAc; R2 = COCH2CH(CH3)2; R3 = Ac; R4 = CH2OH
3.9 R1 = H; R2 = Ac; R3 = COCH2CH(CH3)2; R4 = CO2H
3.10
AcO
AcO
OAc
HO OAc
20
21
18
19
3
1 10
12
15
16
7
1819
6
20
2
17
 
 
Manker and Faulkner11 returned to their investigations of T. reticulatus in 1996.  Although their 
investigation was largely of an ecological nature, they also isolated two new compounds, (3.9 
and 3.10), from another limpet, T. conica, collected in Anawhata Cove, North Island, New 
Zealand.  Compound 3.9 was closely related to the compounds previously isolated from T. 
reticulatus, differing only in the presence of a carboxylic acid moiety in the side chain.  
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Compound 3.10, however, was the first example of a steroidal metabolite isolated from 
Trimusculus.   
 
The second species to be investigated, T. peruvianus has to date provided the largest 
diversity of secondary metabolites. The first specimens of this latter species, collected in El 
Tabo, V region, Chile, afforded (3.11).104  San Martín et al.97 later reported the isolation of (3.6 
and 3.12-3.14) as well as a reisolation of 3.11.  Paradoxically, this time they assigned a Z 
geometry to the ∆13 olefin in 3.11, in addition to the new diterpenes, 3.6 and 3.12-3.14, 
suggesting a possible error in the second manuscript.97 The diterpenes in the subsequent 
manuscript are indicated to be 17-norlabdane diterpenes,97 but since 13C NMR shift details for 
methyl C-17 are provided, we attribute this to poor editing and have included the C-17 methyl 
functionality in the structures provided (vide infra). The comparison of our 13C NMR data for 
compounds 3.3 (isolation discussed later) and 3.2 with those reported for 3.6 has led us to 
conclude that 3.6 (and 3.12-3.14) do indeed have a ∆13 Z olefin geometry (C-12: δC 32.3; C-
16: δC 23.6),100 and thus Trimusculus produces both ∆13 geometric isomers. Our attempts at 
synthesizing similar Pleurobranchaea metabolites (Chapter Five) have revealed that 
isomerisation around the ∆13 olefin does not occur (when a hydroxyl moiety at C-15 is 
present) under the conditions regularly used to isolate these unsaturated compounds and 
thus this possibility can be disregarded.  
OR1
R2
3.6   ∆13 Z; R1 = R3 =  Ac; R2 = OAc
3.11 ∆13 E; R1 = Ac; R2 = OH; R3 = H
3.12 ∆13 Z; R1 = H; R2 = OAc; R3 = Ac
3.13 ∆13 Z; R1 = Ac; R2 = OAc; R3 = H
3.14 ∆13 Z; R1 = Ac; R2 = R3 = H
R1O
COOH
OR3
OR2
3.15 R1= R2 = R3 =  H
3.16 R1 = COCH2CH(CH3)2; R2= R3 = H
3.17 R1 = R3 = COCH2CH(CH3)2; R2 = H; 
3.18 R1 = R2 = COCH2CH(CH3)2; R3 = H
OR3
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Another investigation of T. peruvianus, collected off the Antofagasta Coast, III Region, Chile, 
led to the isolation of four new compounds (3.15-3.18),95 all of which possessed a carboxylic 
acid moiety at C-15, previously only found in 3.9, isolated from T. conica metabolites vide 
supra.
.
11
 
Of further interest was that 3.15-3.18 were all oxygenated at C-3 and C-19, an 
oxygenation pattern not seen in any of the diterpene metabolites isolated previously from this 
genus. Unlike the reported metabolites isolated previously from specimens of T. peruvianus,97 
only the more common ∆13 E geometry was found. The E configuration was confirmed by the 
upfield shift (δC 17.5) of C-16, which the authors attributed to the shielding effect resulting 
from the cisoid relationship with the carboxylic acid, and the downfield shift (δC 41.2) of C-
12.95 An NOE relationship between H-14 and H2-12 further corroborated this assignment. The 
axial orientation of the hydroxyl moiety of C-3 of 3.15 was made on the basis of the small 
coupling constants between H-3 and the vicinal protons of C-2. Base mediated hydrolysis of 
3.16-3.18 to afford 3.15 revealed that compounds 3.15-3.18 possessed the same relative 
configuration.   Furthermore, Díaz-Marrero et al. were able to determine the absolute 
configuration of the labdanes produced by Trimusculus through application of the modified 
Mosher’s method to compound 3.18. Interestingly, Díaz-Marrero et al. suggested that since 
the high degree of selectivity in oxidation sites was reminiscent of certain fungal modes of 
action on diterpene substrates, some symbiotic interaction between these phylletically distinct 
organisms might be plausible. 
 
 A subsequent publication from the same research group,96 described the isolation of two new 
steroids, unusually hydroxylated at C-18 (3.19 and 3.20), from the original collection that 
yielded 3.16-3.18. Apart from 3.10, no steroidal compounds had previously been isolated from 
Trimusculus. What was of further interest was that 3.20 had a ∆7-3α,5α,6β-triol substitution 
and unsaturation pattern, which, while unprecedented in marine steroidal metabolites,96 was 
common in, amongst others, basidiomycete fungi, again tentatively suggesting a relationship 
between Trimusculus and fungal symbionts. The relative configuration of both 3.19 and 3.20 
was determined from NOE data and comparative 13C NMR chemical shift data. 
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Gray et al.10;100 conducted the first examination of the secondary metabolites of the endemic 
T. costatus, collected off the coast at Cintsa, near East London, South Africa and isolated the 
diterpene metabolites 3.1 and 3.2. The 2α,6β,7α oxygenation pattern characteristic of 
Trimusculus diterpenes was established spectroscopically. Gray also attempted a synthesis 
of these compounds from a readily available diterpene precursor,100 aspects of which will be 
discussed in Chapter Four. 
 
Before continuing, it should be noted that in the papers published by Manker and 
Faulkner,11;99 Rovirosa et al.104 and San-Martín et al.97 the numbering of carbons 18-20 differs 
from the standard trends in the diterpene literature. In order to achieve consistency with the 
labdane diterpene numbering system used elsewhere in this thesis, we have adopted the 
numbering system of Gray et al.10;100 and Díaz-Marrero et al.95 as indicated in the structures 
(e.g. 3.1) at the beginning of this chapter. 
 
3.1.3 Ecological and bioactivity studies of Trimusculus metabolites 
 
The earliest studies of the defensive strategies of T. reticulatus were undertaken by Rice,101 
who found that the mucous secreted by these limpets stunned the feet of seastars, effectively 
reducing predation by these creatures.  Rice noted that this form of defence was ideally suited 
to sessile animals such as Trimusculus, living in densely packed colonies, since stunning the 
tube feet of their seastar predators greatly increased the amount of time taken for the seastar 
to feed, thus reducing their predatory efficiency.  
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The first ecological study undertaken using purified Trimusculus metabolites was performed 
by Manker and Faulkner,99 who were unable to determine whether either 3.7 or 3.8 deterred 
predation by seastars. They were, however, able to conclude that specimens of T. reticulatus 
taken from San Nicholas Island, Monterey, and San Diego showed no geographic variation in 
the diversity and relative quantities of metabolites secreted in the limpets’ mucous. Nearly a 
decade later, Manker and Faulkner returned to their ecological study, this time including 3.9 
and 3.10 in their investigations.11 They found that compounds 3.7 and 3.8 were localized in 
the mantle, foot and mucous of T. reticulatus, while 3.9 and 3.10 were evident in the mantle 
and foot tissue of T. conica (no mucous from these limpets was collected for testing). None of 
the compounds were found in the viscera of either species.  This finding supported the 
speculation that these metabolites were deployed externally and thus probably exhibited 
either interspecific anti-feedant or some unknown toxic effects. While they confirmed that the 
mucous from T. reticulatus was repugnant to the seastar Astrometis sp., they found that 
application of diol 3.7 alone did not elicit a response.  A paucity of 3.8 precluded testing to 
confirm whether the lack of a mucous carrier or a possible synergistic effect could be the 
cause of lack of response for 3.7.  Although pellets treated with 3.7 and 3.8 did not deter 
feeding by the rainbow tropical wrasse (Thallosoma lunare), living specimens of T. reticulatus, 
as well as the mucous from these limpets, were found to be toxic to the larvae of the 
tubeworm, Phragmatopoma californica. Compound 3.7 was found to cause 100% mortality of 
these larvae at concentrations greater than 100 µgmL-1, while compound 3.9 had no effect. 
The lack of toxicity of 3.9 to P. californica larvae is probably not unexpected as the source of 
this compound, T. conica, a native New Zealand species, would have co-evolved with 
different predators. 
 
Gray et al.10;100 used bioassay guided (Artemia salina assay) fractionation of T. costatus to 
isolate 3.1 and 3.2.  The difficulties described by Manker and Faulkner in performing 
ecologically significant assays using seastars coupled with a curiosity to determine why the 
Trimusculus metabolites apparently did not deter fish feeding prompted Gray et al.10;100 to 
investigate whether 3.1 and 3.2 were repellent to Pomadasys commersonni (spotted grunter), 
a South African generalist predatory fish. Grey et al. found that 3.1 and 3.2 deterred feeding 
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by this species at sub-naturally occurring levels.10;100 Although Gray did not perform any 
antifouling tests, his field observations of the extensive fouling of colonies of T. costatus in the 
South African intertidal zone led him to conclude that the compounds secreted did not have 
any significant antifouling activity. 
 
 
Unfortunately, no ecological studies have been performed with T. peruvianus.  However, 3.6 
and 3.11-3.14 were tested for antibacterial activity. Only 3.6 showed modest activity (100 
µgmL-1) against both Gram positive and gram negative bacteria.97 In later natural product 
investigations of T. peruvianus,95;96 3.17-3.20 were screened for activity against human colon 
carcinoma cell lines (H-119 and HT-29). Compounds 3.17, 3.18 and 3.20 showed moderate 
activity (IC50 of 12.5 µgmL-1), while 3.19 was significantly more cytotoxic (IC50 of 2.5 µgmL-1).  
Gray100 also screened 3.1 and 3.2 against four different cancer cell lines (LOX melanoma, 
OVCAR3 ovarian cancer, A549 non-small lung cancer and SNB19 CNS cancer) but found no 
significant activity (IC50 > 100 µgmL).   
 
3.1.4 Synthetic approaches to Trimusculus metabolites 
 
As mentioned previously, the first synthesis confirming the relative configurations of 3.7, 
originally isolated by Manker and Faulkner, 99 was performed by Gao et al.,102 in 22% overall 
yield (Scheme 3.1), nearly a decade after the initial isolation. Diol (3.21) was prepared from 
(±)-9-methoxycarbonyl-4,4,10-trimethyl-∆6-8-octalone (3.22) through a series of standard 
transformations. Routine selective protection of the primary alcohol moiety, followed by 
pyridinium chlorochromate (PCC) mediated rearrangement of the allylic tertiary alcohol 
introduced the desired enone functionality. After introducing the exocyclic olefin at C-9, the 
resultant ketone (3.23) was stereospecifically reduced with diisobutylaluminium hydride 
(DIBAH) to afford the desired 6β-hydroxyl epimer (3.24). Gao et al.102 utilized 1,4-addition to 
diene (3.25) in combination with the reduced steric hindrance of the α-face of this compound 
to effect stereospecific addition of the 7α-acetoxy group using N-bromosuccinimide (NBS) in 
acetic acid.  
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Scheme 3.1 Gao et al.’s synthesis of (±)-3.7.102 Reagents and conditions: (a) LAH, Et2O, 0°C, 
2.5 h; (b) BaMnO4, CH2Cl2, RT, 24 h; (c) MeLi, Et2O, -78°C, 3 h; (d) Ac 2O, pyridine, RT, 
DMAP, RT, 24 h; (e) PCC, CH2Cl2, RT, 3 h; (f) K2CO3, MeOH, RT, 5 h; (g) p-TsOH, C6H6, ∆, 6 
h; (h) DIBAH, CH2Cl2, -78°C, 3 h; (i) NBS (1 eq), AcOH, RT, 1 h; (j) K 2CO3, MeOH, RT, 2 h; 
(k) CH2=CHCH2MgBr, CuBr-SMe2 (cat), LiBr (cat), Et2O, -78°C, 2 h; (l) PdCl 2, CuCl, DMF-
H2O, O2, RT, 1 h; (m) TESCl, pyridine, 0°C - RT, 6 h; (n) (C2H5O)P(O)CH2CO2Et, NaH, THF, 
0°C-RT, 6 h; (o) DIBAH, CH 2Cl2, -78°C, 3 h; (p) TESCl, pyridine, 0°C - RT, 0.5 h;  (q) 
isovaleric acid, DCC, DMAP, CH2Cl2, RT, 24 h; (r) TBAF, THF, RT, 6 h.  
 
In continuation of the discussion of the synthesis of Gao et al., intramolecular SN2' epoxide 
formation, coupled with the introduction of the extended side chain through conjugate 
Grignard addition, resulted in the opening of the epoxide with concomitant rearrangement of 
the exocyclic olefin.  Wacker oxidation of the terminal olefin in (3.26) allowed for further 
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elaboration of the alkenyl side chain. Introduction of the desired E geometry at C-13 was 
achieved using the Horner-Wadsworth-Emmons (HWE) modification of the Wittig reaction to 
yield the ester (3.27), which upon reduction with DIBAH yielded the allylic alcohol (3.28). 
Selective protection of the primary alcohol, followed by isovaleric acid esterification of the 
secondary alcohol and subsequent removal of the triethylsilyl (TES) protecting groups 
afforded the racemate (±)-3.7, confirming the relative configuration originally proposed by 
Manker and Faulkner.99 
 
Although Gao et al.102 had used synthesis to confirm the relative configuration of 3.7, the 
absolute configuration of the Trimusculus diterpenes remained undefined. Pathak et al.103 
subsequently established the absolute configuration of 3.7 via synthesis from the readily 
available labdane diterpene (+)-larixol (3.29).The synthesis (Scheme 3.2) commenced with 
the isomerisation of the ∆8,17 olefin in 3.29, affording a mixture of ∆7 (not shown in scheme) 
and ∆8 isomers. Since these isomers were difficult to separate, 2-iodobenzoic acid mediated 
oxidation was performed on the crude isomeric mixture and the desired ketone (3.30) 
isolated. Reduction of this ketone with lithium aluminium hydride (LAH) completed the 
inversion of configuration at C-6, affording the β-hydroxy moiety, which was then esterified 
with isovaleryl chloride. Allylic oxidation at C-7 with selenium dioxide occurred from the less 
sterically hindered α-face affording the 7α-hydroxy moiety, while palladium catalyzed allylic 
rearrangement of the side chain introduced the desired ∆13 E geometry and transposed the 
isovaleryl ester moiety at C-13 to C-15. Finally, selective saponification of the allylic isovaleryl 
ester (an unavoidable consequence of the earlier bisesterification) yielded 3.7 in 30% overall 
yield.  Synthetic 3.7 was found to be identical to the natural product in all respects (1H and 13C 
NMR, IR and [α]D), suggesting that the diterpene natural products of T. reticulatus belong to 
the labdane series. This synthesis also provided a readily accessible source of 3.7 should any 
further biological activity studies of this compound be contemplated. 
 
                                                                                                                            Chapter Three 
 
                                                                                                                                    56                                                                                                                                 
H OH
HO
H OH
HO
H O
HO
H OR
RO
H O
O
O
O
H O
O
a b
c
ef
R = H
R = COCH2CH(CH3)2
      R = COCH2CH(CH3)2
3.7 R = H
d
g
3.29 3.30
OHOH
OR
 
 
Scheme 3.2 Pathak et al.’s103 synthesis of 3.7.  Reagents and conditions: (a) 
NH2CH2CH2NH2, Li, 100 °C, overnight; (b) IBX (no further detail s given); (c) LAH, THF, 0°C; 1 
h; (d) isovaleryl chloride, DMAP, pyridine, 0°C, ov ernight; (e)  SeO2, dioxane-H2O, 60°C, 24 h; 
(f) (PhCN2)2PdCl2, THF, RT, 3 h; (g) K2CO3, MeOH, 4°C (1 h) then RT (9 h). 
 
3.2  New secondary metabolites from T. costatus 
 
3.2.1 Recollection of T. costatus 
 
In May 2006, a collection of 1274 Trimusculus costatus specimens was made from the 
extensive and densely populated colonies of this mollusc occurring in the intertidal region of 
the rocky shore at Cinsta West, South Africa (Figure 3.1). Consistent with previous 
observations by Gray,100 the limpets were growing in densely packed colonies, two to three 
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layers thick in the lower intertidal zone. The specimens collected were directly immersed in 
acetone and stored at -20°C for a period of five mo nths.  
 
 
 
Figure 3.1  The rocky shore at the collection site of T. costatus, Cintsa West. 
 
3.2.2  Extraction and isolation of secondary metabolites 
 
As a pilot study, a portion of the May 2006 collection (527 animals) in acetone (300 mL) was 
selected for the primary extraction. The isolation protocol is represented graphically in 
Scheme 3.3.  The acetone was decanted from the specimens and the animals resuspended 
in acetone (300 mL) and returned to the freezer (-20°C).  The acetone extract was loaded 
onto an HP-20 column and systematically eluted in the manner described in the previous 
chapter, to afford five fractions. Analysis of the 1H NMR spectra of each of these fractions 
showed that the diterpene metabolites, 3.1 and 3.2, occurred predominantly in the 60% and 
80% acetone(aq) fractions. A portion (111 mg) of the 60% fraction (273 mg) was subjected to 
semi-preparative HPLC (60% ethyl acetate, 40% hexane) and 3.1 (30 mg) and 3.2 (41 mg) 
were isolated.  These two metabolites were identical in all respects with those previously 
isolated by Gray et al.10;100 
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Scheme 3.3  First extraction from T. costatus.  
 
Although the absolute configuration of the T .reticulatus metabolites had already been 
established conclusively by Pathak et al.103 and the T. peruvianus metabolites by Díaz-
Marrero et al.,95 we wished to confirm that the diterpene metabolites from T. costatus also 
belonged to the labdane series.  We accordingly chose to esterify both 3.1 and 3.2 with the 
chiral carboxylic acid chloride, (-)-1S-3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-
carbonyl chloride, or (-)-camphanic chloride (3.31). The camphanate esters of natural 
products are often crystalline and are thus regularly used in conjunction with X-ray 
crystallography to determine the absolute configuration of natural products.e.g.105;106 
Metabolites 3.1 and 3.2 were accordingly derivatized with (-)-camphanic chloride to yield the 
camphanate esters (3.32 and 3.33).  The camphanate esters were purified by semi-
preparative HPLC and crystallization attempted from a variety of solvents.  Ultimately only 
3.33 provided crystals suitable for X-ray crystallography from initial dissolution of 3.33 in ethyl 
acetate and allowing the slow diffusion of hexane into the solution over a period of weeks. 
Single crystal X-ray analysis of 3.33 (Figure 3.2) confirmed that 3.2, as well as 3.1 and 3.3 
(from biogenic considerations, isolation of 3.3 still to be discussed) shared a labdane 
configuration, in common with other Trimusculus diterpenes.  
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Figure 3.2  Perspective view of the major conformation adopted by molecules of 3.33. 
 
The 1H NMR spectrum of the 80% acetone(aq)  fraction (483 mg) revealed a complex mixture 
of metabolites.  The fraction was thus resuspended in acetone and adsorbed onto Diol 
stationary phase and eluted with aliquots of solvents of increasing polarity, again as described 
in the previous chapter. Resonances characteristic of terpenoid compounds in the 1H NMR 
spectrum of the 25% ethyl acetate, 75% hexane fraction prompted us to subject this fraction 
to semi-preparative normal phase HPLC (60% ethyl acetate, 40% hexane), affording 
compound 3.2 (58 mg) and an impure fraction (38 mg) containing other interesting 
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metabolites from 1H NMR spectroscopy.  The long retention time of peaks eluting from the 
normal phase column and the extensive “tailing” observed in the chromatogram necessitated 
a change in stationary phase in order to isolate the interesting metabolites in this fraction. 
Accordingly, Diol semi-preparative HPLC (40% ethyl acetate, 60% hexane) afforded 9,11-
secosterol, 3.4, as a yellow oil (30 mg). 9,11-Secosterols (e.g. 3.34),107 appear to be unique to 
the marine environment and to date have only been reported from soft corals,e.g.108-116 
spongese.g.117-122 and tunicates.107 Therefore, the isolation of secosterol 3.4 from T. costatus is 
the first reported isolation of a 9,11-secosterol from a marine mollusc. 
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The molecular formula of 3.4, established as C27H42O4 by HRFABMS data, implied seven 
degrees of unsaturation. The presence of  two α,β-unsaturated ketones (δC 187.5 and 201.8)  
and their corresponding two trisubstituted olefins [δC 135.2 (d), 140.4 (s), 138.7 (d) and 153.5 
(s)] and one secondary hydroxyl functionality (δC 63.0) was further corroborated by the IR 
absorption bands at 1683 and 1624 cm-1 and a broad absorbance band at 3420 cm-1 
respectively. The two α,β-unsaturated ketones accounted for four of the seven degrees of 
unsaturation required by the molecular formula, and the absence of any further carbonyl or 
olefinic functionalities thus suggested a tricyclic skeleton.  Analysis of 13C and DEPT NMR 
spectra confirmed the presence of twenty seven carbons, comprising two trisubstituted 
olefins, one oxymethylene, two conjugated ketones, one oxymethine, two quaternary, four 
methine and eight methylene carbons. The presence of twenty seven carbons suggested a 
steroidal structure, but the tricyclic nature of 3.4 implied rearrangement of the typical 
tetracyclic steroid skeleton, such as in a 9,11-secosterol, e.g. 3.34.107 Analysis of the 1H NMR 
spectrum of 3.4 revealed the presence of two tertiary methyl groups (δH 0.75 and 1.37) as 
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well as three secondary methyl groups (δH 0.86, 0.86 and 0.96), consistent with the those 
reported for 3.34 (Table 3.1), suggesting a similar distribution of methyl groups in these two 
compounds.  Additionally, two deshielded geminal resonances [δH 3.71 (H-11a) and δH 3.84 
(H-11b)], mutually coupled to two other geminal protons [δH 1.15 (H-12a) and 1.71 (H-12b)] in 
an isolated spin system are characteristic of a 9,11-secosterol skeleton with a primary 
hydroxyl group at C-11.107 The 13C NMR chemical shifts of C-11 (δC 59.0) and C-12 (δC 41.3) 
from gHSQC correlations also compared favourably with analogous chemical shifts in similar 
compounds.107-110;122 Finally, a ketone moiety at C-9 is also typical of a 9,11-secosterol, in 
which oxidative cleavage of the C-9, C-11 bond of a steroid precursor has occurred. The 
position of the carbonyl at C-9 was supported by gHMBC correlations from H3-19 (δH 1.37) to 
C-9 (δC 201.8). Further 1H and 13C NMR assignments were made from gHMBC correlations 
from H3-19 to quaternary carbons C-10 (δC 49.2) and C-5 (δC 140.4), as well as to methylene 
carbon C-1 (δC 25.0). A two bond gHMBC correlation from the olefinic methine proton H-7 (δH 
6.69) to the remaining carbonyl carbon (δC 187.5), in addition to a three bond gHMBC 
correlation from the olefinic proton H-4 (δH 6.70) to the same carbon placed the second 
ketone at C-6. A gCOSY correlation between H-4 and oxymethine proton H-3 (δH 4.34) 
allowed for the assignment of C-3 (δC 63.0) from gHSQC data. gCOSY correlations between 
oxymethine H-3 (δH 4.34) and between H2-2 (δH 1.89) followed to allow for the assignment of 
C-2 (δC 27.2) from gHSQC data. Two and three bond gHMBC correlations from H-3 (Figure 
3.3) to both C-2 and C-4 (δC 135.2) and both C-1 and C-5 confirmed the assignments made 
for the A ring.  As the spectroscopic differences between 3.4 and the secosterol 3.34 were 
limited to the substitution pattern around the A and B rings the remaining assignments in the 
right hand hemisphere were made by comparison of the 1H and 13C NMR data of these two 
compounds (Table 3.1) and were supported by exhaustive gHMBC and gCOSY correlations 
where necessary. 
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Figure 3.3  A region of the gHMBC spectrum (CDCl3, 600 MHz; F1 = δC 20 – 205; F2 = δH 4.3 
– 6.9) of 3.4 showing the key correlations used to assign the carbons of the A and B rings. 
The accompanying diagram summarizes the gHMBC correlations indicated in the spectrum. 
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Table 3.1  Comparison of the 1H (600 MHz) and 13C (150 MHz) NMR data (CDCl3) obtained 
for 3.4 with 1H (500 MHz) and 13C (125 MHz) NMR data (CDCl3) reported for 3.34.107  
 
3.4 
 
 
3.34 
Position δC (mult.) 
 
δH 
(int., mult., J/Hz) 
 
δC 
(mult.)† 
δH 
(int.†, mult.,‡ J/Hz) 
1β 
1α  
25.0 (t) 1.77 (1H, m) 
2.17 (1H, ddd 13.5, 13.4, 3.6) 
28.6 1.52 
2.00 
2 
 
27.2 (t) 1.89 (2H, m) 31.0 1.49 
1.89 
3 63.0 (d) 4.34 (1H, m ) 68.3 4.02 (m) 
4 
 
135.2 (d) 6.70 (1H, dd, 4.0, 0.9) 39.2 2.31 (dd, 12.9, 12.9) 
1.95 
5 140.4 (s) - 77.0 - 
6 187.5 (s) - 72.4 4.44 (d, 4.9) 
7 138.7 (d) 6.69 (1H, s) 138.2 6.49 (d, 4.9) 
8 153.5 (s) - 137.3 - 
9 201.8 (s) - 202.8 - 
10 49.2 (s) - 47.0 - 
11a 
11b 
59.0 (t) 3.71 (1H, ddd, 10.7, 9.4, 5.8) 
3.84 (1H, ddd, 10.7, 10.0, 5.6) 
59.1 3.69 (m) 
3.81 (m) 
12a 
12b 
41.3 (t) 1.15 (1H, m) 
1.71 (1H, m) 
40.5 1.15 
1.63 
13 47.9 (s) - 46.1 - 
14 44.0 (d) 3.54 (1H, dd, 11.1, 8.7) 43.5 3.50 (bt, 9.5) 
15 27.0 (t) 1.68 (2H, m) 27.2 1.68 
16a 
16b 
26.4 (t) 1.50 (1H, m) 
1.89 (1H, m) 
29.6 1.46 
1.85 
17 50.3 (d) 1.74 (1H, m) 49.8 1.83 
18 17.7 (q) 0.75 (3H, s) 17.4 0.75 (s) 
19 26.8 (q) 1.37 (3H, s) 21.0 1.47 (s) 
20 34.6 (d) 1.43 (1H, m) 38.5 1.43 
21 18.8 (q) 0.96 (3H, d, 6.7) 19.2 0.97 (d, 6.8) 
22a 
22b 
35.5 (t) 1.02 (1H, m) 
1.35 (1H, m) 
35.3 1.01 (m) 
1.33 
23a 
23b 
24.4 (t) 1.15 (1H, m) 
1.35 (1H, m) 
24.5 1.11 
1.31 
24 39.4 (t) 1.12 (2H, m) 39.4 1.09 
25 28.0 (d) 1.52 (1H, m) 28.0 1.51 
26 22.8 (q) 0.86 (3H, d, 6.6) 22.8 0.85 (d, 7) 
27 23.0 (q) 0.86 (3H, d, 6.6) 23.0 8.85 (d, 7) 
 
† Not provided; ‡ Where provided. 
 
The relative configuration of the A-ring was determined through NOE correlations (Figure 
3.4).  A correlation between H3-19 (δH 1.37) and both H-1β (δH 1.77), and H-3 (δH 4.34) 
implied these were all on the same face of the ring. The configuration indicated in the 
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cyclopentane ring in the right hand hemisphere of the molecule and at C-20 was determined 
from biogenetic considerations. 
 
Figure 3.4  Key NOESY correlations used in the determination of the C-3 configuration of 3.4.   
 
In order to investigate the absolute configuration of 3.4 by chemical means, more material 
needed to be isolated. To do this the remainder of the May 2006 collection of T. costatus (753 
animals) was worked up in the usual manner.  The limpets were immediately resuspended in 
acetone (300 mL) and returned to the freezer along with the original extract.  After one week, 
the second extract from both the first and the second isolation was pooled with the first extract 
from the second isolation.  Concentration in vacuo of these combined extracts commenced 
until the total volume was approximately 300 mL. The isolation procedure is depicted 
graphically in Scheme 3.4. 
 
The pure secosterol 3.4 was found in (380-E and 390-B) providing a total yield (including the 
29.5 mg from the first isolation) of 122 mg from 1274 animals (or 0.096 mg/animal).  A further 
new compound, 3.3, the acetylated product of 3.1 (and ∆13
 
geometric isomer of 3.6) was 
isolated in small quantities (2 mg, 0.002 mg/animal) from semi-preparative HPLC of 379-C.  
The structure of 3.3 was readily confirmed as the ∆13 E geometric isomer of 3.6 through the 
comparison of 1H and
 
13C NMR data of the two compounds, particularly the 13C NMR 
chemical shift of C-12 and C-16 (δC 39.2 and 16.6 respectively, Table 3.2).99;102 Based on 
analysis of the 2D NMR data sets acquired for 3.3, we believe that the 13C NMR chemical 
shifts for C-6 and C-7 have been incorrectly assigned in 3.6.97  As a final confirmation of the 
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structure of 3.3, a portion of 3.1 was acetylated by stirring a portion of this compound with 
pyridine and acetic anhydride (16 h).  The specific rotations and 1H and 13C NMR spectra of 
the naturally occurring and semi-synthesized 3.3 were identical. 
 
Second Extraction
HP-20
40% Me2CO(aq)
60% Me2CO(aq)
80% Me2CO(aq)
100% Me2COH2O
CA
B D
5% EtOAc:
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25% EtOAc:
75% Hexane
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Diol column
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B D
E
F
5% EtOAc:
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50% EtOAc:
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25% EtOAc:
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15% EtOAc:
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10% EtOAc:
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Diol column
100% EtOAc
G
100% MeOH
CA
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85% Hexane
10% EtOAc:
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G
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E
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H
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Scheme 3.4  Second isolation procedure for the May 2006 T. costatus collection.   
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Table 3.2 Comparison of the 1H (600 MHz) and 13C (150 MHz) NMR data obtained for 3.3 
with those reported for 3.6 by San-Martín et al.97 (1H: 300 MHz; 13C: 75 MHz; CDCl3). 
Diterpene 3.3 
 
Diterpene 3.6 
 
 
Position 
 
 
δC 
(mult.) 
 
 
δH 
(int., mult., J/Hz) 
 
 
δC 
(mult.) 
 
 
δH 
(int., mult., J/Hz) 
 
1a 
1b 
38.9 (t) 1.21 (1H, m) 
1.80 (1H, m) 
39.1 (t) † 
2a 
2b 
19.0 (t) 1.54 (1H, m) 
1.69 (1H, m) 
19.2 (t) † 
3a 
3b 
43.1 (t) 1.19 (1H, m) 
1.42 (1H, m) 
43.3 (t) † 
4 33.4 (s) - 33.4 (s) - 
5 49.2 (d) 1.47 (1H, d, 1.1) 49.3 (d) 1.50 (1H, br s) 
6 69.6 (d) 5.31 (1H, br s) 73.6 (d) 5.32 (1H, br s) 
7 73.4 (d) 4.97 (1H, br s) 69.4 (d) 4.98 (1H, br s) 
8 121.7 (s) - 122.1 (s) - 
9 147.7 (s) - 147.8 (s) - 
10 39.5 (s) - 39.6(s) - 
11 26.8 (t) 2.21 (2H, m) 27.2 (t) 2.05 (2H, m) 
12 39.2 (t) 2.11 (2H, m) 32.3 (t) 2.10 (2H, m) 
13 142.3 (s) - 143.1 (s) - 
14 118.1 (d) 5.37 (1H, t, 6.9) 119.3 (d) 5.36 (1H, t, 7.3) 
15 61.3 (t) 4.50 (2H, d, 7.1) 61.1 (t) 4.59 (1H, d, 7.3) 
16 16.6 (q) 1.74 (3H, s) 23.6 (q) 1.73 (3H, br s) 
17 17.0 (q) 1.61 (3H, s) 17.3 (q) 1.58 (3H, s) 
18 33.0 (q) 0.97 (3H, s) 33.2 (q) 0.97 (3H, s) 
19 23.1 (q) 0.95 (3H, s) 23.3 (q) 0.98 (3H, s) 
20 21.0 (q) 1.28 (3H, s) 21.7 (q) 1.30 (3H, br s) 
6-OAc 169.7 (s) - 169.7 (s) - 
 21.5 (q) 2.03 (3H, s) 21.5 (q) 2.04 (3H, s) 
7-OAc 171.1 (s) - 171.1 (s) - 
 21.1 (q) 2.08 (3H, s) 21.1 (q) 2.09 (3H, s) 
15-OAc 169.9 (s) - 169.9 (s) - 
 21.2 (q) 2.06 (3H, s) 21.2 (q) 2.05 (3H, s) 
 
† No values reported. 
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We next attempted the modified Mosher’s method123 to determine the absolute configuration 
of the secondary alcohol moiety in 3.4.  Although the Mosher’s method is routinely used to 
determine the absolute configuration of natural products, the difficulty in this case rested on 
the fact that there were two sites available for esterification with α-methoxy-α-
trifluoromethylphenylacetic acid (MTPA).  This problem was eventually circumvented through 
the selective acetylation of the primary alcohol utilizing Ishihara et al.’s method.124 The 
procedure involved dissolving 3.4 in dichloromethane and reacting the solution with acetyl 
chloride in the presence of a sterically hindered base (collidine) at -78°C.  Although the 
procedure did produce some of the diacetylated product (3.35, 9%), we were able to isolate 
the monoacetate (3.36) as the major product (27%) through semi-preparative HPLC. The 
diacetylated product was identified by the presence of two deshielded methyl singlets (δH 2.02 
and 2.01) but not further characterized. Confirmation of the selective acetylation of the 
primary alcohol was provided by two bond gHMBC correlations from H-11a and H-11b to the 
acetyl carbonyl carbon, as well as the significant downfield shift of these two resonances in 
the 1H NMR spectrum of 3.36 (Figure 3.5). 
 
With 3.36 in hand we were able to make use of the modified Mosher’s method123 to determine 
the absolute configuration at C-3. Dale and Mosher125 postulated that the most stable 
conformation of the α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) moiety in solution is 
when the ester, carbinyl and trifluoromethyl substituents are syn-periplanar (Figure 3.6). 
 
In this syn-periplanar conformation, the diamagnetic effect of the phenyl substituent shields 
the protons of the alkyl chain on the side of this moiety, while the protons of the other alkyl 
chain are deshielded by the methoxy functionality. This spectroscopic method was first 
developed prior to the advent of Fourier transform NMR when most NMR spectrometers were 
operating in the 60-100 MHz range, making complete assignments of the protons in complex 
molecules impossible. 
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Figure 3.5  The downfield 1H NMR (600 MHz, CDCl3) spectra of 3.4 (top) and 3.36 (bottom) 
showing the deshielding of H-12a and H-12b after monoacetylation.  
 
O CF3
Ph OMe
OH
βγδ
β'γ'δ'
HC HB HA
HZ HY HX
(OMe) (Ph)................(R)-MTPA
................(S)-MTPA
 
 
Figure 3.6 The conformation adopted by the (R)- and (S)-MTPA esters of a secondary 
alcohol.123 
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In the early days, when Mosher and Dale invented this method, lanthanide and 13F NMR shift 
reagents, exploiting the chemical shift differences of the CF3 (19F) or OMe (1H) moieties, were 
used.  The configuration of the secondary alcohol in question was thus determined on the 
basis of only two data points, reducing the reliability of the method.  Fortunately, the advent of 
high field, Fourier Transform NMR spectrometers has made it possible to completely assign 
the 1H chemical shifts of complex molecules, greatly increasing the number of data points 
available, and forming the basis of the modified Mosher’s method.123 Once all protons have 
been assigned for both the (R)- and (S)-MTPA esters respectively, the change in chemical 
shift (∆δ = δS – δR) for all protons in the (R)- and (S)-MTPA esters can be calculated. As 
indicated (Figure 3.7), when protons with positive ∆δ values are placed on the right hand side 
of the MTPA functionality and those with negative values on the left, the model can be used to 
determine the absolute configuration of the compound in question. 
 
C
OMTPA
H
∆δ<0 ∆δ>0
HCHX
HBHY
HAHZ
 
 
Figure 3.7  Model for absolute configuration determination in the MTPA esters of secondary 
alcohols.123 
 
The (S)- and (R)-MTPA esters of 3.36  (3.37  and 3.38) were accordingly prepared and the 1H 
and 13C NMR resonances of each ester fully assigned with the aid of gCOSY, gHMBC and 
gHSQC NMR data. The change in chemical shift (∆δ = δS – δR) for all protons was calculated 
and is summarized in Figure 3.8. Ohtani et al.123 had cautioned that sterically hindered 
hydroxyl moieties could cause anomalies in the sign of some of the values obtained. Although 
some anomalies in the values obtained were seen (in the right hand hemisphere of 3.36), 
these anomalies were sufficiently distant from the MTPA ester moiety to be disregarded and 
thus we were able to determine that the configuration at C-3 of the parent secosterol 3.4 is R, 
with the alcohol functionality α-axial to the ring.  
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O
O
RO
0.05
0.05
0.12
0.04
0.00
-0.09
-0.01
R = MTPA
 
 
 
1H number 
S- MTPA ester 3.37 
δH 
R-MTPA ester 3.38 
δH ∆δ 
1a 1.83 1.79 
 0.04 
1b 2.1 1.98 
 0.12 
2 2.04 1.99 
 0.05 
3 5.61 5.61 
 0.00 
4 6.56 6.65 
-0.09 
5 - - 
- 
6 - - 
- 
7 6.67 6.68 
-0.01 
8 - - 
- 
9 - - 
- 
10 - - 
- 
 
Figure 3.8  Proton chemical shifts and calculated ∆δ values obtained from the application of 
the modified Mosher’s method to 3.36 (600 MHz, CDCl3). 
 
During the second isolation procedure, methyl resonances, similar to those observed in the 1H 
NMR spectrum of 3.4, were noted in the 1H NMR spectra of some of the minor fractions. To 
investigate the source of these methyl resonances in addition to isolating more of 3.4 for 
configuration and bioactivity studies, a second collection of T. costatus was made from the 
same location as previously.  A collection (1658 specimens) of T. costatus was immediately 
steeped in acetone (600 mL) and stored at -20°C for  one week.  One week later, this acetone 
was decanted, combined with the first fraction, concentrated to approximately 300 mL and 
loaded onto HP-20 (Scheme 3.5). 
 
The secosterol 3.4 was isolated after exhaustive chromatography and was found in fractions 
388-B, 389-B, 394-C and 394-D (303 mg, 0.183 mg/animal).  Cholest-7-en-3,5,7-triol, 3.5, 
was ultimately isolated through semi-preparative HPLC ( 50% EtOAc, 50% hexane) of 393-B 
(16 mg, 0.010 mg/animal). 
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May 2007 Extraction
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Scheme 3.5 Isolation scheme for May 2007 extraction of T. costatus metabolites. 
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The molecular formula of 3.5 established as C27H46O3 by HRFABMS data, implied five 
degrees of unsaturation. One degree of unsaturation was accounted for by a disubstituted 
olefin [δC 130.7 (d) and 135.4 (d)], evident in the 13C and DEPT135 spectra of 3.5. The 
absence of further unsaturated functionalities led us to deduce a tetracyclic skeleton for 3.5. A 
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closer inspection of the 13C and DEPT NMR spectra suggested the presence of twenty seven 
carbons, comprising one trisubstituted olefin, four quaternary, eight methine (one oxygenated) 
and ten methylene carbons. The twenty seven carbons and tetracyclic nature of 3.5 
suggested a steroid. Analysis of the 1H NMR spectrum of 3.5 revealed the presence of two 
tertiary methyl groups (δH 0.78 and 0.86) as well as three secondary methyl groups (δH 0.84, 
0.85 and 0.88), similar to those found in 3.4 and consistent with a steroid nucleus. The right 
hand hemisphere of 3.5 (rings C and D and the side chain) were assigned through analogy 
with known steroidal compounds, as well as 3.4, and confirmed by exhaustive gHMBC and 
gCOSY correlations (Table 3.3). A two bond gHMBC correlation from the remaining methyl 
functionality H3-19 (δH 0.86), not found in the side chain of 3.5, allowed for the assignment of 
quaternary C-10 (δC 36.92). Further, three bond gHMBC correlations, from H3-19 tentatively 
allowed us to assign methylene carbon C-1 (δC 34.7) and methine carbons C-9 (δC 51.6) and 
C-5 (δC 82.1).  gHMBC correlations between both of two vicinal olefinic methines (δH 6.49 and 
6.22) in an isolated spin system to C-5 (δC 82.1) and another oxygenated quaternary carbon 
(δC 79.4) placed the disubstituted olefin between these two quaternary carbons. The 1H and 
13C chemical shifts for C-6 and C-7 were reminiscent of epidioxy sterols, (e.g. 3.39),126;127 
however, the HRFABMS data [m/z 419.3525 (calcd for C27H47O3 [(M + H)+], 419.3525)] 
supported the structure 3.5. The mass spectrum of the sterol (Figure 3.9) also revealed no 
peak corresponding to the loss of molecular oxygen (M – 32), expected for an epidioxy 
sterol.128 We thus suggested hydroxyl functionalities at C-6 and C-8. Another three bond 
gHMBC correlation from H-9 (δH 1.54) to δC 79.4 allowed us to assign C-8. A three bond 
gHMBC correlation from the more deshielded of the olefinic resonances (H-7, δH 6.49) to C-
14 (δC 51.0) enabled us to assign C-7 (δC 130.7) and suggested that the remaining olefinic 
resonance was C-6 (δC 135.4).  A three bond correlation between H-6 and C-4 provided the 
assignment of C-4 (δC 36.89), which was confirmed by a gCOSY correlation between H-3 (δH 
3.95), and both H-4β (δH 1.88) and H-4α (δH 2.09).  A two bond gHMBC correlation from H-3, 
as well as gCOSY correlations between H-3 and both H-2β  (δH 1.51) and H-2α (δH 1.82), 
allowed us to assign C-2 (δC 30.1). 
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Table 3.3 1H (600 MHz), 13C (150 MHz) and 2D NMR data obtained for 3.5 in CDCl3. 
 
Position δC (mult.) 
δH 
(int., mult., J/Hz) 
 
gHMBC  
 
 
gCOSY  
 
1β 
 
1α  
34.7 (t) 1.67 (1H, ddd, 13.5, 6.9, 
3.5) 
1.95 (1H, m) 
C-2, C-3, C-4,  
C-5, C-19 
C-2, C-19 
H-1b, H-2a, H-2b 
 
H-1a, H-2a, H-2b 
2β  
2α  
30.1 (t) 1.51 (1H, m) 
1.82 (1H, m) 
C-3 
C-3 
H-1a, H-1b, H-2b, H-3 
H-1a, H-1b, H-2a, H-3 
3 66.4 (d) 3.95 (1H, m) C-1, C-2, C-4 H-2a, H-2b, H-4a, H-
4b 
4β 
4α  
36.89 (t) 1.88 (1H, dd, 13.8, 11.7) 
2.09 (1H, ddd, 13.8, 5.0, 
1.9)  
C1, C-2, C3, C-5, C-6 
C1, C-2, C3, C-5, C-6 
H-3, H-4b 
H-3, H-4a 
5 82.1 (s) - - - 
6 135.4 (d) 6.22 (1H, d, 8.5) C-4, C-5, C-8, C-9 H-7 
7 130.7 (d) 6.49 (1H, d, 8.5) C-4, C-5, C-8, 
 C-9, C-14 
H-6 
8 79.4 (s) - - - 
9 51.6 (d) 1.54 (1H, dd, 12.2, 4.6) C7, C-8, C-11 H-11a, H-11b 
10 36.92 (s) - - - 
11a 
11b 
20.6 (t) 1.42 (1H, m) 
1.61 (1H, m) 
C-8 
C-9 
H-9, H-12a, H-12b 
H-9 
12a 
12b 
39.4 (t) 1.17 (1H, m) 
1.95 (1H, m) 
C-13 
C-9, C-10, C-14 
H-11a, H-12b 
H-11a, H-12b 
13 44.7 (s) - - - 
14 51.0 (d) 1.48 (1H, m) C-15 H-15a 
15a 
15b 
23.4 (t) 1.20 (1H, m) 
1.48 (1H, m) 
C-12, C-14, C-18 
- 
H-14, H-15b, H-16b 
H-15a 
16a 
16b 
28.2 (t) 1.36 (1H, m)  
1.92 (1H, m) 
- 
- 
H-15a, H-16b, H-17 
H-16a, H-17 
17 56.4 (d) 1.17 (1H, m) C-13, C-16, C-18, C-20 H-16a, H-16b 
18 12.6 (q) 0.78 (3H, s) C-17, C-14, C-13, C-12 - 
19 18.1 (q) 0.86 (3H, s) C-1, C-2, C-5, C-9, C-
10 
- 
20 35.2 (d) 1.36 (1H, m) C-17 H-17, H-22a 
21 18.6 (q) 0.88 (3H, d, 6.5) C-17, C-22 - 
22 35.9 (t) 1.01 (1H, m) 
1.32 (1H, m) 
- 
- 
H-22b, H-23b 
H-22a, H-23a 
23 23.8 (t) 1.14 (1H, m) 
1.32 (1H, m) 
C-25 
- 
H-22b, H-23b 
H-22a, H-23a, H2-24 
24 39.4 (t) 1.14 (2H, m) C-25, C-26, 
 C-27 
H-23b, H-25 
25 28.0 (d) 1.51 (1H, m) C-24, C-26, C-27 H2-24, H3-26, H3-27 
26 22.8 (q) 0.85 (3H, d, 6.6) C-24, C-25, C-27 H-25 
27 22.5 (q) 0.84 (3H, d, 6.6) C-24, C-25, C-26 H-25 
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Figure 3.9 FAB mass spectrum of 3.5 showing the (M + H)+ peak at 419 amu.  
 
The relative configuration of the A ring of 3.5 was determined spectroscopically (Figure 3.10).  
NOESY correlations between H3-19 (δH 0.86) and all three of H-1β (δH 1.67), H-2β (δH 1.51) 
and H-4β (δH 1.88) suggested that these protons were all on the same face of 3.5.  Similarly, 
NOESY correlations between H-3 (δH 3.95) and all three H-1α (δH 1.95), H-2α (δH 1.82) and 
H-4α (δH 2.09) but not to any of the β protons suggested that the hydroxyl functionality at C-3 
was in a β-equatorial orientation.  The congruency between the 13C NMR chemical shifts of C-
8 and C-9 in 3.5 and the analogous chemical shifts reported for the epidioxy sterol 3.39126;127 
would suggest the same configuration at C-8 and C-9 in 3.5. 
 
CH3
H
HO
H
H
H
H
H
H
8
9
OH OH
 
 
Figure 3.10   Key NOESY correlations used in the determination of the relative configuration 
of the A ring of trihydroxysterol 3.5. 
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3.3 Activity of Trimusculus  metabolites against oesophageal cancer 
 
As part of an ongoing collaborative research product between the Department of Medicinal 
Biochemistry at the University of Cape Town and the Marine Natural Products Research 
Group at Rhodes University, we assayed four of the metabolites (3.1-3.4) isolated from T. 
costatus as well as the ester, 3.32, for their activity against oesophageal cancer. Globally, 
oesophageal cancer is the eighth most devastating form of this disease, with a five year 
survival rate of lower than 10% after diagnosis.129 The incidence of the cancer is generally 
higher in males than in females and is increasing globally. Aetiological studies of this disease 
are complicated by the number and inconsistency of external factors associated with the 
disease.130-132  In the South African context, oesophageal cancer is the second most common 
cancer,133 with studies in Soweto revealing that residents there had a five fold higher risk of 
developing the cancer than the world average.134 High incidence rates have also been 
reported in the former Transkei,131 particularly amongst Xhosa males. Although a wide range 
of factors have been linked to the disease, oesophageal cancer has traditionally been 
associated locally with low socio-economic status, poor nutrition (including maize 
contaminated with Fusarium), and particularly the use of alcohol and tobacco.131;132;134;135 A 
recent study has, however, concluded that the consumption of home-brewed beer (and the 
associated intake of excessive dietary iron) could not directly be related to an increased risk 
of development of oesophageal cancer once adjustment for sex, age and tobacco usage had 
been made.136 Prompted by the extraordinarily high incidences of this form of cancer, Bohr et 
al. detected a strong correlation (approximately 50%) between patients with bacteria of the 
family Heliobacteracea and oesophageal carcinomas, implying that these bacteria may be 
involved in the initiation of the cancer of the oesophagus.134  Similarly, the Human Papilloma 
Virus (HPV) has been detected in 15 -75% of oesophageal tumours studied.135 
  
Although the survival rate of patients with oesophageal cancer has improved over the past 
few decades, long term prognoses are not good.137 Adjuvant radiotherapy has also been 
shown not to improve chances of survival and although chemoradiation has shown promising 
results, the extended treatment periods may lead to poor compliance and proper localization 
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of the treatment has proven problematic.137 A comprehensive strategy consisting of treatment 
with combined cisplatin (3.40) and 5-fluorouracil (3.41) based chemotherapy, in addition to 
surgery, is currently the most commonly used and effective treatment.135  
 
At the Department of Medicinal Biochemistry, University of Cape Town, activity of the pure 
secondary metabolites isolated (and those modified in the course of absolute configuration 
determination) against the oesophageal cancer cell line WHCO1 was determined.  A dose 
response curve was determined from the (MTT) assay and IC50 values hence determined. 
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a colorimetric 
assay, based on the action of a mitochondrial dehydrogenase enzyme on the tetrazolium 
rings of MTT (pale yellow), to form formazan crystals (dark blue).135;138 Viable cells can be 
detected by the accumulation of the cell membrane impermeable formazan crystals within 
them. After solubilisation of the cells by the addition of a detergent, the number of cancerous 
cells surviving in the presence of the potentially cytotoxic compound being tested is directly 
proportional to the level of the formazan crystals present.135;138 A mulitiwell scanning 
spectrophotometer (ELISA reader) is used for the determination of the level of formazan 
present. The IC50 values of metabolites 3.1-3.4 and 3.32 (as well as comparison compounds 
3.40 and 3.42) against the oesophageal cancer cell line WHCO1 are summarized in Table 
3.4. 
 
3.1   R1 = R2 = H;  
3.2   R1 = OAc; R2 = H
3.3   R1 = H; R2= Ac
3.32 R1 = H; R2 = camphanate
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HO
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Table 3.4 Summary of the IC50 values of compounds against the WHCO1 cell line. 
 Compound tested 
 3.1 3.3 3.32 3.2 3.4 3.40 3.42 
IC50 (µM) 25.1 84.2 77.2 23.7 3.2 13.0 9.5 
 
Since only a few compounds were screened against the oesophageal cancer cells (Table 
3.3), we are able to draw only tentative conclusions regarding structure-activity relationships.  
The first conclusion is that oxygenation at C-2 appears to have little effect on the IC50 value 
(3.1 and 3.2). Secondly, the primary alcohol on the alkenyl chain appears to be of some 
importance, since esterification of 3.1 (3.3 and 3.32) brings about a significant increase in the 
IC50 value of the diterpenes.  Furthermore, the bulkiness of the moiety esterified to 3.1 
appears to have little influence on the IC50 value, since 3.3 and 3.32 have comparable values.  
Of the four naturally occurring metabolites (3.1-3.4), only 3.4 had a lower IC50 value than 
cisplatin (3.40).  Another triprenylated toluhydroquinone compound (3.42) used for 
comparative purposes has been included since it has been the subject of some interest in our 
laboratory. A collaborative effort between the Department of Medicinal Chemistry and our own 
research group has revealed that 3.42 (and related analogous diterpenes from the same 
natural product source) induces apoptosis through the generation of reactive oxygen species 
(ROS) as the result of the oxidation of the hydroquinone moiety to a quinone.135  Since ring B 
of 3.4 is structurally similar to a quinone, the possibility exists that this secosterol may have a 
similar mode of action.  Naturally further studies would be required to support this supposition. 
 
 
 
 
                                                                                                                            Chapter Three 
 
                                                                                                                                    78                                                                                                                                 
3.3 Conclusions 
 
The known diterpenes 3.1 and 3.2, as well as one new diterpene, 3.3 were isolated from the 
pulmonate mollusc, T. costatus. The absolute configuration of 3.2, and hence 3.1 and 3.3 was 
determined through X-ray diffraction of a single crystal of the camphanate ester of 3.2.  The 
new 9,11-secosterol, 3.4, was also isolated and the relative configuration determined by 
spectroscopic means.  The modified Mosher’s method was employed to determine the 
absolute configuration of the secondary hydroxyl at C-3.  The new trihydroxylated sterol, 3.5, 
was also isolated and the relative configuration in ring A determined from NOESY data. The 
activity of compounds 3.1-3.4 and 3.32 against an oesophageal cancer cell line was 
investigated, with 3.4 exhibiting modest activity.  
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Chapter Four 
Semi-synthesis of Nitrile-containing Labdane Diterpenes 
with Agrochemical Potential 
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4.1 Introduction 
 
This chapter describes an extension of the PhD thesis research of Gray100 and includes a 
comprehensive investigation of the agrochemical properties of a trio of unusual labdane 
diterpene nitriles 9α-cyano-15,16-epoxy-7β-hydroxylabda-13(16),14-dien-6-one (4.1), 9α-
cyano-15,16-epoxy-7-hydroxylabda-7,13(16),14-trien-6-one (4.2) and 9α-cyano-15,16-epoxy-
6β,7β-dihydroxylabda-13(16),14-diene (4.3). Nitriles 4.1, 4.2 and 4.3 were derived from the 
readily available South African terrestrial plant metabolite hispanolone (4.4). The introduction 
to this chapter provides a synopsis of Gray’s original synthesis of 4.1 and a discussion of the 
relevance of his work to the molluscan chemistry described in Chapter Three.  The 
introduction is followed by a detailed account of how Gray’s initial findings were extended to 
provide firstly, more of 4.1 for in planta studies at Dow AgroSciences in the USA, secondly a 
new minor product, 4.2, from the Michael addition reaction that afforded 4.1 and, thirdly, a 
reduced analogue of 4.1, 4.3, for a limited structure-activity relationship (SAR) study of the 
fungicidal properties of labdane diterpene nitriles. Surprisingly, the promising initial activity of 
4.1 against the economically important plant fungicidal pathogen, Phytophthora infestans 
(potato late blight) could not be reproduced. Fortuitously, 4.1, 4.2 and 4.3 exhibited significant 
activity in the secondary screening against Magnaporthea grisea (rice blast) and Puccinia 
recondita (wheat brown rust) at levels sufficient to warrant further in planta testing. The details 
of the in planta tests performed on 4.1, 4.2 and 4.3 by Dow AgroSciences conclude this 
chapter. 
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4.1.1 A summary of Gray’s original synthesis of the labdane nitrile, 4.1 
 
At the time that Gray et al.10;100 first isolated compounds 3.1 and 3.2 from Trimusculus 
costatus, only the relative configuration of the Trimusculus diterpene metabolites had been 
established via a non-stereoselective synthesis of 4.5 (Scheme 3.1, Chapter Three).102  As a 
consequence Gray et al. attempted a stereoselective semi-synthesis (Scheme 4.1) of 3.1 
from optically active rhinocerotinoic acid (4.5) to unambiguously determine the absolute 
configuration of the Trimusculus metabolites. 
 
OH
COOH
OAc
H
CH2OH
OAc
4.53.1 R = H3.2 R = OAc
1
13
76
R
 
 
Diterpene 4.5 was selected as a synthetic precursor to 3.1 for a number of reasons, the most 
obvious being that a typical labdane configuration at C-5 and C-10 was already in place and a 
ketone functionality at C-7 not only provided oxygenation at this position but also a means to 
direct further oxygenation to C-6. The positioning of the ∆8 and ∆13 olefins and the requisite E 
geometry of the ∆13 olefin in the side chain of 4.5 were also the same as in 4.1.  Finally, the 
report that rhinocerotinoic acid had been isolated from a South African plant Elytropappus 
rhinocerotis,139 a species common in the veld around Grahamstown, meant that a potential 
source of 4.5 existed close at hand.  
 
Unfortunately, preliminary screening of extracts of E. rhinocerotis collected near 
Grahamstown revealed that local specimens of this plant did not contain any 4.5. 
Consequently, the semi-synthesis of 4.5 from sclareol (2.21) described by Dekker,139 which 
had provided the absolute configuration of rhinocerotinoic acid was modified by Gray et al.100 
and 4.5 obtained in an improved 32% overall yield (Scheme 4.1).100;140 
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Scheme 4.1  Stereoselective synthesis of 4.5 from (-)-sclareol (2.21).100;140  Reagents and 
conditions: (a) KMnO4, Me2CO, 15 °C, 18 h; (b) I 2 (cat.), benzene, ∆, 6 h; (c) CrO3-Py2, 
CH2Cl2, RT, 72 h; (d) (C2H5O)2P(O)CH2CO2Et, NaH, THF, RT, 2 h; (e) H2SO4, AcOH, 100 °C, 
4 h; (f) Trituration from hexane.   
 
Although a reliable route to a supply of 4.5 was now available,100;140 synthesizing large 
quantities would prove both time consuming and costly if this material was also going to be 
used to explore various methodologies for stereoselective oxygenation at C-6 and 
subsequent reduction of the C-7 ketone moiety. A similar diterpene, hispanone (4.6), which 
contains the same A and B ring substitution pattern as 4.5, was therefore chosen as a model 
                                                                                                                            Chapter Four 
 
                                                                                                                                    83                                                                                                                                 
compound for oxygenation studies. Hispanone had previously been isolated by members of 
the same research group141 from the local plant, Ballota africana (Figure 4.1). Although 4.6 
was isolated as a minor component from B. africana (and may be an artefact of the isolation 
procedure)141 transformations of the major component, 4.4, to 4.6 were well established.142-144 
 
 
 
 
 
Figure 4.1  The southern African plant, B. africana. 
 
Gray et al. thus isolated 4.4 from B. africana and quantitatively converted this compound to 
4.6 (Scheme 4.2) via an iodine mediated dehydration reaction.  Various methods for 
introducing the desired oxygenation at C-6 in 4.6 were attempted, including manganic acetate 
oxidation to give an epimeric mixture of the C-6 acetates of 4.6 (4.7 and 4.8) and eventually 
the stereoselective Rubottom procedure to give 6α-hydroxy hispanone (4.9).  
 
The epimers 4.7 and 4.8 could be readily separated by semi-preparative HPLC, however, 
both compounds proved surprisingly susceptible to acid hydrolysis, yielding a complex 
inseparable mixture of products. Saponification of 4.7 and 4.8 (Scheme 4.3) was similarly 
unsuccessful, yielding only a small amount of the required saponification product, (4.9, 4%) 
as well as the enols (4.10, 26%) and (4.11, 30%). 
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Scheme 4.2  Gray et al.’s100 approaches to oxygenation at C-6. Reagents and conditions: (a) 
I2 (cat.), C6H6, ∆; (b) Mn(OAc)3, C6H6, ∆; (c) LDA, TMSCl, THF, -78°C-RT, 5 h; (d) m-CPBA, 
CH2Cl2, 0°C-RT, 1 h; (e) HCl wash. 
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Scheme 4.3  Saponification of 4.7 and 4.8.100 
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Gray100 consequently attempted Mori’s potassium cyanide catalyzed transesterification 
reaction (Scheme 4.4),145 which yielded the required 4.9 in low yield (15%) and surprisingly 
the Michael adduct 4.1 as the major product (43%). It is this latter product which was of 
interest to us (vide infra).  
 
O
H OOAc
4.7 6α
4.8 6β
O
H OHO
4.1
O
H OOH
4.9
+
KCN, 
EtOH(aq), 
∆, 18 h
CN
 
 
Scheme 4.4  Compounds resulting from Gray’s100 attempts at KCN mediated 
transesterification. 
 
As part of an ongoing screening program with Dow AgroSciences (Indianapolis, USA), twelve 
compounds (4.1, 4.4, 4.6-4.9 and 4.12-4.17) from Gray’s model studies on 4.4 were subjected 
to two insecticidal (beet army worm and tobacco worm), four fungicidal (potato late blight, 
wheat glume blotch, maize smut and wheat leaf blotch) and two herbicidal (bent grass and 
duckweed) tests. Of all these compounds only the nitrile, 4.1, was found to be active, 
specifically against potato late blight.   
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Potato late blight is caused by the pathogenic fungus  Phytophthora infestans and has been 
ranked as the most devastating disease in world agriculture.146 The pathogen acts quickly and 
is capable of laying waste to entire plantings of potatoes within one week of infection.  In the 
late 1840’s this plant pathogen laid waste to the potato crops in Ireland, leading to widespread 
starvation (over one million people died) and forcing an equivalent number of Irish citizens to 
migrate to other countries.146 Today, potato late blight is just as devastating, especially in 
countries such as Russia, where the potato is a staple food. New, more virulent strains are 
emerging and even with modern fungicides, crop losses due to the pathogen are estimated at 
around 15%.146  A need therefore exists for novel fungicides active against P. infestans and 
since 4.1 showed some potential in this regard, Dow AgroSciences were interested in 
performing further in planta assays.  Unfortunately, as 4.1 was only produced as an 
unexpected side product, supplies were limited and more material needed to be provided in 
order for the in planta tests to be carried out. Although time constraints prevented Gray from 
synthesizing more of 4.1, the potential of the diterpene as an agrochemical warranted further 
investigation, particularly since only three reaction steps were required to produce the novel 
compound from a readily available plant natural product derivative, 4.4.   
 
Our aim was, therefore, to extend Gray’s preliminary discovery to: 
 
• provide sufficient amounts of 4.1 for in planta trials at Dow AgroSciences 
• explore more efficient procedures for extracting 4.4 from B. africana 
• investigate the Michael addition in more detail to discover possible nitrile minor 
products 
• establish unequivocally the α position of the C-9 nitrile substituent in this series of 
compounds implied from NOE studies 
• synthesize analogues of 4.1 for structure-activity relationship studies 
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4.2  Collection of plant material and isolation procedures 
 
4.2.1 Collection of B. africana and extraction and isolation of hispanolone, 4.4 
 
A collection of B. africana was made in November 2003 at Woodbury Lodge, Amakhala 
Game Reserve, situated along the N2 between Grahamstown and Port Elizabeth, Eastern 
Cape, South Africa.  The aerial parts of the collected plants were air-dried for two months 
before being steeped in acetone for three days. The acetone extract was subsequently 
decanted, filtered and concentrated in vacuo to a tenth of its original volume. Overnight 
decolourization of the dark green extract with activated charcoal, followed by filtration through 
celite afforded a gold coloured solution. At the same time that we were isolating 4.4 from B. 
africana, we were experimenting with a new chromatographic medium (HP-20) in our 
laboratory (see Chapter Two for more details). We decided to attempt to use this 
chromatographic stationary phase and compare the results with those reported for the 
isolation of 4.4 by Davies-Coleman et al.,141 involving standard silica gel chromatography. The 
decolourized extract concentrate was thus loaded onto an HP-20 column in the manner 
described in Chapter Two and sequentially stripped with aliquots of aqueous acetone in a 
sequence of decreasing polarity in the normal manner. As we routinely “back loaded” the 
60%(aq) acetone fraction onto a second, smaller HP-20 column as a facile method for removal 
of water (metabolites are re-adsorbed onto the HP-20 column and eluted with pure acetone), 
we diluted this fraction to 1.5L with water and were gratified to notice small crystalline plates 
in solution that we suspected to be 4.4.  We allowed this chromatographic fraction to stand for 
four days at 4°C, before filtering off the resultin g white crystalline plates (3.82 g, 1.5%). The 
plates were confirmed to be 4.4 by comparison of the 1H and 13C NMR data of the crystalline 
material with reported data.141  Most importantly, this method also gave nearly double the 
yield (1.52%) of 4.4 from B. africana over that reported (0.8%) for the isolation of this 
compound using standard normal phase chromatographic methods.141  
 
 
 
                                                                                                                            Chapter Four 
 
                                                                                                                                    88                                                                                                                                 
4.3 Semi-synthesis of a diterpene based agrochemical from hispanolone 
 
Although an established protocol142-144 for the dehydration of 4.4 using thionyl chloride already 
existed, Gray100 had had difficulty duplicating their reported yields and instead opted for 
Mangoni and Bellardini’s iodine catalysed dehydration reaction147 for the conversion of 4.4 to 
4.6.148 Accordingly 4.4 was refluxed with catalytic quantities of molecular iodine in anhydrous 
benzene under a Dean-Stark trap.  Initially unable to achieve the same degree of conversion 
(87%) reported by Gray, we attempted the same method but using toluene sulfonic acid as 
the dehydrating agent. After work-up of the toluene sulfonic acid dehydration reaction, only 
the starting material 4.4 was evident by analysis of the 1H NMR spectrum. The presence of 
4.6 would have been discernable by the appearance of a vinylic methyl singlet at δH 1.79 and 
the disappearance of the methyl doublet of 4.4 (δH 1.11).  Ultimately the difficulties with using 
molecular iodine as the catalyst for dehydration were solved by placing 3Å molecular sieves 
in the collecting vessel of the Dean-Stark trap and we were able to achieve almost 
quantitative dehydration (by NMR) after refluxing for 24 hours.  Standard silica flash 
chromatography (5% ethyl acetate, 95% hexane) afforded pure 4.6 (84%) as crystals (from 
methanol), whose data were identical in all respects to those reported for this 
compound.100;141 The mechanism for the iodine catalyzed reaction is not fully understood, 
although Reeve and Doherty149 suggested that the dehydration may proceed via a carbonium 
ion. 
 
Initial attempts at the α'-acetoxylation of 4.6 using manganic acetate were relatively low 
yielding compared with those reported in the literature.150;151  Bush and Finkbeiner152 had 
suggested that the method of preparation of the manganic acetate might influence the yield 
obtained and we thus decided to compare the yields obtained from commercial manganic 
acetate with those from manganic acetate which we had prepared from manganese 
diacetate.153 The α'-acetoxylation reaction was replicated four times, varying either the solvent 
or reagent as presented in Table 4.1. 
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Table 4.1  Summary of conditions for the α'-acetoxylation of 4.6. 
Source of manganic acetate Solvent Time refluxed % Yield (by NMR) 
Aldrich benzene
 
48 hours 100% 
Self-prepared benzene 48 hours 19% 
Aldrich toluene 48 hours 61% 
Self-prepared toluene 48 hours 0% 
 
As can be seen from Table 4.1, the problem lay with the source of the manganic acetate, with 
material bought from Aldrich proving superior, regardless of the solvent used, for the α'-
acetoxylation reaction.  Our reasoning for using toluene as an alternative solvent lay in the 
higher boiling point of this solvent (111°C as comp ared with 80°C for benzene), which would 
enable the solution to be refluxed at a higher temperature. At the same time, we surmised 
that since the reaction requires the removal of water by means of a Dean-Stark trap, 
benzene’s ability to form an azeotropic mixture with water (which toluene lacks) might 
facilitate this removal and thus improve the yields (Table 4.1). From the results presented in 
Table 4.1, benzene proved to be the better solvent for the α'-acetoxylation reaction. 
 
After workup of the reaction in which commercial manganic acetate and benzene were used 
to achieve the α'-acetoxylation of 4.6, 4.7 and 4.8 were successfully separated (in a 5:2 ratio) 
using normal phase HPLC (10% ethyl acetate, 90% hexane) in 66% overall yield. Later 
attempts at α'-acetoxylation of 4.6, in which acetic acid was added to the reaction mixture 
prior to refluxing, failed to improved the yields obtained in this reaction.  Reportedly,150 acetic 
acid increases the solubility of manganic acetate in organic solvents. Our overall yield of 66% 
is nonetheless a substantial improvement over the 19% overall conversion of 4.6 to 4.7 and 
4.8 reported previously.142   
 
Williams and Hunter153 proposed two mechanisms for the α'-acetoxylation of enones using 
manganic acetate.  The first of these is based on the ligand transfer mechanism similar to that 
proposed for the lead tetraacetate mediated oxidation of enones (Scheme 4.5). 
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Scheme 4.5  Ligand transfer mechanism for α'-acetoxylation of 4.6 by manganic acetate.153 
 
The second mechanism proposed (Scheme 4.6) proceeds via ligand transfer to an α-keto 
radical. This radical based mechanism currently appears to be more widely accepted than the 
ligand transfer mechanism.150;154 
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Scheme 4.6  Radical based mechanism for α'-acetoxylation of enones.154 
 
The final step in the synthesis of 4.1 involved the unexpected Michael addition of a cyanide 
nucleophile to an enone during Mori’s145 mild transesterification procedure (Scheme 4.7). 
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Accordingly, a mixture of 4.7 and 4.8 was dissolved in 95% aqueous ethanol in the presence 
in potassium cyanide and refluxed for 24 hours until the starting material could no longer be 
detected by TLC.  After workup, the reaction mixture was subjected to normal phase semi-
preparative HPLC (10% ethyl acetate, 90% hexane) to give 9α-cyano-15,16-epoxy-7β-
hydroxylabda-13(16),14-dien-6-one, 4.1 (45%), 9α-cyano-15,16-epoxy-7-hydroxylabda-
7,13(16),14-trien-6-one, 4.2 (9%), 6-hydroxy-15,16-epoxylabda-5,8,13(16),14-tetraene-7-one, 
4.11 (2%) and 6α-hydroxy-15,16-8,13(16),14-trien-7-one, 4.9 (1%). The data for 4.1, 4.9 and 
4.11 were identical in all respects to those reported by Gray.100  The structure of the new 
minor product, 4.2, was determined from comparison of 1H and 13C NMR data of this 
compound with those of 4.1 as well as by application of standard  2D NMR techniques as 
follows.  
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Scheme 4.7 The Michael addition and transesterified products resulting from refluxing 4.7 
and 4.8 with KCN in EtOH(aq). 
 
The molecular formula (C21H29O3) of 4.2, which differed from that of 4.1 by the loss of two 
hydrogen atoms, was established by HRFABMS data and implied nine degrees of 
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unsaturation, five of which were accounted for by the decalin and furan ring systems.  The 
presence of a nitrile moiety [δC 119.5 (Figure 4.2), supported by an IR stretching band at 2222 
cm-1 and a ketone functionality (δC 193.6) accounted for a further three degrees of 
unsaturation, leaving one degree of unsaturation unaccounted for.  
 
 
Figure 4.2  Downfield 13C NMR spectrum (400 MHz, CDCl3) of 4.2. 
 
Comparison of the 1H and 13C NMR data of known 4.1 with that of new 4.2 indicated that the 
changes in substitution pattern were limited to ring B.  The disappearance of the signals for C-
7 and C-8 (δC 77.3 and 47.1) and the appearance of the two resonances of a tetrasubstituted 
olefin (δC 145.0 and 120.0) implied that these could be assigned to C-7 and C-8 and 
accounted for the outstanding double bond equivalent. The upfield shift of carbonyl C-6 (δC 
193.6) was consistent with that of an α,β-unsaturated ketone, supporting the ∆7 placement of 
the double bond.  The position of the nitrile moiety at C-9 (δC 46.0) was confirmed by three 
bond gHMBC correlations from H-11a and H-11b (δH 1.85 and 1.99) and Me-17 (δH 2.01) to 
the carbon of the nitrile moiety (9-CN, δC 119.5). The 1,2-transposition of the carbonyl 
functionality from C-7 in 4.7 and 4.8 to C-6 in 4.2 (similar to that observed in 4.1) was 
confirmed by a two bond gHMBC correlation from singlet H-5 (δH 2.75) to carbonyl C-6 (δC 
193.6).  The 1H and 13C NMR data and a summary of all gCOSY and gHMBC correlations for 
4.2 is provided in Table 4.2.  A NOESY correlation between H3-20 (δH 1.00) and H-11a 
tentatively suggested an α-axial placement of the nitrile functionality at C-9. This configuration 
ppm (f1)
105.0110.0115.0120.0125.0130.0135.0140.0145.0150.0155.0160.0165.0170.0175.0180.0185.0190.0195.0
C-6 C-7 
C-15 
C-16 
C-13 
C-8 9-CN 
C-14 
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was later confirmed by X-ray analysis of a single crystal of 4.2 grown from hexane/benzene 
(Figure 4.3).  
 
Figure 4.3 A view of a molecule of 9α-cyano-15,16-epoxy-7-hydroxylabda-7,13(16),14-trien-
6-one, 4.2. 
 
We believe that the 1,2-transposition of the ketone functionality in 4.1 probably occurs after 
the saponification of 4.7 or 4.8 and may be an example of the Lobry de Bruijn-Alberda van 
Eckenstein rearrangement, best known in carbohydrate chemistry. As a small matter of 
interest, this already impressively named reaction is an abbreviation of the even more 
spectacularly named Cornelius Adriaan van Troostenbery Lobry de Bruijn and Willem Alberda 
van Eckenstein reaction.155 The general mechanism for this rearrangement reaction in 4.1 is 
shown below (Scheme 4.8) and proceeds via an enolate. 
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Table 4.2 1H (400 MHz), 13C (100 MHz) and 2D NMR data for 9α-cyano-15,16-epoxy-7-
hydroxylabda-7,13(16),14-trien-6-one (4.2) in CDCl3. 
Position 
 
δC 
(mult.) 
 
δH 
(int., mult., J/Hz) 
 
gHMBC 
 
 
gCOSY 
 
1 35.1 (t) 1.80 (2H, m) C-2, C-3, C-10 H2-2 
2 17.8 (t) 1.60 (2H, m) C-1, C-2 H-3a, H-3b, H2-1 
3 41.9 (t) 1.32 (1H, m) 
1.45 (1H, dddd, 
13.5, 3.5, 3.2, 1.1) 
C-1, C-2, C-4, C-5 
C-1, C-2, C-4, C-5 
H-3b, H2-2 
H-3a, H2-2 
4 32.8 (s) - - - 
5 58.6 (d) 2.75 (1H, s) C-3, C-4, C-6, C-7, 
C-10, C-18 
- 
6 193.6 (s) - - - 
7 145.0 (s) - - - 
8 120.0 (s) - - - 
9 46.0 (s) - - - 
10 52.5 (s) - - - 
11 31.6 (t) 1.85 (1H, m) 
 
1.99 (1H, m) 
C-8, C-9, C-10, 
C-12, C-13, 9-CN 
C-8, C-9, C-12, 
C-13,C-20, 9-CN 
H-11b, H2-12 
 
H-11a, H2-12 
12 24.7 (t) 2.82 (2H, m) C-11, C-13, C-14, C-16 H-11a, H-11b 
13 123.6 (s) - - - 
14 110.5 (d) 6.29 (1H, m) C-13, C-15,C-16 H-15, H-16† 
15 143.3 (d) 7.38 (1H, t, 1.7) C-13, C-16 H-14, H-16† 
16 138.8 (d) 7.28 (1H, m) C-13, C-14,C-15 H-14†, H-15† 
17 12.6 (q) 2.01 (3H, s) C-7, C-9, C-10 - 
18 33.4 (q) 1.16 (3H, s) C-3, C-4, C-5, C-19 - 
19 21.5 (q) 1.24 (3H, s) C-3, C-4, C-5, C-18 - 
20 15.7 (q) 1.00 (3H, s) C-1, C-5, C-9, C-10 - 
9-CN 119.5 (q) - - - 
7-OH  6.46 (br s) C-6, C-7, C-8 - 
 
†Weak gCOSY correlations. 
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Scheme 4.8 Mechanism for the post saponification formation of 4.1, incorporating the Lobry 
de Bruijn-Alberda van Eckenstein rearrangement adapted from Jones.155 
 
Although we now had sufficient 4.1 available to perform in planta bioactivity studies, we 
theorized that a simple reduction of the ketone functionality would produce an additional 
analogue of 4.1 for structure-activity relationship studies and might also improve the 
hydrophilicity of the compound. Naturally, aqueous solubility would be a desirable trait in a 
fungicide as this would increase the ease of aqueous application of a fungicide to crops.  
Accordingly we attempted our first reduction of 4.1 (Scheme 4.9) in the standard manner at 
0°C with lithium aluminium hydride and succeeded in  reducing the ketone functionality at C-6 
to yield 4.3. Analysis of the 1H NMR spectrum of the crude reaction mixture also suggested a 
single product, later determined to be 9α-cyano-15,16-epoxy-6β,7β-dihydroxylabda-
13(16),14-diene (4.3). The single peak in the HPLC trace during the purification process 
confirmed that only one product was formed.  Computer modelling of 4.1 (Figure 4.4) 
revealed that the stereoselectivity of this reduction was probably due to steric hindrance from 
the axial Me-17 and equatorial alkyl side chain on the β-face of the ring leading to hydride 
delivery exclusively to the less hindered α-face of the molecule.   Subsequent attempts at 
reduction of the nitrile moiety with lithium aluminium hydride in refluxing tetrahydrofuran 
(Scheme 4.9) led us to the conclusion that the nitrile functionality was stable under these 
conditions, probably as a result of being situated in a sterically hindered locale. 
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Scheme 4.9  Attempted reduction of the nitrile moiety of 4.1 with LAH in refluxing THF. 
 
 
 
Figure 4.4 Stick and space filling representations of the global energy minimum of 4.1. 
 
The structure of 4.3 was readily deduced by comparison of the 1H and 13C NMR spectra with 
those of 4.1.  The reduction of the ketone functionality was confirmed by the absence of a 
carbonyl resonance in the 13C spectrum of 4.3, as well as the appearance of an additional 
oxymethine signal (δC 69.6 and 4.28) in the 1H NMR spectrum. Additionally, the H-5 
resonance that had appeared as a singlet in the 1H NMR spectrum of 4.1 now appeared as a 
doublet in the 1H NMR spectrum of 4.3.  Evidence that the nitrile functionality was still present 
was provided by the 13C NMR resonance at δC 121.0, as well as the IR stretching band at 
2221 cm-1.  Finally, the molecular formula of 4.3 (C21H30NO3), established from HRFABMS 
data for this compound, confirmed the proposed structure. 
 
The axial positioning of the hydroxyl moiety at C-6 was implied by the small values of the J5,6 
(1.9 Hz) and J6,7 (3.2 Hz) coupling constants (Figure 4.5). Additionally, a NOESY correlation 
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between α-axial proton H-5 (δH 1.44) and H-6 (δH 4.28) supported the β-axial position of the 
hydroxyl at C-6.   
 
H
OH
H
OH
H
H
J5,6 = 1.9 Hz
5 6 7
J6,7 = 3.2 Hz
CN
R
R =
O
 
 
Figure 4.5 Schematic representation of the J5,6  and J6,7 coupling constants in diol 4.3. 
 
4.4 Investigating the agrochemical potential of the nitrile-containing furanolabdanes 
prepared from hispanolone 
 
As mentioned earlier, Gray100 screened twelve furanoditerpenes (4.1, 4.4, 4.6-4.9 and 4.12-
4.17) produced during the course of his model synthetic studies on 4.4 for their agrochemical 
potential. Only 4.1 had evinced any significant activity (80% growth inhibition of potato late 
blight at 200 ppm, causative agent P. infestans) in these assays but the limited quantities of 
this compound available had precluded any further in planta screens.  Having semi-
synthesized sufficient quantities of 4.1, as well as two further nitrile-containing analogues, 4.2  
and 4.3, we submitted these compounds to Dow AgroSciences (Indianapolis, USA) for further 
screening. All three compounds were first evaluated for in vitro inhibition of five plant 
pathogenic fungi (wheat germ blotch, potato late blight, rice blast, wheat leaf blotch and maize 
smut) and also brewers yeast.  Paradoxically, compound 4.1 failed to show any significant 
activity against potato late blight in this in vitro screening process, but did show inhibition of 
rice blast (causative agent Magnaporthea grisea).  All three compounds 4.1, 4.2 and 4.3 were 
nonetheless still investigated for their in planta activity by application as one day protectant 
treatments for control of nine different plant pathogenic fungi (barley leaf blotch, cucurbit 
anthracnose, curcurbit powdery mildew, wheat powdery mildew, wheat glume blotch, potato 
late blight, wheat brown rust, rice blast and wheat leaf blotch). In these one day protective 
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assays, all three compounds were active against rice blast at the 200 ppm level. Nitrile 4.1 
also inhibited the growth of wheat brown rust (causative agent Puccinia recondita f.sp. tritici) 
at the 200 ppm level.   
 
Rice blast is generally held to be the most devastating global fungal rice disease.156  The 
pathogen has been reported in 85 different countries (i.e. nearly every rice growing country in 
the world).157 The disease is particularly prevalent in humid and temperate climates since  
spores are rapidly spread  through contaminated water droplets.158;159 Since rice blast has 
been estimated to account for 10-30% of the annual rice crop losses per annum by some159 
and even up to 50% by others,157 the fungus is of considerable economic significance.   
 
Wheat brown rust is also a devastating plant pathogen and the spores of this fungus are 
rapidly spread by wind and also water droplets.160;161  An estimate in the Netherlands placed 
wheat contamination by wheat brown rust at 50%.161  Although timely treatment can retard the 
growth of the sori (destructive fruiting bodies of the fungus) for a period of two to three weeks, 
crop losses in excess of 50% are not uncommon.161 
 
The appearance of fungal strains resistant to existing fungicides creates the ongoing need for 
new fungicides.156;162 As a result, further evaluations of the activity of compounds 4.1 and 4.3 
at increasing dilution were made.  Unfortunately, infection control with more dilute solutions of 
4.1 and 4.3 (Table 4.3) was not as effective as the controls [tebuconazole (4.18) and 
azoxystrobin (4.19)].  The effect of dilution on the activity of 4.2 could not be measured due to 
insufficient quantities being available, but would presumably be similar.  
 
Interestingly, the structure of azoxystrobin, 4.19, a widely used fungicide active against rice 
blast, is based on the natural products strobilurin A (4.20), isolated from the fungus 
Strobilurus, and oudemansin A (4.21), from the fungus Oudemansiella.156;163;164 Both 4.20 and 
4.21 showed weak activity against rice blast prior to the synthesis of analogues such as 
4.19.156;164 The mode of action of 4.19 is believed to be electron transfer inhibition in the 
mitochondrial complex III.164  Tebuconazol, 4.18, is  believed to inhibit sterol 14α-
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demethylation by a haem-thiolate enzyme of the cytochrome P450 superfamily in fungal 
systems.165;166 
 
Table 4.3  One day protectant disease control of compounds 2, 3 and 4 against M. grisea and 
P. recondita. 
Compound Concentration 
(ppm) 
% Control of M. 
grisea 
% Control of P. 
recondita 
4.1 200 90 80 
 50 33 22 
 12.5 21 22 
4.2 200 91 - 
4.3 200 83 56 
 50 29 22 
 12.5 13 0 
Tebuconazole (4.18) 25 63 100 
Azoxystrobin (4.19) 50 99 99 
 25 99 100 
 12.5 99 100 
  
O
NN
O
CN OMeMeO
O
4.19
Cl
OH
N
N
N
4.18
MeO COOMe
MeO COOMe
OMe
4.214.20
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Compounds containing both nitrile functionalities and activity against rice blast are not 
unprecedented. In addition to 4.19, compound 4.22 and related analogues,167;168 as well as 
compound 4.23 and related analogues have proven to be effective agents for rice blast 
control in preliminary investigations.169  
 
NH
O
CN
F
F
O
N
H
O
NC
4.22 4.23
Cl
NH
O
Br
4.24
Cl
 
 
The activity of 4.22 was linked to its ability to inhibit scytalone dehydratase, the enzyme 
responsible for the production of fungal melanin in rice blast.167;168 Rice blast spores bind to 
the rice plant’s hydrophobic cuticle, after which they germinate in as little as two hours and 
then differentiate into appressoria.158;159  These appressoria are the mechanism through 
which the fungus enters the host and this is achieved through the application of mechanical 
force resulting from the generation of immense turgor pressure within the 
appressoria.158;169;170 Fungal melanin, produced by scytalone dehydratase, plays an important 
role in generating the turgor pressure within the appressoria, thus allowing infection to take 
place.170 Inhibition of melanin production thus prevents infection and interrupts the fungal life 
cycle.  Unfortunately, the fungicidal activity of 4.22 was not directly linked to the nitrile moiety. 
In the case of 4.23, Manabe et al.169 attributed the increased activity of the compound against 
M. grisea to the increased solubility afforded through the substitution of a bromine group in 
4.24 for the more hydrophilic nitrile functionality so again, no further conclusions can be 
drawn as to the importance of the nitrile moiety in terms of fungicidal properties.  
 
 
 
 
 
 
                                                                                                                            Chapter Four 
 
                                                                                                                                    101                                                                                                                                 
4.5 Summary and conclusions 
 
An improved method for extracting hispanolone from B. africana using HP-20 resin was 
discovered, increasing yields by nearly 100% over those reported previously.141 Hispanolone 
was successfully dehydrated using catalytic quantities of molecular iodine in yields 
comparable to those reported148 and acetoxylated using manganic acetate.  Commercially 
purchased manganic acetate gave superior results to that
 
synthesized in-house following the 
method suggested by Williams and Hunter.153 Interestingly, the addition of acetic acid to the 
reaction mixture during reflux as suggested by Demir150 failed to produce the superior results 
claimed by these authors.  Nonetheless, we were still able to report a substantial 
improvement in yield of 4.7 and 4.8 over those reported by Garcia-Alvarez et al.142 The 
application of Mori’s potassium cyanide mediated transesterification reaction procedure 
produced two Michael adducts (4.1 and 4.2) as the major components of the reaction mixture, 
one of which (4.2) had not previously been isolated by Gray, and two saponified products, 4.9 
and 4.11. Reduction of the major nitrile containing compound 4.1 yielded the diol 4.3, the 
nitrile moiety proving to be resistant to lithium aluminium hydride reduction. Although the 
ability of compound 4.1 to prevent infection by potato late blight (Phytophthora infestans as 
indicated by preliminary screening) was not confirmed by subsequent screening, compounds 
4.1, 4.2 and 4.3 were found to have significant activity against rice blast (M. grisea) and 4.1 
against wheat brown rust (Puccinia recondita).  Unfortunately, the activity of these 
compounds declined at low concentrations, limiting their potential as commercial fungicidal 
agents.   
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Chapter Five 
The Semi-synthesis of Two Isomeric 
Labdane Diterpene Aldehyde Metabolites from 
Pleurobranchaea meckelii. 
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5.1 Introduction 
 
This chapter describes the semi-synthesis of two isomeric marine molluscan labdane 
diterpene aldehyde metabolites, labd-13E-ene-8β-ol-15-al (5.1) and labd-13Z-ene-8β-ol-15-al 
(5.2) from the commercially available, terrestrial plant derived, labdane diterpene manool 
(5.3). Diterpenes 5.1 and 5.2 were originally isolated from the Mediterranean nudibranch, 
Pleurobranchaea meckelii.50 Selected synthetic diterpenes arising from the syntheses 
described in this chapter were also evaluated for their activity against an oesophageal cancer 
cell line (WHCO1), the details of which conclude the chapter. 
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5.2 The isolation of 5.1 and 5.2 from P. meckelii by Ciavatta et al.171 
 
Nudibranchs belonging to the Order Notaspidea, e.g. the Mediterranean nudibranch 
Pleurobranchaea meckelii (Figure 5.1), secrete a mucous as possible defence strategy to 
deter predation.9;171 An acetone extract of several specimens of P. meckelii, collected by 
SCUBA from the Gulf of Naples, afforded the two isomeric labdane diterpene aldehyde 
metabolites 5.1 and 5.2,171 the syntheses of which are discussed in this chapter.  Diterpene 
metabolites are commonly sequestered by marine opisthobranch molluscs from their marine 
invertebrate diet.9;171 However, a dietary source of 5.1 and 5.2 could not be identified and their 
presence in the skin of P. meckelii seemed to suggest that these two compounds may be the 
products of de novo biosynthesis (See Chapter One).  A defensive role for 5.1 and 5.2 in the 
chemical ecology of P. meckelii was not established experimentally but rather implied from 
the presence of α,β-unsaturated aldehyde moieties in these two compounds.171 
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Figure 5.1  The notaspidean mollusc, P. meckelii (reproduced with the permission of G. 
Cimino).  
 
5.3 Rationale behind the synthesis of 5.1 and 5.2 
 
Bioactivity studies of marine natural products are frequently hampered by the paucities of 
these compounds available for biological study.172 As predators of other marine invertebrates, 
nudibranchs are positioned near the top of the marine invertebrate food chain.44  Therefore, a 
large-scale removal of any nudibranch species, sufficient to supply sufficient quantities of 
bioactive metabolites for chemical ecology and/or other bioactivity studies, has obvious 
deleterious implications for the marine environment.  The semi-synthesis of selected bioactive 
diterpene marine natural products from common terrestrial plant diterpenes provides one 
possible solution to the bioactive marine diterpene supply problem.  
 
Ciavatta et al.171 alluded to the instability of 5.1 and 5.2 and the implications this instability had 
for structure elucidation and further chemical ecology studies. The relative instability of many 
bioactive marine natural products through facile degradation processes, including 
isomerisation on exposure to sunlight and/or chromatographic media, is often problematic. 
Accordingly, a desirable semi-synthetic strategy would be one that can quantitatively deliver a 
relatively unstable marine natural product for bioactivity studies from a stable precursor 
without prior chromatographic purification. Ciavatta et al.171 had determined the absolute 
stereochemistry of 5.1 by reducing the unstable aldehyde functionality with sodium 
borohydride to the stable labd-13E-ene-8β,15-diol (5.4). We determined that manganese 
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dioxide mediated oxidation of 5.4 and its geometric isomer, labd-13Z-ene-8β,15-diol (5.5) 
would provide a facile route to 5.1 and 5.2 respectively.  
 
5.4 Attempted synthesis of 5.1 and 5.2 via a modification of Wisch’s synthetic strategy 
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During his MSc studies in our laboratory, Wisch had previously synthesized 5.4 in low yield 
(3%) from the synthetic precursor, sclareol (2.21, Scheme 5.1).173 This plant-derived 
diterpene served as a useful labdane precursor for the semi-synthesis of 5.1 and 5.2 as it was 
both commercially available and already possessed the correct configurations at C-5, C-9 and 
C-10.  The major difficulty encountered by Wisch in his synthetic approach was the inversion 
of the configuration at C-8. This inversion was ultimately achieved through phosphorus 
oxychloride dehydration of the tertiary hydroxyl at C-8 in the selectively protected diols (5.6 
and 5.7), to afford the 13-tert-butyldimethylsilanyloxy-14,15-bisnorlabd-8(17)-enes (5.8 and 
5.9). These olefins were subsequently oxidized to 13R-tert-butyldimethylsilanyloxy-14,15,17-
trisnorlabdan-8-one (5.10) and 13S-tert-butyldimethylsilanyloxy-14,15,17-trisnorlabdan-8-one 
(5.11) via ozonolysis, allowing for stereospecific nucleophilic addition of a β-equatorial methyl 
functionality at C-8. Deprotection of the tertiary butyldimethylsilyl protected C-13 hydroxyl 
moiety followed by Swern oxidation yielded a small amount of the ketol (5.12).  A further 
problem in this synthesis was the facile intramolecular cyclization of 5.12 to afford 8β,13-
epoxy-14,15-bisnorlabda-12-ene (5.13).   The ∆13 olefin in 5.4 and 5.5 was introduced via a 
Horner-Wadsworth-Emmons (HWE) modification of the Wittig reaction.  
 
                                                                                                                            Chapter Five 
 
                                                                                                                                    106                                                                                                                
H
OH
HO
H
OH
O
H
OH
OH
H
OH
OTBDMS
H
OTBDMS
H
OTBDMS
O
H
OTBDMS
OH
H
OH
OH
H
OH
O
H
OH
COOEt
H
OH
CH2OH
2.21
13
a b
c
de
f
g h
j
i
5.4 ∆13 E
5.5 ∆13 Z
13
5.8 13-(R)
5.9 13-(S)
5.10 13-(R)
5.11 13-(S)
5.20 13-(R)
5.21 13-(S)
5.22 13-(R)
5.23 13-(S)
5.12
5.25 13-(R)
5.27 13-(S)5.26
5.6 13-(R)
5.7 13-(S)
5.32 ∆13 E
5.33 ∆13 Z
 
 
Scheme 5.1 Wisch’s synthetic approach to compounds 5.4 and 5.5.173 Reagents and 
conditions: (a) KMnO4, Me2O, 15°C-RT, 48 h; (b) LAH, THF, 0°C-RT, 2 h; (c) 2, 6-lutidine, 
TBDMS triflate, CH2Cl2, -78°C, 2 h; (d) POCl 3, DMAP, pyridine, 0°C, 3 h; (e) O 3, CH2Cl2, -
78°C,  0.5 h, then PPh 3, RT, 2 h; (f) MeLi, THF, -78°C-RT, 12 h; (g) TBAF,  THF, ∆, 4 h, then 
RT 12 hours; (h) oxalyl chloride, DMSO, CH2Cl2 -78°C, 1h then Et 3N, 1 h, then RT 2 h; (i) 
(C2H5O)2P(O)CH2CO2Et, NaH, THF, RT, 12 h; (j) DIBAH, CH2Cl2, 0°C, 4 h.  
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Time constraints resulted in the termination of Wisch’s synthesis only one oxidation step short 
of the desired target, 5.1, and we decided to repeat his synthesis, however, using 5.3 instead 
of 2.21 as a starting material.  Manool, 5.3, also a commercially available labdane diterpene, 
possessed a structure similar to 2.21 with the exception that the desired ∆8(17)
 
olefin was 
already in place.  Starting with 5.3 thus eliminated the need for the non-selective phosphorus 
oxychloride dehydration step, which was one of the lower yielding steps in Wisch’s synthetic 
route because three vinylic isomers were obtained. Cognizant of the facile intramolecular 
cyclization of 5.12 to 5.13 under Swern conditions, we anticipated that the milder conditions 
associated with Dess-Martin periodinane oxidation might reduce the tendency of 5.12 to 
cyclise to 5.13. 
 
Our modified synthesis (Scheme 5.2) was similarly initiated with potassium permanganate 
mediated oxidative cleavage of the terminal olefin of 5.3 to yield 14,15-bisnorlabd-8(17)-ene-
13-one (5.14), which provided a ketone functionality at C-13, suitable for the later introduction 
of an olefin at this position. The 1H NMR spectrum of the crude reaction mixture revealed a 
characteristic deshielded methyl ketone singlet (H3-16, δH 2.08) and the retention of the ∆8(17) 
olefinic resonances (δH 4.82 and 4.43), confirming the regioselective oxidative cleavage of the 
∆14
 
olefin. Similarly, the 13C NMR spectrum (Figure 5.2) revealed the appearance of a ketone 
carbon (δC 209.1, C-13) and the retention of two olefinic resonances attributable to C-8 [δC 
148.4, (s)] and C-17 [δC 106.3, (t)]. Methyl ketone 5.14 was purified by silica flash 
chromatography (10% ethyl acetate, 90% hexane) and the 1H and 13C NMR data and specific 
rotation data for this compound were identical with published data.174;175  
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Scheme 5.2 Proposed synthesis of 5.1 and 5.2. Reagents and conditions: (a) KMnO4, 
PTEACl, CH2Cl2, 16°C-RT, 48 h; (b) LAH, THF, 0°C-RT, 3 h; (c) 2,6  lutidine, TBDMS triflate, 
CH2Cl2, -78°C, 2 h; (d) O 3, CH2Cl2, -78°C, 10 min, then PPh 3, RT, 4 h; (e) MeLi, THF, -78°C-
RT, 14 h; (f) TBAF, THF, ∆, 4 h; (g) oxalyl chloride, DMSO, CH2Cl2 -78°C, 1h then Et 3N, 1 h, 
then RT 3 h; (h) (C2H5O)2P(O)CH2CO2Et, NaH, THF, RT, 12 h; (i) DIBAH, CH2Cl2, 0°C, 4 h; (j) 
MnO2, CH2Cl2.  
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Figure 5.2  The 13C NMR spectra (100 MHz, CDCl3) of 5.3 (top), 5.14 (middle) and 5.15 
(bottom). 
 
Our initial attempts at the permanganate oxidation of 5.3 to afford 5.14 proved to be low 
yielding (36%).  We thus decided to try and improve the workup by adsorbing the organic 
material from the manganese dioxide dominated reaction mixture onto HP-20 polystyrene 
beads. Attempted centrifugation to separate the HP-20 beads from the thick brown precipitate 
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of manganese dioxide produced by the reaction was unsuccessful. Further attempts to 
separate the HP-20 beads from the manganese dioxide via flushing the beads out with water 
were similarly ineffective.  Reduction of the manganese dioxide with a solution of oxalic acid 
and sodium thiosulfate,176 followed by extraction of the organic component in the usual 
manner, only resulted in a modest improvement (ca. 5%) to the isolated yield of 5.14.  A 
compromise between the different workup methods, i.e. first filtering the reaction mixture 
through celite and then reducing the remaining manganese dioxide did not improve the yield, 
although this method was preferred since it reduced the amount of oxalic acid and sodium 
thiosulphate required for the reduction. Finally, by changing the solvent employed in the 
reaction from acetone to dichloromethane and adding the phase transfer catalyst, 
phenyltriethylammonium chloride (PTEACl),177 5.14 was consistently obtained in 56% yield. 
This yield was in accordance with the yields reported for the oxidation of an analogous 
labdane diterpene, larixol (3.29) to the corresponding diketone (5.16),176 but somewhat less 
than the 93% alluded to by do Céu Costa et al.177 
 
H OH
OH
3.29
H OH
O
5.16
 
 
Although the C-13 ketone was required for later elaboration of the alkyl side chain, it was 
deemed necessary first to introduce the correct configuration at C-8.  Oxidation of the ∆8(17)
 
olefin to a ketone would allow stereospecific alkylation with methyl lithium (Scheme 5.2, step 
e). Initially, we opted to protect the C-13 ketone and reduction of 5.14 with lithium aluminium 
hydride in anhydrous tetrahydrofuran afforded the C-13 epimers, 14,15-bisnorlabd-8(17)-ene-
13R-ol (5.15) and 14,15-bisnorlabd-8(17)-ene-13S-ol  (5.17) in an 8:7 ratio (93% combined 
isolated yield) after purification by semi-preparative HPLC (14% ethyl acetate, 86% hexane). 
The disappearance of the C-13 carbonyl resonance in the 13C NMR spectrum of 5.14 and the 
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appearance of an NMR chemical shift attributable to an oxymethine at C-13 (δC 68.9 for 5.15) 
is shown in Figure 5.2. Although compounds 5.15 and 5.17 had been reported previously in 
the chemical literature,178;179 neither had been fully characterized (1H and 13C NMR data 
incomplete, specific rotation data not provided). The fully assigned 1H and 13C NMR data and 
specific rotations of both 5.15 and 5.17 are provided in Chapter Seven. We thus decided to 
determine the configuration at C-13 by means of the modified Mosher’s method as described 
in Chapter Three and prepared the (R)- and (S)-MTPA esters (5.18 and 5.19 respectively) of 
5.17 in the usual manner.123;125  Diterpene 5.17 also proved a useful model compound for the 
determination of the configuration of secondary alcohols and was used as a trial compound to 
practise the modified Mosher’s method prior to the determination of the configuration at C-3 in 
3.4 (Chapter Three). The 1H and 13C NMR data for each of these compounds were fully 
assigned using gCOSY, gHMBC and gHSQC experiments and a summary of the 1H ∆(δS-δR)  
values is provided in Figure 5.3. 
 
The protection of alcohols 5.15 and 5.17 was necessary to prevent an intramolecular 
cyclization from occurring subsequent to oxidation of the exocyclic ∆8(17)
 
olefin (vide supra).  
As Wisch had previously found a silyl ether protecting group to be stable to the reaction 
conditions employed later in the synthesis, yet readily removed by treatment with tetra-n-
butylammonium fluoride (TBAF), we adopted the same protection strategy.  Separation of the 
C-13 epimers 5.15 and 5.17 by semi-preparative HPLC proved time consuming, particularly at 
this early stage in the synthesis, and a mixture of 5.15 and 5.17 (purified by silica flash 
chromatography) was thus reacted with t-butyldimethylsilyl trifluoromethane sulfonate in 
anhydrous dichloromethane and the base 2,6-lutidine to yield the silyl ethers 5.8 and 5.9 in 
81% combined isolated yield. Unfortunately, 5.8 and 5.9 proved inseparable by semi-
preparative HPLC (hexane).  The 1H and 13C NMR spectra (Figure 5.4) of the mixture of 5.8 
and 5.9 revealed the characteristic signals at [δH 0.04 (6H) and 0.88 (9H)] and (δC -4.5, -4.7 
and 25.9) of the tertiary butyldimethylsilyl ether and the molecular formula (C24H47SiO, [M + 
H]+) of the protected epimers was confirmed by HRFABMS data. 
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1H number δH (S)-MTPA ester (5.18) δ (R)-MTPA ester (5.19) ∆(δS-δR) 
H-1a 0.98 0.91 +0.07 
H-1b 1.67 1.62 +0.05 
H-2a 1.45 1.44 +0.01 
H-2b 1.54 1.53 +0.01 
H-3a 1.16 1.16  0.00 
H-3b 1.38 1.37 +0.01 
H-5 1.06 1.02 +0.04 
H-6a 1.30 1.26 +0.04 
H-6b 1.70 1.68 +0.02 
H-7a 1.93 1.90 +0.03 
H-7b 2.35 2.32 +0.03 
H-9 1.58 1.48 +0.10 
H-11a 1.24 1.23 +0.01 
H-11b 1.37 1.37  0.00 
H-12a 1.38 1.29 +0.09 
H-12b 1.83 1.77 +0.06 
H-13 5.10 5.12 -0.02 
H3-16 1.24 1.31 -0.07 
H-17a 4.39 4.22 +0.17 
H-17b 4.77 4.69 +0.08 
H3-18 0.86 0.85 +0.01 
H3-19 0.79 0.78 +0.01 
H3-20 0.63 0.57 +0.06 
 
Figure 5.3 1H chemical shifts (600 MHz, CDCl3) and calculated ∆δ values obtained from the 
application of the Modified Mosher’s method to 5.17. 
 
Following the successful protection of 5.15 and 5.17, we were in a position to perform a 
reductive ozonolysis of the ∆8(17) olefin of 5.8 and 5.9 to afford the ketones 5.10 and 5.11.  
Accordingly, a constant stream of ozone was bubbled through a solution of 5.8 and 5.9 in 
anhydrous dichloromethane until the solution had changed to a deep blue colour, indicating 
that the solution was saturated with ozone. The reaction mixture was purged of ozone with 
nitrogen, triphenylphosphine added, and the solution stirred at room temperature.  Once 
reduction of the ozonide intermediate had been confirmed by TLC, hydrogen peroxide was 
added to the solution to precipitate any remaining triphenylphosphine as triphenylphosphine 
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oxide, which could be removed by filtration through a silica plug. The C-13 epimers 5.10 and 
5.11 were then separated by semi-preparative HPLC (5% ethyl acetate, 95% hexane) in an 
89% combined isolated yield. Analysis of the 13C NMR spectrum of 5.10 (Figure 5.4) revealed 
the disappearance of the ∆8(17) olefinic resonances present in the 13C NMR spectra of 5.8 and 
5.9 and the appearance of the expected endocyclic ketone resonance (δC 212.0 in 5.10). 
Further comparison of the 1H and 13C data of 5.10 and 5.11 with those reported for the 
corresponding compounds by Wisch173 confirmed that the desired compounds had been 
obtained.  
 
Having successfully synthesized compounds 5.10 and 5.11 we were now able to perform the 
stereospecific alkylation of the C-8 carbonyl to introduce the desired configuration at this 
position. After reviewing the literature pertaining to the nucleophilic addition of a methyl 
functionality to similar cyclohexanone-type systems,180;181 Wisch concluded that methyl lithium 
would be the most effective alkylating agent, and later demonstrated by means of GLC 
analysis of the products from this reaction that the nucleophilic addition of the methyl 
functionality at C-8 using methyl lithium gave a single product. Subsequent NMR analysis 
confirmed a β-axial hydroxyl functionality at this stereocentre as described below.   
 
Methyl lithium was thus added drop wise to a cooled (-78°C) solution of 5.10 or 5.11 in 
anhydrous tetrahydrofuran.  After quenching the reaction, and subsequent workup, the 
reaction mixture was purified by semi-preparative HPLC (10% ethyl acetate, 90% hexane) to 
yield both the tertiary alcohols (5.20 or 5.21), in the same isolated yield of 82%. The 
disappearance of the C-8 carbonyl resonance at ca. 212 ppm in the 13C spectra and 
appearance of a downfield methyl singlet at ca. 1.12 ppm in the 1H NMR spectra of both 5.20 
and 5.21 relative to 5.10 and 5.11 respectively suggested that the addition of a methyl 
functionality at C-8 had been successful. The configuration at C-8 was confirmed by analysis 
of the 1H and 13C NMR spectra of 5.20 and 5.21. The configuration at C-8 (β-axial hydroxyl 
and α-equatorial methyl functionalities) in 5.20 (and similarly for 5.21) was supported by 
threefold spectroscopic evidence, which included the deshielding of the H3-20 angular methyl 
protons (δH 0.94), the shielding of C-6 (δC 18.1) and downfield shift of the C-17 methyl carbon 
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resonance (δC 30.6).171;182;183 The shielding of the C-6 resonance is attributed to a γ-gauche 
affect associated with a β-axially orientated hydroxyl functionality at C-8.184 Conversely, an 
8α-methyl substituent shields the H3-20 protons (δH 0.80), the C-17 methyl carbon resonance 
is shifted upfield (δC 24.0) while the C-6 resonance is shifted downfield (δC 20.5).171;185 The 
13C NMR spectrum of 5.20 is included in Figure 5.4. 
 
 
 
Figure 5.4 The 13C NMR spectra (100 MHz, CDCl3) of 5.8 and 5.9, 5.10, 5.20 and 5.22. 
 
The next step in our synthesis required the elaboration of the alkyl side chain with the correct 
bond geometry. To achieve this, the protecting group was removed  by refluxing a 
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tetrahydrofuran solution of either 5.20 or 5.21 and tetra-n-butylammonium fluoride and 
purification of the reaction products by semi-preparative HPLC (50% ethyl acetate, 50% 
hexane) to afford diols (5.22) and (5.23) in 87% isolated yield. Analysis of the 13C NMR 
spectra of 5.22 (Figure 5.5) and 5.23 revealed the disappearance of the characteristic methyl 
resonances of the protecting group at (δC 25.9, -4.4 and -4.7) in both compounds. After slow 
evaporation from ether, crystals of 5.22, suitable for X-ray diffraction were obtained.  The 
crystal structure of 5.22 (Figure 5.5) confirmed the absolute configuration at both C-8 and C-
13. The secondary structure of 5.22 is of interest as it appears to comprise an infinite ribbon 
of hydrogen bonded molecules in which both C-8 and C-13 hydroxyl groups act as both a 
hydrogen bond donor and acceptor (Figure 5.6) and is reminiscent of a supramolecular 
zipper.186 We were unable to crystallize 5.23, which might suggest that a similar molecular 
zipper arrangement is not possible for this epimer.  
 
Figure 5.5 A view of a molecule of 14,15-bisnorlabd-8(17)-en-8β,13R-diol, 5.22, from the 
crystal structure. 
 
Swern oxidation of the secondary alcohol of 5.22 and 5.23 as described by Wisch,173;187 failed 
to yield the desired ketone product, 5.12, but instead resulted in a complex mixture of 
products as determined from inspection of the 1H and 13C NMR spectra of the reaction 
mixture. Monitoring of the reaction by TLC had shown that all the starting material had been 
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consumed, yet analysis of the 13C NMR spectrum of the reaction mixture and testing for a 
ketone functionality in the reaction mixture with 2,4-dinitrophenol hydrazone (2,4-DNP 
reagent) confirmed that this functional group was not present.  Wisch had only attempted this 
reaction once and we thus forced to conclude that his results were not reproducible. 
 
Figure 5.6 A portion of the infinite ribbon formed by molecules of 5.22 from the crystal 
structure. 
 
 An alternative oxidation procedure, using Dess-Martin periodinane (DMP),188 had been 
contemplated from the outset of the synthesis in the hope of improving the yields from the 
Swern oxidation. Dess-Martin periodinane (5.24) is an efficient oxidizing agent, suitable for 
the oxidation of primary alcohols to aldehydes and secondary alcohols to ketones.188;189 The 
oxidation occurs under mildly acidic to neutral conditions188;189 and we thus hoped that by 
using this milder oxidizing agent, we would be able to isolate 5.12 as the major product from 
the oxidation of 5.22 or 5.23 and avoid the competing cyclization to (5.13). 
 
O
I
O
OAcAcO
OAc
5.24
 
                                                                                                                            Chapter Five 
 
                                                                                                                                    117                                                                                                                
Since we had exhausted our supplies of 5.22 and 5.23 in our earlier attempts at the Swern 
oxidation, we instead used 14,15-bisnorlabda-8α,13R-diol (5.25, Scheme 5.3) as a model 
compound.  Model compound 5.25 was readily obtained from the potassium permanganate 
oxidation of 5.21 to 8α-hydroxy-14,15-bisnorlabda-13-one (5.26, Scheme 5.1) and 
subsequent reduction of 5.26 with lithium aluminium hydride to yield 14,15-bisnorlabda-
8α,13R-diol 5.25 and its C-13 epimer 14,15-bisnorlabda-8α,13S-diol (5.27).  The attempted 
Dess-Martin oxidation of 5.25 in anhydrous tetrahydrofuran,188 afforded the tricyclic ether 
(5.28, Scheme 5.3) as the major product. Further attempts at the Dess-Martin periodinane 
oxidation in acetonitrile at both 0°C and 24°C were  similarly unsuccessful.  Finally, a one pot 
oxidation and HWE reaction, using Dess-Martin periodinane as oxidant and either 
tetrahydrofuran or acetonitrile as solvent, was attempted. When tetrahydrofuran was used as 
a solvent, the oxidation procedure was allowed to run for one hour, before deprotonated 
triethylphosphonoacetate (in tetrahydrofuran) was added drop wise and stirring continued 
overnight. Conversely, when acetonitrile was used as a solvent, the oxidation was allowed to 
run for one hour, before 5% aqueous sodium bicarbonate was added and the organic and 
aqueous fractions separated. The organic fraction was dried with anhydrous magnesium 
sulfate and concentrated to dryness in vacuo.  After further drying of the reaction mixture on a 
freeze dryer for two hours, this mixture was immediately taken up in anhydrous 
tetrahydrofuran, deprotonated triethylphosphonoacetate in tetrahydrofuran added, and the 
reaction allowed to stir overnight at ambient temperature.  After workup of both the reaction 
mixtures, semi-preparative HPLC (33% ethyl acetate, 67% hexane) afforded 5.28, from both 
the oxidation performed in tetrahydrofuran (46%) and acetonitrile (38%).  Analysis of the 13C 
NMR spectrum of 5.28 revealed the absence of any ester or carbonyl resonances, but the 
spectrum did contain resonances attributable to a trisubstituted olefin [δC 147.9 (s) and 94.6 
(d)], which were consistent with those reported for 5.28. Comparison of the remaining 1H and 
13C NMR data of 5.28 as well as the specific rotation with those previously reported for the 
compound,100 confirmed that we had isolated 5.28 from the reaction mixture. Bigley et al.190 
had also reported that 5.26 readily dehydrated to 5.28 in solution at room temperature and 
quantitatively in the presence of even trace amounts of acid.  Since the mechanism (Scheme 
5.3) proceeds via 5.26, we deemed the oxidation to have been successful, but unfortunately 
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the concomitant cyclization appeared unavoidable. Although reportedly 5.28 can be hydrated 
to 5.26 (and by analogy 5.13 to 5.12) using aqueous methanolic acetate or methanolic 
semicarbazide acetate,191 Bigley et al.190 had been unable to reproduce this hydration, and 
were only able to achieve partial hydration of 5.28 to 5.26 using aqueous methanolic acid at 
room temperature. Since partial conversion of 5.13 to 5.12 would not be adequate for our 
needs, we decided not to pursue this synthetic approach any further. 
HO
OH
H
DMP O
H
H
O
H
O
O
H
H
O
OH
H
H
O
5.25 5.26
5.28
 
 
Scheme 5.3 Tentative mechanism for the formation of 5.28 from 5.25.100 
 
Our failure to repeat Wisch’s synthesis, even with some modification, required us to 
investigate another synthetic approach to 5.4 and 5.5. Two non-stereoselective syntheses of 
5.4 and 5.5 had been reported.64;192  A racemic mixture of 5.4 had previously been obtained in 
good yield through the biomimetic cyclization of (E,E,E)-geranylgeranyl acetate in the 
presence of a mercury (II) triflate/N,N-dimethylaniline cyclization complex.64 This method was 
deemed unsuitable as our goal was a stereoselective synthesis of 5.1 and 5.2. 
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Popa et al.192 had serendipitously synthesized 5.4 (and 5.29, the 8α-hydroxy epimer of 5.4) 
via a series of successive MnO2 and Ag2O oxidations of 5.3 to yield (5.30).  The ∆8(17) olefin of 
the final oxidation product, 5.30, was subsequently epoxidised with perphthalic acid and 
reduced with lithium aluminium hydride to afford 5.4 and 5.29 as the minor and major 
products respectively. A search of the chemical literature revealed examples of epoxidation of 
the ∆8(17) olefin in related diterpenes, where the formation of the α-epoxide is always favoured 
(75-80%) over the β-epoxide (20-25%).178;193-195 As only the minor product, the β-epoxide, 
could be reduced to afford the desired configuration at C-8, this method was not viable. 
 
5.5 Synthesis of 5.1 and 5.2 via a regioselective HWE reaction performed on 5.31 
 
Having decided against a synthetic route involving the epoxidation of the ∆8(17)
 
olefin, we 
opted for a strategy (Scheme 5.4) dependent on a regioselective HWE reaction performed on 
14,15,17-trisnorlabdane-8,13-dione (5.31). From past experience with labdane diterpenes, we 
knew that C-8 is sterically hindered by β-axial Me-20 and the β-equatorial alkyl chain at C-9, 
and we thus reasoned that this situation might lead to preferential attack at the less hindered 
ketone at C-13 of 5.31. Although 5.31 could readily be accessed via reductive ozonolysis of 
5.14 (or another suitable precursor, vide infra), it was hoped that by performing the HWE 
reaction on 5.31, regioselective olefination at C-13 would occur to afford two ∆13 geometric 
isomers, ethyl 17-norlabd-13-E-en-8-one-15-oate (5.32) and ethyl 17-norlabd-13-Z-en-8-one-
15-oate (5.33). At this stage there were two possible options, the first being to attempt a 
regioselective and stereospecific methylation of the C-8 ketone functionality.  Reetz et al.196 
had demonstrated that a ketone could be preferentially methylated in the presence of an ester 
functionality using methyl titanium trichloride, generated by treating methyl lithium with 
titanium tetrachloride at -78°C. Should the methyl titanium chloride reaction prove effective in 
yielding the desired C-8 alcohols, ethyl labd-13-E-en-8β-ol-15-oate (5.34) and ethyl labd-13-
Z-en-8β-ol-15-oate (5.35), facile reduction of the ester moiety would yield the desired diols, 
5.4 and 5.5.  If the methyl titanium chloride reaction did not prove to be regioselective, the 
second option would be to protect the ketone at C-8 as an acetonide (5.36 and 5.37), reduce 
the ester moieties to the corresponding alcohols, (5.38 and 5.39) with lithium aluminium 
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hydride followed by deprotection to afford (5.40 and 5.41).  A number of methods existed for 
this acetonide deprotection, including mild methods such as the addition of catalytic quantities 
of molecular iodine in acetone197 or montmorillonite clay in acetone.198 We would then be able 
to perform the methyl lithium reaction on 5.40 and 5.41 to afford 5.4 and 5.5, without any 
competing reactions occurring.  
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Scheme 5.4 Proposed alternative route to 5.4 and 5.5. Reagents and conditions: (a) PCC, 
CH2Cl2, RT; (b) O3, CH2Cl2, -78°C then PPh 3, RT; (c) (C2H5O)2P(O)CH2CO2Et, NaH, THF, RT; 
(d) CH3TiCl3, Et2O, -30°C to -10°C (e) LAH, THF, 0°C to RT; (f) HOCH 2CH2OH, p-TsOH, 
C6H6; (g) I2 or montmorillonite clay, Me2CO, RT; (h) MeLi, Et2O, -78°C to RT. 
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Diketone 5.31 could be accessed in a number of different ways. One of the earliest cited 
methods was to increase the temperature during the potassium permanganate oxidation of 
5.3, thus also increasing the proportion of 5.31 to 5.14 to a maximum reported yield of 36%.174 
Alternatively, we could use the known O3/ triphenylphosphine reaction,174;199-201 which we had 
already employed on the methyl ketone 5.14, although this route provided 5.14 in low overall 
yield from 5.3 because of the initial low yielding (56%) potassium permanganate  oxidation of 
5.3.  Another reported method for the synthesis of the diketone involved the use of osmium 
tetroxide and periodic acid
 
on manool at pH 6.202  The high cost and toxicity of osmium 
tetroxide was a major deterrent for us and we consequently devised a new method to effect 
this transformation. A pyridinium chlorochromate oxidation of 5.3 (Scheme 5.4) was chosen 
as this reaction involves a migration of the ∆14 olefin to ∆13 with concomitant oxidation of the 
transposed alcohol functionality to yield (E)-labda-8(17)dien-15-al (5.42) and (Z)-labda-
8(17)dien-15-al (5.43),203 which could easily be converted to 5.31 by reductive ozonolysis. 
 
Manool, 5.3, was thus reacted with pyridinium chlorochromate to yield the aldehydes, 5.42 
and 5.43.203;204 Analysis of the 1H NMR spectrum of the reaction mixture immediately revealed 
the presence of two pairs of deshielded doublets (δH 9.97 and δH 9.82) which corresponded to 
the aldehyde protons of the E and Z isomeric aldehydes (ratio 2:1). The combined yield of 
5.42 and 5.43 was 90% after silica flash chromatography (6% ethyl acetate, 94% hexane) of 
the reaction mixture. The remainder of the 1H and 13C NMR data of the column purified 
reaction mixture were consistent with those in the literature.203;204 The aldehydes, 5.42 and 
5.43, were unstable, which required that the ozonolysis reaction was performed immediately 
after the purification step. 
 
The ozonolysis procedure followed was identical to that previously discussed for the 
ozonolysis of 5.8 and 5.9.  After ozonolysis and reduction of the resultant ozonide with 
triphenylphosphine, the reaction mixture was purified by silica flash chromatography (50% 
ethyl acetate, 50% hexane) to afford 5.31 in 78% yield as the sole product.  Diketone 5.31 
could easily be distinguished from the mixture of aldehydes comprising the starting material, 
5.42 and 5.43, by the appearance of a deshielded methyl singlet in the 1H NMR spectrum (δH 
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2.07, Figure 5.7), the absence of any olefinic and aldehyde resonances in the 13C NMR 
spectrum of  5.31. 
 
 
Figure 5.7 The 1H NMR (400 MHz, CDCl3) spectra of 5.31 (top), 5.32 (middle) and 5.34 
(bottom). 
 
With an efficient procedure for the synthesis of diketone 5.31 (71% overall yield from 5.3) in 
place, we were able to attempt a regioselective olefination of the more accessible methyl 
ketone functionality of 5.31 via the HWE reaction (Scheme 5.5). The Horner-Wadsworth-
Emmons modification of the Wittig reaction is an important tool for the preparation of alkenes 
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and utilizes resonance stabilized phosphonate anions (e.g. 5.44), which react with ketones 
and aldehydes under mildly basic conditions to form intermediate betaines (e.g. 5.45 and 
5.46).205;206 An irreversible decomposition of the betaine through the syn elimination of oxygen 
to the phosphorus atom via a four membered transition state (e.g. 5.47 and 5.48) occurs to 
afford an olefin (e.g. 5.32 and 5.33).  The bond geometry of the olefin formed, for example, in 
the HWE reaction performed on 5.31 is determined by the relative stabilities of 5.47 and 5.48. 
This stability is influenced by the degree of steric interaction between the ethoxycarbonyl 
functionality and the adjacent methyl or alkyl groups,100;205;206 making the trans-
diastereoisomer (5.47) more stable, and hence leading to preferential formation of the E-
alkene. Resonance stabilized phosphonates are generally used to prepare trans olefins, 
although the degree of selectivity is diminished when ketones are used rather than 
aldehydes.207 The preparation of cis olefins requires an aldehyde precursor and the use of 
customized HWE reagents at low temperatures (-78°C) , a base e.g. potassium 
hexamethyldisilazane (KHMDS) and the expensive potassium chelating agent, crown ether 
18C6.208  
 
In our early attempts at using the HWE reaction using only one equivalent of 
triethylphosphonoacetate, we found that we were routinely reisolating unreacted 5.31 from the 
reaction mixture and we accordingly adjusted the proportion of reagents relative to 5.31, 
ultimately finding that using three equivalents of triethylphosphonoacetate and two and a half 
equivalents of sodium hydride maximized yields of ethyl 17-norlabd-13-E-en-8-one-15-oate, 
5.32, and ethyl 17-norlabd-13-E-en-8-one-15-oate, 5.33. The tricyclic isomeric compounds, 
ethyl 17-norabiet-13(15)-E-en-8β-ol-16-oate (5.49) and ethyl 17-norabiet-13(15)-Z-en-8β-ol-
16-oate (5.50) were also isolated as minor products. The proportion of base to 
triethylphosphonoacetate was kept below 1:1 as we reasoned that 5.49 and 5.50 were 
forming from a base catalyzed aldol condensation of 5.31 to 5.51, which subsequently 
underwent an HWE reaction at C-13. The structural elucidation of the tricyclic products, 5.49 
and 5.50, will be discussed later (Chapter Six, Section 6.2). The desired ethyl esters, 5.32 
and 5.33, were isolated from the reaction mixture in 74% combined overall yield (E/Z ratio 
3:1) via normal phase HPLC (6% ethyl acetate, 94% hexane). 
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Scheme 5.5 Mechanism for the HWE reaction between triethylphosphonoacetate and 5.31.207 
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The molecular formula (C21H36O3) of 5.32 was established from HRFABMS data and implied 
five degrees of unsaturation, two of which could be attributed to an α,β-unsaturated ester, one 
to a carbonyl functionality and the remaining two to the decalin ring system of 5.32. 
Preliminary analysis of the 13C NMR spectrum 5.32 revealed the retention of one ketone 
functionality (δC 211.7) and the appearance of chemical shifts attributable to an unsaturated 
ethyl ester functionality [δC 166.8 (s), 160.1 (s), 115.7 (d), 59.4 (t), 14.3 (q)]. Comparison of 
the 1H and 13C NMR data of 5.31 and 5.32 (Figure 5.7) limited the differences to the alkenoate 
side chain of these two compounds. gHMBC correlations of 5.31 (see Table 5.1 and Figure 
5.8) from each of H-7b (δH 2.41), H-7a (δH 2.27), H-9 (δH 1.99), H2-11 (δH 1.36) and H-12a (δH 
                                                                                                                            Chapter Five 
 
                                                                                                                                    125                                                                                                                
1.87) to C-8 (δC 211.7) confirmed that the ketone functionality remained at C-8, and hence 
that preferential olefination had occurred at C-13. The regioselective olefination at C-13 was 
also implied by a downfield chemical shift of H3-16 (adjacent to C-13) from δH 2.07 to δH 2.13 
from comparison of the 1H NMR spectra of 5.31 and 5.32 (Figure 5.7). The gHMBC 
correlations used to confirm the structure of the alkenyl side chain are shown in Figure 5.8. 
The E bond geometry of the ∆13 olefin in 5.32 was determined from 13C NMR chemical shifts 
of methyl C-16 and methylene C-12 (δC 18.7 and 40.2 respectively).99;102 Similarly, the 
presence of a Z ∆13 olefin in 5.33 was determined from the 13C NMR chemical shift of the 
vinylic Me-16 carbon resonance (δC 25.0) and the allylic methylene C-12 signal (δC 32.6). The 
two minor tricyclic products from the same HWE reaction (5.49 and 5.50), were isolated in 9% 
combined yield (E/Z ratio 7:2). 
 
As mentioned in the earlier discussion of our new synthetic route to 5.4 and 5.5, the 
ketoesters, 5.32 and 5.33, were required to attempt a chemoselective alkylation of the ketone 
functionality at C-8 in the presence of the α,β-unsaturated ester in the alkenyl chain.  Reetz et 
al.196 had reported the preferential alkylation of a ketone moiety over that of an ester 
functionality using a non-basic methyl titanium trichloride reagent. This reagent is generated 
by ligand exchange between methyl lithium of methyl Grignard reagents and titanium 
tetrachloride.196;209 In the transition state of carbonyl addition using titanium based alkylation 
agents, the reagent and substrate are bound tightly together, since the carbonyl-titanium bond 
is shorter than other metal-oxygen bonds.196;209 This short carbonyl-titanium bond facilitates 
discrimination between various ketones and aldehydes and other different carbonyl containing 
functionalities e.g. esters based on steric factors.196 We accordingly attempted to prepare the 
methyl titanium chloride under the conditions described by Reetz et al.196 using methyl lithium 
and titanium tetrachloride in ether at -78°C, but a ll attempts at using this reagent on 5.32 were 
unsuccessful, yielding only starting material upon purification.  We believe this was possibly 
due to water in either the distilled solvents or titanium tetrachloride, which prevented the 
formation of the methyl titanium chloride reagent at the small scale (0.06 mmol of 5.32) at 
which the reaction was being performed.  
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Table 5.1 1H (400 MHz), 13C (100 MHz), gCOSY and gHMBC NMR data for 5.32 in CDCl3. 
Position δC (mult.) 
 
δH 
(int., mult., J/Hz) 
 
gHMBC gCOSY 
1a 
  b 
39.3 (t) 1.14 (1H, ddd, 13.2, 12.2, 4.9) 
1.74 (1H, m) 
2, 9, 10, 20 
2, 3, 10, 20 
1b, 2 
1a, 2 
2 19.0 (t) 1.50 (2H, m) 1, 4, 10 1a, 1b, 3a, 3b 
3a 
  b 
41.9 (t) 1.23 (1H, m) 
1.44 (1H, m) 
1, 2, 4, 18, 19 
1, 18, 19 
2, 3b, 18  
2, 3a 
4 33.7 (s) - - - 
5 54.3 (d) 1.46 (1H, m) 1, 4, 6, 7, 9, 
10, 20, 18, 19 
6a, 6b 
6a 
  b 
24.1 (t) 1.64 (1H, dddd, 13.3,  
13.1, 13.0, 5.0) 
2.05 (1H, m) 
5, 7 
 
5, 7 
5, 6b, 7a, 7b 
 
5, 6a, 7a, 7b 
7a 
  b 
42.6 (t) 2.27 (1H, ddd, 13.3, 7.2, 6.8) 
2.41 (1H, ddd, 13.2, 4.8, 2.1) 
5, 6, 8 
5, 6, 8, 9 
6a, 6b, 7b 
6a, 6b, 7b 
8 211.7(s) - - - 
9 63.2 (d) 1.99 (1H, m) 1, 7, 8, 12, 20 11a, 12a 
10 42.6 (s) - - - 
11 19.6 (t) 1.36 (2H, m)  8, 9, 12, 13 9, 12a, 12b 
12a 
   b 
40.2 (t) 1.87 (1H, m) 
2.18 (1H, m) 
9, 11, 13, 14 
11 
9, 11, 12b 
11, 12a 
13 160.1 (s) - - - 
14 115.7 (d) 5.61 (1H, dd, 2.1, 1.2) 12, 14, 16 14 
15 166.8 (s) - - - 
16 18.7 (q) 2.13 (3H, d, 1.2) 12, 13, 15, 16 15 
18 33.5 (q) 0.94 (3H, s) 3, 4, 5, 18 - 
19 21.7 (q) 0.84 (3H, s) 3, 4, 5, 19 3a 
20 14.7 (q) 0.71 (3H, s) 1, 5, 9, 10 1a, 9 
-OCH2CH3 59.4 (t) 4.13 (2H, dq, 7.1, 0.5) 15, -OCH2CH3 -OCH2CH3 
-OCH2CH3 14.3 (q) 1.26 (3H, t, 7.1) -OCH2CH3 -OCH2CH3 
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Figure 5.8 Upfield section (F1 = δC 100 – 210, F2 = δH 1.2 – 4.3) of the gHMBC spectrum 
(400 MHz, CDCl3) of 5.32. The accompanying figure indicates key correlations from the 
gHMBC spectrum of 5.32.  
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Following the unsuccessful methyl titanium chloride reaction, we decided to attempt the 
reaction using only methyl lithium, methyl magnesium bromide or methyl magnesium chloride 
as alkylating agents, reasoning that the ketone at C-8 would probably be more reactive than 
the α,β-unsaturated ester in the alkenyl chain and thus be more susceptible to nucleophilic 
addition.  Although methyl lithium mediated alkylation had been demonstrated to afford only 
the 8β-hydroxyl moiety,173 we considered that using a less reactive alkylating reagent such as 
methyl magnesium bromide, or the even less reactive methyl magnesium chloride, might 
result in a higher proportion of C-8 addition products. For similar reasons, we decided to 
attempt the reaction at -78°C to slow the reaction down. Gratifyingly, chemoselective 
methylation of the C-8 ketone in 5.32 (and also 5.33, once the reaction protocol had been 
established) proceeded smoothly using all three alkylating agents. The methyl nucleophile 
attacked the endocyclic ketone with Re-facial selectivity to afford ethyl labd-13E-en-8β-ol-15-
oate, 5.34, and ethyl labd-13Z-en-8β-ol-15-oate, 5.35, respectively. The reaction mixture was 
purified using semi preparative HPLC (14% ethyl acetate, 86% hexane) with none of the di-
addition product or addition to the ester carbonyl being detectable (in the 1H NMR spectrum of 
the crude reaction mixture). Although we were expecting the methyl lithium reaction to afford 
only the 8β-hydroxyl epimer, previous studies with Grignard reagents on various 
cyclohexanones had found that a mixture of the α- and β-epimers was to be expected.180;181 
Since molecular modelling of related diterpenes had shown that the β face of the molecule 
around C-8 was sterically hindered, delivery from the α-face of the ring system was probably 
favoured, accounting for the controlled formation of only the 8β-hydroxy epimers.  We were 
encouraged to find that the yields of 5.34 and 5.35 were enhanced when methyl magnesium 
chloride (81%) was used, as opposed to either methyl magnesium bromide (70%) or methyl 
lithium (51%). Using the same method as used in 5.20 and 5.21, the 8β-axial orientation of 
the alcohol substituent in 5.34 and 5.35 was supported by threefold spectroscopic evidence 
viz. the deshielding of the H3-20 angular methyl protons (δH 0.94 in both), the shielding of C-6 
(δC 18.1 and 18.3 respectively) and a downfield shift of the C-17 methyl carbon resonance (δC 
30.6 in both) in the 1H and 13C NMR spectra of these two compounds, similar to 5.20 and 
5.21.171;182;183 The 1H NMR spectrum of 5.34 is shown in Figure 5.7. 
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Two different methods for the reduction of the ester functionalities of 5.34 and 5.35 were 
attempted.  Reduction of 5.34 with diisobutylaluminium hydride (DIBAH) in tetrahydrofuran at 
0°C afforded labd-13 E-ene-8β,15-diol, 5.4, in 53% yield after purification with semi-
preparative HPLC (50% ethyl acetate, 50% hexane).  The yield of 5.4 was marginally 
improved to 66% by the use of lithium aluminium hydride in ether at 0°C, but no further 
improvement in yield could be made by altering either solvent (e.g.THF) or temperature (e.g. -
20°C). The reduction of the ester was determined by  analysis of the 1H NMR spectrum of 5.4, 
where the absence of the methyl triplet (δH 1.26) and methylene quartet (δH 4.13) of the ester 
functionality, in addition to the appearance of an oxymethylene doublet (δH 4.14), were 
immediately apparent. In the 13C NMR spectrum of 5.4, the retention of the vinylic resonances 
[δC 123.1 (d) and δC 140.4 (s)], the disappearance of the ester carbonyl resonance (δC 166.8) 
and the appearance of an additional oxymethylene resonance (δC 59.4) confirmed the loss of 
only the ester moiety.  All other 1H and 13C NMR data were consistent with those in the 
literature for 5.4, with the exception of the data published by Giang et al.210 who we believe to 
have erroneously identified a diterpenoid compound, isolated from Leonurus heterophyllus, as 
5.4. Although the specific rotation of synthetic (+)-5.4 ([α]D + 21) was lower in magnitude than 
that established by Ciavatta et al.171 ([α]D + 32), for the reduction product of the nudibranch 
derived 5.1, it was significantly different to the specific rotations reported for 5.4 isolated from 
terrestrial plants ([α]D 0 and +99).210;211 The negative specific rotation previously reported for 
ent-5.4 ([α]D -32)182;212 is in agreement with the established labdane stereochemistry of  semi-
synthetic 5.4 and supports that proposed by Ciavatta et al. for marine-derived 5.4.  
 
The target aldehyde, labd-13E-ene-8β-ol-15-al 5.1 (1H and 13C NMR spectra shown in Figure 
5.9) was quantitatively procured by stirring 5.4 in dichloromethane with manganese dioxide 
(10 eq) overnight. The 1H NMR spectrum (in deuterated benzene) of 5.1 clearly revealed the 
appearance of an aldehyde doublet (δH 9.91) and the disappearance of an oxymethylene 
signal (δH 4.14) relative to 5.4.  Filtration through celite gave a 25:1 mixture of 5.1:5.2 (i.e. > 
95% E isomeric purity from NMR analysis). The ratio of 5.1:5.2 changed substantially (15:1) 
after an attempt was made to remove the small amount of labd-13Z-ene-8β-ol-15-al, 5.2, in 
the isomeric mixture using normal phase HPLC (20% ethyl acetate, 80% hexane) and this 
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isomerisation was suggestive of the instability of these α,β-unsaturated aldehyde compounds 
to silica chromatography. An analogous manganese dioxide
 
oxidation of 5.5 gave 5.2:5.1 in a 
50:1 ratio (i.e. > 98% Z isomeric purity from NMR analysis) which, after normal phase HPLC, 
also reverted to a mixture of 11:1 (Z:E) geometric isomers. The 1H and 13C NMR data of the 
25:1 mixture of predominantly 5.1 (acquired in deuterated chloroform) was consistent in all 
respects with the spectroscopic data published for the corresponding P. meckelii metabolite 
(Table 5.3).171 In our hands, the 1H NMR spectrum of the isomeric mixture, containing almost 
exclusively 5.2, showed evidence of initial partial isomerisation followed by total degradation 
(to form an inseparable mixture of products) on standing in a solution of  deuterated 
chloroform
 
(12 h).  Accordingly, the NMR data for the Z isomer dominated mixture was 
obtained in deuterated benzene. We consequently also avoided using chloroform for 
recording the specific rotations of 5.1 and 5.2.  Paradoxically, Ciavatta et al.171 reported 
negative specific rotations for chloroform solutions of 5.1 ([α]D -35.2) and 5.2 ([α]D -28.2) 
isolated from P. meckelii, which are opposite in sign to those obtained for our semi-synthetic 
5.1 ([α]D +26) and 5.2 ([α]D +24) recorded in benzene but also opposite in sign and magnitude 
to the specific rotation (recorded in chloroform) of both the reduction product precursor, 5.4, 
derived from 5.1 isolated from P. meckelii,171 and our semi-synthetic 5.4.  Interestingly, a 
negative specific rotation ([α]D -8.5) was reported for 5.29, the 8α-epimer of 5.4.185 While 
epimerization at C-8 is an unlikely explanation for the discrepancy between the signs of the 
specific rotations of the naturally occurring and synthetic 5.1 and 5.2, we believe that this 
discrepancy may be related to the facile isomerisation and instability of the α,β-aldehydes to 
both chromatographic media and solution in deuterated chloroform.  
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Table 5.2 Comparison of the 13C NMR (125 MHz) of marine derived 5.1 and semi-synthetic 
5.1 (150 MHz) in CDCl3. The 1H (600 MHz) and 13C (150 MHz) data of synthetic 5.1 in C6D6 
are also presented. 
 
Marine 5.1171 
 
 
 
Synthetic 5.1 
 
Position 
δC
† 
(mult.) 
 δC
‡
  
(mult.) 
 δC
§ 
(mult.) 
δH
┴ 
(int., mult., J/ Hz) 
1a 
1b 
  39.3 (t)  39.3 (t)  39.3 (t) 0.65 (1H, m) 
1.48 (1H, m) 
2a 
2b 
18.2(t)  18.2 (t)  18.61 (t) 1.18 (1H, m) 
1.49 (1H, m) 
3a 
3b 
42.3 (t)  42.3 (t)  42.4 (t) 1.10 (1H, ddd, 14.2, 6.6, 3.8) 
1.37 (1H, ddd (11.8, 3.8, 1.4) 
4 33.3 (s)  33.2 (s)  33.4 (s) - 
5 55.9 (d)  55.9 (d)  56.0 (d) 0.63 (1H, dd, 12.2, 2.4) 
6a 
6b 
18.1 (t)  18.1 (t)  18.62 (t) 1.23 (1H, m) 
1.33 (1H, m) 
7a 
7b 
42.0 (t)  41.9(t)  42.6 (t) 1.18 (1H, m) 
1.54 (1H, ddd, 13.5, 3.5, 3.3) 
8 73.1 (s)  73.1 (s)  72.4 (s) - 
9 58.8 (d)  58.8 (d)  58.8 (d) 0.41 (1H, dd, 4.6, 2.6) 
10 39.3 (s)  39.0 (s)  39.2 (s) - 
11a 
11b 
23.3 (t)  23.3 (t)  23.5 (t) 1.20 (1H, m) 
1.43 (1H, m) 
12a 
12b 
44.3 (t)  44.3 (t)  44.4 (t) 1.80 (1H, m) 
1.84 (1H, m) 
13 164.1 (s)  164.2 (s)  162.1 (s) - 
14 127.2 (d)  127.1 (d)  127.3 (d) 5.93 (1H, ddd (7.8, 2.5, 1.3) 
15 191.4 (d)  191.4 (d)  190.0 (d) 9.91 (1H, d, 7.8) 
16 17.6(q)  17.6(q)  17.0(q) 1.60 (1H, d, 1.3) 
17 30.6 (q)  30.6 (q)  30.8 (q) 0.86 (3H, s) 
18 33.4 (q)  33.4 (q)  33.7 (q) 0.88 (3H, s) 
19 21.6 (q)  21.6 (q)  21.9 (q) 0.85 (3H, s) 
20 15.1 (q)  15.1 (q)  15.3 (q) 0.95 (3H, s) 
 
†
 
125 MHz, CDCl3; ‡ 150 MHz, CDCl3; § 150 MHz, C6D6; ┴ 600 MHz, C6D6 
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Figure 5.9 The 1H (600 MHz) and 13C (150 MHz) NMR spectra of 5.1 in C6D6. 
 
5.6 The anti-oesophageal cancer activity of selected labdane diterpenes from this 
chapter 
 
Seven of the diterpenes (5.1-5.5, 5.32, 5.49 and 5.50) discussed within this chapter were sent 
to the Department of Medicinal Biochemistry, at the University of Cape Town, as an extension 
of the previous evaluation of labdane diterpenes, isolated from T. costatus (Chapter Three, 
Section 3.3), for their activity against oesophageal cancer cell lines.  A dose response curve 
ppm (f1)
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was obtained using the (MTT) assay and IC50 values (Table 5.4) determined against the 
WHCO1 oesophageal cancer cell line. 
 
OH
H
5.49 ∆13 E
5.50 ∆13Z
CO2Et
H
CO2Et
O
5.32
13
8
H
CH2OH
OH
5.4 ∆13 E
5.5 ∆13 Z
H
OH
CHO
5.1 ∆13 E
5.2 ∆13 Z
13 13
13
 
Table 5.3 Summary of the IC50 values of compounds against the WHCO1 cell line. 
 Compound tested 
 5.1 5.2 5.4 5.5 5.32 5.49 5.50 
IC50 (µM) 5.4 16.7 49.6 121.6 No activity 48.5 No activity 
 
Once again, the limited number of compounds assayed prevented us from drawing more than 
tentative conclusions regarding structure-activity relationships.  In all cases, the ∆13 [or ∆13(15)] 
E isomers (5.1, 5.4 and 5.49) had lower IC50 values than their Z isomeric counterparts, 
particularly in the case of 5.49 and 5.50, where 5.49 revealed modest activity while 5.50 was 
inactive.  The aldehydes, 5.1 and 5.2, were significantly more active than the diols, 5.4 and 
5.5, with 5.1 possessing an IC50 value nearly an order of magnitude lower than that of the 
corresponding diol, 5.4.   
 
5.7 Conclusions 
 
The target compounds, 5.1 and 5.2 were successfully synthesized in 19% and 6% overall 
yield respectively from a commercially available labdane diterpene precursor, 5.3.  The 
successful synthetic strategy (Scheme 5.6) depended on a regioselective HWE reaction on 
the diketone, 5.31, which afforded 5.32 and 5.33. The second obstacle in the successful 
synthetic strategy surrounded the stereospecific and chemoselective alkylation of the C-8 
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carbonyl moiety of 5.32 and 5.33. Stereospecific and chemoselective alkylation was achieved 
with methyl lithium, methyl magnesium bromide and methyl magnesium chloride at -20°C with 
the latter reagent proving to be the most efficient.  Reduction of the esters, 5.34 and 5.35, 
was best achieved using LAH.  Facile oxidation of the primary alcohols, 5.4 and 5.5 to their 
corresponding aldehydes, 5.1 and 5.2 was achieved with manganese dioxide.  The aldehydes 
5.1 and 5.2 proved unstable in deuterated chloroform and degraded to an inseparable mixture 
of products within twelve hours. The aldehydes also isomerised when subjected to standard 
chromatographic procedures. The anti-oesophageal cancer activity of compounds 5.1-5.5, 
5.32, 5.49 and 5.50 was evaluated and the aldehydes 5.1 and 5.2 were found to be the most 
cytotoxic. 
a b
5.3 5.42 ∆
13 E
5.43 ∆13 Z
c
d
90% 78%
90%
HO CHO
5.31
O
O
5.32 ∆13 E
5.33 ∆13 Z
O
CO2Et
74%
CO2Et
OH
81%
f
CH2OH
OH
1
5
8
13
15
16
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1819
20
5.34 ∆13 E
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e
66%
5.4 ∆13 E
5.5 ∆13 Z
CHO
OH
5.1 ∆13 E
5.2 ∆13 Z
 
 
Scheme 5.6 The final synthetic route to 5.1 and 5.2. Regents and conditions: (a) PCC, 
CH2Cl2, RT, 26 h (b) O3, CH2Cl2, -78°C, 10 min, then PPh 3, RT, 4 h; (c) 
(C2H5O)2P(O)CH2CO2Et, NaH, THF, 0 °C to RT, 16 h; (d) MeMgCl, Et 2O, -20 °C (1 h) to RT (3 
h); (e) LAH, THF, 0°C (0.5 h) to RT (2 h); f) MnO 2, CH2Cl2, RT, 16 h.   
                                                                                                                              Chapter Six 
 
                                                                                                                                    135                                                                                                 
 
 
 
 
 
 
Chapter Six 
The Semi-synthesis of Tricyclic Diterpenes  
with Anti-malarial Activity 
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6.1 Introduction 
 
This chapter describes an extension of the research discussed in Chapter Five, where ethyl 
17-norabiet-13(15)-E-en-8β-ol-16-oate (5.49) and ethyl 17-norabiet-13(15)-Z-en-8β-ol-16-oate 
(5.50) were isolated as the minor products of a regioselective HWE reaction performed on 
(5.31). An investigation of the natural product literature revealed reports of similar tricyclic 
compounds (6.1-6.5) with anti-malarial properties.213;214 Since we are cognizant of the impact 
that malaria has on developing nations including our own (vide infra)  and were in possession 
of a readily accessible starting material (5.51), from which analogues, 5.49-5.50, as well as 
17-norpimaran-13α-ethoxy-8,16-olactone (6.6), 17-norisopimar-15-ene-8β,13β-diol (6.7), 17-
norisopimarane-8β,16-diol (6.8) and 17-norabiet-13(15)-ene-8β,16-diol (6.9) could be derived, 
we decided to further investigate the potential of analogous tricyclic norditerpenes as anti-
malarial agents. This chapter thus consists of a discussion of the synthesis and structural 
elucidation of the semi-synthetic norditerpenes (5.49-5.50 and 6.6-6.9) and culminates in a 
critical evaluation of their anti-malarial potential from parasite inhibition and haemolytic 
studies.  
 
6.2
OH
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R2
HO
6.3 R1 = OH; R2 = CH3
6.7 R1 = H; R2 = OH
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6.1.1 Natural products analogues as anti-malarial drug agents 
 
Malaria is a parasitic disease, with between 300 and 660 million clinical cases reported each 
year.215-217 Although statistics vary widely from source to source, approximately 70% of all 
cases appear to be concentrated on the African continent,216 where at least one million deaths 
per annum are directly (and up to three million deaths indirectly) attributed to the disease.218 
More than 75% of the deaths recorded are of children under the age of five,218 translating into 
the staggering figure that every forty seconds a child in Africa dies of malaria.215;218   
 
Of the four different species of parasite that cause malaria (Plasmodium falciparum, P. vivax, 
P. malariae and P. ovale), P. falciparum, is the most virulent, prevalent and drug resistant 
species.218;219 In Africa, the transfer of P. falciparum to its human host is greatly aided by the 
mosquito Anopheles gambiae.215;218;219 The female A. gambiae is the most successful vector 
of malarial parasites as a result of both its affinity for biting humans and longevity, the latter 
being particularly important since a time period of 8-30 days, dependent on ambient 
temperature, is required for the parasite to complete that part of its lifecycle spent within the 
mosquito.215;218;219 The global concentration of malaria in tropical regions has been directly 
linked to the shortened gestation period required by the parasite within the mosquito at 
sustained temperatures over 18°C. 215;218;219 
 
Although nearly two billion people are exposed to malaria every year,216-219 the countries 
where malaria is most prevalent are also amongst the poorest worldwide and thus can afford 
neither proper treatment nor management of the disease for their citizens.215;218-220 As a result, 
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large pharmaceutical companies have been reluctant to take the financial risk of developing 
anti-malarial treatments219 and resistance to existing malarial prophylactics is 
increasing.215;218-223 
 
The low cost of chloroquine (6.10) and its related analogues [e.g. amodiaquine (6.11) and 
halofantrine (6.12)] have made them the most common treatment for malaria in Africa. 
Chloroquine has been used as an anti-malarial in Africa since the late 1970’s and has its 
structural roots in quinine (6.13),220;222 a natural product derived from the bark of the Peruvian 
Cinchona tree, brought to Europe in the seventeenth century.220;222 Resistance to chloroquine 
was first reported in 1986 and has since become widespread.222  The malarial Plasmodium 
produces large amounts of free Fe(II) haem during its lifecycle through degradation of the 
host erythrocyte’s haemoglobin.219-221  This free Fe(II) haem is toxic to the parasite and is 
accordingly oxidized to Fe(III) haematin, which is then stored within vacuoles as a crystalline 
pigment (called haemozoin), rendering it harmless to the parasite. Chloroquine and its 
analogues are concentrated within the same vacuole, preventing crystallization of the 
haematin, and thus killing the malarial parasites once lethal concentrations of haematin have 
been reached.219-221 
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The alternative cost-effective treatment available to combat chloroquine resistance is the 
combination of pyrimethamine (6.14) and sulfadoxine (6.15).219-221  Unfortunately, this 
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treatment targets the enzymes dihydrofolate reductase (DHFR) and dihydropteroate 
synthase, the alleles coding for which are susceptible to point mutations, thus enabling the 
malarial parasites to evolve rapid resistance to this combination treatment.219-222 
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The most promising new natural product derived anti-malarials to date are the artemesinins 
(6.16-6.18),219;220 all of which are structural analogues of the active component of artemesinin 
(6.19), isolated from the Chinese herb “qinhao” (Artemesia annua)224 with an endoperoxide 
bridge. The artemesinins are rapidly converted to the active form dihydroartemesinin (6.20) in 
the human body. Dihydroartemesinin is active against the gametocytes that comprise the 
sexual reproduction stage and infect the mosquito.220 Unfortunately, the artemesinins have 
short half lives in the human body and must thus be administered continually over five to 
seven days, and this can be problematic in the African context where poor health care 
structures lead to poor compliance.219;220  Additionally, although the artemesinins are relatively 
inexpensive by global standards, they are still considerably more expensive than the quinoline 
and pyrimethamine-sulfadoxine alternatives and beyond what many developing nations can 
afford.219;220  
 
Although the vogue over the last decade or so has been to focus on target-based drug 
discovery (i.e. where a specific “gene, gene product or molecular mechanism” has been 
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targeted),225 the number of new compounds reaching the market has been decreasing, 
despite large investments into research and development by pharmaceutical companies.225 
As can be seen (vide supra) from the brief overview of current anti-malarial agents in use, two 
of the main groups, viz. the chloroquines and artemesinins are analogues of naturally 
occurring bioactive compounds. We thus proposed to investigate the anti-malarial properties 
of analogues of a naturally occurring series of tricyclic diterpenes 6.1-6.5.  Although Asili and 
coworkers213;214 had reported anti-plasmodial activity for 6.1-6.5, they considered the weak 
anti-plasmodial activity of these diterpenes to be an indirect consequence of echinocytic and 
stomatocytic changes to the erythrocyte cell membrane, leading to compromised cell function 
and death of the malarial parasites through indirect destruction of their host cells.  Our 
objective was thus to investigate the effects of synthetically produced analogues of 6.1-6.5 in 
the hopes of better understanding or even obviating the apparent erythrocyte modifying 
behaviour of this class of compounds. 
 
6.2 Semi-synthesis of potential anti-malarial compounds 
  
As mentioned previously (Chapter Five, Section 5.5), we serendipitously synthesized 
compounds 5.49 and 5.50 in low (9%) combined isolated yield while performing an HWE 
reaction on 5.31. We postulated that excess sodium hydride (acting as a base) initiated an 
intramolecular aldol condensation of 5.31 to 5.51, which in turn reacted with the HWE reagent 
affording 5.49 and 5.50 (Scheme 6.1).  Our observation of this initial intramolecular cyclization 
was not without precedent, since 8-hydroxy-13-podocarpanone, 5.51, had previously been 
prepared by stirring either a solution of 5.31 in methanolic potassium hydroxide or ethanolic 
sodium ethoxide to afford 5.51 in 68% and 80% yield respectively,174;202 To confirm that 
sodium hydride was inducing an intramolecular cyclization of 5.31, we attempted the 
cyclization of 5.31 directly by adding sodium hydride to an anhydrous solution of this 
compound in tetrahydrofuran and established that two equivalents of sodium hydride provided 
5.51 in almost quantitative yield (by NMR). The reaction was also closely monitored by TLC 
(TLC plate developed with iodine). Once all starting material appeared to have been 
converted to a single product, 5.51, the reaction was halted by the addition of a few drops of 
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dilute HCl and the reaction mixture washed with water. Analysis of the 1H NMR spectrum of 
the reaction mixture clearly showed the disappearance of the diagnostic deshielded methyl 
singlet (δH 2.07) in 5.31, while the 13C NMR spectrum revealed the disappearance of the 
methyl ketone resonance (δC 209.2) and the appearance of a new ketone carbonyl resonance 
(δC 210.7) and an oxygenated quaternary carbon resonance (δC 75.5). Analysis of the 13C 
NMR spectrum of 5.51 also revealed that the reaction was stereospecific as no duplication of 
13C NMR resonances was observed (Figure 6.1). In our hands, 5.51 was unstable and rapidly 
degraded at room temperature in deuterated chloroform solution, preventing us from 
obtaining a full 2D NMR data set or a crystal structure of the compound. We were thus unable 
to determine conclusively whether the hydroxyl at C-8 was β-axial or α-equatorial. However, 
from a conformational perspective, a trans B/C ring junction would be favoured over the 
alternative cis B/C ring junction. Hugel et al.182 had also proposed the β-axial orientation of 
the hydroxy at C-9 on the basis of a CD spectrum consistent with a trans B/C ring junction. 
The subsequent X-ray diffraction analysis of 5.50, synthesized from 5.51 (vide infra) provided 
further confirmation of the β-axial orientation of the C-8 hydroxyl functionality. 
 
OH
O
NaH OO
O O
H
HHH
O
O
5.31 5.51
H
 
 
Scheme 6.1 Mechanism of the sodium hydride mediated intramolecular aldol condensation of 
5.31 to 5.51. 
 
At the time that we first identified 5.49 and 5.50, Jaroszewski and coworkers’213 paper 
reporting the anti-malarial activity of compounds 6.2-6.5 came to our attention.  We reasoned 
that the C-13 carbonyl functionality would prove a versatile scaffold for producing 
norabietane, norpimarane and norisopimarane analogues of these compounds, especially 
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since 5.51 could be accessed in approximately 71% yield from manool (5.3) by our 
established methodology.  
ppm (f1)
2030405060708090100110120130140150160170180190200210
 
 
Figure 6.1 The 13C NMR spectrum of 5.51, demonstrating the absence of duplicated 
resonances. 
 
Since Jaroszewski and coworkers213 had reported the anti-plasmodial activity of isopimarane 
diterpenoids, we decided to synthesize 6.7, differing only from 6.3 in the replacement of the 
methyl group at C-13 with a hydroxyl functionality and the absence of a secondary alcohol 
moiety at C-3. An established procedure for the preparation of nor-isopimarane 6.7 existed,202 
and 5.51 was accordingly reacted with vinyl magnesium bromide in tetrahydrofuran to yield 
17-norisopimar-15-ene-8β,13β-diol, 6.7, which was subsequently purified by normal phase 
semi-preparative HPLC (75% ethyl acetate, 25% hexane). Although no optical rotation data 
were available, comparison of the 13C NMR data and melting points of 6.7 with those reported 
by Buckwalter et al.202 confirmed our product to be identical to theirs.   
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Extensive overlap in the methyl envelope of the 1H NMR spectrum of 6.7 (in both deuterated 
chloroform and deuterated benzene) prevented us from confirming the configuration at C-13. 
However, molecular modelling of the starting material, 5.51 (Figure 6.2) revealed that the     
Si-facial selectivity may be due to reduced steric hindrance in the α-face of the molecule.  The 
alternative C-13 epimer (6.21), with the hydroxyls trans to one another, would also 
presumably lead to an unfavourable 1,3-diaxial interaction between the C-8 hydroxyl and C-
13 ethene functionality (Figure 6.2). 
 
 
Figure 6.2 Stick molecular model representation of 5.51 (top) and stick representations of the 
two possible C-13 epimers 6.7 (bottom left) and 6.21 (bottom right).  
 
Although we had previously isolated the minor products, 5.49 and 5.50, from the HWE 
reaction of 5.31 with triethylphosphonoacetate, more of each of these needed to be 
synthesized in an attempt at obtaining crystal structures of one of these compounds to 
confirm the Re-facial selectivity of the intramolecular aldol condensation reaction. The HWE 
reaction, using 5.51 as a starting material, was thus reattempted and a mixture of the E and Z 
trisubstituted olefins obtained. Semi-preparative normal phase HPLC (10% ethyl acetate, 90% 
hexane) of the isomeric mixture afforded the pure E and Z isomers in a 4:3 ratio in 70% 
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overall isolated yield.  As mentioned previously, while the HWE reaction is used to 
preferentially prepare either the E or Z geometric isomer, the stereoselectivity of the reaction 
is diminished when ketones are used as opposed to aldehydes,207 and thus similar 
proportions of both geometric isomers were not unexpected.  The spectroscopic 
determination of the structure of 5.49 is discussed below.   
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The molecular formula (C21H34O3) of 5.49 was determined from accurate mass data and was 
found to be consistent with 5.32. The retention of resonances in the 13C spectrum of 5.49 
attributable to the α,β-unsaturated ethyl ester functionality [δC 166.3 (s), 159.4 (s), 116.1 (d) 
59.6 (t) and 14.3 (q)] was noted.  The HRFAB mass data implied five degrees of unsaturation, 
two of which were accounted for by the unsaturated ester moiety and in the absence of any 
other evidence for further unsaturation suggested that 5.49 was tricyclic. The absence of the 
methyl resonance in 5.32 (δH 2.13) in the 1H NMR spectrum of 5.49, coupled with the 
appearance of a deshielded oxygenated quaternary carbon (δC 73.9) and the discrepancy of 
two hydrogen atoms between the molecular formulae further supported a tricyclic skeleton 
similar to that of 6.7. Comparison of our 1H and 13C NMR data for 5.49 (Table 6.1) with those 
of other tricyclic norditerpene compounds (e.g. 6.7) allowed us to assign the majority of the A 
and B rings of 5.49.  gCOSY correlations (Table 6.1) between H-9 (δH 1.17) and H-11a (δH 
1.43) and H-11b (δH 1.79) supported by gHSQC data allowed us to assign C-11 (δC 22.4).  
Similarly C-12 (δC 29.6) was assigned through gCOSY correlations between both the protons 
of C-11 to both H-12a (1.76) and H-12b (δH 3.92).   Three bond gHMBC correlations from H-9, 
H-12a and H-12b allowed us to assign C-14 (δC 53.3), while a two bond gHMBC correlation 
from H-12a and H-12b to a quaternary carbon as well as three bond gHMBC correlations from 
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H-11a and H-11b to the same quaternary carbon, allowed us to assign C-13 (δC 159.4). A two 
bond gHMBC correlation (Figure 6.3) from H-15 (δH 5.60) to C-13 allowed us to place the 
unsaturated ester moiety at this position, which was subsequently confirmed by gHMBC 
correlations from H-12a, H-12b, H-14a (δH 2.05) and H-14b (δH 2.20) to C-15. The quaternary 
C-8 (δC 73.9) was assigned on the basis of gHMBC correlations from H-6a (δH 1.40), H-7a, 
(δH 1.44), H-7b (δH 1.75), H-9, H-11a, H-11b and H-14b. Crystallization of 5.49 from ether 
produced crystals suitable for X-ray diffraction analysis (Figure 6.4) and indirectly confirmed 
the Si-facial selectivity of the Grignard reaction in the synthesis of 5.51 (vide supra), the β-
axial orientation of the C-8 hydroxyl functionality, and hence the Re-facial selectivity of the 
intramolecular aldol condensation reaction in both 5.49 and 5.51. The structure of 5.49 was 
therefore unequivocally established as 17-norabiet-13(15)-E-en-8β-ol-16-oate.  Norditerpenes 
5.49 and 5.50 were assigned to the abietane series because the C2 substituent at C-13 (i.e. 
the ∆13(15) olefin) had neither a syn nor anti relationship with the angular methyl group at C-10 
required for membership to either the pimarane or isopimarane diterpene series 
respectively.226 
 
A cursory comparison of the 1H and 13C NMR spectra of 5.50 and 5.49 revealed these two 
compounds to be structurally similar.  The only major differences in the 13C NMR spectra of 
5.49 and 5.50 were the chemical shifts of C-12 (δC 29.6 and 37.9) and C-14 (δC 53.3 and 
45.3) respectively, which we attributed to 5.49 and 5.50 being ∆13(15) isomers of each another.  
The HRFAB mass data of the two compounds were also identical, further confirming this 
assessment. 
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Table 6.1 The 1H (400 MHz), 13C (100 MHz), gHMBC and gCOSY data (CDCl3) of 5.49. 
Position 
 
δC  
(mult) 
 
δC  
(Int., Mult, J/Hz) 
 
gHMBC gCOSY 
1a 
1b 
39.7 (t) 0.87 (1H, m) 
1.67 (1H, m) 
2, 10, 20 
2, 3 
1b, 2 
1a, 2 
2a 
2b 
18.4 (t) 1.38(1H, m) 
1.59 (1H, m) 
1 
1 
1a, 1b 
1a, 1b 
3a 
3b 
42.1 (t) 1.14 (1H, m) 
1.39 (1H, m) 
1, 2, 3, 6, 19 
4, 5 
2, 3b 
2a 
4 33.3 (s) - - - 
5 56.3 (d) 0.91 (1H, d, 3.5) 1, 4, 6, 7, 9, 10, 20 6 
6a 
6b 
18.3 (t) 1.40 (1H, m) 
1.58 (1H, m) 
3, 4, 5, 7, 8, 10 
3, 4, 7, 8, 10 
5, 7b 
5, 7b 
7a 
7b 
41.5 (t) 1.44 (1H, m) 
1.75 (1H, m) 
5, 8 
5, 6, 8 
7b 
6, 7a 
8 73.9 (s) - - - 
9 56.4 (d) 1.17 (1H, m) 5, 8, 10, 11, 12, 
14, 20 
11a, 11b 
10 37.4 (s) - - - 
11 22.4 (t) 1.43 (1H, m) 
1.79 (1H, m) 
8, 9, 12 
8, 9, 12, 13, 15 
11b, 12a, 12b 
11a, 12a, 12b 
12 29.6 (t) 1.76 (1H, m) 
3.92 (1H, m) 
9, 11, 13, 15 
9, 11, 13, 14, 15 
11a, 11b, 12b,  
11a, 11b, 12a 
13 159.4 (s) - - - 
14 53.3 (t) 2.05 (1H, dd, 13.1, 2.3) 
2.20 (1H, ddd, 13.1, 1.6, 0.7) 
7, 8, 9, 12, 13, 15 
7, 8, 9, 12, 13, 15 
14b 
14a 
15 116.1 (d) 5.60 (1H, t, 1.4) 12, 13, 14, 16 14a 
16 166.3 (s) - - - 
17 - - - - 
18 33.6 (q) 0.87 (3H, s) 3, 4, 5, 19 - 
19 21.7 (q) 0.84 (3H, s) 4, 3, 5, 18 - 
20 15.4 (q) 0.94 (3H, s) 1, 9, 10 - 
-OCH2CH3 59.6 (t) 4.13 (2H, q, 7.1) 15, -OCH2CH3 -OCH2CH3 
-OCH2CH3 14.3 (q) 1.26 (3H, t, 7.1) -OCH2CH3 -OCH2CH3 
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Figure 6.3 Downfield section (F1 = δC 0 – 180; F2 = δH 1.5 – 6.0) of the gHMBC spectrum 
(400 MHz, CDCl3) of 5.49. The accompanying structure summarizes the gHMBC correlations 
indicated in the spectrum. (Reference for 1JC,H doublets).227  
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Figure 6.4 A view of a molecule of ethyl 17-norabiet-13(15)-E-en-8β-ol-16-oate (5.49) from 
the crystal structure. 
 
In an attempt to save time and circumvent the problems associated with the facile 
degradation of 5.51, we also attempted a one-pot cyclization and HWE reaction on 5.51.  
Accordingly, 5.51 was prepared in the standard manner and once all starting material was 
consumed (monitored by TLC), the deprotonated HWE reagent was added drop wise to the 
reaction mixture via a cannula. After the standard workup and purification by semi-preparative 
HPLC (10% ethyl acetate, 90% hexane), we observed both a reduction in overall yield of the 
two geometric isomers, 5.49 and 5.50 (32% as opposed to 70% by the previous method) and, 
curiously, a change in the E/Z ratio (2:1 as opposed to 4:3). Subsequent reattempts at 
improving the yields from the one pot reaction were unsuccessful, but on one occasion a 
minor crystalline compound, 6.6, was isolated from the reaction mixture in low yield (10%).  
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The molecular formula (C21H34O3) of 6.6 was established by HRFABMS and implied five 
degrees of unsaturation, only one of which could be accounted for by an unsaturated 
functionality i.e. carbonyl resonance (δC 170.7). Comparison of the 1H and 13C NMR spectra of 
6.6 with those of 5.49 and 5.50 suggested that 6.6 shared a similar tricyclic norditerpene 
skeleton, accounting for three degrees of unsaturation, and initially indicating that differences 
between 6.6 and 5.49 were confined to the substitution pattern around ring C and the 
presence of an additional ring. Further analysis of 1H, 13C and DEPT135 NMR spectra 
revealed the presence of four methyls (δC 33.6, 21.7, 16.0 and 14.8), nine methylenes, one 
oxymethylene, two methine, four quaternary carbons and one carbonyl functionality. A 
combination of gHSQC data and gCOSY correlations between H-9 (δH 1.06) and H-11a (δH 
1.20) and H-11b (δH 1.80) allowed us to assign C-11 (δC 18.6) from gHSQC correlations.  We 
similarly assigned C-12 (δC 35.6) from gCOSY correlations between H-11a and H-11b and H-
12a (δH 1.57) and H-12b (δH 1.94). A three bond gHMBC correlation from H-11b allowed us to 
assign the quaternary C-8 resonance (δC 83.0), the deshielded nature of which implied 
oxygenation at this centre. The assignment of C-8 was confirmed by a two bond correlation 
from H-7a (δH 1.52) and H-7b (δH 1.96), The upfield shift of H3-20 (δH 0.94) suggested an axial 
oxygenated moiety at C-8.171 A further three bond gHMBC correlation from H-11b allowed us 
to assign quaternary C-13 (δC 71.6), and this assignment was further supported by gHMBC 
correlations from H-12a and H-12b to C-13. A two bond gHMBC correlation (Figure 6.5) from 
the oxymethylene protons (δH 3.44 and δH 3.45) of an ethoxy functionality also allowed us to 
place this moiety at C-13.  Three bond gHMBC correlations (Figure 6.5) between H-12b and 
H-9 (δH 1.06) to a further methylene carbon resonance (δC 44.4) enabled the assignment of 
this carbon as C-14. Three bond gHMBC correlations from the two protons (δH 2.58 and 2.66) 
of a methylene carbon (δC 41.1) to both C-12 and C-14 allowed us to assign C-15. 
Confirmation of the assignment of C-14 was given by gHMBC correlations from both H-14a 
(δH 1.67) and H-14b (δH 1.75) to C-8 and C-9.  A two bond gHMBC correlation from H-15a (δH 
2.58) and H-15b (δH 2.66) to a shielded carbonyl functionality (δC 170.7) provided the 
assignment of C-16 as part of a lactone ring, which thus accounted for the fourth ring. A 
lactone ring also explained the deshielded nature of C-8 (δC 83.0), which was greater than 
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that expected when a tertiary alcohol was present at this carbon (i.e. 73.9, see Table 6.1). 
The fully assigned 1H and 13C NMR data for 6.6 are presented in Table 6.2. 
 
 
 
Figure 6.5 A section (F1 = δC 34 – 85; F2 = δH 0.8 – 3.7) of the gHMBC spectrum (600 MHz, 
CDCl3) of 6.6. The accompanying structure shows the key correlations indicated in the 
spectrum. 
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Table 6.2  1H (600 MHz), 13C (150 MHz), gCOSY and gHMBC NMR data for 6.6 in CDCl3. 
 
 
Position 
 
 
δC 
(mult) 
 
δH 
(int., mult., J/Hz) 
 
gHMBC 
 
gCOSY 
 
1a 
1b 
39.5 (t) 0.85 (1H, m) 
1.62 (1H, m) 
2, 10, 20 
2 
1b, 2a 
1a, 2a, 2b 
2a 
2b 
18.4 (t) 1.39 (1H, m) 
1.60 (1H, m) 
1, 3, 4, 10 
1, 3 
1a, 2b, 3a 
1a, 2a, 2b, 3b 
3a 
3b 
41.9 (t) 1.12 (1H, m) 
1.40 (1H, m) 
2, 3, 18 
1, 2, 4, 10 
2a, 2b, 3b 
2b, 3a 
4 33.2 (s) - - - 
5 55.8 (d) 0.87 (1H, dd, 12.2, 1.9) 6, 10 6 
6a 
6b 
17.7 (t) 1.54 (1H, m) 
1.70 (1H, m) 
7 
†
 
5, 7b 
†
 
7a 
7b 
40.0 (t) 1.52 (1H, m) 
1.96 (1H, m) 
6, 8, 9, 13 
5, 6, 8, 13 
7b 
6, 7a 
8 83.0 (s) - - - 
9 56.1 (d) 1.06 (1H, dd, 12.5, 3.9) 1, 10, 11, 12, 14 11a, 11b 
10 37.1 (s) - - - 
11a 
11b 
18.6 (t) 1.20 (1H, m) 
1.80 (1H, m) 
10, 12 
8, 9, 13 
11b, 12a, 12b 
11a, 12a 
12a 
 
12b 
35.6 (t) 1.57 (1H, m) 
 
1.94 (1H, m) 
13, 15 
 
9, 13, 14 
11a, 11b, 12b, 
 15a‡ 
11a, 12b 
13 71.6 (s) - - - 
14a 
14b 
44.4 (t) 1.67 (1H, dd, 12.8, 2.4) 
1.75 (1H, dd 12.8, 3.0) 
8, 9, 13, 15 
8, 9, 13, 15 
14b, 15b 
14a 
15a 
15b 
41.1 (t) 2.58 (1H, dd, 18.0, 1.8) 
2.66 (1H, dd, 18.0, 2.3) 
12, 13, 14, 16 
12, 13, 14, 16 
12a ‡, 15b 
15a 
16 170.7 (s) - - - 
17 - - - - 
18 33.6 (q) 0.87 (3H, s) 3, 4, 5, 19 - 
19 21.7 (q) 0.84 (3H, s) 3, 4, 5, 19 - 
20 14.8 (q) 0.94 (3H, s) 9, 10, 18 - 
-OCH2CH3 56.2 (t) 3.44 (1H, q, 8.5) 
3.45 (1H, q, 7.0) 
-OCH2CH3, 13 
-OCH2CH3, 13 
-OCH2CH3 
-OCH2CH3 
-OCH2CH3 16.0 (q) 1.15 (3H, t, 7.0) -OCH2CH3 -OCH2CH3 
 
†
 No correlations detected; ‡ W coupling 
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Final confirmation of the structure of 6.6 as 17-norpimaran-13α-ethoxy-8,16-olactone was 
provided by X-ray analysis of a single crystal of this compound (crystallized from hexane, 
Figure 6.6). The two independent molecules A and B in the asymmetric unit adopt essentially 
the same conformation except for the slightly different orientation of the ethoxy groups. A 
putative mechanism for the formation of 6.6 from 5.31 during the HWE reaction is presented 
in Scheme 6.2.   
 
 
Figure 6.6 Perspective view of the two molecules of 17-norpimaran-13α-ethoxy-8,16-
olactone, 6.6, comprising the crystallographic asymmetric unit.  
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Scheme 6.2  Putative mechanism for the formation of 6.6 from 5.31 during the HWE reaction. 
 
  
In the original publication that prompted the research described in this chapter, Jaroszewski 
and co-workers213;214 suggest that compounds with polar functionalities concentrated on one 
side (ring A in their case) of the molecule initiated changes to the shape of the erythrocyte. 
Since we wished to further investigate the structure-activity relationships using analogous 
compounds, we decided to reduce the ethyl esters 5.49 and 5.50 with lithium aluminium 
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hydride to determine if a similar trend was evident in our compounds when a polar substituent 
was situated at C-8 instead of C-3.  Accordingly, we simultaneously reduced the E and Z ethyl 
esters 5.49 and 5.50 with lithium aluminium hydride in tetrahydrofuran in separate reaction 
vessels but under the same conditions.  Upon workup and subsequent normal phase semi-
preparative HPLC (100% ethyl acetate) of the respective reduction mixtures of 5.49 and 5.50, 
it was immediately apparent from the HPLC chromatogram that while the reduction of the E 
ethyl ester 5.49 yielded a single product, 17-norisopimarane-8β-16-diol (6.8), the reduction of 
the Z ethyl ester 5.50 yielded two products, 17-norabietane-13(15)-ene-8β,16-diol (6.9) and 
6.8. 
 
6.8
OH OH
OHOH
H H
6.9   ∆13(15) Z
6.22 ∆13(15) E
13
15
13
 
 
Comparison of the 1H and 13C spectra of the reduction product 6.8 with those of the parent 
compound 5.49 revealed that the olefinic resonances (δH 5.60, δC 159.4 and δC 116.1) had 
disappeared, while an additional oxymethylene (δC 60.3) and methylene carbon (δC 40.4) 
evident in the DEPT135 spectrum, indicated that not only had the ethyl ester been reduced to 
a primary alcohol as expected, but an unexpected 1,4-Michael addition of hydride to the 
exocyclic olefin had also occurred. The molecular formula (C19H34O2) of 6.8 was established 
by HRFABMS and confirmed the proposed tricyclic structure.
 
Extensive overlap of the 
resonances (in both deuterated chloroform and benzene) in the methyl envelope of the 1H 
NMR spectrum (Figure 6.7) of 6.8 prevented us from determining the configuration at C-13 by 
spectral means. However, scrutiny of the 13C NMR spectrum of 6.8 (Figure 6.8) revealed no 
doubling of the 13C resonances expected from a mixture of diastereomers and this 
information, coupled with the single peak in the HPLC chromatogram of 6.8 lead us to 
conclude that only one C-13 epimer had formed. It should be reiterated that this 1,4-hydride 
addition was unexpected as the hydride ion is an example of a hard nucleophile and would 
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thus be expected to react preferentially with the carbonyl functionality (a hard electrophile), 
yielding a product such as (6.22).228   
 
ppm (t1)
0.600.700.800.901.001.101.201.301.401.501.601.701.801.902.002.102.202.302.402.502.602.702.802.903.003.103.203.303.40
 
 
Figure 6.7  The 1H NMR (600 MHz, C6D6) spectrum of 6.8. 
 
ppm (t1)
17.520.022.525.027.530.032.535.037.540.042.545.047.550.052.555.057.560.062.565.067.570.072.5
 
 
Figure 6.8  The 13C  NMR (150 MHz, C6D6) spectrum of 6.8.  
 
A cursory examination of the 1H
 
and
 
13C NMR spectrum of one of the products from the lithium 
aluminium hydride reduction of 5.50 revealed it to be identical in all respects to 6.8. The 1H 
and 13C NMR spectra of a second product from the reduction of 5.50 revealed that, while the 
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ethyl ester [δH 4.12 and 1.25; δC 167.2 (s), 59.7 (t) and 14.3 (q)] resonances had disappeared, 
the olefinic resonances [δH 5.65, δC 142.1 (s) and 123.5 (d)] had been retained.  The 
appearance of additional oxymethylene resonances (δH 4.12 and 3.92 and δC 57.5) in the 1H 
and 13C NMR spectrum suggested that 6.9 was the expected reduction product of 5.50. Final 
confirmation of the 17-norabiet-13(15)-ene-8β,15-diol structure of 6.9 was provided by the 
molecular formula (C19H32O2) established from HRFABMS data. 
 
6.3 The anti-plasmodial activity of the tricyclic norditerpenes 
 
In continuation of our ongoing research on the activity of tricyclic norditerpenes against P. 
falciparum parasites and our interest in a possible correlation between this activity and 
echinocytic and stomatocytic erythrocyte membrane modifying effects, semi-synthetic 
analogues 5.49-5.50 and 6.6-6.9 were sent to the Division of Pharmacology, University of 
Cape Town (UCT), where they were assayed for both parasite inhibitory and haemolytic 
properties (results provided in Table 6.3). The inhibition studies were performed by 
transferring parasite-infected erythrocytes to microtitre plates and treating these with varying 
concentrations of the semi-synthetic compounds, using chloroquine as a control.  After 
incubating the cells at 37°C for forty eight hours,  parasite viability was measured by 
determining parasite lactate dehydrogenase activity, relative to solvent controls (wells 
containing 0.5% DMSO). The haemolytic activity of the tricyclic norditerpenes was determined 
relative to uninfected cells, which had also been incubated for forty eight hours and measured 
by determining the absorbance at 405 nm, relative to saponin treated wells, used as 100% 
haemolysis controls. Changes in the erythrocyte shape were monitored by both light and 
phase contrast microscopy. The shape changing effects of the tricyclic norditerpenes on 
erythrocytes at sub-haemolytic concentrations were monitored by incubating erythrocytes in 
the presence of the norditerpenes at 100, 50 or 25 µgmL-1 for forty eight hours and were then 
assessed by light microscopy.  
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Table 6.3  Parasite-inhibitory and haemolytic properties of 5.49-5.50 and 6.6-6.9 compared to 
chloroquine (CQ, 6.10). 
 5.49 
 
5.50 
 
6.6 6.7 6.8 6.9 CQ 
IC50 (µgmL-1) ± 
SD† 
5.7 
±4.6 
3.9 
±1.2 
19.6 
±6.6 
10.7 
±5.3 
13.3 
±5.1 
10.6 
±3.3 
0.0103 
±0.0023 
% Haemolysis‡ 
200 µgmL-1 17 34 0 0.2 5 102 ND 
% Haemolysis 
100 µgmL-1 3 9 0 0.6 0 2 ND 
% Stomatocytes§ 
100 µgmL-1 8 17 ┴ 0 1 3 64 ND 
% Echinocytes 
100 µgmL-1 0 0 9 2 2 0 ND 
% Stomatocytes 
50 µgmL-1 2 11 1 1 1 5 ND 
% Echinocytes 
50 µgmL-1 2 0 2 3 3 1 ND 
 
†Mean IC50 values and standard deviations (SD) were derived from IC50 determinations 
carried out on four separate occasions for 5.49-5.50 and 6.6-6.9 and on three occasions for 
chloroquine (CQ). ‡Percentage haemolysis was calculated relative to that obtained with 0.2% 
saponin.  §The percentages of malformed erythrocytes (stomatocytes and echinocytes) 
present in erythrocyte samples incubated with the various compounds for forty eight hours are 
also indicated. ┴Mixture of knizocytes and stomatocytes. ND = not determined. 
 
Jaroszewski and coworkers213;214;229;230 had proposed that the apparent activity of many 
natural products and synthetic compounds e.g. 6.2-6.5 could be linked to the incorporation of 
these compounds into the erythrocyte membrane, which in turn caused shape changes in the 
erythrocyte. Such shape changes disrupted erythrocyte function and therefore the inhibition of 
parasite growth subsequently observed was not a reflection of compound toxicity, but rather a 
measure of the destruction of the parasites’ host cell. Compounds that ultimately destroy 
erythrocytes cannot be considered true anti-malarial agents. After structure activity studies of 
six betulinic acid analogues,230 6.23-6.28, they determined that 6.23-6.25 with hydrogen 
donating functional groups (-CO2H, -CH2OH and -CONH2) caused the erythrocytes to 
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transform into echinocytes, while analogues 6.26-6.28 (containing -CHO, -Me and -CO2Me 
functional groups) caused stomatocytes to form. Jaroszewski and coworkers subsequently 
concluded that in both cases the “anti-malarial” activity of these compounds could be ascribed 
to the shape changes induced in the erythrocyte host at subhaemolytic concentrations.  
R
HO H
H
6.23 R = CO2H
6.24 R = CH2OH
6.25 R = CONH2
6.26 R = CHO
6.27 R = Me
6.28 R = CO2Me
 
 
 
 
Figure 6.9  Phase-contrast micrograph of erythrocytes incubated with medium alone (A) or 
100 µgmL-1 of
 
compounds 6.6 (B), 5.49 (C), 5.50 (D), 6.6 (E), 6.8 (F) and 6.9 (G, H). Small 
arrows indicate type II stomatocytes in C and knizocytes in D. The large arrow denotes a type 
I echinocyte in E, and arrowheads in H indicate erythrocyte ghosts. 
 
Three of our semi-synthetic compounds, 5.49, 5.50 and 6.9, showed haemolytic activity 
similar to that observed by Jaroszewski and coworkers at concentrations in the 100–200 
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µgmL-1
 
range (Table 6.3), suggesting that these compounds may accumulate in the 
erythrocyte bilayer. Haemolysis was negligible in this concentration range for compounds 6.6-
6.8. At a concentration of 100 µgmL-1, 6.9, the most haemolytic compound, induced the 
formation of stomatocyte type III shapes (Table 6.9, Figures 6.9G, 6.9H), despite possessing 
the -CH2OH functionality that Jaroszewski and coworkers230 had suggested was responsible 
for echinocytic shape changes. Interestingly, occasional erythrocyte ghosts were also present 
in the culture containing 6.9 (Figures 6.9G and 6.9H).  The second most haemolytic 
compound, 5.50, caused a mixture of knizocytes and type III stomatocytes to form (Table 6.3, 
Figure 6.9D) at the 100 µgmL-1
 
level, and only a small number of type II stomatocytes formed 
when incubated with 5.49 (Figure 6.9C). Only a modest increase in type I echinocytes was 
found for 6.6 (Table 6.3, Figure 6.9E), since control cultures contained 3-4% echinocytes, 
while the remaining compounds  6.7 and 6.8 displayed neither significant haemolytic effects 
nor erythrocyte shape modification effects.  Although the compounds with the highest 
haemolytic effects (5.49, 5.50 and 6.9) had the lowest IC50 values, and those with negligible 
haemolytic and erythrocyte shape changing effects (6.6-6.8) had the highest IC50 values 
(Table 6.3), it could be argued that the parasite inhibitory activity of the latter three 
compounds was not a consequence of erythrocyte shape changes. It may therefore 
tentatively be concluded that compounds 6.6-6.8 potentially affect either a parasite-specific 
target, or may possibly bind to the erythrocyte membrane at sub-haemolytic concentrations 
and somehow compromise the function of the erythrocyte and hence parasite viability. In the 
intra-erythrocytic development stages of the malarial parasites, a decrease in membrane 
deformability has been reported and linked to the release of several parasite proteins and 
their interaction with the erythrocyte plasma cell membrane and sub-membranous protein 
skeleton, resulting in a modification of cell function and structure.231  During the early stages 
(i.e. the first twenty four hours), erythrocytes maintain their usual biconcave shape, permitting 
normal circulation in the blood stream, while in the final forty eight hours, the deformation of 
erythrocyte cell membranes is decreased and the erythrocytes adhere to other cells to allow 
microvascular sequestration into the post-capillary venules of various organs.231-233 It is thus 
possible that the binding of 6.6-6.8 to the erythrocyte cell membrane interferes with the 
interaction of the parasite proteins with this membrane and prevents this stage of the parasite 
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lifecycle from being successfully completed.  Further studies focused on the binding of 
compounds 6.7-6.8 binding to the erythrocyte cell membrane could thus possibly better allow 
us to understand the mode of action of these three norditerpenes.  
 
6.4 Conclusions  
 
Six analogues (5.49-5.50 and 6.6-6.9) of naturally occurring tricyclic norditerpenes (6.1-6.5) 
with anti-plasmodial activity were semi-synthesized from commercially available 5.3 via the 
common intermediate, 5.51. Norditerpenes 5.49 and 5.50 had previously been isolated as 
minor components of an HWE reaction on 5.31, and the combined yield of these compounds 
was increased to 70% through first performing an intramolecular aldol condensation of 5.31 to 
5.51 before reacting with the HWE reagent.  Since 5.51 was unstable, a one pot cyclization-
HWE was attempted but resulted in reduced  yields (32%) of 5.49 and 5.50 and a change in 
the E/Z ratio from 4:3 (from the two step reaction) to 2:1 (in the one-pot reaction).  On one 
occasion 6.6 was isolated as a minor product from the one pot reaction.  X-ray diffraction 
analysis of 5.49 and 6.6 established the absolute configuration of these norditerpenes, and by 
extrapolation the Re-facial selectivity of the intramolecular aldol condensation of 5.31. Lithium 
aluminium hydride reduction of 5.49 exclusively yielded the unexpected 1,4-hydride addition 
product, 6.8, while simultaneous reduction of 5.50 under identical reaction conditions yielded 
both 6.9 and 6.8. Reacting 5.51 with vinyl magnesium bromide afforded the final analogue, 
6.7. 
 
Tricyclic norditerpenes 5.49-5.50 and 6.6-6.9 were screened for anti-plasmodial activity and 
exhibited IC50 values in the concentration range of 3.9-19.6 µgmL-1. Compounds 5.49, 5.50 
and 6.9 caused haemolysis over a range of concentrations (100-200 µgmL-1) and also 
erythrocyte shape changes.  Compounds 6.6-6.8 had the highest IC50 values but induced little 
to no haemolysis or erythrocyte shape changes. Further investigations should be performed 
to determine whether the binding of these compounds at concentrations too low to induce 
erythrocyte shape changes compromises erythrocyte function and hence parasite viability or 
whether these compounds affect a parasite-specific target. 
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7.1 General experimental procedures 
 
7.1.1 Analytical 
 
Melting points were determined using a Reichert hot-stage microscope and are uncorrected. 
Optical rotations were measured on a Perkin-Elmer 141 polarimeter calibrated at the sodium-
D line (589 nm) and the concentration of solutions used is expressed in g/100 mL. Circular 
dichroism spectra were collected on a Jasco J720 spectropolarimeter in MeOH by Ms. L. 
Cartner of the Natural Products Chemistry Group, National Cancer Institute, Frederick, United 
States of America. Infrared spectra were recorded on a Perkin-Elmer Spectrum 2000 FT-IR 
spectrometer with compounds as films (neat) on NaCl disks. NMR spectra were acquired on 
Bruker 400 MHz Avance and 600 MHz Avance II spectrometers using standard pulse 
sequences.  Chemical shifts are reported in ppm, referenced to residual solvent resonances 
(CDCl3 δH 7.25, δC 77.2, C6D6 δH 7.15, δC 128.0) Coupling constants are reported in Hz 
directly from the NMR spectra and corresponding coupling constants have not been matched. 
Low resolution mass spectra were recorded on a Finnigan GCQ spectrometer at 70 eV.  High 
resolution fast atom bombardment mass spectra (Micromass 70-70E spectrometer) were 
obtained by Prof. L. Fourie of the Mass Spectrometry Unit, Northwest University, 
Potchefstroom, South Africa.  
  
7.1.2 Chromatography 
 
General laboratory solvents were distilled from glass before use.  Analytical normal phase thin 
layer chromatography was performed on DC-Plastiekfolien Kieselgel 60 RP18 F254 plates.  
Plates were viewed under UV light (254 nm) and developed either with I2 or by spraying with 
10% H2SO4 in MeOH followed by heating. HP-20 beads used were manufactured by Diaion 
and supplied by Supelco. Open column chromatography was performed using Machery-Nagel 
Chroma-Bond OH Diol (0.45 µm) and flash chromatography was performed using Kieselgel 
60 (230-400 mesh) silica gel. Normal phase semi-preparative HPLC separations were 
performed on a Whatman Magnum 9 Partisil 10 column using a Spectra-Physics Spectra-
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Series P100 isocratic pump and a Waters 410 Differential Refractometer. Diol semi-
preparative HPLC separations were performed on a Machery-Nagel VP 250/10 Nucleosil 100-
7 OH column using a Spectra-Physics Spectra-Series P100 isocratic pump and a Waters 410 
Differential Refractometer. 
 
7.1.3 Synthesis  
 
All reactions requiring anhydrous conditions were conducted in flame-dried apparatus either 
under a dry argon atmosphere or using an anhydrous calcium chloride drying tube.  Dry 
solvents were prepared by standard procedures as described by Perrin and Amarego234 and 
stored over the appropriate drying agent under an atmosphere of dry nitrogen.  Immediately 
prior to their use in anhydrous reactions, Et2O, THF and C6H6 were distilled from 
Na/benzophenone ketyl, while CH2Cl2, CH3CN and Et3N were distilled from calcium hydride.  
DMSO was distilled at reduced pressure from calcium hydride and stored over 4Å molecular 
sieves under nitrogen. Organic extracts were dried over anhydrous MgSO4.  All reactions 
were magnetically stirred. 
 
7.1.4 Molecular modelling 
 
Molecular modelling was performed using the Cerius2 (version 4.5) software package 
developed by BIOSYMM/Molecular Simulations Inc. running on a Unix-based platform and 
using the default Universal Force Field.235 Charges were included via the charge equilibration 
method236 by applying the Qeq_charged 1.0 parameter set.  The local minimum conformer 
was then subjected to a molecular dynamics routine (constant n, V, E) of 500 annealing 
cycles (300 to 500 K). The lowest energy conformer was then selected and transferred to the 
MaterialsStudio 2.2 package of Accelrys Inc., on Linux-based Pentium IV computers where it 
was optimized and subjected to full frequency analysis (zero imaginary frequencies) in DMol3 
(Accelrys Inc.) using the PW91 functional with the double numeric and polarization (DNP) 
basis set. 
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7.2 Chapter Two Experimental 
 
7.2.1 Collection and extraction 
 
A single yellow nudibranch specimen (6 x 8 cm) was dredged from a depth of 115m near 
Marion Island (46° 52' S, 37° 54'E) during early Au tumn, 2005 and immediately frozen and 
stored at -20°C until it could be transferred to Me 2CO (250 mL).  The nudibranch was 
exhaustively extracted with Me2CO and the extracts combined.  The Me2CO extract was 
subjected to HP-20 and open column Diol chromatography, followed by normal phase semi-
preparative HPLC (as described by Scheme 2.5 and Chapter Two Sections 2.4 and 2.5) to 
afford 12S,13R,14S-isocopalan-13-ol-12,14-diacetate (2.1, 3 mg), 3-(14S)-isocopal-12-ene-
15-oyl-1-acetyl-sn-glycerol (2.2, 29 mg) and 3-(14S)-isocopal-12-ene-15-oyl-2-acetyl-sn-
glycerol (2.3, 10 mg). 
 
O OR2
OR1
O
2.2 R1 = H; R2 = Ac
2.3 R1 = Ac; R2 = H
H
OAc
OH
H
OAc
2.1
 
12S,13R,14S-Isocopalan-13-ol-12,14-diacetate (2.1): yellow oil; [α]D25
 
+3 (c 0.2, CHCl3); 1H 
and 13C NMR data, see Table 2.4; HRFABMS m/z  409.2953 (calcd for C24H41O5 [(M + H)+], 
409.2954). 
3-(14S)-Isocopal-12-ene-15-oyl-1-acetyl-sn-glycerol (2.2): yellow oil; [α]D25  +10 (c 2.0, 
CHCl3), lit.68;83 +13.9, +21.9; [θ]216 7359, lit.68 5412; 1H and 13C NMR data, see Table 2.1; 
HRFABMS m/z  421.2954 (calcd for C25H41O5 [(M + H)+], 421.2954).  
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3-(14S)-Isocopal-12-ene-15-oyl-2-acetyl-sn-glycerol (2.3): yellow oil; [α]D25 +23 (c 1.0, 
CHCl3), lit.68;87
 
+10.2, +66.9; 1H and 13C NMR data, see Table 2.2; HRFABMS m/z  421.2956 
(calcd for C25H41O5 [(M + H)+], 421.2954).  
7.3 Chapter Three Experimental  
 
7.3.1 Collection and extraction 
R1
R2
OAc
OAc
3.1 R1 = H; R2= CH2OH
3.2 R1 = OAc; R2= CH2OH
3.3 R1 = H; R2 = CH2OAc
13
O
HO
HO
O
H
H
3.4
HO OH
OH
3.5
20
6
1819
1
16
11
17
10
4
13
21
6
18
19
1 15
11 22
20
3
26
25 27
89
13
21
6
18
19
1 15
11
20
3
26
25
27
8
 
Two separate collections of Trimusculus costatus were made from the densely populated 
colonies of this mollusc at Cintsa west, South Africa.  The first collection was made in May, 
2006 and comprised 1274 specimens.  The Me2CO extract was subjected to HP-20 and open 
column Diol chromatography, followed by normal phase and/or Diol semi-preparative HPLC 
(as described in Schemes 3.4 and 3.5 and Chapter Three, Section 3.3) to afford 6β,7α-
diacetoxylabda-8,13E-dien-15-ol (3.1, 30 mg), 2α,6β,7α-triacetoxylabda-8,13E-dien-15-ol 
(3.2, 41 mg), 6β,7α,15-triacetoxylabda-8,13E-diene (3.3, 2 mg, 0.002 mg/animal) and 3α,11-
dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.4, 122 mg, 0.096 mg/animal). It should be 
noted that 3.1 and 3.2 were not isolated exhaustively, so the mass per animal is not reported. 
The second collection was made in May 2007 from the same location, comprised 1658 
animals, and was extracted exhaustively with Me2CO. The Me2CO extract was subjected to 
HP-20 and open column Diol chromatography, followed by normal phase and/or Diol semi-
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preparative HPLC (as described by Scheme 3.6 and Chapter Three, Section 3.3) to afford 3.4 
(303 mg, 0.183 mg/animal) and cholest-7-en-3,5,7-triol (3.5, 16 mg, 0.010 mg/animal).  
 
6β,7α-Diacetoxylabda-8,13E-dien-15-ol (3.1): pale yellow oil; [α]D24 +93 (c 1.6, CHCl3), 
lit.10;100 +93; IR (film) νmax 3461, 2924, 2872, 1742, 1365 cm-1; 1H NMR (CDCl3, 400 MHz) δ 
5.43 (1H, dt, J = 6.7, 0.9 Hz, H-14), 5.31 (1H, m, H-6), 4.96 (1H, d, J = 1.1 Hz, H-7), 4.16 (2H, 
d, J = 6.8 Hz, H2-15), 2.15 (2H, m, H2-11), 2.09 (2H, m, H2-12), 2.07 (3H, s, 7-OAc) 2.02 (6-
OAc), 1.81 (1H, ddd, J = 12.5, 4.4, 3.4 Hz, H-1b), 1.71 (3H, s, H3-16), 1.66 (1H, m, H-2b), 
1.61 (3H, s, H3-17), 1.54 (1H, m, H-2a), 1.47 (1H, m, H-5), 1.41 (1H, m, H-3b), 1.27 (3H, s, 
H3-20), 1.22 (2H, m, H-1a and H-3a), 0.96 (3H, s, H3-18), 0.95 (3H, s, H3-19); 13C NMR 
(CDCl3, 100 MHz) δ 169.9 (s, 7-OAc), 169.7 (s, 6-OAc), 147.8 (s, C-9), 139.8 (s, C-13), 123.1 
(d, C-14), 121.6 (s, C-8), 73.4 (d, C-7), 69.6 (d, C-6), 59.3 (t, C-15), 49.2 (d, C-5), 43.1 (t, C-
3), 39.5 (s, C-10), 39.2 (t, C-12), 38.9 (t, C-1), 33.4 (s, C-4), 33.0 (q, C-18), 27.0 (t, C-11), 
23.0 (q, C-19), 21.5 (q, 6-OAc), 21.1 (q, 7-OAc), 21.0 (q, C-20), 18.9 (t, C-2), 17.0 (q, C-17), 
16.4 (q, C-16);  HRFABMS m/z 406.2718 (calcd for C24H38O5 [M+], 406.2719). 
 
2α,6β,7α-Triacetoxylabda-8,13E-dien-15-ol (3.2): colourless oil; [α]D24 +60 (c 1.7, CHCl3), 
lit.10;100 +62; IR (film) νmax 3450, 2942, 2863, 1742, 1716  cm-1; 1H NMR (CDCl3, 400 MHz) δ 
5.43 (1H, dt, J = 6.7, 0.9 Hz, H-14), 5.31 (1H, m, H-6), 5.11 (1H, tt, J =  11.7, 4.1 Hz, H-2), 
4.98 (1H, d, J =  1.0 Hz, H-7), 4.16 (2H, d, J = 6.8 Hz, H2-15), 2.21 (2H, m, H2-11), 2.12 (1H, 
m, H-1b), 2.10 (2H, m, H2-12), 2.07 (3H, s, 6-OAc), 2.02 (3H, s, 7-OAc), 2.00 (3H, s, 2-OAc), 
1.79 (1H, ddd, J = 12.2, 4.2, 1.9 Hz, H-3b), 1.70 (3H, s, H3-16), 1.61 (3H, s, H3-17), 1.51 (1H, 
d, J = 1.4 Hz, H-5), 1.35 (3H, s, H3-20), 1.26 (1H, m, H-3a), 1.25 (1H, m, H-1a), 1.02 (6H, s, 
H3-18, H3-19); 13C NMR (CDCl3, 100 MHz) δ 170.5 (s, 7-OAc), 169.7 (s, 6-OAc), 169.5 (s, 2-
OAc), 146.7 (s, C-9), 139.4 (s, C-13), 123.4 (d, C-14), 122.2 (s, C-8), 73.3 (s, C-7), 69.0 (d, C-
6), 68.5 (d, C-2), 59.3 (t, C-15), 48.8 (d, C-5), 47.7 (t, C-3), 43.9 (t, C-1), 40.5 (s, C-4), 39.1 (t, 
C-12), 34.3 (s, C-10), 33.0 (q, C-18), 26.8 (t, C-11), 23.7 (q, C-19), 21.9 (q, C-20), 21.4 (q, 7-
OAc), 21.1 (q, 6-OAc), 17.0 (q, C-17), 16.4 (q, C-16), 14.1 (q, 2-OAc);   HRFABMS m/z 
464.2760 (calcd for C26H40O7 [M+], 464.2772). 
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6β,7α,15-Triacetoxylabda-8,13E-diene (3.3): pale yellow oil; [α]D24 +48 (c 0.2, CHCl3); IR 
(film) νmax 2957, 2871, 1737, 1679, 1622 cm-1; 1H and 13C NMR data, see Table 3.2; 
HRFABMS m/z 449.2909 (calcd for C26H41O6 [(M + H)+], 449.2903). 
 
3α,11-Dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.4): bright yellow orange oil; [α]D    
+32 (c 1.5, CHCl3); IR (film) νmax 3420, 2957, 1683, 1624, 1462 cm-1; 1H NMR and 13C NMR 
see Table 3.1; HRFABMS m/z 430.3082 (calcd for C27H42O4 [M+], 430.3083). 
 
Cholest-7-en-3,5,7-triol (3.5): white amorphous solid; [α]D24 +4 (c 1.5, CHCl3); IR (film) νmax 
3401, 2953, 1459, 1377, 1228 cm-1; 1H and 13C NMR data, see Table 3.3; HRFABMS m/z 
419.3525 (calcd for C27H47O3 [(M + H)+], 419.3525). 
 
7.3.2 Synthetic aspects 
 
7.3.2.1 Preparation of the camphanate esters of 3.1 and 3.2 
OAc
OAc
O
O
O
O
R1
OAc
OAc
OH
R1 (-)-camphanic chloride, 
Et3N, DMAP, CH2Cl2, 
RT, 5h
3.1 R1 = H
3.2 R1 = OAc
3.32 R1 = H
3.33 R1 = OAc
1
6
2'
19
16
20
13
18
17
10
4
10'
9'
8'
6' 7'
4'
1'
H H
 
This method is representative. Diterpene 3.1 (30 mg, 0.07 mmol), camphanic chloride (34 mg, 
0.16 mmol, 2.1 eq), Et3N (60 µL, 7.05 mmol, 6 eq) and DMAP (5 mg, 0.04 mmol, 0.5 eq) were 
dissolved in anhydrous CH2Cl2 (2 mL) under an Ar atmosphere and stirred at ambient 
temperature (5 h).  The reaction mixture was concentrated to dryness, taken up in Et2O (5 
mL) and washed with 1M HCl (1 mL) followed by H2O (2 x 5 mL). The organic partition was 
dried (MgSO4) and concentrated to an amorphous solid (69 mg).  Normal phase HPLC (33% 
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EtOAc, 67% hexane) afforded the camphanate ester 3.32 (35 mg, 81%) as a yellow oil. The 
camphanate ester of 3.2 (3.33, 83%) was similarly prepared. Several attempts at growing 
crystals of 3.32 using a variety of solvents (e.g. propane, hexane, C6H6, EtOH, MeOH, Et2O, 
EtOAc) and mixtures of these solvents failed to yield any crystals. Crystals of 3.33, suitable 
for X-ray diffraction, were grown using the slow diffusion method (hexane/EtOAc).  
 
Camphanate ester (3.32): pale yellow oil; 1H NMR (CDCl3, 400 MHz) δ 5.39 (1H, t, J = 7.2 
Hz, H-14), 5.29 (1H, m, H-6), 4.95 (1H, d, J = 1.1 Hz, H-7), 4.73 (2H, d, J = 6.8 Hz, H2-15), 
2.42 (1H, ddd, J = 13.5, 10.8, 4.2 Hz, H-3'b), 2.17 (2H, m, H2-11), 2.11 (2H, m, H2-12), 2.07 
(3H, s, 7-OAc) 2.02 (6-OAc), 2.02 (1H, m, H-3'a), 1.91 (1H, ddd, J = 13.2, 10.8, 4.6 Hz, H-
4'b), 1.81 (1H, ddd, J = 12.5, 4.4, 3.4 Hz, H-1b), 1.75 (3H, br s, H3-16), 1.68 (1H, ddd, J = 
13.2, 9.2, 4.2 Hz, H-4'a), 1.66 (1H, m, H-2b), 1.59 (3H, s, H3-17), 1.52 (1H, m, H-2a), 1.47 
(1H, m, H-5), 1.41 (1H, m, H-3b), 1.26 (3H, s, H3-20), 1.22 (2H, m, H-1a and H-3a), 1.09 (3H, 
s, H3-8'), 1.03 (3H, s, H3-10'), 0.95 (3H, s, H3-18), 0.94 (3H, s, H3-19), 0.93 (3H, s, H3-9'); 13C 
NMR (CDCl3, 100 MHz) δ 178.1 (s, C-6'), 169.9 (s, 7-OAc), 169.6 (s, 6-OAc), 167.5 (s, C-1'), 
147.5 (s, C-9), 143.5 (s, C-13), 121.6 (s, C-8), 117.4 (d, C-14), 91.1 (s, C-2'), 73.3 (d, C-7), 
69.5 (d, C-6), 62.2 (t, C-15), 54.7 (s, C-7'),  54.2 (C-5'), 49.2 (d, C-5), 43.0 (t, C-3), 39.4 (s, C-
10), 39.2 (t, C-12), 38.9 (t, C-1), 33.4 (s, C-4), 33.0 (q, C-18), 30.5 (t, C-3'), 28.9 (t, C-4'), 26.7 
(t, C-11), 23.0 (q, C-19), 21.5 (q, 6-OAc), 21.1 (q, 7-OAc), 21.0 (q, C-20), 18.9 (t, C-2), 17.0 
(q, C-17), 16.74 (q, C-9'), 16.68 (q, C-10'), 16.6 (q, C-16), 9.7 (q, C-8'); HRFABMS m/z 
587.3584 (calcd for C34H51O8 [(M + H)+], 587.3584). 
 
Camphanate ester (3.33): colourless plates (from hexane/EtOAc); mp 154-155°C; 1H NMR 
(CDCl3, 600 MHz) δ 5.40 (1H, dt, J = 7.1, 0.9 Hz, H-14), 5.31 (1H, m, H-6), 5.12 (1H, tt, J = 
11.7, 4.1 Hz, H-2), 4.98 (1H, d, J = 0.8 Hz, H-7), 4.74 (2H, m, H2-15), 2.42 (1H, ddd, J = 13.5, 
10.8, 4.2 Hz, H-3'b), 2.19 (1H, m, H-11b), 2.13 (1H, m, H-11a), 2.10 (2H, m, H-1b and H-12b), 
2.09 (1H, m, H-12a), 2.08 (3H, s, 7-OAc), 2.03 (3H, s, 6-OAc), 2.02 (3H, s, 2-OAc), 2.02 (1H, 
m, H-3'a), 1.91 (1H, ddd, J = 13.2, 10.8, 4.6 Hz, H-4'b), 1.80 (1H, ddd, J = 12.3, 4.1, 1.8 Hz, 
H-3b), 1.76 (3H, br s, H3-16), 1.68 (1H, ddd, J = 13.2, 9.2, 4.2 Hz, H-4'a), 1.62 (3H, s, H3-17), 
1.51 (1H, d, J = 1.2 Hz, H-5), 1.36 (3H, s, H3-20), 1.27 (1H, dd, J = 11.9, 7.0 Hz, H-3a), 1.25 
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(1H, dd, J = 11.9, 7.8 Hz, H-1a), 1.10 (3H, s, H3-8'), 1.04 (3H, s, H3-10'), 1.03 (6H, s, H3-19 
and H3-20), 0.94 (3H, s, H3-9'); 13C NMR (CDCl3, 150 MHz) δ 178.1 (s, C-6'), 170.5 (s, 2-
OAc), 169.7 (s, 7-OAc), 169.5 (s, 6-OAc), 167.5 (s, C-1'), 146.5 (s, C-9), 143.2 (s, C-13), 
122.4 (s, C-8), 117.6 (d, C-14), 91.1 (s, C-2'), 73.2 (d, C-7), 69.0 (d, C-6), 68.4 (d, C-2), 62.2 
(t, C-15) 54.7 (s, C-7'), 54.2 (s, C-5'), 48.8 (d, C-5), 47.8 (t, C-3), 43.9 (t, C-1), 40.5 (s, C-4), 
39.2 (t, C-12), 34.3 (s, C-10), 33.0 (q, C-18), 30.6 (t, C-3'), 29.0 (t, C-4'), 26.7 (t, C-11), 23.7 
(q, C-19), 22.0 (q, C-20), 21.5 (q, 2-OAc), 21.4 (q, 6-OAc), 21.1 (q, 7-OAc), 17.0 (q, C-17), 
16.8 (q, C-9'), 16.72 (q, C-10'), 16.67 (q, C-16), 9.7 (q, C-8'); HRFABMS m/z 646.3718 (calcd 
for C36H54O10 [M+], 646.3717). 
 
Crystal data for 3.33: C36H52O10, M = 644.78, 0.12 x 0.12 x 0.09 mm3, monoclinic, space 
group P21 (No. 4), a = 10.4893(2), b = 7.7835(2), c = 21.1003(5) Å, β = 93.518(1)°,  V = 
1719.46(7) Å3, Z = 2, Dc = 1.245 g/cm3, F000 = 696, MoKα   radiation, λ = 0.71073 Å,  T = 
113(2)K, 2θmax = 51.3º, 6480 reflections collected, 6480 unique (Rint = 0.0000).  Final GooF = 
1.045, R1 = 0.0606, wR2 = 0.1508, R indices based on 5199 reflections with I >2sigma(I) 
(refinement on F2), 429 parameters, 1 restraint.  Lp corrections applied, µ = 0.090 mm-1.  
Absolute structure parameter = 0.1(13)237 Tables of atomic co-ordinates and interatomic bond 
angles and bond lengths have not been deposited with the Cambridge data base and are 
provided in Appendix I. 
 
7.3.2.2 Acetylation of 3.1 
OAc
OAc
OAc
OAc
OAc
OH
Ac2O, DMAP, 
pyridine, RT, 16h
1
6
19
16
20
13
18
17
10
4
15
3.1 3.3
H H
 
A solution of 3.1 (65 mg, 0.13 mmol) in pyridine (1 mL) and acetic hydride (1 mL) was stirred 
at ambient temperature overnight (16 h).  The pyridine and acetic anhydride were removed in 
vacuo (0.5 mm Hg) and the remaining pale yellow oil (68 mg) purified by normal phase HPLC 
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(50% EtOAc, 50% hexane) to afford 3.3 (53 mg, 90%) as a pale yellow oil: [α]D24 +52 (c  4.8, 
CHCl3), 3.3 from T. costatus [α]D24 +48; 1H and 13C NMR data consistent with those of the 
natural product; HRFABMS m/z 449.2909 (calcd for C26H41O6 [(M + H)+], 449.2903). 
 
7.3.2.3 Selective acetylation of 3.4124 
 
O
HO
HO
O
1
19
10
11
13
15
20
21
25
26
27
18
H
H
3.4
7
O
R1O
R2O
O
1
19
10
11
13
15
20
21
25
26
27
18
H
H
7
Collidine, acetyl chloride,
 
CH2Cl2, -78°C, 3 h
3.35 R1 = R2 = Ac
3.36 R1 = H, R2 =Ac
 
 
Anhydrous conditions. The 9,11 secosterol 3.4 (62 mg, 0.14 mmol) and collidine (0.28 mmol, 
2 eq) were taken up in anhydrous CH2Cl2 (1 mL) and cooled to -78°C under an Ar 
atmosphere. A solution of acetyl chloride (0.19 mmol, 2 eq.) in anhydrous CH2Cl2 (120 µL) 
was added in a drop wise  fashion and stirred at -78°C (3 h).  The solution was quenched with 
H2O (1 mL) and concentrated to dryness in vacuo (0.5 mmHg). The resultant yellowish solid 
(103 mg) was taken up in EtOAc and passed through a Teflon micropore filter to remove the 
whitish precipitate that formed and the yellow filtrate concentrated to a yellow oil (71 mg).  
The yellow oil was subjected to Diol HPLC (40% EtOAc, hexane 60%) to afford both 3.35 (6 
mg, 9%) and 3α-hydroxy-11-acetoxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.36, 17 mg, 
27%).  Analysis of the 1H NMR spectrum of each of the two fractions suggested that 3.35 was 
the diaceylated product (not further characterized) and that 3.36 was the desired 11-OAc 
product.   
 
3α-Hydroxy-11-acetoxy-9,11-seco-cholest-4,7-dien-6,9-dione (3.36): yellow oil; [α]D34 +19 
(c 0.6, CHCl3); 1H NMR (CDCl3, 600 MHz) δ 6.69 (1H, dd, J = 4.0, 0.9 Hz, H-4), 6.66 (1H, s, 
H-7), 4.33 (1H, m, H-3), 4.19 (1H, m, H-11b), 4.15 (1H, m, H-11a), 3.44 (1H, dd, J = 11.2, 8.4 
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Hz, H-14), 2.18 (1H, ddd, J = 13.5, 13.3, 3.4 Hz, H-1b), 2.01 (3H, s, 11-OAc), 1.89 (1H, m, H-
16b), 1.87 (2H, m, H2-2), 1.76 (1H, m, H-1a), 1.73 (2H, m, H-12b and H-17), 1.66 (2H, m, H2-
15), 1.50 (2H, m, H-16a and H-25a), 1.43 (1H, m, H-20), 1.35 (2H, m, H-22b and H-23b), 1.35 
(3H, s, H3-19), 1.26 (1H, m, H-12a), 1.14 (1H, m, H-23a), 1.13 (2H, m, H2-24), 1.01 (1H, m, H-
22a), 0.97 (3H, d, J = 6.7 Hz, H3-21), 0.85 (3H, s, H3-27), 0.85 (3H, s, H3-26), 0.77 (3H, s, H3-
18); 13C NMR (CDCl3, 150 MHz) δ 200.4 (s, C-9), 187.5 (s, C-6), 171.0 (s, 11-OAc), 153.4 (s, 
C-8), 140.5 (s, C-5), 138.2 (d, C-7), 135.3 (d, C-4), 63.1 (d, C-3), ), 61.0 (t, C-11), 50.7 (d, C-
17), 49.1 (s, C-10), 47.7 (s, C-13), ), 43.7 (d, C-14), 39.4 (t, C-24), 37.2 (t, C-12), 35.4 (t, C-
22), 34.6 (d, C-20), 27.9 (d, C-25), 27.3 (t, C-15), 27.2 (t, C-2), 26.7 (q, C-19), 26.3 (t, C-16), 
25.0 (t, C-1), 24.4 (t, C-23), 22.7 (q, C-26), 22.5 (q, C-27), 21.1 (q, 11-OAc), 18.9 (q, C-21), 
17.5 (q, C-18);   HRFABMS m/z 472.3188 (calcd for C29H44O5 [M+], 472.3189). 
 
7.3.2.4 Preparation of the (R)- and (S)-MTPA esters of 3.36 
 
O
HO
AcO
O
1
19
10
11
13
15
20
21
25
26
27
18
H
H
7
3.36
O
O
AcO
O
1
19
10
11
13
15
20
21
25
26
27
18
H
H
7
3.37 (S)-MTPA ester
3.38 (R)-MTPA ester
OF3C
OMe
1'
3'
9'
10'
7'
4'
MTPA, DCC, DMAP,
CH2Cl2, RT, 1.5 h
 
This method is representative. R-α-methoxy-α-trifluoromethylphenylacetic acid (6 mg), DCC 
(48 mg) and DMAP (7 mg) were added to a solution of 3.36 in anhydrous CH2Cl2 (2 mL). The 
solution was shaken periodically over period of 1.5 hours at ambient temperature, diluted with 
EtOAc (3 mL) and H2O (1 mL) and filtered. The resulting solution was washed with 1M HCl (1 
mL), H2O (1 mL), saturated aqueous NaHCO3 (1 mL) and once more with H2O (1 mL) in the 
order presented. The resulting colourless oil (7 mg) was purified by semi-preparative HPLC 
(25% EtOAc, 75% hexane) to afford 3.38 (6 mg). The (S)-MTPA ester, 3.37, was similarly 
prepared from 3.36, using S-α-methoxy-α-trifluoromethylphenylacetic acid. 
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(S)-MTPA ester (3.37): yellow oil; 1H NMR (CDCl3, 600 MHz) δ 7.46 (2H, m, H-4' and H-8'), 
7.37 (3H, m, H-5', H-6' and H-7'), 6.67 (1H, s, H-7), 6.56 (1H, dd, J = 4.3, 0.9 Hz, H-4), 5.61 
(1H, m, H-3), 4.21 (1H, m, H-11b), 4.16 (1H, m, H-11a), 3.43 (3H, s, H3-9'), 2.10 (1H, m, H-
1b), 2.04 (2H, m, H2-2), 2.01 (3H, s, 11-OAc), 1.89 (1H, m, H-16b), 1.83 (1H, H, H-1a), 1.74 
(1H, m, H-12b), 1.73 (1H, m, H-17), 1.67 (2H, m, H2-15), 1.52 (1H, m, H-16a), 1.49 (1H, m, H-
25), 1.43 (1H, m, H-20), 1.37 (1H, m, H-22b), 1.36 (1H, m, H-23a), 1.24 (1H, m, H-12a), 1.17 
(1H, m, H-23a), 1.14 (2H, m, H2-24), 1.01 (1H, m, H-22a), 0.98 (3H, d, J = 6.7 Hz, H3-21), 
0.86 (3H, d, J = 6.6 Hz, H3-27), 0.86 (3H, d, J = 6.6 Hz, H3-26), 0.77 (3H, s, H3-18); 13C NMR 
(CDCl3, 150 MHz) δ 199.7 (s, C-9), 186.6 (s, C-6), 170.1 (s, 11-OAc), 165.6 (s, C-1'), 153.6 
(s, C-8), 143.2 (s, C-5), 138.1 (d, C-7), 132.5 (s, C-3'), 129.7 (d, C-7'), 129.7 (d, C-7'), 129.6 
(d, C-4), 128.5 (d, C-6'), 127.2 (d, C-8'), 127.2 (d, C-4'), 124.1 (s, C-10'), 122.2 (s, C-2'), 67.7 
(d, C-3), 60.9 (t, C-11), 55.4 (q, C-9'), 50.7 (d, C-17), 48.9 (s, C-10), 47.8 (s, C-13), 43.8 (d, C-
14), 39.4 (t, C-24), 37.3 (t, C-12), 35.4 (t, C-22), 34.6 (d, C-20), 28.0 (d, C-25), 27.4 (t, C-15), 
26.5 (q, C-19), 26.3 (t, C-16), 25.4 (t, C-1), 24.4 (t, C-23), 24.4 (t, C-2), 22.5 (q, C-27), 22.5 (q, 
C-26), 21.1 (q, 11-OAc), 19.0 (q, C-21), 17.6 (q, C-18). 
 
(R)-MTPA ester (3.38): yellow oil; 1H NMR (CDCl3, 600 MHz) δ 7.45 (2H, m, H-4' and H-8'), 
7.37 (3H, m, H-5', H-6' and H-7'), 6.68 (1H, s, H-7), 6.65 (1H, dd, J = 4.4, 0.9 Hz, H-4), 5.61 
(1H, m, H-3), 4.20 (1H, m, H-11b), 4.16 (1H, m, H-11a), 3.49 (3H, s, H3-9'), 3.43 (1H, dd, J = 
11.1, 8.2 Hz, H-14), 2.01 (3H, s, 11-OAc), 1.99 (2H, m, H2-2), 1.98 (1H, m, H-1b), 1.89 (1H, 
m, H-16b), 1.79 (1H, m, H-1a), 1.74 (1H, m, H-17), 1.72 (1H, m, H-12b), 1.67 (2H, m, H2-15), 
1.53 (1H, m, H-16a), 1.51 (1H, m, H-25), 1.45 (1H, m, H-20), 1.37 (2H, m, H-22b and H-23b), 
1.37 (3H, s, H3-19), 1.26 (1H, m, H-12a), 1.14 (3H, m, H-23a and H2-24), 1.01 (1H, m, H-22a), 
0.98 (3H, d, J = 6.7 Hz, H3-21), 0.86 (3H, d, J = 6.6 Hz, H3-27), 0.86 (3H, d, J = 6.6 Hz, H3-
26), 0.77 (3H, s, H3-18); 13C NMR (CDCl3, 150 MHz) δ 199.7 (s, C-9), 185.6 (s, C-6), 171.0 (s, 
11-OAc), 165.8 (s, C-1'), 153.7 (s, C-8), 143.4 (s, C-5), 138.1 (d, C-7), 132.5 (s, C-3'), 129.7 
(d, C-4), 129.6 (d, C-7'), 129.6 (d, C-5'), 128.5 (d, C-6'), 127.1 (d, C-8'), 127.1 (d, C-4'), 124.1 
(s, C10'), 122.2 (s, C-2'), 67.5 (d, C-3), 60.9 (t, C-11), 55.5 (q, C-9'), 50.8 (d, C-17), 48.9 (s, 
C10), 47.8 (d, C-13), 43.8 (d, C-14), 39.4 (t, C-24), 37.3 (t, C-12), 35.4 (t, C-22), 34.6 (d, C-
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20), 28.0 (d, C-25), 27.4 (t, C-15), 26.4 (q, C-19), 26.3 (t, C-16), 25.2 (t, C-1), 24.5 (t, C-23), 
24.1 (t, C-2), 22.8 (q, C-26), 22.5 (q, C-27), 21.1 (q, 11-OAc), 19.0 (q, C-21), 17.6 (q, C-18).  
 
7.3.3 Activity of Trimusculus metabolites against oesophageal cancer 
 
7.3.3.1 Cell lines and screening protocol 
 
Assays were performed at the Department of Medicinal Biochemistry at the University of 
Cape Town by Dr C. Whibley and Dr O. Osoniyi. The protocol described here has been taken 
from the thesis of Dr C. Whibley133 and is presented in truncated form. 
 
The human oesophageal cancer cell line  (WHCO1) screened against was obtained as a gift 
from Prof. R. Veale, University of the Witwatersrand, South Africa and derived from South 
African patients with squamous cell carcinoma of the oesophagus.238 Samples for the MTT 
assay138 were plated in 96 well plates to a final volume of 100 µL.  MTT reagent (10 µL, 
Roche cat # 1465007) was added and the cells incubated (4 h, 37°C). Solubilisation reagent 
(100 µL) was added to each well and incubation continued (16 h, 37°C). Upon completion of 
the incubation time, plates were read (595 nm) on an Anthos microplate reader 2001. To 
determine IC50 values, 1500 cells per well were seeded in 90 µL Dulbecco/Vogt Modified 
Eagle's Minimal Essential Medium (DMEM) in Cellstar 96 well plates.  After incubation (24 h), 
test samples were plated at a range of concentrations in 10 µL medium, with a final 
concentration of 0.2% DMSO and again incubated (48 h). Observations were made and 
processed in the manner described for the MTT assay. A dose-response curve was analyzed 
by non-linear regression analysis [non-linear regression (sigmoidal dose response with 
variable slope)] using the GraphPad Prism 4.00 package of GraphPad Software, San Diego, 
USA to determine the specific IC50 value for the compound tested against the WHCO1 cell 
line.  The formula used was Y = bottom + [(top-bottom)/(1 + 10(logIC50 – X) x hillslope)], where Y is 
the absorbance at 595nm, X is the concentration of the test compound, bottom is the 
minimum absorbance (also the absorbance of the medium blank) and the hillslope is the 
slope of the curve. 
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7.4 Chapter Four Experimental 
 
7.4.1 Isolation of hispanolone using HP-20 Chromatography 
 
The aerial parts of B. Africana were collected from Woodbury Lodge, Amakhala Game 
Reserve, situated on the N2 between Grahamstown and Port Elizabeth in the Eastern Cape 
of South Africa in November 2003 and air dried for two months.  Once dry, the leaves (250 g) 
were steeped in Me2CO (2.5 L) for four days, the Me2CO was decanted, filtered and 
concentrated in vacuo (250 mL). The resulting dark green liquid was treated with activated 
charcoal (20 g), stirred overnight, and filtered through a Celite plug to remove the particulate 
charcoal.  This extract was diluted to a volume of approximately 1 L and passed through an 
HP-20 column (500 mL). The collected eluent was diluted with H2O until the solution began to 
take on a cloudy appearance, whereupon this solution was again passed through the column.  
This method was repeated until a final concentration of approximately 20% Me2CO was 
achieved.  The column was stripped with a 40% Me2CO solution (1.5 L) and the eluent 
discarded. The fraction obtained from a successive 60% Me2CO stripping was collected, 
diluted to 30% Me2CO in H2O and allowed to stand at 4°C for 4 days.  The resu lting white 
plates (3.82 g, 1.5%) were collected by filtration and confirmed to be 4.4 by comparison of 
acquired 13C NMR data with those in the chemical literature.141 
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Hispanolone (4.4): white plates (from Me2CO/H2O); mp 133-135°C, lit. 141 147-148°C; [ α]D32     
-19 (c 6.4, CHCl3), lit.141 -18.7; IR (film) νmax 2919, 2863, 1697, 1469, 1116 cm-1; 13 C NMR 
(CDCl3, 100 MHz) δ 211.8 (s, C-7), 143.0 (d, C-15), 138.6 (d, C-16), 124.8 (s, C-13), 110.7 (d, 
C-14), 81.7 (s, C-9), 50.9 (d, C-8), 46.4 (d, C-5), 43.3 (s, C-10), 41.3 (t, C-3), 39.2 (t, C-6), 
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34.8 (t, C-11), 33.6 (q, C-18), 33.1 (s, C-4), 31.9 (t, C-1), 21.6 (t, C-12), 21.4 (q, C-19), 18.5 (t, 
C-2), 16.2 (q, C-20), 8.2 (q, C-17).   
 
7.4.2 Dehydration of hispanolone 
 
Method A: Attempted dehydration of 4.4 using p-TsOH in C6H6 
 
Hispanolone (4.4, 200 mg, 0.63 mmol) and p-TsOH (12 mg, 0.06 mmol, 0.1 eq.) were taken 
up in anhydrous C6H6 (30 mL) and refluxed under a Dean-Stark trap for (48 h).  This solution 
was then washed with 5% NaCO3 (1.2 mL), followed by H2O (3 x 15 mL).  The aqueous 
fractions were backwashed with CH2Cl2 (3 x 20 mL), all organic fractions were pooled, dried 
with MgSO4, filtered and concentrated in vacuo to afford a yellowish oil (168 mg).  Analysis of 
the 1H NMR spectrum of the reaction mixture revealed that no dehydration of the starting 
material had taken place. 
 
Method B: Dehydration of 4.4 using I2 in C6H6147 
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This method is representative. Hispanolone (4.4, 199 mg, 0.63 mmol) was taken up in 
anhydrous C6H6 (10 mL), and I2 (10 mg, 40 mmol) added, turning the solution a bright pink 
colour. This solution was refluxed (24 h) under a Dean-Stark trap, into which 3Å molecular 
sieves had been placed. The process had been monitored by TLC and was stopped when no 
further conversion to hispanone was noticed. The C6H6 solution was washed with 5% 
aqueous Na2S2O3 (3 x 5 mL) followed H2O (1 x 20 mL).  The aqueous partition fractions were 
pooled and backwashed with EtOAc (3 x 20 mL). The C6H6 and EtOAc partitions were pooled, 
dried with MgSO4, filtered and concentrated in vacuo to afford a brownish oil (175 mg). Silica 
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flash column chromatography (5% EtOAc, 95% hexane) followed, to afford hispanone (159 
mg, 84%)  as pale yellow needles (crystallized from MeOH).  
 
Hispanone (4.6): pale yellow needles (from MeOH); mp 65-66°C, lit. 141 69-70°C; [ α]D32 +34 (c 
2.2, CHCl3), lit.141  +43.3; IR (film) νmax 2930, 2855, 1661, 1607, 1470 cm-1; 1H NMR (CDCl3, 
400 MHz) δ  7.36 (1H, t, J = 1.4 Hz, H-15), 7.26 (1H, m, H-16), 6.30 (1H, d, J = 0.9 Hz, H-14), 
2.52 (2H, m, H2-12), 2.48 (1H, m, H-6b), 2.45 (2H, m, H2-11), 2.36 (1H, m, H-6a), 1.96 (1H, 
ddd, J = 12.3, 4.8, 2.8 Hz, H-1b), 1.79 (3H, s, H3-17), 1.71 (1H, dd, J = 14.2, 3.8, H-5), 1.68 
(1H, m, H-2b), 1.58 (1H, m, H-2a), 1.48 (1H, ddd, J = 13.2, 4.8, 3.7 Hz, H-3b), 1.42 (1H, ddd, 
J = 13.4, 12.9, 3.9 Hz, H-1a), 1.23 (1H, m, H-3a), 1.09 (3H, s, H3-20), 0.92 (3H, s, H3-19), 
0.89 (3H, s, H3-18); 13C NMR (CDCl3, 100 MHz) δ 200.3 (s, C-7), 167.0 (s, C-9), 143.0 (d, C-
15), 138.6 (d, C-16), 130.4 (s, C-8), 124.5 (s, C-13), 110.6 (d, C-14), 50.3 (d, C-5), 41.3 (t, C-
3), 40.9 (s, C-10), 35.9 (t, C-1), 35.2 (t, C-6), 33.1 (s, C-4), 32.5 (q, C-18), 30.2 (t, C-11), 24.2 
(t, C-12), 21.3 (q, C-19), 18.6 (t, C-2), 18.1 (q, C-20), 11.5 (q, C-17); HRFABMS m/z 301.2167 
(calcd for C20H29O2 [(M + H)+], 301.2168). 
 
7.4.3 Acetoxylation of 4.6 using Mn(OAc)3.2H2O in C6H6150;151;153 
 
7.4.3.1 Preparation of [(Mn(OAc)3.2H2O]153 
 
This method is representative. Powdered KmnO4 (2.5 g, 18 mmol) was added to a solution of 
Mn(OAc)2.4H2O (14.6 g, 59.6 mmol) in glacial acetic acid (174 mL), which had first been 
heated under reflux for 30 minutes, following which the entire solution was refluxed for a 
further 30 minutes.  The dark brown solution was stirred at room temperature overnight (16 
h), forming a dark brown precipitate. This precipitate was collected by gravity filtration, 
washed with cold water (50 mL) and dried in a vacuum desiccator in the presence of KOH to 
yield manganic acetate (14.9 g, 94%) as a dark brown powder.  
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7.4.3.2 Acetoxylation of 4.6 using Mn(OAc)3.2H2O  in C6H6150;151;153  
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This method is representative. Proportionally equivalent volumes of toluene and quantities of 
self-prepared Mn(OAc)3.H2O were used in the optimization attempts, the results of which are 
summarized in Table 4.1. Prior to the addition of 4.6, the Mn(OAc)3.2H2O (1.77 g, 1.5 g per 
mmol of hispanone) was refluxed in anhydrous C6H6 (3 h) under a Dean-Stark trap, into which 
3Ǻ molecular sieves had been placed. After this, hispanone (357 mg, 1.18 mmol) was taken 
up in anhydrous C6H6 (2 mL) and transferred to the reaction vessel via cannula. Refluxing 
continued (24 h) and the reaction was monitored by TLC.  Once no further conversion of the 
starting material was noted, the reaction solution was concentrated (50 mL) in vacuo and 
washed with 5% aqueous Na2S2O7 (30 mL), stirring until the dark brown manganese 
precipitate had been reduced.  This mixture was acidified with conc. HCl (0.5 mL) and 
subsequently neutralised (5% NaHCO3, 6.0 mL). The organic and aqueous phases were then 
separated. The aqueous phase was back extracted with CH2Cl2 (3 x 50 mL) and all organic 
partition fractions combined, dried (MgSO4), concentrated in vacuo to yield a brownish oil and 
partially purified by silica flash chromatography (5% EtOAc, 95% hexane), to afford a yellow 
oil (337 mg, 80%). Analysis of 1H NMR data indicated a 5:2 mixture of the α- and β-
acetoxylated products.  These isomers were separated using semi-preparative HPLC (10% 
EtOAc, 90% hexane) to afford 6α-acetoxy-14,15-epoxylabda-8,13(16),14-trien-7-one (4.7, 
200 mg, 0.56 mmol, 47% yield) and 6β-acetoxy-14,15-epoxylabda-8,13(16),14-trien-7-one 
(4.8, 79 mg, 0.22 mmol, 19% yield) as yellow oils.  
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6α-Acetoxy-14,15-epoxylabda-8,13(16),14-trien-7-one (4.7):148 yellow oil; [α]D19 +50 (c 2.4, 
CHCl3), lit.148  +51; IR (film) νmax 2932, 2871,1747, 1674, 1616 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 7.36 (1H, br s, H-15), 7.25 (1H, br s, H-16), 6.29 (1H, br s, H-14), 5.63 (1H, d, J = 
13.4 Hz, H-6), 2.52 (2H, m, H2-12), 2.49 (1H, m, H-11b), 2.43 (1H, m, H-11a), 2.18 (3H, s, 6-
OAc), 2.04 (1H, d, J = 13.4 Hz, H-5), 1.98 (1H, m, H-1b), 1.80 (3H, s, H3-17),  1.67 (1H, dddd, 
J = 13.6, 13.6, 4.2, 2.9 Hz, H-2b), 1.57 (1H, m, H-2a), 1.44 (1H, m, H-3b), 1.42 (1H, m, H-1a), 
1.27 (1H, m Hz, H-3a), 1.27 (3H, s, H3-20), 1.05 (3H, s, H3-18), 1.00 (3H, s, H3-19); 13C NMR 
(CDCl3, 100 MHz) δ 194.6 (s, C-7), 170.3 (s, 6-OAc), 166.9 (s, C-9), 143.1 (d, C-15), 138.6 (d, 
C-16), 128.9 (s, C-8), 124.2 (s, C13), 110.5 (d, C-14), 74.7 (d, C-6), 53.8 (d, C-5), 42.7 (d, C-
3), 42.5 (s, C-10), 36.4 (t, C-1), 35.5 (q, C-18), 33.5 (s, C-4), 30.4 (t, C-11), 24.1 (t, C-12), 
21.9 (q, C-19), 21.3 (q, 6-OAc), 19.9 (q, C-20), 18.4 (t, C-2), 11.6 (q, C-17); HRFABMS m/z 
359.2222 (calcd for C22H31O4 [(M + H)+], 359.2222). 
 
6β-Acetoxy-14,15-epoxylabda-8,13(16),14-trien-7-one (4.8):148 white amorphous solid; 
[α]D19  -66  (c 1.1, CHCl3), lit.148  -61; IR (film) νmax 2932, 2855, 1667, 1606, 1471 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 7.37 (1H, t, J = 1.6 Hz, H-15), 7.27 (1H, br s, H-16), 6.31 (1H, br s, 
H-14), 5.79 (1H, d, J = 3.2 Hz, H-6), 2.58 (2H, m, H2-12), 2.53 (1H, m, H-11b), 2.50 (1H, m, 
H-11a), 2.06 (3H, s, 6-OAc), 1.96 (1H, m, H-1b), 1.85 (3H, s, H3-17),  1.77 (1H, m, H-2b), 1.76 
(1H, d, J = 3.2 Hz, H-5), 1.61 (1H, m, H-2a),  1.45 (1H, m, H-3b), 1.42 (3H, s, H3-20), 1.36 
(1H, ddd, J = 13.5, 13.1, 3.4 Hz, H-1a), 1.24 (1H, ddd, J = 13.8, 13.5, 3.1 Hz, H-3a), 1.05 (3H, 
s, H3-18), 1.04 (3H, s, H3-19) ; 13C NMR (CDCl3, 100 MHz) δ 193.5 (s, C-7), 169.6 (s, 6-OAc), 
168.5 (s, C-9), 143.1, d, C-15), 138.6 (d, C-16), 129.3 (s, C-8), 124.4 (s, C-13), 110.5 (d, C-
14), 70.2 (d, C-6), 53.0 (d, C-5), 43.5 (t, C-3), 41.1 (s, C-10), 37.6 (t, C-1), 33.8 (s, C-4), 32.5 
(q, C-18), 30.7 (t, C-11), 23.0 (q, C-19), 21.8 (q, C-20), 21.4 (q, 6-OAc), 18.6 (t, C-2), 11.7 (q, 
C-17); HRFABMS m/z 359.2222 (calcd for C22H31O4 [(M + H)+], 359.2222). 
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7.4.4 Michael addition of cyanide to 4.7 and 4.8100;145 
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A 5:2 mixture of 4.7 and 4.8 (152 mg, 0.43 mmol) and KCN (70 mg, 1.08 mmol, 2.5 eq) were 
taken up in 95% EtOH (3 mL) and refluxed (24 h) until the starting material was no longer 
visible under TLC. All solvent was removed in vacuo and the off-white residue taken up in 
EtOAc (15 mL), which was subsequently washed with H2O (3 x 10 mL). The aqueous 
fractions were pooled and backwashed with CH2Cl2 (2 x 5 mL), after which the combined 
organic fractions were dried (MgSO4) and concentrated in vacuo to afford a pale yellow oil 
(150 mg). Semi-preparative HPLC (10% EtOAc, 90% hexane) was then used to isolate 9α-
cyano-15,16-epoxy-7β-hydroxylabda-13(16),14-dien-6-one (4.1, 65 mg, 45%) as a very pale 
yellow solid, 9α-cyano-15,16-epoxy-7β-hydroxylabda-7,13(16),14-trien-6-one (4.2, 14 mg, 
9%) as fine needle-like white crystals (from hexane/C6H6), 6α-hydroxy-15,16-epoxylabda-
8,13(16),14-trien-7-one (4.9, 2 mg, 1%) as white plates and 6-hydroxy-15,16-epoxylabda-
5,8,13(16),14-tetraen-7-one (4.11, 3 mg, 2%) as a pale yellow oil. 
 
9α-Cyano-15,16-epoxy-7β-hydroxylabda-13(16),14-dien-6-one (4.1):100 pale yellow oil; 
[α]D25 +53 (c 0.8, CHCl3), lit.100 +56; IR (film) νmax 3437, 2928, 2859, 2852, 2221 cm-1;  1H NMR 
(CDCl3, 400 MHz) δ 7.36 (1H, t, J = 1.6 Hz, H-15), 7.26 (1H, br s, H-16), 6.27 (1H, d, J = 0.7, 
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H-14), 3.96 (1H, dd, J = 10.9, 1.9 Hz, H-7), 3.72 (1H, br d, J = 3.2, 7-OH), 2.72 (1H, s, H-5), 
2.71 (2H, m, H2-12), 1.94 (1H, m, H-11b), 1.86 (1H, m, H-8), 1.74 (2H, m, H2-1), 1.61 (2H, m, 
H2-2), 1.54 (1H, m, H-11a), 1.42 (3H, d, J = 6.4 Hz, H3-19), 1.38 (1H, m, H-3b), 1.30 (3H, s, 
H3-19), 1.29 (1H, m, H-3a), 1.01 (3H, s, H3-18), 0.88 (3H, s, H3-20); 13C NMR (CDCl3, 100 
MHz) δ 208.9 (s, C-6), 143.1 (d, C-15), 138.8 (d, C-16), 123.5 (s, C-13), 120.2 (s, 9-CN), 
110.5 (d, C-14), 77.3 (s, C-7), 59.7 (d, C-5), 53.3 (q, C-9), 47.1 (d, C-8), 47.0 (q, C-10), 41.6 
(t, C-3), 35.1 (t, C-1), 32.6 (s, C-4), 32.3 (q, C-18), 31.6 (t, C-11), 24.6 (t, C-12), 22.1 (q, C-
19), 18.1 (t, C-2), 15.8 (q, C-20), 14.7 (q, C-17); HRFABMS m/z 344.2226 (calcd for 
C21H30NO3 [(M + H)+], 344.2226). 
 
9α-Cyano-15,16-epoxy-7β-hydroxylabda-7,13(16),14-trien-6-one (4.2): white needles (from 
hexane/C6H6); mp 138-139°C; [ α]D25 -44 (c 0.7, CHCl3); IR (film) νmax 3397 (br), 2927, 2863, 
2351, 2222, 1683 cm-1; 1H and 13C NMR data, see Table 4.2; EIMS m/z (rel. int.) 341 [M+] 
(13), 326 (100), 243 (12), 167 (15), 95 (17); HRFABMS m/z 341.1992 (calcd for C21H27NO3 
[(M)+], 341.1990).  
 
Crystal data for 4.2: C21H27NO3, M = 341.44, monoclinic, space group P21 (no. 4), a = 
6.2718 (1) Å, b = 14.6696(2) Å, c = 9.7782(2) Å, β = 103.735(1)°, V = 873.92(3) Å3, Z = 2, Dc 
1.298 Mg/m3, µ(Mo Kα ) = 0.086 mm-1, F(000) = 368. A total of 3700 reflections were 
collected, of which 3410 were observed [I>2σ(I)]. The structure was solved by direct methods 
and refined on F2 using all data, with non-hydrogen atoms treated anisotropically. All H atoms 
were located but were added in idealised positions in a riding model. The final R factors were 
R1 = 0.0385 (all data), 0.0334 (observed data), wR2 = 0.0846 (all data), 0.0816 (observed 
data) for 231 parameters. Crystallographic data (excluding structure factors) have been 
deposited at the Cambridge Crystallographic Data Centre (deposition no. 262101). 
 
6α-Hydroxy-15,16-epoxylabda-8,13(16),14-trien-7-one (4.9): white plates; mp 88-89°C, 
lit.148 95-96°C; [ α]D32 +48 (c 1.0, CHCl3), lit.148 +51; IR (film) νmax 2434, 2920, 2855, 1663, 
1465 cm-1; 1H NMR (CDCl3, 400 MHz), δ 7.37 (1H, t, J = 1.7 Hz, H-15), 7.26 (1H, dd, J = 1.4, 
0.8 Hz, H-16), 6.30 (1H, dd, J = 1.7, 0.8 Hz, H-14), 4.39 (1H, d, J = 13.1 Hz, H-5), 3.77 (1H, s, 
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6-OH), 2.54 (2H, m, H2-12), 2.52 (1H, m, H-11a), 2.44 (1H, m, H-11b), 1.95 (1H, m, H-9), 1.85 
(3H, s, H3-17), 1.69 (1H, d, J = 13.1 Hz, H-5), 1.68 (1H, m, H-2a), 1.57 (1H, m, H-2b), 1.46 
(1H, m, H-3a), 1.39 (1H, ddd, J = 13.4, 12.5, 3.8 Hz, H-1b), 1.27 (1H, m, H-3b), 1.25 (3H, s, 
H3-20), 1.17 (6H,s, H3-18, H3-19); 13C NMR (CDCl3, 100 MHz) δ  201.7 (s, C-7), 168.9 (s, C-
9), 143.1 (d, C-15), 138.7 (d, C-16), 127.4 (s, C-8), 124.2 (s, C-13), 110.5 (d, C-14), 73.3 (d, 
C-6), 56.7 (d, C-5), 42.8 (t, C-3), 42.5 (s, C-10), 36.7 (t, C-1), 35.8 (q, C-18), 34.0 (s, C-4), 
30.6 (t, C-11), 24.0 (t, C-12), 22.0 (q, C-19), 19.4 (q, C-20), 18.2 (t, C-2), 11.6 (q, C-17); 
HRFABMS m/z 317.2117 (calcd for C20H29O3 [(M + H)+], 317.2117).  
 
6-Hydroxy-15,16-epoxylabda-5,8,13(16),14-tetraen-7-one (4.11): pale yellow oil; [α]D32 -38 
(c 0.7, CHCl3), lit.100  -41;  IR (film) νmax 3367, 2928, 1620, 1605, 1456 cm-1; 1H NMR (CDCl3, 
400 MHz) δ 7.38 (1H, t, J = 1.7 Hz, H-15), 7.28 (1H, m, H-16), 6.99 (1H, br s, 6-OH),  6.32 
(1H, dd, J = 1.7, 0.8 Hz, H-14), 2.67 (1H, m, H-11b), 2.56 (1H, m, H2-12), 2.53 (1H, m, H-
11a), 2.05 (1H, m, H-1b), 1.98 (3H, s, H3-17), 1.89 (1H, m, H-3b), 1.83 (1H, m, H-2b), 1.72 
(1H, m, H-2a), 1.42 (1H, m H-3a), 1.38 (3H, s, H3-18), 1.38 (6H, s, H3-19, H3-20); 13C NMR 
(CDCl3, 100 MHz) δ 181.7 (s, C-7), 165.8 (s, C-9), 143.1 (s, C-6 & d, C-15), 140.5 (s, C-5), 
138.7 (d, C-16), 127.4 (s, C-8), 124.4 (s, C-13), 110.5 (d, C-14), 43.9 (s, C-10), 37.3 (t, C-3), 
35.7 (s, C-4), 31.5 (t, C-11), 29.4 (t, C-1), 28.1 (q, C-18), 27.9 (q, C-20), 27.6 (q, C-19), 23.8 
(t, C-12), 17.2 (t, C-2), 11.6 (q, C-17); HRFABMS m/z 315.1960 (calcd for C20H27O3 [(M + 
H)+], 315.1960).   
 
7.4.5 Lithium aluminium hydride reduction of 4.1 
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This method is representative. LAH (4 mg, 0.04 mmol) was dissolved in anhydrous THF (1.5 
mL) and stirred (30 min) under an Ar atmosphere at 0°C.  The nitrile was dissolved in 
anhydrous THF (2 mL) and added drop wise via cannula to the LAH solution. This mixture 
was maintained at 0°C for a further 3 hours while s tirring.  HCl (1 M, 1 drop) was added, and 
the solution was neutralised with NaOH (1 M, 1 drop). The THF was removed in vacuo and 
the organic component taken up in EtOAc (5 mL) and washed with H2O (3 X 2 mL). This 
organic fraction was dried (MgSO4) and concentrated to afford a yellowish oil (17 mg). 
Subsequent purification by semi-preparative HPLC in (20% EtOAc, 80% hexane) afforded 9α-
cyano-15,16-epoxy-6β,7β-dihydroxylabda-13(16),14-diene (4.3) as a colourless oil (13 mg, 
98%).  
 
9α-Cyano-15,16-epoxy-6β,7β-dihydroxylabda-13(16),14-diene (4.3): colourless oil; [α]D19 
+37 (c 1.2, CHCl3); IR (film) νmax 3437, 2938, 3859, 2852, 2221 cm-1; 1H NMR (CDCl3, 400 
MHz), δ 7.35 (1H, t, J = 1.6 Hz, H-15), 7.24 (1H, dd, J = 1.4, 0.9 Hz, H-16), 6.27 (1H, m, H-
14), 4.28 (1H, dd, J = 3.2, 1.9 Hz, H-6), 3.52 (1H, dd, J = 10.9, 3.5 Hz, H-7), 2.65 (2H, m, H2-
12), 2.11 (1H, m, H-8), 1.95 (1H, ddd, J = 14.0, 12.2, 6.5 Hz, H-11b), 1.66 (1H, m, H-2b), 1.60 
(2H, m, H2-1), 1.55 (1H, m, H-2a), 1.53 (1H, m, H-11a), 1.44 (1H, d, J = 1.8 Hz, H-5), 1.41 
(1H, m, H-3b), 1.28 (1H, m, H-3a), 1.26 (3H, m, H3-17), 1.25 (6H, s, H3-19, H3-20), 1.03 (3H, 
s, H3-18); 13C NMR (CDCl3, 100 MHz) δ 143.0 (d, C-15), 138.7 (d, C-16), 124.0 (s, C-13), 
121.0 (s, C-21), 110.6 (d, C-14), 74.3 (d, C-7), 69.6 (d, C-6), 54.1 (s, C-9), 51.2 (d, C-5), 43.0 
(t, C-3), 41.9 (s, C-10), 38.0 (d, C-8), 37.6 (t, C-1), 34.5 (s, C-4), 33.4 (q, C-18), 31.7 (t, C-11), 
24.6 (t, C-12), 24.5 (q, C-19), 18.6 (t, C-2), 17.1 (q, C-17), 13.2 (q, C-20); HRFABMS m/z 
345.2304 (calcd for C21H31NO3 [M +], 345.2304). 
 
7.4.6 In planta test methods  
 
The in planta assays were performed at Dow AgroSciences (Indianapolis, USA) and methods 
described here are as supplied by Dr B. Nader. For evaluations in 1 day protectant tests, 
samples of the compounds were dissolved in acetone at 2000 ppm, then diluted in acetone to 
500 and 125 ppm. Samples were then brought to final concentrations of 200, 50 and 12.5 
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ppm by addition of 9 volumes of milli-Q water containing 110 ppm Triton X-100. Applications 
were made in 20 mL spray volumes using a turntable sprayer equipped with two Spraying 
Systems Co. 1/4JAUPM-SS nozzles with 4010055 fluid caps and a spray pressure of 206 
kPa.  
Inoculation of plants was done by spraying suspensions of 5 x 105 - 6 x 106
 
conidia per mL, 
depending on the pathogen, 1 day after application. Conidial suspensions were prepared with 
de-ionized water containing 3 drops of Tween-20 per 100 mL of suspension. Inoculated plants 
were placed in a dew room (99–100% relative humidity, 20°C) overnight to allow infection. 
The plants were then moved to either a greenhouse or growth chamber at a suitable 
temperature, daylength and humidity for expression of the disease.  
 
Evaluations of disease control were made 6 days after inoculation in the case of M. grisea 
and 7 days after inoculation in the case of P. recondita, by visual estimation of disease 
severity. Percent disease control was calculated from disease severity ratings by the 
calculation: %DC = (1- %DStrt/%DSuntrt) x 100, where %DC is percent disease control; %DStrt 
is the observed percent disease severity for treated plants; and %DSuntrt is the observed 
percent disease severity for untreated controls.  
7.5 Chapter Five Experimental 
7.5.1 Attempted synthesis of 5.1 and 5.2 via a modification of Wisch’s synthetic strategy 
 
7.5.1.1 KMnO4 oxidation of 5.3174;176;190;239;240 
 
Method A: Oxidation using Me2CO (distilled over KMnO4) as a solvent. Manool (5.3, 540 mg, 
1.86 mmol) was dissolved in Me2CO (30 mL) and finely powdered KMnO4 (1.18 g, 7.44 mmol, 
4 eq) was added slowly over 2 hours. The temperature of the the reaction mixture was 
maintained between 16°C and 20°C and stirring conti nued (48 h).The reaction mixture was 
allowed to settle (24 h) and filtered through Celite (545 coarse) after which the solvent was 
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removed in vacuo.  The reaction mixture was taken up in CH2Cl2 (15 mL) and washed with a 
mixture of 3% aqueous oxalic acid (10 mL) and saturated aqueous Na2S2O3 (10 mL) to reduce 
the brown MnO2 precipitate.  The organic fraction was washed with H2O (2 x 15 mL), dried 
(MgSO4) and concentrated to afford a yellow oil (360 mg) which was purified using silica flash 
chromatography (10% EtOAc, 90% hexane) to afford 5.14 (176 mg, 36%) as a colourless oil. 
 
Method B: KMnO4 mediated oxidation of 5.3 using CH2Cl2 as a solvent with 
phenyltriethylammonium chloride (PTEACl) as a phase transfer catalyst 
 
H
HO
H
O
5.3 5.14
14
8
17
13
KMnO4, PTEACl,
 
CH2Cl2, 16-20°C
1
6
19
16
20
15
18
17
10
4
8 1
6
19
20
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10
4
 
 
This method is representative. Manool (5.3, 1.00g, 3.46 mmol) and PTEACl (1.84 g, 37.0 
mmol, 10.7 eq) were dissolved in CH2Cl2 (100 mL) and finely powdered KMnO4 (1.69 g, 10.7 
mmol, 3 eq) was added slowly over 2 hours. The temperature of the reaction mixture was 
maintained between 16°C and 20°C and stirring conti nued (48 h).The reaction mixture was 
allowed to settle (24 h) and filtered through Celite (545 coarse) after which the solvent was 
removed in vacuo.  The reaction mixture was taken up in CH2Cl2 (15 mL) and washed with a 
mixture of 1.5% aqueous oxalic acid (30 mL) and saturated aqueous Na2S2O3 (15 mL), which 
reduced the brown precipitate.  The organic fraction was washed with H2O (2 x 15 mL), dried 
(MgSO4) and concentrated to afford a yellow oil (652 mg) which was purified using silica flash 
chromatography (10% EtOAc, 90% hexane) to afford 14,15-bisnorlabd-8(17)-en-13-one (5.14, 
512 mg, 56%) as a colourless oil and manool (5.3, 34 mg, 3%). 
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14,15-Bisnorlabd-8(17)-en-13-one (5.14):174-176;239;241;242 colourless oil; [α]D32 +32 (c 2.9, 
CHCl3) lit.242 +35.8; IR (film) νmax 2926, 2834, 1711, 1641, 1455 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 4.82 (1H, br s, H-17b), 4.43 (1H, br s, H-17a), 2.55 (1H, ddd, J = 12.7, 9.3, 4.0 Hz, H-
12b), 2.37 (1H, ddd, J
 
= 12.7, 4.2, 2.5 Hz, H-7b), 2.29 (1H, m, H-12a), 2.08 (3H, s, H3-16), 
1.94 (1H, m, H-7b), 1.84 (1H, m, H-11a), 1.78 (1H, m, H-1b), 1.72 (1H, m, H-6b), 1.55 (2H, m, 
H-9, H-11b), 1.54 (1H, m, H-2b), 1.50 (1H, m, H-2a), 1.37 (1H, m, H-3b), 1.29 (1H, dddd, J = 
13.4, 13.4, 13.1, 4.4 Hz, H-6b), 1.17 (1H, ddd, J = 13.2, 13.2, 4.2 Hz, H-3b), 1.10 (1H, m, H-
1a), 1.09 (1H, dd, J  = 12.6, 2.5, Hz, H-5), 0.83 (3H, s, H3-18), 0.80 (3H, s, H3-19), 0.69 (3H, 
s, H3-20); 13C NMR (CDCl3, 100 MHz) δ 209.1 (s, C-13), 148.4 (s, C-8), 106.3 (t, C-17), 56.4 
(d, C-9), 55.6 (d, C-5), 42.9 (t, C-12), 42.2 (t, C-3), 39.8 (s, C-10), 39.1 (t, C-7), 33.6 (q, C-18), 
33.6 (s, C-4), 29.9 (q, C-16), 24.5 (t, C-6), 21.7 (q, C-19), 19.4 (t, C-2), 17.7 (t, C-11), 14.3 (q, 
C-20); HRFABMS m/z 262.2296 (calcd for C18H30O [M+], 262.2297).  
 
7.5.1.2 Reduction of methyl ketone 5.14 with LAH 
H
O
H
OH
13
5.15 13-(R)
5.17 13-(S)5.14
8
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13
LAH, THF, 0°C 8
17
1
6
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This method is representative. Methyl ketone (5.14, 90 mg, 0.34 mmol) was dissolved in 
anhydrous THF (2 mL) and added via cannula to a 0°C solution of LAH (26 mg, 0.69 mmol,  2 
eq) in anhydrous THF (10 mL).  The reaction was allowed to warm naturally to ambient 
temperature (3 h) before 5% aqueous NaHCO3 (3 drops) was added.  The reaction mixture 
was acidified with 1M HCl (0.5 mL), concentrated to dryness, taken up in EtOAc (5 mL) and 
washed with H2O (3 x 5 mL).  The organic fraction was dried (MgSO4) and concentrated to 
afford a colourless oil (92 mg).  Semi-preparative HPLC (14% EtOAc, 86% hexane) followed 
to afford 5.17 14,15-bisnorlabd-8(17)-en-13S-ol (5.17, 45 mg, 53%) and 14,15-bisnorlabd-
8(17)-en-13R-ol (5.15, 39 mg, 40%) as colourless oils in 93% combined isolated yield. 
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14,15-Bisnorlabd-8(17)-en-13R-ol (5.15): colourless oil; [α]D34 +28 (c 1.0, CHCl3); IR (film) 
νmax 3353, 2832, 1645, 1462, 1387 cm-1; 1H NMR (CDCl3, 400 MHz) δ 4.81 (1H, br s, H-17b), 
4.48 (1H, br s, H-17a), 3.76 (1H, m, H-13), 2.38 (1H, ddd, J =  12.7, 4.1, 2.4 Hz, H-7b), 1.97 
(1H, ddd, J =  13.6, 12.7, 5.0 Hz, H-7a), 1.77 (1H, m, H-1b), 1.72 (1H, m, H-6b), 1.59 (2H, m, 
H-2b, H-12b),  1.58 (1H, m, H-9), 1.56 (2H, m, H-2a, H-11b), 1.46 (1H, m, H-11a), 1.38 (1H, 
m, H-3b), 1.31 (1H, m, H-6b), 1.29 (1H, m, H-2a), 1.26 (1H, m, H-12a), 1.18 (1H, m, H-3a), 
1.17 (3H, d, J =  6.2 Hz, H3-16), 1.07 (1H, dd, J = 12.7, 2.8 Hz, H-5), 1.02 (1H, ddd, J =  13.2, 
12.8, 3.6 Hz, H-1a), 0.86 (3H, s, H3-18), 0.79 (3H, s, H3-19), 0.67 (3H, s, H3-20); 13C NMR 
(CDCl3, 100 MHz) δ 148.8 (s, C-8), 106.2 (t, C-17), 68.9 (d, C-13), 57.0 (d, C-9), 55.6 (d, C-5), 
42.2 (t, C-3), 39.8 (s, C-10), 39.1 (t, C-1), 38.6 (t, C-12), 38.4 (t, C-7), 33.62 (q, C-18), 33.57 
(s, C-4), 24.5 (t, C-6), 23.5 (q, C-16), 21.7 (q, C-19), 19.8 (t, C-2), 19.4 (t, C-11), 14.4 (q, C-
20); HRFABMS m/z
  
264.2453 (calcd for C18H32O [M+], 264.2453). 
 
14,15-Bisnorlabd-8(17)-en-13S-ol (5.17): colourless oil; [α]D34 +30 (c 1.5, CHCl3); IR (film) 
νmax 3391, 2923, 1644, 1456, 1410 cm-1; 1H NMR (CDCl3, 400 MHz) δ 4.81 (1H, br s, H-17b), 
4.52 (1H, br s, H-17a), 3.76 (1H, m, H-13), 2.38 (1H, ddd, J = 12.6, 4.0, 2.0 Hz, H-7b), 1.95 
(1H, ddd, J = 13.4, 12.6, 4.8 Hz, H-7a), 1.76 (1H, m, H-1b), 1.70 (1H, m, H-6b), 1.57 (2H, m, 
H-9, H-12b), 1.56 (1H, m, H-2b), 1.52 (1H, H-2a), 1.50 (H, m, H-11b), 1.46 (1H, H-11a), 1.37 
(1H, m, H-3b), 1.30 (1H, m, H-6a), 1.22 (1H, m, H-12a), 1.17 (3H, d, J = 6.2 Hz, H3-16), 1.16 
(1H, m, H-3a), 1.08 (1H, dd, J = 12.7, 2.6 Hz, H-5), 1.01 (1H, ddd, J = 13.5, 12.8, 3.6 Hz, H-
1a), 0.86 (3H, s, H3-18), 0.79 (3H, s, H3-19), 0.67 (3H, s, H3-20); 13C NMR (CDCl3, 100 MHz) 
δ 148.6 (s, C-8), 106.5 (t, C-17), 68.4 (d, C-13), 56.8 (d, C-9), 55.6 (d, C-5), 42.2 (t, C-3), 39.7 
(s, C-10), 39.1 (t, C-1), 38.4 (t, C-7), 38.3 (t, C-12), 33.62 (q, C-18), 33.57 (s, C-4), 24.4 (t, C-
6), 23.6 (q, C-16), 21.7 (q, C-19), 19.5 (t, C-11), 19.4 (t, C-2), 14.4 (q, C-20); HRFABMS m/z
  
264.2454 (calcd for C18H32O [M+], 264.2453). 
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7.5.1.3 Preparation of the (R)- and (S)-MTPA esters of 5.17 
 
H
OH
13
5.17
H
5.18 (S)-MTPA ester
5.19 (R)-MTPA ester
O
O
CF3
MeO
1'
3'
9'
10'
7'
4'
TBDMS triflate, 2,6-lutidine,
 
CH2Cl2, -78°C
8
17
13
1
6
19
20
18
10
4
 
 
This method is representative for the preparation of either the (R)- or (S)-MTPA esters of 
5.17.  R-α-methoxy-α-trifluoromethylphenylacetic acid (37 mg), DCC (74 mg) and DMAP (11 
mg) were added to a solution of 5.17 in anhydrous CH2Cl2 (2 mL). The solution was shaken 
periodically over period of 1.5 hours at ambient temperature, diluted with a combination of 
EtOAc (8 mL) and H2O (1 mL) and filtered. The resulting solution was washed with 1M HCl (1 
mL), H2O (3 mL), saturated aqueous NaHCO3 (2 mL) and once more with H2O (3 mL) in the 
order presented. The resulting colourless oil (19 mg) was purified by semi-preparative HPLC 
(hexane) to afford 5.19 (6 mg). The (S)-MTPA ester (5.18) of 5.17 was similarly prepared from 
S-α-methoxy-α-trifluoromethylphenylacetic acid. 
 
(S)-MTPA ester (5.18):  1H NMR (CDCl3, 600 MHz) δ 7.53 (2H, m, H-4', H-8'), 7.38 (3H, m, 
H-5', H-6', H-7'), 5.10 (1H, m, H-13), 4.77 (1H, s, H-17b), 4.39 (1H, s, H-17a), 3.53 (3H, s, H3-
9'), 2.35 (1H, ddd, J = 12.7, 3.9, 2.4 Hz, H-7b), 1.93 (1H, ddd, J = 13.6, 13.0, 4.9 Hz, H-7a), 
1.83 (1H, m, H-12b), 1.70 (1H, m, H-6b), 1.67 (1H, m, H-1b), 1.58 (1H, m, H-9), 1.54 (1H, m, 
H-2b), 1.54 (1H, m, H-2a), 1.38 (2H, m, H-3b, H-12b), 1.37 (1H, m, H-11b), 1.30 (1H, m, H-
6a), 1.24 (1H, m, H-11a), 1.24 (1H, d, J =  6.2 Hz, H3-16), 1.16 (1H, ddd, J = 13.7, 13.4, 3.8 
Hz, H-3a), 1.06 (1H, dd, J = 12.6, 2.6 Hz, H-5), 0.98 (1H, ddd, J =  13.7, 13.0, 3.8 Hz, H-1a), 
0.86 (3H, s, H3-18), 0.79 (3H, s, H3-19), 0.63 (3H, s, H3-20); 13C NMR (CDCl3, 150 MHz) δ 
166.3 (s, C-1'), 148.1 (s, C-8), 132.4 (s, C-3'), 129.5 (d, C-5'), 129.5 (d, C-7'), 128.4 (d, C-6'), 
127.5 (d, C-4'), 127.5 (d, C-8'), 124.4 (s, C-10'), 122.5 (s, C-2'), 106.5 (t, C-17), 74.7 (d, C-13), 
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56.6 (d, C-9), 55.5 (d, C-5), 55.5 (q, C-9'), 42.1 (t, C-3), 39.7 (s, C-10), 39.1 (t, C-1), 38.3 (t, 
C-7), 34.7 (t, C-12), 33.61 (q, C-18), 33.57 (s, C-4), 24.4 (t, C-6), 21.7 (q, C-19), 19.7 (q, C-
16), 19.4 (t, C-2), 19.4 (t, C-11), 14.4 (q, C-20). 
 
(R)-MTPA ester (5.19): 1H NMR (CDCl3, 600 MHz) δ 7.54 (2H, m, H-4', H-8'), 7.38 (3H, m, H-
5', H-6', H-7'), 5.12 (1H, m, H-13), 4.69 (1H, s, H-17b), 4.22 (1H, s, H-17a), 3.57 (3H, d, J = 
0.7 Hz, H3-9'), 2.32 (1H, ddd, J = 12.7, 4.1, 2.4 Hz, H-7b), 1.90 (1H, ddd, J = 13.7, 13.0, 4.9 
Hz, H-7a), 1.77 (1H, m, H-12b), 1.68 (1H, m, H-6b), 1.62 (1H, m, H-1b), 1.53 (1H, m, H-3b), 
1.48 (1H, d, J = 11.2 Hz, H-9), 1.44 (1H, m, H-2a), 1.37 (2H, m, H-3b, H-11b), 1.31 (3H, d, J = 
5.0 Hz, H3-16), 1.29 (1H, m, H-12a), 1.26 (1H, m, H-6a), 1.23 (1H, m, H-11a), 1.16 (1H, ddd, 
J  = 13.7, 13.4, 4.0 Hz, H-3a), 1.02 (1H, dd, J = 12.6, 2.7 Hz, H-5), 0.91 (1H, ddd, J = 13.7, 
13.0, 3.8 Hz, H-1a), 0.85 (3H, s, H3-18), 0.78 (3H, s, H3-19), 0.57 (3H, s, H3-20); 13C NMR 
(CDCl3, 150 MHz) δ 166.2 (s, C-1'), 148.0 (s, C-8), 132.7 (s, C-3'), 129.4 (d, C-5'), 129.4 (d, 
C-7'), 128.3 (d, C-6'), 127.2 (d, C-4'), 127.2 (d, C-8'), 124.2 (s, C-10'), 122.5 (s, C-2'), 106.5 (t, 
C-17), 74.5 (d, C-13), 56.7 (d, C-9), 55.5 (d, C-5), 55.4 (q, C-9'), 42.1 (t, C-3), 39.6 (s, C-10), 
39.0 (t, C-1), 38.3 (t, C-7), 34.9 (t, C-12), 33.60 (q, C-18), 33.55 (s, C-4), 24.4 (t, C-6), 21.7 (q, 
C-19), 20.1 (q, C-16), 19.4 (t, C-2), 19.1 (t, C-11), 14.4 (q, C-20).   
 
7.5.1.4 TBDMS protection of the 14,15-bisnorlabd-8(17)-en-13-ols, 5.15 and 5.17 
 
H
OH
13
5.15 13-(R)
5.17 13-(S)
H
OTBDMS
5.8 13-(R)
5.9 13-(S)
TBDMS triflate, 2,6-lutidine,
 
CH2Cl2, -78°C
8
17
13
1
6
19
20
18
10
4
 
 
A solution of a mixture of 5.15 and 5.17 (346 mg, 1.31 mmol) in anhydrous CH2Cl2 (5 mL) was 
cooled (-78°C) and 2,6-lutidine (3.01 mmol, 2.4 eq)  followed by TBDMS triflate (2.03 mmol, 
1.6 eq) were added.  The reaction mixture was allowed to warm naturally to ambient 
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temperature and was stirred for a further 2 hours, after which 50% AcOH (6 mL) was added 
and the organic and inorganic layers separated. The organic fraction was washed with H2O (3 
x 5 mL), dried (MgSO4) and concentrated to afford a pale brown oil (473 mg). Subsequent 
purification by silica flash chromatography (5% EtOAc, 95% hexane) afforded a mixture of 13-
tert-butyldimethylsilanyloxy-14,15-bisnorlabd-8(17)-enes 5.8 and 5.9 (441 mg, 89% combined 
isolated yield). 
 
13-tert-Butyldimethylsilanyloxy-14,15-bisnorlabd-8(17)-enes (5.8 and 5.9): pale brown oil; 
1H and 13C NMR data consistent with literature values;173; HRFABMS m/z 379.3397 (calcd for 
C24H47SiO [(M + H)+], 379.3396).  
 
7.5.1.5 Reductive ozonolysis of the TMDMS ethers 5.17 and 5.15173 
H
OTBDMS
5.8 13-(R)
5.9 13-(S)
H
O
O
5.10 13-(R)
5.11 13-(S)
i) O3, CH2Cl2, -78°C
 
ii) PPh3, CH2Cl2, RT
8
13
1
6
19
20
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10
4
Si
1'
4'
5'6'
2'
 
 
A mixture of 5.17 and 5.15 (208 mg, 0.43 mmol) were dissolved in anhydrous CH2Cl2 (20 mL),  
the solution chilled to -78°C and O 3 bubbled through for 10 minutes, until the solution had 
turned blue, indicating that the solution was saturated with O3. While allowing the reaction 
mixture to warm to ambient temperature, N2 was bubbled through the solution to remove any 
excess O3. After one hour, triphenylphosphine (450 mg, 3.1 eq) was added and allowed to stir 
(4 h), after which H2O2 (30%, 5 mL) was added slowly (over a period of 30 minutes) to oxidize 
the remaining triphenylphosphine.  The solution was washed with saturated brine (1 x 10 mL) 
and H2O (2 x 10 mL), concentrated in vacuo, taken up in 15% EtOAc in hexane and passed 
through a silica plug (5 mL) to remove any remaining triphenylphosphine oxide.  The C-13 
epimers were separated by semi-preparative HPLC (5% EtOAc, 95% hexane) to afford 13S-
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tert-butyldimethylsilanyloxy-14,15,17-trisnorlabdan-8-one  (5.10, 115 mg, 55%) and 13R-tert-
butyldimethylsilanyloxy-14,15,17-trisnorlabdan-8-one (5.11, 71 mg, 34%) in 89% overall yield. 
 
13S-tert-Butyldimethylsilanyloxy-14,15,17-trisnorlabdan-8-one (5.10): colourless oil; 
[α]D34      -34 (c 4.1, CHCl3), lit.173 -32; IR (film) νmax 2929, 2856, 1713, 1460, 1254 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 3.76 (1H, m, H-13), 2.38 (1H, ddd, J = 13.2, 4.9, 2.2 Hz, H-7b), 
2.26 (1H, dddd, J = 13.4, 13.2, 7.0, 1.0 Hz, H-7a), 2.02 (1H, m, H-6b), 2.01 (1H, m, H-9), 1.74 
(1H, m, H-1b), 1.66 (1H, m, H-11b), 1.63 (1H, m, H-6a), 1.49 (2H, m, H2-2), 1.48 (1H, m, H-
12b), 1.46 (1H, m, H-5), 1.43 (1H, m, H-3b), 1.22 (1H, m, H-3a), 1.17 (2H, m, H-3a, H-11a), 
1.09 (3H, d, J = 6.2 Hz, H3-16), 1.09 (1H, m, H-1a), 0.94 (3H, s, H3-19), 0.86 (9H, s, H3-4', H3-
5', H3-6'), 0.82 (3H, s, H3-19), 0.69 (3H, s, H3-20), 0.03 (3H, s, H3-1'), 0.02 (3H, s, H3-2'); 13C 
NMR (CDCl3, 100 MHz) δ 212.0 (s, C-8), 68.7 (d, C-13), 64.5 (d, C-9), 54.3 (d, C-5), 42.8 (s, 
C-10), 42.7 (t, C-7), 42.0 (t, C-3), 39.3 (t, C-1), 39.0 (t, C-12), 33.7 (s, C-4), 33.5 (q, C-18), 
25.9 (q, C-4', C-5', C-6'), 24.1 (q, C-16), 23.1 (t, C-6), 21.7 (q, C-19), 19.0 (t, C-2), 18.1 (s, C-
3'), 17.1 (t, C-11), 14.6 (q, C-20), -4.5 (q, C-1'), -4.7 (q, C-2'); HRFABMS m/z 380.3111 (calcd 
for C23H44SiO2  [M+], 380.3111). 
 
13R-tert-Butyldimethylsilanyloxy-14,15,17-trisnorlabdan-8-one (5.11): colourless oil; 
[α]D34 -32 (c 3.5, CHCl3), lit.173 -37; IR (film) νmax 2929, 2856, 1714, 1462, 1255 cm-1;1H NMR 
(CDCl3, 400 MHz) δ 3.74 (1H, m, H-13), 2.38 (1H, ddd, J = 13.2, 4.9, 2.2 Hz, H-7b), 2.27 (1H, 
m, H-7a), 2.04 (1H, m, H-6b), 1.98 (1H, m, H-9), 1.77 (1H, m, H-1b), 1.63 (1H, m, H-6a), 1.57 
(1H, m, H-11b), 1.51 (1H, m, H-5), 1.50 (2H, m, H2-2), 1.46 (1H, m, H-12b), 1.42 (1H, m, H-
3b), 1.38 (1H, m, H-11a), 1.22 (1H, m, H-12a), 1.16 (1H, m, H-12a), 1.04 (1H, m, H-1a), 1.08 
(3H, d, J = 6.1 Hz, H3-16), 0.94 (3H, s, H3-18), 0.87 (9H, s, H3-4', H3-5', H3-6') 0.83 (3H, s, H3-
19), 0.70 (3H, s, H3-20), 0.03 (3H, H3-1'), 0.02 (3H, s, H3-2'); 13C NMR (CDCl3, 100 MHz) δ 
212.3 (s, C-8), 69.2 (d, C-13), 64.5 (d, C-9), 54.3 (d, C-5), 42.8 (s, C-10), 42.7 (t, C-7), 41.9 (t, 
C-3), 39.5 (t, C-1), 39.3 (t, C-12), 33.7 (s, C-4), 33.5 (q, C-18), 25.9 (q, C-4', C-5', C-6'), 24.2 
(q, C-16), 24.1 (t, C-6), 21.7 (q, C-19), 19.1 (t, C-2), 18.7 (t, C-11), 18.1 (s, C-3'), 14.7 (3H, s, 
H3-20), -4.3 (q, C-1'), -4.6 (q, C-2'); HRFABMS m/z 380.3111 (calcd for C23H44SiO2 [M+], 
380.3111). 
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7.5.1.6 Nucleophilic addition of MeLi to 5.11 and 5.10173 
H
OTBDMS
O
5.10 13-(R)
5.11 13-(S)
H
OH
5.20 13-(R)
5.21 13-(S)
MeLi, THF, -78°C
O
8
13
1
6
19
20
18
10
Si
1'
4'
5'6'
2'
 
 
This method is representative of the methylation of both 5.11 and 5.10.  A solution of 5.11 (25 
mg, 0.07 mmol) in anhydrous THF (5 mL) was cooled to -78°C and 1.6 M MeLi solution (0.19 
mmol, 2.5 eq) added drop wise . The solution was allowed to reach ambient temperature and 
left to stir (14 h).  Excess MeLi was quenched with an ice cold slurry of saturated aqueous 
NaHCO3 (2 mL), all THF removed in vacuo and the contents of the reaction vessel taken up in 
Et2O (5 mL).  The Et2O solution was washed with H2O (3 x 5 mL), dried (MgSO4) and 
concentrated to a yellow oil (27 mg), which was subsequently purified by semi-preparative 
HPLC (10% EtOAc, 90% hexane) to afford 13R-tert-butyldimethylsilanyloxy-14,15-bisnorlabd-
8(17)-en-8β-ol (5.20, 20 mg, 82% yield) as a pale yellow oil. 13S-tert-Butyldimethylsilanyloxy-
14,15-bisnorlabd-8(17)-en-8β-ol (5.21) was similarly prepared from 5.10 in identical yield. 
 
13R-tert-Butyldimethylsilanyloxy-14,15-bisnorlabd-8(17)-en-8β-ol (5.20): pale yellow 
amorphous solid; [α]D26 +8 (c 2.2, CHCl3), lit.173 +15; IR (film) νmax 2926, 2863, 1471, 1372, 
1256 cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.74 (1H, m, H-13), 1.73 (1H, m, H-7b), 1.68 (1H, m, 
H-12b), 1.60 (1H, m, H-2b), 1.52 (1H, m, H-6b), 1.48 (1H, m, H-6a), 1.49 (1H, m, H-7a), 1.48 
(1H, m, H-12b), 1.44 (1H, m, H-12a), 1.42 (1H, m, H-11b), 1.39 (1H, m, H-2a), 1.38 (1H, m, 
H-3b), 1.28 (1H, m, H-11a), 1.13 (1H, m, H-3a), 1.12 (3H, d, J = 6.2 Hz, H3-16), 1.11 (3H, s, 
H3-17), 0.94 (3H, s, H3-20), 0.88 (9H, s, H3-4', H3-5', H3-6'), 0.87 (1H, m, H-1a), 0.85 (3H, s, 
H3-18), 0.85 (1H, m, H-5), 0.81 (3H, s, H3-19), 0.75 (1H, m, H-9), 0.05 (3H, s, H3-1') 0.04 (3H, 
s, H3-2');  13C NMR (CDCl3, 100 MHz) δ 73.3 (s, C-8), 69.1 (d, C-13), 59.1 (d, C-9), 56.0 (d, C-
5), 43.8 (t, C-12), 42.2 (t, C-7), 42.1 (t, C-3), 39.2 (t, C-1), 39.1 (s, C-10), 33.4 (q, C-18), 33.3 
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(s, C-4), 30.6 (q, C-17), 25.9 (q, C-4', C-5', C-6'), 23.6 (q, C-16), 21.7 (q, C-19), 21.4 (t, C-11), 
18.3 (t, C-2), 18.2 (s, C-3'), 18.1 (d, C-6), 15.0 (q, C-20), -4.4 (q, C-1'), -4.7 (q, C-2'); 
HRFABMS m/z 396.3424 (calcd for C24H48SiO2 [M+], 396.3424).   
 
13S-tert-Butyldimethylsilanyloxy-14,15-bisnorlabd-8(17)-en-8β-ol (5.21): pale yellow oil; 
[α]D26 +13 (c  1.7, CHCl3), lit.173 +11; IR (film) νmax 2915, 2856, 1469, 1366, 1252 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 3.74 (1H, m, H-13), 1.73 (1H, m, H-7b), 1.68 (1H, m, H-12b), 1.60 
(1H, m, H-2b), 1.52 (1H, m, H-6b), 1.48 (1H, m, H-6a), 1.49 (1H, m, H-7a), 1.43 (1H, m, H-
12b), 1.42 (1H, m, H-11b), 1.40 (1H, m, H-12a), 1.39 (1H, m, H-2a), 1.38 (1H, m, H-3b), 1.23 
(1H, m, H-11a), 1.13 (1H, m, H-3a), 1.12 (3H, d, J = 6.0 Hz, H3-16), 1.12 (3H, s, H3-17), 0.94 
(3H, s, H3-20), 0.88 (9H, s, H3-4', H3-5', H3-6'), 0.87 (1H, m, H-1a), 0.85 (3H, s, H3-18), 0.85 
(1H, m, H-5), 0.81 (3H, s, H3-19), 0.75 (1H, m, H-9), 0.04 (6H, s, H3-1', H3-2');  13C NMR 
(CDCl3, 100 MHz) δ 73.2 (s, C-8), 69.0 (d, C-13), 59.2 (d, C-9), 56.0 (d, C-5), 43.7 (t, C-12), 
42.2 (t, C-7), 42.1 (t, C-3), 39.2 (t, C-1), 38.9 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 30.6 (q, 
C-17), 25.9 (q, C-4', C-5', C-6'), 23.5 (q, C-16), 21.7 (q, C-19), 21.1 (t, C-11), 18.3 (t, C-2), 
18.2 (t, C-6), 18.2 (s, C-3'), 15.1 (q, C-20), -4.5 (q, C-1'), -4.7 (q, C-2'); HRFABMS m/z 
396.3424 (calcd for C24H48SiO2 [M+], 396.3424).   
 
7.5.1.7 TBAF mediated deprotection of 5.21 and 5.20173 
 
H
OTBDMS
OH
5.20 13-(R)
5.21 13-(S)
H
OH
OH
5.22 13-(R)
5.23 13-(S)
TBAF, THF, ∆ 8
13
1
6
19
20
18
10
 
 
This method is representative for the deprotection of both 5.21 and 5.20. A solution of 5.20 
(42 mg, 0.11 mmol) and TBAF (1 M, 0.66 mmol, 6 eq) in THF (2 mL) was refluxed (4 h). The 
solution was allowed to cool to ambient temperature and saturated aqueous NH4Cl (2.5 mL) 
added. The THF was removed in vacuo and the solution taken up in Et2O (5 mL). The organic 
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fraction was washed with H2O (3 x 5 mL), dried (MgSO4) and concentrated to afford a yellow 
oil (35 mg).  Semi-preparative HPLC (50% EtOAc, 50% hexane) followed to afford 14,15-
bisnorlabd-8(17)-en-8β,13R-diol (5.22, 26 mg, 87%) which could be crystallized by slow 
evaporation from Et2O. 14,15-bisnorlabd-8(17)-en-8β,13S-diol (5.23) was similarly prepared 
from 5.21 in similar yield. 
 
14,15-Bisnorlabd-8(17)-en-8β,13R-diol (5.22): pale yellow plates (from ether); mp 95-96°C; 
[α]D26 +9 (c 5.6, CHCl3), lit.173 +18; IR (film) νmax 3384, 2923, 2856, 1464, 1384 cm-1;  1H NMR 
(CDCl3, 400 MHz) δ 3.75 (1H, m, H-13), 1.73 (1H, m, H-7b), 1.69 (1H, m, H-1b), 1.59 (1H, m, 
H-6b), 1.52 (2H, m, H2-2), 1.50 (1H, m, H-11b), 1.49 (2H, m, H-3b, H-12b), 1.46 (1H, m, H-
7a), 1.44 (1H, m, H-6b), 1.38 (2H, m, H-12a, H-11a), 1.19 (3H, d, J = 6.2 Hz, H3-16), 1.15 
(1H, m, H-3a), 1.12 (3H, s, H3-17), 0.94 (3H, s, H3-20), 0.86 (1H, m, H-1a), 0.85 (3H, s, H3-
18), 0.82 (1H, m, H-5), 0.81 (3H, s, H3-19), 0.77 (1H, m, H-9); 13C NMR (CDCl3, 100 MHz) δ 
73.2 (s, C-8), 68.6 (d, C-13), 59.1 (d, C-9), 55.9 (d, C-5), 43.2 (t, C-12), 42.2 (t, C-7), 42.0 (t, 
C-3), 39.2 (t, C-1), 39.0 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 30.6 (q, C-17), 23.4 (q, C-16), 
21.6 (q, C-19), 21.3 (t, C-11), 18.3 (t, C-2), 18.1 (t, C-6), 15.1 (q, C-20); HRFABMS m/z 
282.2557 (calcd for C18H34O2 [M+], 282.2559).  
 
Crystal data for 5.22: C18H34O2, M = 282.45, 0.25 x 0.25 x 0.20 mm3, orthorhombic, space 
group P212121 (No. 19), a = 8.4923(2), b = 9.9407(2), c = 20.4323(4) Å, V = 1724.88(6) Å3, Z 
= 4, Dc = 1.088 g/cm3, F000 = 632, MoKα radiation,  λ = 0.71073 Å,  T = 113(2)K, 2θmax = 52.7º, 
3520 reflections collected, 3520 unique (Rint = 0.0000).  Final GooF = 1.045, R1 = 0.0433, 
wR2 = 0.0999, R indices based on 2781 reflections with I >2sigma(I) (refinement on F2), 195 
parameters, 0 restraints.  Lp corrections applied, µ = 0.068 mm-1.  Absolute structure 
parameter = -1.8(12).237 Tables of atmomic co-ordinates and interatomic bond angles and 
bond lengths have not been deposited with the Cambridge data base and are provided in 
Appendix II. 
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14,15-Bisnorlabd-8(17)-en-8β,13S-diol (5.23): pale yellow amorphous solid; [α]D26 +16 (c 
2.4, CHCl3), lit.173 +8; IR (film) νmax 3321, 2923, 2863, 1462, 1370 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 3.75 (1H, m, H-13), 1.72 (1H, m, H-7b), 1.66 (1H, m, H-1b), 1.58 (1H, m, H-6b), 1.55 
(1H, m, H-11b), 1.54 (1H, m, H-12b), 1.49 (3H, m, H2-2, H-7a), 1.45 (1H, m, H-12a), 1.38 (1H, 
m, H-3b), 1.26 (1H, m, H-11a), 1.17 (3H, d, J = 6.4 Hz, H3-16), 1.13 (1H, m, H-3b), 1.12 (3H, 
s, H3-17), 0.93 (3H, s, H3-20), 0.87 (1H, m, H-1a), 0.85 (1H, m, H-5), 0.84 (3H, s, H3-18), 0.80 
(3H, s, H3-19), 0.76 (1H, dd, J = 4.4, 2.6 Hz, H-9); 13C NMR (CDCl3, 100 MHz) δ 73.2 (s, C-8), 
68.5 (d, C-13), 59.0 (d, C-9), 55.9 (d, C-5), 43.1 (t, C-12), 42.1 (t, C-7), 42.0 (t, C-3), 39.2 (t, 
C-1), 38.9 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 30.6 (q, C-17), 23.4 (q, C-16), 21.6 (q, C-
19), 21.2 (t, C-11), 18.3 (t, C-2), 18.1 (t, C-6), 15.1 (q, C-20); HRFABMS m/z 282.2560 (calcd 
for C18H34O2 [M+], 282.2559).   
 
7.5.1.8 Attempted Swern oxidation187 of  5.22 and 5.23 
 
This method is representative.  Oxalyl chloride (100 µL, 1.15 mmol, 5.4 eq) was added to 
anhydrous CH2Cl2 (3 mL) at -78°C and stirred (10 min). Anhydrous DM SO (100 µL, 1.41 
mmol, 6.62 eq) was added and after further stirring (10 min), 5.22 (60 mg, 0.21 mmol) in 
anhydrous CH2Cl2 (3 mL) was added via cannula and stirring continued (1 h) before adding 
Et3N (600 µL, 4.30 mmol, 20 eq) and stirring continued at -78°C (1 h).  After allowing the 
solution to warm to ambient temperature (3 h), saturated aqueous NH4Cl (4 mL) was added 
and the reaction mixture stirred (1 h).  All solvent was then removed in vacuo and the 
resultant oil taken up in Et2O (5mL) and washed with H2O (3 x 5 mL) before drying the organic 
fraction (MgSO4) to afford a colourless oil (74 mg).  Testing the solution with 2,4 DNP 
hydrazone for a ketone proved negative, TLC and 1H NMR revealed that although the starting 
material had been consumed, an inseparable complex mixture of products had formed, which 
resisted further purification. 
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7.5.1.9 KMnO4 mediated oxidation of 2.21 using CH2Cl2 as a solvent with 
phenyltriethylammonium chloride (PTEACl) as a phase transfer catalyst 
H
OH
HO
H
OH
O
2.21 5.26
KMnO4, PTEACl, 
CH2Cl2, 16-20°C
8
13
1
6
19
20
18
10 8
13
1
6
19
20
18
10
16
16
17
 
 
This method is representative. Sclareol (2.21, 1.00g, 3.25 mmol) and PTEACl (1.73 g, 10.7 
mmol, 3 eq) were dissolved in CH2Cl2 (100 mL) and finely powdered KMnO4 (1.59 g, 10.7 
mmol, 3 eq) was added slowly over 2 hours. The temperature of the reaction mixture was 
maintained between 16°C and 20°C and stirring conti nued (48 h).The reaction mixture was 
allowed to settle (24 h) and filtered through Celite (545 coarse) after which the solvent was 
removed in vacuo.  The reaction mixture was taken up in CH2Cl2 (15 mL) and washed with a 
mixture of 1.5% aqueous oxalic acid (30 mL) and saturated aqueous Na2S2O3 (15 mL), which 
reduced the brown precipitate.  The organic fraction was washed with H2O (2 x 15 mL), dried 
(MgSO4) and concentrated to afford a yellow oil (652 mg) which was purified using silica flash 
chromatography (20% EtOAc, 80% hexane)  to afford 8α-hydroxy-14,15-bisnorlabda-13-one 
(5.26, 455 mg, 53%) as a colourless oil. 
  
8α-hydroxy-14,15-bisnorlabda-13-one (5.26):190;243 white amorphous solid; [α]D24 +6 (c 0.4, 
CHCl3, lit.243 +7; IR (film) νmax 3423, 2922, 1713, 1450, 1117 cm-1; 1H NMR (CDCl3, 400 MHz) 
δ 2.61 (2H, m, H2-12), 2.26 (1H, s, 8-OH), 2.11 (3H, s, H3-16), 1.84 (1H, ddd, J = 12.2, 3.4, 
3.2 Hz, H-7b), 1.73 (1H, m, H-11b), 1.66 (1H, m, H-2a), 1.62 (1H, m, H-1b), 1.58 (1H, m, H-
6b), 1.52 (1H, m, H-11a), 1.42 (1H, m, H-6a), 1.39 (1H, m, H-7a), 1.34 (1H, m, H-3b), 1.25 
(1H, m, H-2b), 1.14 (3H, s, H3-17), 1.12 (1H, m, H-3b), 1.06 (1H, m, H-9), 0.91 (1H, m, H-1a), 
0.88 (1H, m, H-5), 0.85 (3H, s, H3-18), 0.79 (3H, s, H3-20), 0.77 (3H, s, H3-19); 13C NMR 
(CDCl3, 100 MHz) δ 210.4 (s, C-13), 73.7 (s, C-8), 60.7 (d, C-9), 56.1 (d, C-5), 46.2 (t, C-12), 
44.5 (t, C-7), 41.9 (t, C-3), 40.1 (t, C-1), 39.3 (s, C-10), 33.3 (q, C-18), 33.2 (s, C-4), 30.0 (q, 
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C-16), 24.1 (q, C-17), 21.5 (q, C-19), 20.5 (t, C-2), 18.8 (t, C-11), 18.4 (t, C-6), 15.2 (q, C-20); 
HRFABMS m/z 280.2405 (calcd for C18H32O2 [M+], 280.2402). 
 
7.5.1.10 LAH reduction of methyl ketone 5.26  
 
H
OH
O
H
OH
OH
5.25 13-(R)
5.27 13-(S)5.26
LAH, THF, 0°C
8
13
1
6
19
20
18
10
16
 
 
This method is representative. Methyl ketone (5.26, 400 mg, 1.42 mmol) was dissolved in 
anhydrous THF (5 mL) and added via cannula to a 0°C solution of LAH (116 mg, 2.84 mmol , 
2 eq) in anhydrous THF (15 mL).  The reaction was allowed to warm naturally to ambient 
temperature (2 h) before 5% aqueous NaHCO3 (1 mL) was added.  The reaction mixture was 
acidified with 1M HCl (2.0 mL), concentrated to dryness, taken up in EtOAc (5 mL) and 
washed with H2O (3 x 5 mL).  The organic fraction was dried (MgSO4) and concentrated to 
afford a colourless oil (425 mg).  Semi-preparative HPLC (30% EtOAc, 70% hexane) followed 
to afford 14,15-bisnorlabda-8α,13S-diol (5.27, 189 mg, 47%) and 14,15-bisnorlabda-8α,13R-
diol (5.25, 169 mg, 42%) as colourless oils in 89% combined isolated yield. 
 
14,15-Bisnorlabda-8α,13R-diol (5.25): colourless oil, [α]D23 -30 (c 1.2, CHCl3), lit.173 -30; IR 
(film) νmax 3343, 2935, 2870, 1460, 1130 cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.76 (1H, m, H-
13), 1.81 (1H, ddd, J = 12.1, 3.6, 3.2 Hz, H-7b), 1.63 (1H, m, H-2b), 1.59 (1H, m, H-1b), 1.57 
(1H, m, H-6b), 1.56 (1H, m, H-12b), 1.53 (1H, m, H-11b), 1.45 (1H, m, H-12a), 1.43 (1H, m, 
H-7a), 1.40 (1H, m, H-6a), 1.34 (1H, m, H-3b) 1.32 (1H, m, H-11b), 1.25 (1H, m, H-2a), 1.22 
(1H, m, H-9), 1.14 (3H, d, J = 6.2 Hz, H3-16), 1.13 (3H, s, H3-17), 1.12 (1H, m, H-3a), 0.94 
(1H, m, H-5), 0.94 (1H, ddd, J = 12.6, 12.2, 3.5 Hz, H-1a), 0.84 (3H, s, H3-18), 0.77 (3H, s, H3-
19), 0.76 (3H, s, H3-20); 13C NMR (CDCl3, 100 MHz) δ 74.6 (s, C-8), 69.7 (d, C-13), 61.5 (d, 
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C-9), 56.0 (d, C-5), 44.2 (t, C-7), 42.3 (t, C-12), 42.0 (t, C-3), 39.7 (t, C-1), 39.2 (s, C-10), 33.4 
(q, C-18), 33.2 (s, C-4), 24.3 (q, C-17), 23.8 (q, C-16), 22.1 (t, C-11), 21.5 (q, C-19), 20.5 (t, 
C-2), 18.4 (t, C-6), 15.2 (q, C-20); HRFABMS m/z 282.2551 (calcd for C18H34O2 [M+], 
282.2559). 
 
14,15-Bisnorlabda-8α,13S-diol (5.27): white needles (from hexane/EtOAc); mp 94-95°C, 
lit.173 97-99°C; [ α]D23 +4 (c 0.5, CHCl3), lit.173 +8; IR (film) νmax 3346, 2932, 2861, 1460, 1132 
cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.76 (1H, m, H-13), 1.81 (1H, ddd, J = 12.1, 3.6, 3.2 Hz, H-
7b), 1.63 (1H, m, H-2b), 1.59 (1H, m, H-1b), 1.57 (1H, m, H-6b), 1.56 (1H, m, H-12b), 1.53 
(1H, m, H-11b), 1.45 (1H, m, H-12a), 1.43 (1H, m, H-7a), 1.40 (1H, m, H-6a), 1.34 (1H, m, H-
3b) 1.32 (1H, m, H-11b), 1.25 (1H, m, H-2a), 1.22 (1H, m, H-9), 1.14 (3H, d, J = 6.2 Hz, H3-
16), 1.13 (3H, s, H3-17), 1.12 (1H, m, H-3a), 0.94 (1H, m, H-5), 0.94 (1H, ddd, J = 12.6, 12.2, 
3.5 Hz, H-1a), 0.84 (3H, s, H3-18), 0.77 (3H, s, H3-19), 0.76 (3H, s, H3-20);   13C NMR (CDCl3, 
100 MHz) δ 74.4 (s, C-8), 65.4 (d, C-13), 58.4 (d, C-9), 56.2 (d, C-5), 44.2 (t, C-7), 42.0 (t, C-
3), 40.8 (t, C-12), 39.8 (t, C-1), 39.2 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 24.6 (q, C-17), 
23.2 (q, C-16), 21.5 (q, C-19), 20.5 (t, C-2), 20.0 (t, C-11), 18.4 (t, C-6), 15.2 (q, C-20); 
HRFABMS m/z 282.2551 (calcd for C18H34O2 [M+], 282.2559). 
   
7.5.1.11 Attempted Dess-Martin periodinane oxidation of 5.27  
 
H
OH
OH
13
5.25
H
O
5.28
Method A/ 
Method B
8
13
1
6
19
20
18
10
16
173
 
 
These methods are representative.  The Dess-Martin periodinane (DMP) used in these 
reactions had previously been prepared in our research group using the method described by 
Dess and Martin.188   
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Method A: Oxidation in CH3CN, followed by HWE reaction in THF 
 
Compound 5.25 (60 mg, 0.21 mmol) and DMP (132 mg, 0.31 mmol, 1.5 eq) were dissolved in 
CH3CN (10 mL) and stirred at ambient temperature (45 min). The reaction was quenched with 
aqueous NaHCO3 (5%, 10 mL), all solvent removed in vacuo and the residue taken up in 
Et2O and washed with H2O (3 x 5 mL). The Et2O fraction was dried (MgSO4) and 
concentrated to afford a yellow oil (31 mg). 
 
The reaction mixture [31 mg, 0.11 mmol (assuming 100% conversion)] was then transferred 
to a freeze dryer (2 h) and taken up in THF (5 mL) and cooled (0°C).  The HWE reagent, 
triethylphosphonoacetate, (0.22 mmol, 2 eq) was deprotonated with NaH (60%, 4 mg, 0.22 
mmol, 2 eq) and added as a THF solution (3 mL) to the reaction mixture, and stirred allowed 
to warm to ambient temperature while stirring overnight (15 h). Saturated NH4Cl (1 mL) was 
added, all solvent removed in vacuo and the resultant oil taken up in Et2O (5 mL), which was 
washed with H2O (3 x 5 mL).  The organic fraction was dried (MgSO4), concentrated to a 
yellow oil (124 mg) and subsequently purified by semi-preparative HPLC (33% EtOAc, 67% 
hexane) to afford 8α,13-epoxy-14,15-bisnorlabda-12-ene (5.28, 23 mg, 38%) as an 
amorphous solid. 
 
Method B: Oxidation and HWE performed in THF 
 
Compound 5.25 (40 mg, 0.14 mmol) and DMP (60 mg, 0.14 mmol, 1 eq) were dissolved in 
CH3CN (10 mL) and stirred at ambient temperature (45 minutes), after which the solution was 
cooled (0°C).  The HWE reagent, triethylphosphonoac etate, (0.71 mmol, 5.0 eq) was 
deprotonated with NaH (60%, 14 mg, 0.71 mmol, 5 eq) and added as a THF solution (3 mL) 
to the reaction mixture, and stirred allowed to warm to ambient temperature while stirring 
overnight (15 h). Saturated NH4Cl (2 mL) was added, all solvent removed in vacuo and the 
resultant oil taken up in Et2O (5 mL), which was washed with H2O (3 x 5 mL).  The organic 
fraction was dried (MgSO4), concentrated to a a yellow oil (72 mg), which was subsequently 
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purified by semi-preparative HPLC (33% EtOAc, 67% hexane) to afford 8α,13-epoxy-14,15-
bisnorlabda-12-ene (5.28, 18 mg, 45%) as an amorphous solid. 
 
8α,13-Epoxy-14,15-binorlabda-12-ene (5.28):100;190;195;243 amorphous solid; [α]D23 +5 (c 2.3, 
CHCl3), lit.100 +3; IR (film) νmax 3440, 2932, 1452, 1382, 1125 cm-1; 1H NMR (CDCl3, 400 MHz) 
δ 4.42 (1H, br s, H-12), 1.92 (2H, ddd, J = 12.4, 3.8, 3.2 Hz, H2-7), 1.81 (2H, m, H2-11), 1.77 
(1H, m, H-6b), 1.66 (3H, s, H3-16), 1.59 (1H, m, H-2b), 1.55 (2H, m, H2-1), 1.43 (1H, m, H-2a), 
1.39 (1H, m, H-9), 1.37 (2H, m, H2-3), 1.30 (1H, m, H-6a), 1.15 (3H, s, H3-17), 0.96 (1H, dd, J 
= 12.2, 2.2 Hz, H-5), 0.86 (3H, s, H3-18), 0.80 (6H, s, H3-19, H3-20); 13C NMR (CDCl3, 100 
MHz) δ 147.9 (s, C-13), 94.6 (d, C-12), 76.2 (s, C-8), 56.2 (d, C-5), 52.5 (d, C-9), 41.9 (t, C-3), 
41.1 (t, C-2), 39.3 (t, C-1), 36.7 (s, C-10), 33.5 (q, C-18), 33.2 (s, C-4), 21.6 (q, C-19), 20.4 (q, 
C-18), 20.1 (q, C-17), 19.8 (t, c-6), 18.6 (t, C-2), 18.3 (t, C-11), 15.0 (q, C-20); HRFABMS m/z 
262.2293 (calcd for C18H30O [M+], 262.2297). 
 
7.5.2 Synthesis of 5.1 and 5.2 via a regioselective HWE reaction performed on 5.31 
 
7.5.2.1 Pyridinium chlorochromate mediated oxidative rearrangement of 5.3203;204 
H
CHO
5.42 ∆13 E
5.43 ∆13 Z
HO
H
5.3
8
17
13
8
PCC, CH2Cl2, RT
16
19 18
1
6
20 11
17
3
15
 
 
A solution of manool (5.3, 170 mg, 0.59 mmol) and pyridinium chlorochromate (417 mg, 1.90 
mmol, 3.3 eq) in CH2Cl2 (8 mL) was stirred (26 h) at room temperature. Et2O (8 mL) was 
added, and the formation of an orange precipitate noted.  The solution was then filtered 
through a Celite 545 plug and the filtrate concentrated in vacuo to afford a dark brown oil 
(195 mg).  The oil was purified by silica flash chromatography (6% EtOAc, 94% hexane) to 
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afford an inseparable mixture of (E)-labda-8(17)dien-15-al (5.42) and (Z)-labda-8(17)dien-
15-al (5.43) in a 2:1 ratio (154 mg, 90% yield) as a pale yellow oil; 1H and 13C NMR data 
consistent with literature values;204 HRFABMS m/z 289.2531 (calcd for C20H33O [(M + H)+], 
289.2531. 
 
7.5.2.2 Reductive ozonolysis of 5.42 and 5.43 
H
CHO
O
5.42 ∆13 E
5.43 ∆13 Z
13
8
H
O
O
5.31
13
8
i) O3, CH2Cl2, -78°C
 
ii) PPh3, CH2Cl2, RT
16
19 18
1
6
20 11
3
 
 
The isomeric mixture of 5.42 and 5.43 (100 mg, 0.35 mmol) was dissolved in anhydrous 
CH2Cl2 (5 mL) and cooled (-78°C).  A steady stream of O 3 was bubbled through the solution 
(10 min) until the solution had turned a pale blue colour whereupon N2 was bubbled through 
the solution to remove excess O3. After the addition of triphenylphosphine (548 mg, 2.10 
mmol, 6 eq) the solution was stirred at ambient temperature (4 h). The solution was cooled to 
0°C, H 2O2 (30%, 1 mL) added and stirring continued (0.5 h). The solution was then washed 
with water (3 x 5 mL), the combined organic extracts dried (MgSO4) and concentrated. 
Subsequent purification of the concentrated organic material by silica flash chromatography 
(50% EtOAc, 50% hexane) afforded 5.31 (72 mg, 78%).  
 
15,16,17-Trisnorlabdane-8,13-dione (5.31):174;200;244 colourless oil; [α]D20  -28 (c 1.3, CHCl3) 
lit.174 -11; IR (film) νmax 2940, 1709, 1698, 1355, 1164 cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.56 
(1H, ddd, J = 17.4, 8.3, 5.3 Hz, H-12a), 2.38 (1H, ddd, J = 13.3, 4.8, 2.0 Hz, H-7b), 2.25 (1H, 
m, H-7a), 2.17 (1H, m, H-12a), 2.07 (3H, s, H3-16), 2.04 (m, 1H, H-9), 2.01 (m, 1H, H-6b), 
1.79 (1H, m, H-1b), 1.76 (1H, ddd, J = 10.7, 5.3, 2.9 Hz, H-11b), 1.61 (1H, m, H-6a), 1.59 (1H, 
m, H-11a), 1.51 (2H, m, H2-2), 1.46 (1H, dd, J = 12.9, 2.8 Hz, H-5), 1.42 (1H, m, H-3b), 1.21 
(2H, m, H-1a, H-3a), 0.93 (3H, s, H3-18), 0.82 (3H, s, H3-19), 0.70 (3H, s, H3-20); 13C NMR 
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(CDCl3, 100 MHz) δ 212.3 (s, C-8), 209.2 (s, C-13), 63.1 (d, C-9), 54.1 (d, C-5), 42.8 (t, C-12), 
42.7 (s, C-10), 42.6 (t, C-7), 41.8 (t, C-3), 39.1 (t, C-1), 33.7 (s, C-4), 33.5 (q, C-18), 29.9 (q, 
C-16), 23.9 (t, C-6), 21.7 (q, C-19), 19.0 (t, C-2), 16.1 (t, C-11), 14.5 (q, C-20); HRFABMS: 
m/z  265.2168 (calcd for C17H28O2 [M+], 265.2168). 
 
7.5.2.2 Regioselective olefination of 5.31 via the HWE reaction 
H
O
O
5.31
13
8
H
CO2Et
O
5.32 ∆13 E
5.33 ∆13 Z
+ OH
H
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5.50 ∆13Z
CO2Et
TEPA, NaH, 
THF, 0°C
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A solution of triethylphosphonoacetate (1660 µL, 3 eq) in anhydrous THF (5 mL) was 
deprotonated with NaH (140 mg, 2.5 eq) for 30 minutes before addition to a 0°C solution of 
5.31 (737 mg).  The solution was warmed to ambient temperature and stirred overnight (16 
h), whereupon HCl (1 M, 3 mL) was added and the solution concentrated.  The resultant 
yellow oil was taken up in Et2O (5 mL) and washed with H2O (3 x 5 mL). The organic fraction 
was dried (MgSO4), concentrated and excess triethylphosphonoacetate removed by silica 
flash chromatography (9% EtOAc, 91% hexane). The mixture of HWE products obtained 
(927 mg) was further purified by semi-preparative HPLC (6% EtOAc, 94% hexane) to afford 
ethyl 17-norlabd-13-E-en-8-one-15-oate (5.32, 409 mg, 55%), ethyl 17-norlabd-13-E-en-8-
one-15-oate (5.33,174 mg, 19%), ethyl 17-norabiet-13(15)-E-en-8β-ol-16-oate (5.49, 62 mg, 
7%) and ethyl 17-norabiet-13(15)-E-en-8β-ol-16-oate (5.50,18 mg, 2%). 
 
Ethyl 17-norlabd-13-E-en-8-one-15-oate (5.32): pale yellow oil; [α]D34 -20 (c, 0.5, CHCl3); 
IR (film) νmax 2948, 1713, 1642, 1218, 1146 cm-1; 1H and 13C NMR data, see Table 5.1; 
HRFABMS m/z 334.2509 (calcd for C21H34O3 [M+], 334.2508). 
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Ethyl 17-norlabd-13-Z-en-8-one-15-oate (5.33): pale yellow oil; [α]D25 -57 (c, 0.9, CHCl3); 
IR (film) νmax 2945, 1712, 1646, 1244, 1168 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.60 (1H, br 
s, H-14), 4.11 (2H, dd, J = 13.2, 6.4 Hz, -OCH2CH3), 2.85 (1H, m, H-12b), 2.34 (2H, m, H2-
7), 2.13 (1H, m, H-9), 2.11 (1H, m, H-12a), 2.03 (1H, m, H-6b), 1.90 (1H, m, H-11b), 1.89 
(3H, s, H3-16), 1.73 (1H, m, H-1b), 1.63 (2H, m, H2-6), 1.52 (2H, m, H2-2), 1.48 (1H, m, H-5), 
1.43 (1H, m, H-3), 1.35 (1H, m, H-11a), 1.23 (1H, m, H-3a), 1.25 (3H, t, J = 6.6 Hz, -
OCH2CH3), 1.19 (1H, m, H-1a), 0.95 (3H, s, H3-18), 0.83 (3H, s, H3-19), 0.69 (3H, s, H3-20); 
13C NMR (100 MHz, CDCl3) δ 212.0 (s, C-8), 166.4 (s, C-15), 160.5 (s, C-13), 116.3 (d, C-
14), 63.6 (d, C-9), 59.5 (t, -OCH2CH3), 54.2 (d, C-5), 42.7 (s, C-10), 42.6 (t, C-7), 41.9 (t, C-
3), 39.1 (t, C-1), 33.6 (s, C-4), 33.5 (q, C-18), 32.6 (t, C-12), 25.0 (q, C-16), 24.1 (t, C-6), 
21.7 (q, C-19), 20.0 (t, C-11), 19.0 (t, C-2), 14.7 (q, C-20),  14.4 (q, -OCH2CH3); HRFABMS 
m/z 334.2509 (calcd for C21H34O3 [M+], 334.2508). 
 
Ethyl 17-norabiet-13(15)-E-en-8β-ol-16-oate (5.49): white plates (from Et2O); mp 110-
111°C; [ α]D34 -68.1 (c 1.8, CHCl3); IR (film) νmax 2942, 1720, 1634, 1156, 1046 cm-1; 1H and 
13C NMR data, see Table 6.1; LREIMS m/z (rel int) 334 [M+] (30), 319 (100), 273 (50), 207 
(53), 149 (35); HRFABMS m/z 334.2509 (calcd for C21H34O3 [M+], 334.2508).  
 
Crystal data for 5.49: C21H34O3, M = 334.48, orthorhombic, space group P212121 (no. 19), a 
= 7.3750(2) Å, b = 9.7769(3) Å, c = 27.077(1) Å, V = 1952.4(1) Å3, Z = 4, Dc = 1.138 Mg/m3, 
µ(MoKα) = 0.074 mm-1, F(000) = 736. A total of 4302 reflections were collected of which 2405 
were observed [I > 2σ(I)]. The structure was solved by direct methods and refined on F2 using 
all data, with non-hydrogen atoms treated anisotropically. All H atoms were located and then 
added in idealised positions in a riding model. The final R factors were R1 = 0.1455 (all data), 
0.0510 (observed data), wR2 = 0.0917 (all data), 0.0742 (observed data) for 222 parameters. 
Crystallographic data (excluding structure factors) have been deposited at the Cambridge 
Crystallographic Data Centre (deposition no. 620303). 
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Ethyl 17-norabiet-13(15)-Z-en-8β-ol-16-oate (5.50): yellow oil; [α]D34 +66 (c 0.8, CHCl3); IR 
(film) νmax 2941, 1695, 1652, 1165, 1037 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.75 (1H, t, J = 
1.5 Hz, H-15), 4.12 (2H, dq, J =  7.1, 1.0 Hz, -OCH2CH3), 3.66 (1H, dd, J = 13.5, 0.9 Hz, H-
14b), 2.34 (1H, m, H-12b), 2.11 (1H, dt, J = 12.8, 4.3 Hz, H-12a), 1.86 (1H, dd, J = 13.5, 0.9 
Hz, H-14a), 1.78 (1H, m, H-11b), 1.77 (1H, m, H-7a), 1.67 (1H, m, H-1b), 1.62 (2H, m, H-2b, 
H-11a), 1.55 (1H, m, H-6b), 1.52 (1H, m, H-7a), 1.40 (1H, m, H-2a), 1.39 (1H, m, H-3b), 1.37 
(1H, m, H-6a), 1.25 (3H, t, J = 7.1 Hz, -OCH2CH3), 1.16 (1H, m, H-9) 1.15 (1H, m, H-3a), 0.94 
(3H, s, H3-20), 0.88 (1H, m, H-5), 0.87 (3H, s, H3-18), 0.86 (1H, m, H-1a), 0.84 (3H, s, H3-19) ; 
13C NMR (CDCl3, 100 MHz)  δ 167.2 (s, C-16), 160.0 (s, C-13), 115.6 (d, C-15), 74.3 (s, C-8), 
59.7 (t, -OCH2CH3), 56.7 (d, C-9), 56.4 (d, C-5), 45.3 (t, C-14), 42.4 (t, C-7), 42.1 (t, C-3), 39.7 
(t, C-1), 37.9 (t, C-12), 37.5 (s, C-10), 33.7 (q, C-18), 33.3 (s, C-4), 23.5 (t, C-11), 21.7 (q, C-
19), 18.5 (t, C-2), 18.3 (t, C-6), 15.3 (q, C-20), 14.3 (q, -OCH2CH3); LREIMS m/z (rel int) 334 
[M+] (35), 319 (100), 273 (36), 255 (27), 207 (33); HRFABMS m/z 335.2582 (calcd for 
C21H35O3 [(M + H)+], 335.2588).   
 
 
7.5.2.4 Chemoselective alkylation of 5.32 and 5.33 
 
 
Method A: Attempted chemoselective alkylation using MeTiCl3196 
 
Anhydrous conditions. An ether solution of TiCl4 (1 M, 60 µL, 0.06 mmol, 1 eq) was added to 
ether (2 mL) at -78°C, followed by drop wise  addit ion of MeLi (1.6 M, 40 µL, 0.06 mmol, 1 
eq) with vigorous stirring.  The solution was allowed to warm to -50°C and changed to a 
deep purple colour, whereupon it was slowly added via cannula to a cooled solution (-50°C) 
of 5.32 (19 mg, 0.06 mmol) in ether (1 mL) and allowed to stir (8 h, temperature gradually 
allowed to warm to -30°C over this time). The react ion was quenched with H2O (1 mL), then 
washed with H2O (3 x 5 mL), dried (MgSO4) and concentrated to a green oil (16 mg).  
Analysis of the 1H spectrum of the reaction mixture revealed only unreacted 5.32.   
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Method B: Chemoselective alkylation of 5.32 and 5.33 using MeMgCl 
H
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13
8
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6
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This method is representative of the alkylation of 5.32. A solution of 5.32 (76 mg, 0.23 mmol) 
in anhydrous Et2O (5 mL) was cooled to -20°C.  An ether solution of  MeMgCl (3 M, 100 µL, 
1.3 eq) was slowly added drop wise with vigorous stirring. The solution was maintained at     
-20°C (1 h), warmed to 0°C (3 h) and excess MeMgCl quenched through the addition of 3 
drops of H2O. The reaction mixture was further acidified with HCl (1 M, 2 mL) and stirred 
until the solution had become clear. The Et2O solution was washed with H2O (3 x 5 mL), 
dried (MgSO4) and concentrated in vacuo to afford a pale yellow oil.  Subsequent purification 
of this oil via semi-preparative HPLC (14% EtOAc, 86% hexane) afforded ethyl labd-13E-en-
8β-ol-15-oate (5.34, 64 mg, 81%). In the same manner, ethyl labd-13Z-en-8β-ol-15-oate, 
5.35 (81%), was obtained from 5.33. The reaction was also attempted in the same manner 
using either MeLi or MeMgBr as the alkylating agent to afford 5.34 in lower yield (50% and 
71% respectively).  
 
Ethyl labd-13E-en-8β-ol-15-oate (5.34): pale yellow oil; [α]D34 +25 (c 2.2, CHCl3); IR (film) 
νmax 3498, 2937, 1712, 1454, 1163 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.67 (1H, dd, J = 2.3, 
1.1 Hz, H-14), 4.14 (2H, q, J = 7.1 Hz, -OCH2CH3), 2.15 (1H, m, H-12b), 2.14 (1H, m, H-
12a), 2.12 (3H, d, J = 1.3 Hz, H3-16), 1.75 (1H, m,  H-7b), 1.66 (1H, m, H-1b), 1.57 (1H, m, 
H-11b), 1.56 (1H, m, H-2b), 1.50 (1H, m, H-6b), 1.49 (1H, m, H-7a), 1.48 (1H, m, H-6a), 1.41 
(2H, m, H-2a and H-11a), 1.36 (1H, m, H-3b), 1.26 (3H, t, J = 7.1 Hz, -OCH2CH3), 1.13 (3H, 
s, H-17), 1.12 (1H, m, H-3a), 0.94 (3H, s, H3-20), 0.87 (1H, m, H-1a), 0.86 (3H, s, H3-18), 
0.85 (1H, m, H-9), 0.81 (3H, s, H3-19), 0.79 (1H, dd, J =  4.4, 2.7 Hz, H-5); 13C NMR (CDCl3, 
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100 MHz) δ 166.9 (s, C-15), 160.2 (s, C-13), 115.3 (d, C-14), 73.1 (s, C-8), 59.5 (t, -
OCH2CH3), 58.8 (d, C-9), 55.9 (d, C-5), 44.6 (t, C-12), 42.3 (t, C-7), 42.0 (t, C-3), 39.2 (t, C-
1), 39.0 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 30.6 (q, C-17), 23.6 (t, C-11), 21.6 (q, C-19), 
19.0 (q, C-16), 18.3 (t, C-2), 18.1 (t, C-6), 15.1 (q, C-20), 14.3 (q, -OCH2CH3); HRFABMS 
m/z 351.2895  (calcd for C22H39O3 [(M + H)+], 351.2899). 
 
Ethyl labd-13Z-en-8β-ol-15-oate (5.35): pale yellow oil; [α]D34 +15 (c 0.7, CHCl3); IR (film) 
νmax 3461, 2923, 1709, 1451, 1159 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.60 (1H, d, J = 1.3 
Hz, H-14), 4.12 (2H, q, J = 7.1 Hz, -OCH2CH3), 2.75 (1H, ddd, J = 12.4, 6.2, 2.7 Hz), 2.65 
(1H, ddd, J = 12.4, 5.8, 5.3 Hz, H-12a), 1.90 (3H, d, J = 2.8 Hz, H3-16), 1.75 (2H, m, H-1b 
and H-7b), 1.60 (1H, m, H-2b), 1.51 (2H, m, H-6b, H-11b), 1.49 (2H, m, H-6a, H-7a), 1.41 
(1H, m, H-11a), 1.37 (1H, m, H-3b), 1.25 (3H, t, J = 7.1 Hz, -OCH2CH3), 1.24 (3H, s, H3-17), 
1.14 (1H, ddd, J = 13.9, 6.6, 4.2 Hz, H-3a), 0.94 (3H, s, H3-20), 0.94 (1H, ddd, J = 14.0, 6.8, 
4.0 Hz, H-1a), 0.86 (3H, s, H3-18), 0.85 (1H, m, H-9), 0.84 (1H, m, H-5), 0.82 (3H, s, H3-19); 
13C NMR (CDCl3, 100 MHz) δ 166.2 (s, C-15), 159.9 (s, C-13), 115.9 (s, C-14), 59.4 (d, C-9), 
59.3 (t, -OCH2CH3), 55.9 (d, C-5), 42.4 (t, C-7), 42.0 (t, C-3), 39.1 (t, C-1), 39.0 (s, C-10), 
36.7 (t, C-12), 33.4, (q, C-18), 33.3 (s, C-10), 30.6 (q, C-17), 25.1 (q, C-16), 23.8 (t, C-11), 
21.7(q, C-19), 18.3 (t, C-6), 18.2 (t, C-2), 15.1 (q, C-20), 14.4 (q, -OCH2CH3); HRFABMS 
m/z 351.2895 (calcd for C22H39O3 [(M + H)+], 351.2899). 
 
7.5.2.5 Reduction of 5.34 and 5.35 
H
CO2Et
OH
5.34 ∆13 E
5.35 ∆13 Z
8 DIBAH/ LAH,
Et2O, 0°C H
CH2OH
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Method A: Reduction of 5.34 using DIBAH 
 
Compound 5.34 (101 mg, 0.29 mmol) was dissolved in anhydrous Et2O (10 mL) and cooled 
to 0°C.  DIBAH (580 µL, 0.58 mmol, 2 eq) was added and stirring continued (4 h) after which 
the solution was warmed to ambient temperature.  Saturated aq. NH4Cl (2 mL) was added 
slowly and the ether solution washed with H2O (3 x 2 mL).  The organic fraction was then 
dried (MgSO4) and concentrated to afford a white amorphous powder which was further 
purified by semi-preparative HPLC (50% EtOAc, 50% hexane) to afford labd-13E-ene-8β,15-
diol (5.4, 47 mg, 54%) as a white amorphous powder. Similar yields (53%) were obtained for 
the reduction of 5.35 to labd-13E-ene-8β,15-diol, 5.5. No improvement in yield was obtained 
by performing the reaction at -20°C or in THF. 
Method B:  Reduction of 5.34 and 5.35 using LAH 
 
This method is representative. Compound 5.35 (42 mg, 0.12 mmol) was dissolved in 
anhydrous Et2O (2 mL) and cooled to 0°C.  LAH (14 mg, 0.36 mmol,  3 eq) was added and 
stirring continued (0.5 h) after which the solution was warmed to ambient temperature over a 
period of 2 hours.  HCl (1 M, 3 mL) was added slowly and the ether solution washed with 
H2O (3 x 2 mL).  The organic fraction was then dried (MgSO4) and concentrated to afford a 
white amorphous powder which was further purified by semi-preparative HPLC (50% EtOAc, 
50% Hexane) to afford labd-13E-ene-8β,15-diol 5.4 (24 mg, 66%). Similar yields (64%) were 
obtained for the reduction of 5.35 to labd-13E-ene-8β,15-diol, 5.5. No improvement in yield 
was obtained by performing the reaction at -20°C or  in THF. 
 
Labd-13E-ene-8β,15-diol (5.4): white amorphous powder; [α]D34 +21 (c 1.5, CHCl3), lit.171 
+32; IR (film) νmax 3420, 2921, 1189, 912, 758 cm-1; 1H NMR (CDCl3, 600 MHz) δ 5.41 (1H, 
dt, J = 6.9, 1.2 Hz, H-14), 4.14 (1H, d, J = 6.9 Hz, H2-15), 2.05 (1H, m, H-12b), 2.02 (1H, m, 
H-12a), 1.77 (1H, m, H-7b), 1.69 (3H, s, H3-16), 1.67 (1H, m, H-1b), 1.59 (1H, dt, J = 13.5, 
3.4 Hz, H-2b), 1.54 (1H, m, H-6b), 1.52 (2H, m, H-6a, H-11b), 1.51 (1H, m, H-7a), 1.42 (1H, 
m, H-2a), 1.40 (1H, m, H-11a), 1.38 (1H, m, H-3b), 1.14 (1H, m, H-3a), 1.13 (3H, s, H3-17), 
0.94 (3H, s, H3-20), 0.86 (3H, s, H3-18), 0.88 (1H, m, H-1a), 0.85 (1H, m, H-5), 0.81 (3H, s, 
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H3-19), 0.79 (1H, dd, J = 4.3, 2.7 Hz, H-9); 13C NMR (CDCl3, 150 MHz) δ 140.4 (s, C-13), 
123.1 (d, C-14), 73.2 (s, C-8), 59.4 (t, C-15), 58.8 (d, C-9), 55.9 (d, C-5), 43.3 (t, C-12), 42.2 
(t, C-7), 42.0 (t, C-3), 39.1 (t, C-1), 38.9 (s, C-10), 33.4 (q, C-18), 33.2 (s, C-4), 30.6 (q, C-
17), 23.9 (t, C-6), 21.6 (q, C-19), 18.3 (t, C-6), 18.2 (t, C-2), 16.4 (q, C-2), 15.1 (q, C-20); 
HRFABMS m/z 308.2715 (calcd for C20H36O2 [M+],  308.2715). 
    
Labd-13Z-ene-8β,15-diol (5.5): white amorphous powder; [α]D34 +24 (c 1.0, CHCl3); IR (film) 
νmax 
 3395, 2930, 1182, 909, 758 cm-1; 1H NMR (CDCl3, 600 MHz,) δ 5.37 (1H, t, J = 7.1 Hz, 
H-14), 4.13 (2H, d, J = 6.8 Hz, H2-15), 2.08 (1H, m, H-12b), 2.05 (1H, m, H-12a), 1.77 (3H, 
d, J = 0.9 Hz, H3-16), 1.76 (1H, m, H-7b), 1.69 (1H, ddd, J = 12.3, 4.3, 3.0 Hz, H-1b), 1.60 
(1H, dt, J = 13.4, 3.1 Hz, H-2b), 1.52 (1H, m, H-6b), 1.50 (1H, m, H-6a), 1.48 (1H, m, H-7a), 
1.45 (1H, m, H-11b), 1.41 (1H, m, H-2a), 1.39 (1H, m, H-3b), 1.31 (1H, m, H-11a), 1.17 (3H, 
s, H3-17), 1.14 (1H, m, H-3a), 0.93 (3H, s, H3-20), 0.89 (1H, m, H-1a), 0.86 (3H, s, H3-18), 
0.84 (1H, m, H-5), 0.81 (3H, s, H3-19), 0.79 (1H, dd, J = 2.7, 1.6 Hz, H-9); 13C NMR (CDCl3, 
150 MHz) δ  140.9 (s, C-13), 123.6 (d, C-14), 73.1 (s, C-8), 59.32 (d, C-9), 59.28 (t, C-15), 
55.9 (d, C-5), 42.2 (t, C-7), 42.0 (t, C-3), 39.1 (t, C-1), 38.9 (s, C-10), 36.0 (t, C-12), 33.4 (q, 
C-18), 33.3 (s, C-4), 30.6 (q, C-17), 24.5 (t, C-11), 23.6 (q, C-16), 21.6 (q, C-19), 18.3 (t, C-
6), 18.2 (t, C-2), 15.1 (q, C-20); HRFABMS m/z 308.2716 (calcd for C20H36O2 [M+], 
308.2715). 
 
7.5.2.6 MnO2 oxidation of 5.4 and 5.5 
MnO2, CH2Cl2, RT
H
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This method is representative. The allylic alcohol 5.4 (41 mg, 0.14 mmol) was dissolved in 
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anhydrous CH2Cl2 (2 mL) and finely powdered activated MnO2 (87 mg, 1.36 mmol, 10 eq) 
added.  The solution was stirred at ambient temperature overnight (16 h) and filtered through 
Celite 545 to give labd-13E-ene-8β-ol-15-al  (5.1, 37 mg, 90%) as a white amorphous 
powder (>95% purity from NMR).  Labd-13Z-ene-8β-ol-15-al (5.2) was obtained in similar 
yield (91%) and purity via the oxidation of 5.5. 
 
Labd-13E-ene-8β-ol-15-al (5.1):171 white amorphous powder [α]D34 +26 (c 1.4, C6H6); IR 
(film) νmax 3481, 2921, 1668, 1454, 1382 cm-1; 1H and 13C NMR data, see Table 5.2; 
HRFABMS m/z 306.2559  (calcd for C20H34O2 [M+], 306.2559). 
 
 
Labd-13Z-ene-8β-ol-15-al (5.2):171 pale yellow oil [α]D34 +24 (c 0.9, C6H6); IR (film) νmax 
3410, 2915, 1661, 1447, 1381 cm-1; 1H NMR (C6D6, 600 MHz) δ 10.08 (1H, d, J = 7.9 Hz, H-
15), 5.81 (1H, d, J = 7.9 Hz, H-14), 2.19 (1H, ddd, J = 10.9, 6.0, 5.8 Hz, H-12b), 2.17 (1H, 
ddd, J = 10.9, 6.2, 5.8 Hz, H-12a), 1.52 (1H, m, H-1b), 1.49 (3H, d, J = 1.3 Hz, H3-16), 1.48 
(1H, m, H-2b), 1.47 (1H, m, H-7b), 1.46 (1H, m, H-11b), 1.36 (1H, m, H-3b), 1.35 (1H, m, H-
6b), 1.32 (1H, m, H-6a), 1.25 (1H, m, H-11a), 1.20 (1H, m, H-2a), 1.17 (1H, m, H-7a), 1.10 
(1H, ddd, J = 13.5, 6.6, 4.0 Hz, H-3a), 0.93 (3H, s, H3-20), 0.89 (3H, s, H3-18), 0.88 (3H, s, 
H3-17), 0.83 (3H, s, H3-19), 0.68 (1H, ddd, J = 13.2, 6.4, 3.4 Hz, H-1a), 0.63 (1H, dd, J = 
12.1, 2.3 Hz, H-5), 0.43 (1H, dd, J = 4.4, 2.6 Hz, H-9); 13C NMR (C6D6, 150 MHz) δ 189.2 (d, 
C-15), 162.9 (s, C-13), 128.3 (d, C-14), 72.3 (s, C-8), 59.3 (d, C-9), 55.9 (d, C-5), 42.6 (t, C-
3), 42.3 (t, C-7), 39.4 (t, C-1), 39.2 (s, C-10), 36.3 (t, C-12), 33.6 (q, C-18), 33.4 (s, C-4), 
30.9 (q, C-17), 25.1 (t, C-11), 24.5 (q, C-16), 21.9 (q, C-19), 18.60 (t, C-6), 18.57 (t, C-2), 
15.3 (q, C-20); HRFABMS m/z 306.2559  (calcd for C20H34O2 [M+], 306.2559). 
 
7.5.3 Activity of selected diterpenes from Chapter Five against oesophageal cancer 
 
See section 7.3.3. 
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7.6 Chapter Six Experimental  
 
7.6.1 Semi-synthesis of potential anti-malarial compounds 
 
7.6.1.1 NaH mediated intramolecular aldol condensation of 5.31 
 
O
OH
O
HH
O
5.31 5.51
13
20
81
16
5
NaH, THF, RT
8
19 18
1
6
20 11
14
3
 
 
This method is representative. NaH (60%, 18 mg, 1 eq) was added to a solution of 5.31 (241 
mg, 0.91 mmol) in anhydrous THF (60 mL) and the resulting mixture stirred under Ar at 
ambient temperature (6 h). The yellow solution was concentrated to dryness, taken up in Et2O 
(5 mL), and washed with H2O acidified with a few drops of 1 M HCl (3 x 5 mL). The organic 
fraction was concentrated in vacuo to afford 8-hydroxy-13-podocarpanone (5.51) as a pale 
yellow amorphous solid (228 mg, 95%). 
 
8-Hydroxy-13-podocarpanone (5.51):202 pale yellow amorphous solid; [α]D28 +12 (c 2.2, 
CHCl3); 13C NMR (CDCl3, 100 MHz) δ 210.7 (s, C-13), 75.5 (s, C-8), 57.3 (t, C-14), 56.1 (d, C-
9), 55.3 (d, C-5), 42.2 (t, C-3), 42.0 (t, C-7), 41.4 (t, C-12), 39.8 (t, C-1), 37.5 (s, C-10), 33.6 
(q, C-18), 33.2 (s, C-4), 21.8 (q, C-19), 21.4 (t, C-11), 18.4 (t, C-2), 17.9 (t, C-6), 15.3 (q, C-
20). 
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7.6.1.2 Alkenylation of 5.31202 
OH
O
H
5.51
OH
OH
H
CH2=CHMgBr,
 
THF, 0°C
6.7
13
8
16
19 18
1
6
20 11
3
15
 
A THF solution of vinyl magnesium bromide (0.92 mmol, 1.5 eq) was added to a cooled (0°C) 
solution of 5.51 (162 mg, 0.61 mol) in anhydrous THF under an Ar atmosphere. The solution 
was gradually warmed to ambient temperature and stirred (1.5 h). Et2O (10 mL) and a 
saturated aqueous solution of NH4Cl (6 mL) were added, and the resulting mixture was stirred 
(10 min), after which the organic and aqueous phases were separated and the aqueous 
fraction was extracted with Et2O (3 x 5 mL). The organic fractions were pooled, dried 
(MgSO4), and concentrated to afford a yellow oil (362 mg). This oil was subsequently purified 
by semi-preparative HPLC (75% EtOAc, 25% hexane) to afford 17-norisopimar-15-ene-
8β,13β-diol (6.7, 48 mg, 27%)  which yielded white plates (from hexane). 
 
17-Norisopimar-15-ene-8β,13β-diol (6.7):202 white plates (from hexane); mp 157.5-159.5°C 
lit.202 154-155°C; [ α]D28  -6 (c 2.6, CHCl3); IR (film) νmax 3299, 2945, 1436, 1196, 761 cm-1; 1H 
NMR (C6D6, 600 MHz) δ 5.71 (1H, dd, J = 17.3, 10.7 Hz, H-15), 5.25 (1H, d, J = 13.7 Hz, H-
16b), 4.96 (1H, d, J = 10.7 Hz, H-16a), 1.76 (1H, ddd, J = 13.4, 12.8, 3.2 Hz, H-11b), 1.63 
(1H, m, H-7b), 1.60 (3H, m, H-1b, H-2b, H-12b), 1.59 (1H, m, H-6b), 1.52 (1H, dd, J = 14.0, 
2.6 Hz, H-14b), 1.39 (1H, m, H-3b), 1.40 (1H, m, H-6a), 1.37 (2H, m, H-2a, H-11a), 1.21 (1H, 
m, H-12a), 1.16 (1H, dd, J = 13.3, 3.9 Hz, H-3a), 1.13 (3H, s, H3-20), 1.11 (1H, d, J = 14.0 Hz, 
H-14a), 1.04 (1H, ddd, J = 13.4, 12.9, 4.0 Hz, H-7a), 0.90 (3H, s, H3-18), 0.89 (3H, s, H3-19), 
0.71 (2H, m, H-1a, H-5), 0.56 (1H, d, J = 12.6, 2.8 Hz, H-9); 13C NMR (150 MHz, C6D6) δ 
146.2 (d, C-15), 111.3 (t, C-16), 73.4 (s, C-13), 72.4 (s, C-8), 56.5 (d, C-5), 56.1 (d, C-9), 49.7 
(t, C-14), 42.5 (t, C-3), 42.4 (t, C-7), 39.8 (t, C-1), 37.6 (s, C-10), 38.6 (t, C-12), 33.9 (q, C-18), 
33.5 (s, C-4), 22.0 (q, C-19), 18.9 (t, C-2), 18.2 (t, C-6), 16.6 (t, C-11), 15.7 (q, C-20); LREIMS 
m/z (rel int) 293 [(M + H)+] (1), 274 (72), 259 (100), 149 (39), 136 (45); HRFABMS m/z 
293.2481 (calcd for C19H33O2 [(M + H)+], 293.2480).  
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7.6.1.3 HWE reaction on 5.51  
OH
O
H
5.51
TEPA, NaH, THF, RT OH
H
5.49 ∆13 E
5.50 ∆13Z
CO2Et
 
 
 
This method is representative. Triethylphosphonoacetate (380 µL, 1.90 mmol, 2.5 eq) was 
added to an anhydrous solution of NaH (60%, 38 mg, 1.90 mmol, 2.5 eq) in THF (15 mL), and 
the mixture was stirred under an Ar atmosphere (0.5 h). A solution of 5.31 (264 mg, 0.76 
mmol) in anhydrous THF (10 mL) was added via cannula and the reaction mixture stirred at 
ambient temperature (10 h), after which HCl (1 M, 3 drops) was added and the mixture 
concentrated in vacuo. The resulting oil was taken up in Et2O (5 mL) and washed with H2O (3 
x 5 mL). The combined organic fractions were dried (MgSO4) and concentrated in vacuo to 
afford a yellow oil, which was subsequently purified on silica (20% EtOAc, 80% hexane) to 
afford a mixture of the E/Z isomers 5.49 and 5.50. This mixture was further purified using 
semi-preparative HPLC (10% EtOAc, 90% hexane) to afford ethyl 17-norabiet-13(15)-E-en-
8β-ol-16-oate (5.49, 105 mg, 41%) and ethyl 17-norabiet-13(15)-Z-en-8β-ol-16-oate (5.50, 76 
mg, 29%). The one-pot reaction cyclization-HWE reaction referred to in Chapter Six was 
simply a combination of the methods described in Section 7.6.1.1 and here. On one isolated 
occasion the minor product 17-norpimaran-13α-ethoxy-8,16-olactone, 6.6, was isolated in 
10% yield from the one-pot cyclization-HWE reaction.  
 
H
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O
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17-Norpimaran-13α-ethoxy-8,16-olactone (6.6): white needles (from hexane); mp 143-
144°C; [ α]D25 +12 (c 0.7, CHCl3); IR (film) νmax 2922, 2952, 1716, 1086, 986 cm-1; 1H and 13C 
data, see Table 6.2; LREIMS m/z (rel int) 334 [M+] (18), 319 (35), 288 (100), 276 (70), 228 
(31); HRFABMS m/z 334.2509 (calcd for C21H34O3 [M+], 334.2508).  
 
Crystal data for 6.6: C21H34O3, M = 334.48, monoclinic, space group P21 (no. 4), a = 
6.9880(1) Å, b = 22.0165(4) Å, c = 12.6710(3) Å, β = 101.345(1)°, V = 1911.36(6) Å3, Z = 4, 
Dc = 1.162 Mg/m3, µ(MoKα ) = 0.075 mm-1, F(000) = 736. A total of 8635 reflections were 
collected of which 5846 were observed [I > 2σ(I)]. The structure was solved by direct methods 
and refined on F2 using all data, with non-hydrogen atoms treated anisotropically. All H atoms 
were located and then added in idealised positions in a riding model. The final R factors were 
R1 = 0.0828 (all data), 0.0387 (observed data), wR2 = 0.0782 (all data), 0.0692 (observed 
data) for 441 parameters. Crystallographic data (excluding structure factors) have been 
deposited at the Cambridge Crystallographic Data Centre (deposition no. 620304). 
 
7.6.1.4 Reduction of 5.49 and 5.50 with LAH 
 
OH
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A solution of either the ethyl ester 5.49 (90, 0.27 mmol) or the ethyl ester 5.50 (59 mg, 0.18 
mmol) in anhydrous THF (5 mL) was added to a cooled (0°C) solution of LAH (2.2 eq) in THF 
(5 mL). The solution was stirred (2.5 h) while gradually warming to ambient temperature. The 
remaining LAH was quenched with H2O (2 mL), concentrated in vacuo, and taken up in Et2O 
(5 mL), which was washed with H2O (3 x 5 mL). The combined organic partition fractions were 
dried (MgSO4) and concentrated under reduced pressure to afford a yellow oil. The oil was 
purified by normal-phase HPLC (100% EtOAc). The reduction of the Z isomer 5.50 yielded 
17-norisopimarane-8β,16-diol (6.8, 8 mg, 15%) and 17-norabiet-13(15)-ene-8β,16-diol (6.9, 
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24 mg, 46%). The reduction of the E isomer 5.49 yielded exclusively 6.8 (35 mg, 43%).  
 
17-Norisopimarane-8β,16-diol (6.8): yellow oil, [α]D34  -10 (c 3.5, CHCl3); IR (film) νmax 3361, 
2921, 1451, 1060, 735 cm-1; 1H NMR (C6D6, 600 MHz) δ 3.43 (2H, t, J =  6.6 Hz, H2-16), 1.72 
(1H, m, H-12b), 1.70 (1H, m, H-13), 1.60 (1H, m, H-2b), 1.59 (2H, m, H-1b, H-2a), 1.51 (1H, 
ddd, J = 13.5, 3.9, 2.8 Hz, H-7b), 1.44 (1H, m, H-11b), 1.43 (1H, m, H-6a), 1.42 (1H, m, H-
11a), 1.39 (1H, m, H-3b), 1.36 (1H, m, H-6b), 1.33 (1H, m, H-14b), 1.27 (1H, m, H-15b), 1.25 
(H-15a), 1.17 (1H, m, H-7a), 1.14 (1H, m, H-3a), 1.05 (3H, s, H3-20), 0.90 (3H, s, H3-18), 0.89 
(3H, s, H3-19), 0.72 (1H, m, H-5), 0.71 (1H, m, H-12a), 0.70 (1H, m, H-14a), 0.69 (1H, m, H-
1a), 0.62 (1H, dd, J = 12.4, 3.3 Hz, H-9) ; 13C NMR (CDCl3, 150 MHz) δ 71.3 (s, C-8), 60.3 (t, 
C-16), 56.7 (d, C-9), 56.5 (d, C-5), 49.3 (t, C-14), 42.8 (t, C-7), 42.5 (t, C-3), 40.4 (t, C-15), 
39.7 (t, C-1), 37.5 (s, C-10), 33.88 (t, C-12), 33.85 (q, C-18), 33.5 (s, C-4), 29.4 (d, C-13), 
22.0 (q, C-19), 20.7 (t, C-6), 18.9 (t, C-2), 18.5 (t, C-11), 15.8 (q, C-20) ; LREIMS m/z (rel int) 
294 [M+] (1), 279 (100), 261 (85), 243 (21), 179 (16); HRFABMS m/z 295.2637(calcd for 
C19H35O2 [(M + H)+], 295.2636).  
 
17-Norabiet-13(15)-ene-8β,16-diol (6.9): yellow oil; [α]D34 -11 (c 1.4, CHCl3); IR (film) νmax 
3446, 2945, 1709, 1386, 757 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.65 (1H, dd, J = 8.1, 6.8 Hz, 
H-15), 4.12 (1H, dd, J = 11.6, 6.8 Hz, H-16b), 3.92 (1H, dd, J = 11.6, 8.1 Hz, H-16a), 2.49 
(1H, dd, J = 13.2, 2.1 Hz, H-14b), 2.27 (1H, m, H-12b), 1.97 (1H, dt, J = 12.8, 4.5 Hz, H-12a), 
1.79 (1H, m, H-7b), 1.77 (1H, m, H-14a), 1.72 (1H, m, H-11b), 1.64 (1H, m, H-1b), 1.58 (1H, 
m, H-2b), 1.54 (1H, m, H-6b), 1.45 (1H, m, H-7a), 1.40 (2H, m, H-3b, H-6a), 1.38 (1H, m, H-
11a), 1.37 (1H, m, H-2a), 1.12 (1H, m, H-3a), 1.10 (1H, m, H-9), 0.94 (3H, s, H3-20), 0.90 (1H, 
m, H-5), 0.87 (3H, s, H3-18), 0.85 (1H, m, H-1a), 0.84 (3H, s, H3-19); 13C NMR (CDCl3, 100 
MHz) δ 142.1 (s, C-13), 123.5 (d, C-15), 73.0 (s, C-8), 57.5 (t, C-16), 56.7 (d, C-9), 56.4 (d, C-
5), 44.4 (t, C-14), 42.1 (t, C-3), 41.3 (t, C-7), 39.5 (t, C-1), 37.4 (s, C-10), 36.7 (t, C-12), 33.6 
(q, C-18), 33.3 (s, C-4), 23.1 (t, C-11), 21.7 (q, C-19), 18.4 (t, C-6), 18.3 (t, C-2), 15.4 (q, C-
20) ; LREIMS m/z (rel int) 292 [M+] (2), 259 (86), 179 (92), 149 (100), 91 (93); HRFABMS m/z 
293.2480 (calcd for C19H33O2 [(M + H)+], 293.2481).  
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7.6.2 Malaria Parasite Viability, Haemolysis, and Erythrocyte Shape Assays 
 
Details as provided by Dr H. Hoppe of the Division of Pharmacology, Faculty of Health 
Sciences, University of Cape Town. P. falciparum (3D7 strain) was cultured under an 
atmosphere of 3% CO2, 4%O2, and 93% N2 in RPMI-1640 medium supplemented with 50 mM 
glucose, 0.65 mM hypoxanthine, 25 mM HEPES, 0.2% (w/v) NaHCO3, 0.048 mgmL
-1 
gentamicin, 0.5% (w/v) Albumax II, and 2-4% (v/v) human O+ erythrocytes. Parasite-infected 
erythrocytes from culture were mixed with fresh culture medium and erythrocytes to yield a 
2% parasitemia and 2% haematocrit suspension and distributed in microtiter plates at 100 
µL/well. Serial dilutions of each compound were prepared in a duplicate plate and transferred 
to the parasite plate at 100 µL/well. The plates were incubated at 37°C for 48 h,  and parasite 
viability in each well was determined by measuring parasite lactate dehydrogenase activity.245
 
Parasite viabilities were determined relative to solvent controls (wells containing 0.5% 
DMSO). To assess haemolytic activity, duplicate plates containing normal, uninfected 
erythrocytes at 2% haematocrit were also incubated for 48 h with the various compound 
dilutions. The intact erythrocytes were sedimented in the microtiter plate wells by 
centrifugation at 200g for 3 min, and released haemoglobin in the supernatants was 
measured by removing aliquots and measuring absorbance at 405 nm. Wells treated with 
0.2% saponin (from Quillaja bark supplied by Sigma-Aldrich, Steinheim, Germany) were used 
as 100% haemolysis controls. Erythrocyte shape changes after 48 h incubation with the 
various test compounds were assessed by removing aliquots from treated wells and 
preparing Giemsa-stained thin blood smears for light microscopy. In addition, aliquots were 
wet-mounted under glass coverslips and viewed directly by phase-contrast microscopy. To 
assess the effects of the compounds on erythrocyte shape at subhaemolytic concentrations, 
2% haematocrit suspensions of fresh erythrocytes were incubated with parasite culture 
medium alone (control) or with medium containing 100, 50, or 25 µgmL-1 of the various 
compounds for 48 h. After incubation, the erythrocyte suspensions were mounted directly 
under coverslips on microscope slides and immediately viewed with a Nikon Eclipse E600 
light microscope using a 100 x Apochromat oil-immersion objective and phase contrast optics. 
Images were captured with a Media Cybernetics CoolSNAP-Pro monochrome cooled charge-
coupled device camera. Discocytes, echinocytes, stomatocytes, and knizocytes in the 
samples were defined according to Lim et al.246
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        Table 1 - Crystal Data and Details of the Structure Determination 
                    
  
                                   Crystal Data 
  
        Formula                                                C36 H50 O10   
 
        Formula Weight                                              642.76   
 
        Crystal System                                          Monoclinic   
 
        Space group                                  P21          (No.  4)   
 
        a, b, c [Angstrom]            10.4893(2)    7.7835(2)   21.1003(5)   
 
        alpha, beta, gamma [deg]              90  93.5180(10)           90   
 
        V [Ang**3]                                              1719.46(7)   
 
        Z                                                                2   
 
        D(calc) [g/cm**3]                                            1.242   
 
        Mu(MoKa) [ /mm ]                                             0.090   
 
        F(000)                                                         692   
 
        Crystal Size [mm]                             0.09 x  0.12 x  0.12   
 
                               Data Collection 
  
        Temperature (K)                                                113   
 
        Radiation [Angstrom]                             MoKa      0.71073   
 
        Theta Min-Max [Deg]                                     3.3,  25.7   
 
        Dataset                                -12: 12 ;  -9:  9 ; -25: 25   
 
        Tot., Uniq. Data, R(int)                      6480,   6480,  0.000   
 
        Observed data [I > 2.0 sigma(I)]                              5199   
 
                                  Refinement 
  
        Nref, Npar                                              6480,  429   
 
        R, wR2, S                                     0.0606, 0.1606, 1.04   
 
        w = 1/[\s^2^(Fo^2^)+(0.0759P)^2^+1.0114P] where P=(Fo^2^+2Fc^2^)/3   
 
        Max. and Av. Shift/Error                                0.00, 0.00   
 
        Flack x                                                    0.1(13)   
 
        Min. and Max. Resd. Dens. [e/Ang^3]                    -0.40, 0.69 
                                  
        Table S2 - Final Coordinates and Equivalent Isotropic Displacement 
                   Parameters of the non-Hydrogen atoms 
                   
  
        Atom          x            y            z      U(eq) [Ang^2] 
          
        O21      0.29576(18)    0.3315(2)  0.41881(10)    0.0340(6) 
  
        O23        0.2071(2)    0.5234(3)  0.48244(11)    0.0428(7) 
  
        O25      0.80342(18)    0.7270(3)  0.34918(10)    0.0375(7) 
  
        O27        0.9860(2)    0.5787(3)  0.34612(13)    0.0578(9) 
  
        O29        0.6715(2)    0.5547(3)  0.20077(10)    0.0455(8) 
  
        O31        0.8231(4)    0.6515(5)  0.14112(18)   0.1052(17) 
  
       *O33A       0.1134(6)    1.3843(8)    0.2036(3)   0.0384(19) 
  
       *O35A      -0.0061(4)    1.2262(7)    0.1334(2)   0.0578(17) 
  
        O37        0.2057(4)    1.6011(4)  0.11305(14)   0.0779(13) 
  
        O46        0.3489(5)    1.7526(5)    0.0637(4)     0.154(3) 
  
        C1         0.3945(3)    0.5695(4)  0.36634(14)    0.0311(6) 
  
        C2         0.4131(3)    0.4318(4)  0.41718(14)    0.0319(9) 
  
        C3         0.5142(3)    0.3020(4)  0.40160(16)    0.0352(9) 
  
        C4         0.6445(3)    0.3822(4)  0.38936(14)    0.0343(9) 
  
        C5         0.6191(3)    0.5272(4)  0.33962(14)    0.0313(9) 
  
        C6         0.7354(3)    0.6008(4)  0.30913(15)    0.0364(9) 
  
        C7         0.6951(3)    0.6902(4)  0.24827(15)   0.0389(10) 
  
        C8         0.5753(3)    0.7974(4)  0.25000(15)   0.0400(10) 
  
        C9         0.4969(3)    0.7882(4)  0.29829(14)    0.0343(9) 
  
        C10        0.5196(3)    0.6675(4)  0.35500(14)    0.0294(8) 
  
        C11        0.3804(3)    0.9064(4)  0.29799(15)    0.0378(9) 
  
        C12        0.2663(3)    0.8405(4)  0.25645(16)   0.0427(10) 
  
        C13        0.1556(3)    0.9644(5)  0.24535(16)   0.0422(11) 
  
        C14        0.1583(4)    1.1247(5)  0.26660(17)   0.0508(11) 
  
        C15        0.0549(4)    1.2581(6)    0.2531(2)   0.0655(11) 
  
        C16        0.0452(3)    0.8859(5)    0.2080(2)   0.0576(13) 
         Table 2 - Final Coordinates and Equivalent Isotropic Displacement 
                   Parameters of the non-Hydrogen atoms(continued)  
  
        Atom          x            y            z      U(eq) [Ang^2] 
         
        C17        0.5551(4)    0.9170(5)  0.19385(17)   0.0529(12) 
  
        C18        0.7166(3)    0.4350(4)  0.45172(15)    0.0402(7) 
  
        C19        0.7238(3)    0.2392(4)  0.35989(17)   0.0427(10) 
  
        C20        0.5571(3)    0.7812(4)  0.41338(14)    0.0335(7) 
  
        C22        0.1998(3)    0.3939(4)  0.45130(14)    0.0333(9) 
  
        C24        0.0873(3)    0.2776(4)  0.44456(16)   0.0391(10) 
  
        C26        0.9301(3)    0.7050(4)  0.36070(14)    0.0348(9) 
  
        C28        0.9918(3)    0.8557(5)  0.39353(16)   0.0417(10) 
  
        C30        0.7465(3)    0.5448(5)  0.15202(16)   0.0445(10) 
  
        C32        0.7194(4)    0.3892(6)    0.1124(2)   0.0654(14) 
  
       *C34A       0.0700(6)    1.3362(9)    0.1460(4)     0.043(2) 
  
        C36        0.1470(4)    1.4358(6)    0.1001(2)   0.0673(16) 
  
        C38        0.2876(4)    1.6232(6)    0.0663(2)   0.0661(14) 
  
        C39        0.2806(4)    1.4699(5)  0.02612(18)   0.0531(12) 
  
        C40        0.1477(5)    1.4860(9)   -0.0079(2)     0.097(2) 
  
        C41        0.0569(4)    1.4631(8)    0.0447(3)     0.099(2) 
  
        C42        0.2598(3)    1.3324(5)  0.07550(17)   0.0466(11) 
  
        C43        0.3694(5)    1.3081(9)    0.1247(2)     0.092(2) 
  
        C44        0.2234(6)    1.1555(7)    0.0498(4)     0.117(3) 
  
        C45        0.3912(6)   1.4499(10)   -0.0155(3)     0.110(2) 
  
       *C34B      0.1445(14)   1.4101(15)    0.1779(6)     0.043(4) 
  
       *O33B       0.0444(7)   1.3068(10)    0.1845(4)     0.041(2) 
  
       *O35B       0.2097(8)    1.4602(8)    0.2247(3)     0.065(3) 
  
  
          U(eq) = 1/3 of the trace of the orthogonalized U Tensor 
  
           Starred Atom sites have a S.O.F less than 1.0 
 
                                  
        Table 3 - Hydrogen Atom Positions and Isotropic Displacement 
                   Parameters 
                     
        Atom          x            y            z     U(iso) [Ang^2] 
         
        H1A          0.32930      0.65250      0.37920       0.0370 
  
        H1B          0.36200      0.51530      0.32610       0.0370 
  
        H2           0.43480      0.48540      0.45950       0.0380 
  
        H3A          0.48340      0.23660      0.36340       0.0420 
  
        H9           0.79490      0.50490      0.29990       0.0440 
  
        H11A         0.35460      0.91960      0.34210       0.0450 
  
        H11B         0.40470      1.02140      0.28260       0.0450 
  
        H12A         0.29680      0.80760      0.21470       0.0510 
  
        H12B         0.23400      0.73500      0.27620       0.0510 
  
        H14          0.23120      1.15890      0.29250       0.0610 
  
        H16A         0.07060      0.85730      0.16530       0.0870 
  
        H16B         0.01840      0.78120      0.22920       0.0870 
  
        H16C        -0.02590      0.96770      0.20480       0.0870 
  
        H17A         0.62400      0.90070      0.16500       0.0800 
  
        H17B         0.55560      1.03620      0.20880       0.0800 
  
        H17C         0.47280      0.89170      0.17130       0.0800 
  
        H3B          0.52580      0.21970      0.43720       0.0420 
  
        H5           0.57430      0.46420      0.30340       0.0370 
  
        H7           0.76670      0.76460      0.23530       0.0470 
  
        H19A         0.72490      0.13740      0.38720       0.0640 
  
        H19B         0.81140      0.27980      0.35600       0.0640 
  
        H19C         0.68550      0.20970      0.31780       0.0640 
  
        H20A         0.64270      0.82880      0.40910       0.0500 
  
        H20B         0.55690      0.71160      0.45210       0.0500 
  
        H20C         0.49550      0.87530      0.41590       0.0500 
  
        H24A         0.01350      0.33370      0.46200       0.0590 
                                  
         Table 3 - Hydrogen Atom Positions and Isotropic Displacement 
                   Parameters  (continued) 
                   
  
        Atom          x            y            z     U(iso) [Ang^2] 
         
        H24B         0.10640      0.17060      0.46770       0.0590 
  
        H24C         0.06800      0.25180      0.39950       0.0590 
  
        H28A         1.06550      0.81690      0.42060       0.0630 
  
        H28B         0.93020      0.91230      0.41970       0.0630 
  
        H28C         1.02030      0.93700      0.36190       0.0630 
  
        H32A         0.72200      0.41930      0.06740       0.0980 
  
        H32B         0.63450      0.34480      0.12050       0.0980 
  
        H32C         0.78380      0.30110      0.12330       0.0980 
  
        H40A         0.13630      1.60010     -0.02820       0.1170 
  
        H40B         0.13400      1.39580     -0.04070       0.1170 
  
        H41A         0.00410      1.56690      0.04990       0.1190 
  
        H41B         0.00050      1.36240      0.03690       0.1190 
  
        H43A         0.44580      1.27220      0.10370       0.1390 
  
        H43B         0.34680      1.21960      0.15510       0.1390 
  
        H43C         0.38650      1.41660      0.14720       0.1390 
  
        H44A         0.29530      1.10650      0.02840       0.1760 
  
        H44B         0.14910      1.16550      0.01960       0.1760 
  
        H44C         0.20240      1.08050      0.08500       0.1760 
  
        H45A         0.40580      1.55870     -0.03730       0.1650 
  
        H45B         0.37170      1.35970     -0.04700       0.1650 
  
        H45C         0.46800      1.41840      0.01070       0.1650 
  
        H18A         0.66070      0.50530      0.47680       0.0600 
  
        H18B         0.79250      0.50160      0.44240       0.0600 
  
        H18C         0.74260      0.33190      0.47580       0.0600 
  
              
         The Temperature Factor has the Form of Exp(-T) Where 
        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
     Table 4 - (An)isotropic  Displacement Parameters 
               
  
    Atom    U(1,1) or U  U(2,2)     U(3,3)     U(2,3)     U(1,3)     U(1,2)  
     
    O21     0.0311(10) 0.0251(11) 0.0466(12) -0.0018(9)  0.0082(9) -0.0065(9) 
  
    O23     0.0428(12) 0.0376(13) 0.0493(13)-0.0077(11) 0.0125(10)-0.0047(10) 
  
    O25     0.0297(10) 0.0330(11) 0.0507(13)-0.0093(10)  0.0087(9) -0.0088(9) 
  
    O27     0.0435(13) 0.0475(16) 0.0812(18)-0.0172(14)-0.0059(12) 0.0076(12) 
  
    O29     0.0421(12) 0.0513(14) 0.0451(13)-0.0138(11) 0.0182(10)-0.0128(11) 
  
    O31       0.113(3)   0.108(3)   0.103(3)  -0.051(2)   0.075(2)  -0.060(2) 
  
    O33A      0.046(3)   0.031(3)   0.039(4)   0.002(3)   0.010(3)   0.004(2) 
  
    O35A      0.053(3)   0.065(3)   0.055(3)   0.015(2)   0.000(2)  -0.010(3) 
  
    O37       0.119(3) 0.0568(19) 0.0590(17)-0.0058(15) 0.0134(18) 0.0224(19) 
  
    O46       0.115(3)   0.062(3)   0.284(7)   0.022(4)   0.008(4)  -0.037(3) 
  
    C2      0.0320(15) 0.0262(16) 0.0382(16)-0.0005(13) 0.0071(13)-0.0056(12) 
  
    C3      0.0377(16) 0.0211(14) 0.0470(17)-0.0007(13) 0.0046(13)-0.0045(13) 
  
    C4      0.0335(14) 0.0257(15) 0.0442(17)-0.0010(14) 0.0057(13)-0.0005(13) 
  
    C5      0.0335(15) 0.0229(14) 0.0377(16)-0.0014(13) 0.0050(12)-0.0053(12) 
  
    C6      0.0351(15) 0.0283(15) 0.0463(18)-0.0058(14) 0.0065(13)-0.0043(13) 
  
    C7      0.0425(17) 0.0367(18) 0.0387(17)-0.0041(14) 0.0116(14)-0.0084(14) 
  
    C8      0.0458(18) 0.0307(17) 0.0440(18) 0.0017(14) 0.0064(14)-0.0052(14) 
  
    C9      0.0395(16) 0.0255(15) 0.0378(16)-0.0015(13) 0.0018(13)-0.0019(13) 
  
    C10     0.0308(14) 0.0204(14) 0.0377(16)-0.0012(12) 0.0072(12)-0.0014(11) 
  
    C11     0.0487(18) 0.0251(15) 0.0396(16) 0.0040(14) 0.0034(14) 0.0039(14) 
  
    C12     0.0428(17) 0.0321(17) 0.0533(19) 0.0043(16) 0.0033(15) 0.0048(15) 
  
    C13     0.0421(18) 0.0426(19) 0.0433(18) 0.0119(15) 0.0129(14) 0.0080(15) 
  
    C14       0.070(2)   0.046(2) 0.0377(18) 0.0067(16) 0.0142(17) 0.0241(19) 
  
    C16     0.0376(17)   0.050(2)   0.085(3)   0.016(2) 0.0022(18)-0.0001(17) 
  
    C17       0.067(2)   0.046(2)   0.047(2) 0.0121(17) 0.0131(17)-0.0004(19) 
  
    C19     0.0375(16) 0.0262(16)   0.065(2)-0.0012(16) 0.0084(15) 0.0026(14) 
  
       Table 4 - (An)isotropic  Displacement Parameters (continued) 
               
  
    Atom    U(1,1) or U  U(2,2)     U(3,3)     U(2,3)     U(1,3)     U(1,2) 
   
    C22     0.0356(16) 0.0290(16) 0.0360(16) 0.0033(14) 0.0068(12) 0.0014(13) 
  
    C24     0.0329(15) 0.0381(18) 0.0469(18) 0.0013(15) 0.0073(13)-0.0029(13) 
  
    C26     0.0359(16) 0.0314(17) 0.0378(16) 0.0040(14) 0.0070(13)-0.0011(14) 
  
    C28     0.0392(16) 0.0410(18) 0.0458(18)-0.0056(15) 0.0095(14)-0.0102(15) 
  
    C30     0.0325(16)   0.058(2) 0.0438(18)-0.0078(17) 0.0088(14)-0.0024(17) 
  
    C32       0.051(2)   0.081(3)   0.066(2)  -0.028(2) 0.0176(18)  -0.005(2) 
  
    C34A      0.030(3)   0.041(4)   0.058(5)   0.000(4)   0.004(4)   0.007(3) 
  
    C36       0.069(3)   0.051(2)   0.086(3)   0.033(2)   0.039(2)   0.025(2) 
  
    C38       0.060(2)   0.048(2)   0.090(3)   0.009(2)   0.003(2)  -0.009(2) 
  
    C39       0.056(2)   0.059(2)   0.046(2) 0.0082(18) 0.0173(17) 0.0121(19) 
  
    C40       0.100(4)   0.118(5)   0.070(3)  -0.009(3)  -0.029(3)   0.045(4) 
  
    C41       0.039(2)   0.075(3)   0.183(6)   0.031(4)  -0.004(3)   0.004(2) 
  
    C42     0.0422(18)   0.047(2)   0.052(2) 0.0043(17) 0.0144(15) 0.0057(16) 
  
    C43       0.078(3)   0.117(5)   0.081(3)   0.028(3)  -0.001(3)   0.049(3) 
  
    C44       0.107(5)   0.047(3)   0.197(7)  -0.008(4)   0.005(5)   0.018(3) 
  
    C34B      0.067(9)   0.029(5)   0.035(7)   0.011(5)   0.013(6)   0.011(6) 
  
    O33B      0.047(4)   0.050(4)   0.026(4)   0.008(3)   0.014(3)   0.016(4) 
  
    O35B      0.110(6)   0.036(3)   0.048(4)  -0.001(3)  -0.010(4)  -0.028(4) 
  
  
            
         The Temperature Factor has the Form of Exp(-T) Where 
        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
        T = 2*(Pi**2)*Sumij(h(i)*h(j)*U(i,j)*Astar(i)*Astar(j)), for 
      Anisotropic Atoms. Astar(i) are Reciprocal Axial Lengths and 
          h(i) are the Reflection Indices. 
      Table 5 - Bond Distances (Angstrom) 
                    
        O21    -C2         1.460(4)     C7     -C8         1.511(4) 
  
        O21    -C22        1.343(4)     C8     -C9         1.350(4) 
  
        O23    -C22        1.203(4)     C8     -C17        1.511(5) 
  
        O25    -C6         1.454(4)     C9     -C11        1.529(4) 
  
        O25    -C26        1.347(4)     C9     -C10        1.529(4) 
  
        O27    -C26        1.195(4)     C10    -C20        1.548(4) 
  
        O29    -C7         1.466(4)     C11    -C12        1.528(5) 
  
        O29    -C30        1.335(4)     C12    -C13        1.517(5) 
  
        O31    -C30        1.188(5)     C13    -C14        1.326(5) 
  
        O33A   -C15        1.585(8)     C13    -C16        1.491(5) 
  
        O33A   -C34A      1.325(10)     C14    -C15        1.516(6) 
  
        O33B   -C15        1.494(9)     C22    -C24        1.487(4) 
  
        O33B   -C34B      1.337(16)     C26    -C28        1.490(5) 
  
        O35A   -C34A       1.190(8)     C30    -C32        1.489(6) 
  
        O35B   -C34B      1.230(15)     C34A   -C36        1.512(9) 
  
        O37    -C38        1.358(6)     C34B   -C36       1.656(13) 
  
        O37    -C36        1.445(6)     C36    -C41        1.473(7) 
  
        O46    -C38        1.198(6)     C36    -C42        1.547(6) 
  
        C1     -C2         1.521(4)     C38    -C39        1.463(6) 
  
        C1     -C10        1.549(4)     C39    -C40        1.534(7) 
  
        C2     -C3         1.515(4)     C39    -C42        1.519(5) 
  
        C3     -C4         1.539(4)     C39    -C45        1.505(8) 
  
        C4     -C18        1.533(4)     C40    -C41        1.517(7) 
  
        C4     -C19        1.543(4)     C42    -C43        1.513(6) 
  
        C4     -C5         1.553(4)     C42    -C44        1.520(7) 
  
        C5     -C10        1.558(4)     C1     -H1A          0.9900 
  
        C5     -C6         1.525(4)     C1     -H1B          0.9900 
  
        C6     -C7         1.499(4)     C2     -H2           1.0000 
       Table S5 - Bond Distances (Angstrom) (continued) 
                    
  
        C3     -H3A          0.9900     C20    -H20C         0.9800 
  
        C3     -H3B          0.9900     C24    -H24A         0.9800 
  
        C5     -H5           1.0000     C24    -H24B         0.9800 
  
        C6     -H9           1.0000     C24    -H24C         0.9800 
  
        C7     -H7           1.0000     C28    -H28A         0.9800 
  
        C11    -H11A         0.9900     C28    -H28B         0.9800 
  
        C11    -H11B         0.9900     C28    -H28C         0.9800 
  
        C12    -H12A         0.9900     C32    -H32A         0.9800 
  
        C12    -H12B         0.9900     C32    -H32B         0.9800 
  
        C14    -H14          0.9500     C32    -H32C         0.9800 
  
        C16    -H16A         0.9800     C40    -H40A         0.9900 
  
        C16    -H16B         0.9800     C40    -H40B         0.9900 
  
        C16    -H16C         0.9800     C41    -H41A         0.9900 
  
        C17    -H17A         0.9800     C41    -H41B         0.9900 
  
        C17    -H17B         0.9800     C43    -H43A         0.9800 
  
        C17    -H17C         0.9800     C43    -H43B         0.9800 
  
        C18    -H18A         0.9800     C43    -H43C         0.9800 
  
        C18    -H18B         0.9800     C44    -H44A         0.9800 
  
        C18    -H18C         0.9800     C44    -H44B         0.9800 
  
        C19    -H19A         0.9800     C44    -H44C         0.9800 
  
        C19    -H19B         0.9800     C45    -H45A         0.9800 
  
        C19    -H19C         0.9800     C45    -H45B         0.9800 
  
        C20    -H20A         0.9800     C45    -H45C         0.9800 
  
        C20    -H20B         0.9800 
  
 
 
 
 
 
             
    Table 6 - Bond Angles    (Degrees) 
                
    C2     -O21    -C22        118.6(2)   C9     -C8     -C17        124.2(3) 
  
    C6     -O25    -C26        117.6(2)   C8     -C9     -C10        123.4(3) 
  
    C7     -O29    -C30        119.1(3)   C8     -C9     -C11        119.3(3) 
  
    C15    -O33A   -C34A       107.7(5)   C10    -C9     -C11        117.3(3) 
  
    C15    -O33B   -C34B       104.0(8)   C1     -C10    -C9         109.3(2) 
  
    C36    -O37    -C38        104.9(3)   C1     -C10    -C20        109.6(2) 
  
    C2     -C1     -C10        112.5(3)   C1     -C10    -C5         105.8(2) 
  
    O21    -C2     -C3         104.5(2)   C5     -C10    -C20        115.2(3) 
  
    C1     -C2     -C3         112.2(3)   C9     -C10    -C20        106.9(2) 
  
    O21    -C2     -C1         108.8(2)   C5     -C10    -C9         110.0(2) 
  
    C2     -C3     -C4         114.0(3)   C9     -C11    -C12        113.5(3) 
  
    C3     -C4     -C18        111.2(3)   C11    -C12    -C13        116.1(3) 
  
    C3     -C4     -C19        106.3(2)   C12    -C13    -C16        112.6(3) 
  
    C3     -C4     -C5         106.9(2)   C14    -C13    -C16        124.4(3) 
  
    C5     -C4     -C19        109.0(2)   C12    -C13    -C14        123.1(3) 
  
    C18    -C4     -C19        106.8(3)   C13    -C14    -C15        125.5(4) 
  
    C5     -C4     -C18        116.1(3)   O33A   -C15    -C14        104.3(4) 
  
    C4     -C5     -C6         116.7(3)   O33B   -C15    -C14        111.4(4) 
  
    C6     -C5     -C10        112.8(3)   O21    -C22    -C24        110.3(3) 
  
    C4     -C5     -C10        117.3(2)   O23    -C22    -C24        125.9(3) 
  
    O25    -C6     -C5         112.7(2)   O21    -C22    -O23        123.9(3) 
  
    C5     -C6     -C7         110.2(3)   O25    -C26    -O27        123.5(3) 
  
    O25    -C6     -C7         106.7(2)   O27    -C26    -C28        124.2(3) 
  
    O29    -C7     -C8         108.0(2)   O25    -C26    -C28        112.3(3) 
  
    C6     -C7     -C8         115.3(3)   O29    -C30    -O31        123.1(4) 
  
    O29    -C7     -C6         106.2(2)   O31    -C30    -C32        124.6(4) 
  
    C7     -C8     -C9         122.4(3)   O29    -C30    -C32        112.2(3) 
  
    C7     -C8     -C17        113.5(3)   O33A   -C34A   -C36        106.0(5) 
Table 6 - Bond Angles    (Degrees)  (continued) 
  
    O35A   -C34A   -C36        127.1(7)   C36    -C42    -C39         90.5(3) 
  
    O33A   -C34A   -O35A       126.6(7)   C36    -C42    -C43        113.6(3) 
  
    O33B   -C34B   -O35B      120.6(11)   C36    -C42    -C44        114.2(4) 
  
    O33B   -C34B   -C36        103.7(9)   C2     -C1     -H1A          109.00 
  
    O35B   -C34B   -C36       135.7(11)   C2     -C1     -H1B          109.00 
  
    O37    -C36    -C41        105.5(4)   C10    -C1     -H1A          109.00 
  
    O37    -C36    -C42        101.6(3)   C10    -C1     -H1B          109.00 
  
    O37    -C36    -C34B        87.3(5)   H1A    -C1     -H1B          108.00 
  
    O37    -C36    -C34A       125.0(4)   O21    -C2     -H2           110.00 
  
    C34B   -C36    -C42        109.2(6)   C1     -C2     -H2           110.00 
  
    C34A   -C36    -C42        113.4(4)   C3     -C2     -H2           110.00 
  
    C41    -C36    -C42        106.0(4)   C2     -C3     -H3A          109.00 
  
    C34A   -C36    -C41        103.9(4)   C2     -C3     -H3B          109.00 
  
    C34B   -C36    -C41        139.1(6)   C4     -C3     -H3A          109.00 
  
    O37    -C38    -O46        120.3(5)   C4     -C3     -H3B          109.00 
  
    O37    -C38    -C39        107.8(4)   H3A    -C3     -H3B          108.00 
  
    O46    -C38    -C39        131.9(5)   C4     -C5     -H5           102.00 
  
    C40    -C39    -C42        102.4(3)   C6     -C5     -H5           102.00 
  
    C42    -C39    -C45        118.4(4)   C10    -C5     -H5           102.00 
  
    C38    -C39    -C42        100.5(3)   O25    -C6     -H9           109.00 
  
    C40    -C39    -C45        116.5(4)   C5     -C6     -H9           109.00 
  
    C38    -C39    -C40        102.5(4)   C7     -C6     -H9           109.00 
  
    C38    -C39    -C45        114.2(4)   O29    -C7     -H7           109.00 
  
    C39    -C40    -C41        104.0(4)   C6     -C7     -H7           109.00 
  
    C36    -C41    -C40        101.3(4)   C8     -C7     -H7           109.00 
  
    C39    -C42    -C44        115.9(4)   C9     -C11    -H11A         109.00 
  
    C43    -C42    -C44        107.2(4)   C9     -C11    -H11B         109.00 
  
    C39    -C42    -C43        115.1(4)   C12    -C11    -H11A         109.00 
Table 6 - Bond Angles    (Degrees)  (continued) 
               
     C12    -C11    -H11B         109.00   C4     -C19    -H19B         109.00 
  
    H11A   -C11    -H11B         108.00   C4     -C19    -H19C         109.00 
  
    C11    -C12    -H12A         108.00   H19A   -C19    -H19B         109.00 
  
    C11    -C12    -H12B         108.00   H19A   -C19    -H19C         109.00 
  
    C13    -C12    -H12A         108.00   H19B   -C19    -H19C         110.00 
  
    C13    -C12    -H12B         108.00   C10    -C20    -H20A         109.00 
  
    H12A   -C12    -H12B         107.00   C10    -C20    -H20B         110.00 
  
    C13    -C14    -H14          117.00   C10    -C20    -H20C         110.00 
  
    C15    -C14    -H14          117.00   H20A   -C20    -H20B         110.00 
  
    C13    -C16    -H16A         109.00   H20A   -C20    -H20C         109.00 
  
    C13    -C16    -H16B         110.00   H20B   -C20    -H20C         109.00 
  
    C13    -C16    -H16C         109.00   C22    -C24    -H24A         109.00 
  
    H16A   -C16    -H16B         109.00   C22    -C24    -H24B         109.00 
  
    H16A   -C16    -H16C         109.00   C22    -C24    -H24C         109.00 
  
    H16B   -C16    -H16C         109.00   H24A   -C24    -H24B         109.00 
  
    C8     -C17    -H17A         109.00   H24A   -C24    -H24C         110.00 
  
    C8     -C17    -H17B         109.00   H24B   -C24    -H24C         109.00 
  
    C8     -C17    -H17C         110.00   C26    -C28    -H28A         109.00 
  
    H17A   -C17    -H17B         109.00   C26    -C28    -H28B         109.00 
  
    H17A   -C17    -H17C         109.00   C26    -C28    -H28C         110.00 
  
    H17B   -C17    -H17C         109.00   H28A   -C28    -H28B         110.00 
  
    C4     -C18    -H18A         109.00   H28A   -C28    -H28C         109.00 
  
    C4     -C18    -H18B         109.00   H28B   -C28    -H28C         109.00 
  
    C4     -C18    -H18C         109.00   C30    -C32    -H32A         110.00 
  
    H18A   -C18    -H18B         109.00   C30    -C32    -H32B         109.00 
  
    H18A   -C18    -H18C         110.00   C30    -C32    -H32C         109.00 
  
    H18B   -C18    -H18C         109.00   H32A   -C32    -H32B         109.00 
  
    C4     -C19    -H19A         109.00   H32A   -C32    -H32C         110.00 
    Table 6 - Bond Angles    (Degrees)  (continued) 
               
  
    H32B   -C32    -H32C         109.00   H43A   -C43    -H43C         110.00 
  
    C39    -C40    -H40A         111.00   H43B   -C43    -H43C         109.00 
  
    C39    -C40    -H40B         111.00   C42    -C44    -H44A         109.00 
  
    C41    -C40    -H40A         111.00   C42    -C44    -H44B         109.00 
  
    C41    -C40    -H40B         111.00   C42    -C44    -H44C         109.00 
  
    H40A   -C40    -H40B         109.00   H44A   -C44    -H44B         110.00 
  
    C36    -C41    -H41A         111.00   H44A   -C44    -H44C         109.00 
  
    C36    -C41    -H41B         111.00   H44B   -C44    -H44C         109.00 
  
    C40    -C41    -H41A         111.00   C39    -C45    -H45A         109.00 
  
    C40    -C41    -H41B         112.00   C39    -C45    -H45B         109.00 
  
    H41A   -C41    -H41B         109.00   C39    -C45    -H45C         109.00 
  
    C42    -C43    -H43A         109.00   H45A   -C45    -H45B         109.00 
  
    C42    -C43    -H43B         109.00   H45A   -C45    -H45C         110.00 
  
    C42    -C43    -H43C         109.00   H45B   -C45    -H45C         109.00 
  
    H43A   -C43    -H43B         109.00 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       
         Table 7 - Torsion Angles (Degrees) 
                  
         C2     -O21    -C22    -C24        177.3(2) 
  
         C2     -O21    -C22    -O23         -4.5(4) 
  
         C22    -O21    -C2     -C1         -82.0(3) 
  
         C22    -O21    -C2     -C3         158.0(2) 
  
         C6     -O25    -C26    -O27         -9.0(4) 
  
         C26    -O25    -C6     -C7        -111.0(3) 
  
         C6     -O25    -C26    -C28        171.1(3) 
  
         C26    -O25    -C6     -C5         128.0(3) 
  
         C30    -O29    -C7     -C6        -114.6(3) 
  
         C7     -O29    -C30    -O31         -8.5(5) 
  
         C30    -O29    -C7     -C8         121.2(3) 
  
         C7     -O29    -C30    -C32        173.5(3) 
  
         C15    -O33A   -C34A   -O35A         4.9(9) 
  
         C34A   -O33A   -C15    -C14         96.6(5) 
  
         C15    -O33A   -C34A   -C36       -169.2(4) 
  
         C38    -O37    -C36    -C41        -73.8(4) 
  
         C38    -O37    -C36    -C42         36.6(4) 
  
         C36    -O37    -C38    -C39         -1.3(4) 
  
         C36    -O37    -C38    -O46        178.4(5) 
  
         C38    -O37    -C36    -C34A       166.3(5) 
  
         C2     -C1     -C10    -C9         173.4(2) 
  
         C2     -C1     -C10    -C5          55.0(3) 
  
         C10    -C1     -C2     -C3         -57.4(3) 
  
         C10    -C1     -C2     -O21       -172.6(2) 
  
         C2     -C1     -C10    -C20        -69.7(3) 
  
         C1     -C2     -C3     -C4          55.3(4) 
  
         O21    -C2     -C3     -C4         173.0(2) 
  
         C2     -C3     -C4     -C5         -51.1(3) 
   Table 7 - Torsion Angles (Degrees)  (continued) 
                     
         C2     -C3     -C4     -C18         76.6(3) 
  
         C2     -C3     -C4     -C19       -167.4(3) 
  
         C19    -C4     -C5     -C6         -52.8(3) 
  
         C18    -C4     -C5     -C10        -70.5(4) 
  
         C3     -C4     -C5     -C10         54.3(3) 
  
         C18    -C4     -C5     -C6          67.9(4) 
  
         C19    -C4     -C5     -C10        168.8(3) 
  
         C3     -C4     -C5     -C6        -167.4(3) 
  
         C4     -C5     -C6     -C7         160.3(3) 
  
         C4     -C5     -C6     -O25        -80.7(3) 
  
         C4     -C5     -C10    -C9        -174.2(3) 
  
         C4     -C5     -C10    -C1         -56.3(3) 
  
         C10    -C5     -C6     -C7         -59.6(3) 
  
         C6     -C5     -C10    -C20        -75.1(3) 
  
         C6     -C5     -C10    -C9          45.8(3) 
  
         C10    -C5     -C6     -O25         59.4(3) 
  
         C4     -C5     -C10    -C20         64.9(4) 
  
         C6     -C5     -C10    -C1         163.8(2) 
  
         O25    -C6     -C7     -C8         -81.3(3) 
  
         O25    -C6     -C7     -O29        159.2(2) 
  
         C5     -C6     -C7     -O29        -78.2(3) 
  
         C5     -C6     -C7     -C8          41.3(4) 
  
         C6     -C7     -C8     -C17        166.5(3) 
  
         O29    -C7     -C8     -C17        -75.1(3) 
  
         C6     -C7     -C8     -C9         -12.0(4) 
  
         O29    -C7     -C8     -C9         106.5(3) 
  
         C7     -C8     -C9     -C10         -1.1(5) 
  
         C7     -C8     -C9     -C11        177.4(3) 
Table 7 - Torsion Angles (Degrees)  (continued) 
                     
         C17    -C8     -C9     -C10       -179.4(3) 
  
         C17    -C8     -C9     -C11         -0.9(5) 
  
         C11    -C9     -C10    -C1          50.0(3) 
  
         C11    -C9     -C10    -C5         165.7(3) 
  
         C8     -C9     -C10    -C5         -15.8(4) 
  
         C8     -C9     -C10    -C20        110.0(3) 
  
         C8     -C9     -C11    -C12         81.6(4) 
  
         C10    -C9     -C11    -C12        -99.8(3) 
  
         C11    -C9     -C10    -C20        -68.6(3) 
  
         C8     -C9     -C10    -C1        -131.5(3) 
  
         C9     -C11    -C12    -C13       -170.4(3) 
  
         C11    -C12    -C13    -C16       -176.2(3) 
  
         C11    -C12    -C13    -C14          4.0(5) 
  
         C12    -C13    -C14    -C15        175.4(3) 
  
         C16    -C13    -C14    -C15         -4.4(6) 
  
         C13    -C14    -C15    -O33A      -106.1(5) 
  
         O33A   -C34A   -C36    -C42         97.7(6) 
  
         O35A   -C34A   -C36    -O37        158.9(6) 
  
         O35A   -C34A   -C36    -C41         38.3(8) 
  
         O35A   -C34A   -C36    -C42        -76.3(8) 
  
         O33A   -C34A   -C36    -C41       -147.7(5) 
  
         O33A   -C34A   -C36    -O37        -27.1(7) 
  
         C34A   -C36    -C41    -C40       -155.4(5) 
  
         O37    -C36    -C41    -C40         71.6(5) 
  
         O37    -C36    -C42    -C43         63.9(4) 
  
         C42    -C36    -C41    -C40        -35.6(5) 
  
         O37    -C36    -C42    -C39        -53.9(3) 
  
         C34A   -C36    -C42    -C43        -72.8(6) 
Table 7 - Torsion Angles (Degrees)  (continued) 
                   
          C34A   -C36    -C42    -C44         50.6(6) 
  
         C41    -C36    -C42    -C39         56.1(4) 
  
         C41    -C36    -C42    -C43        173.9(4) 
  
         C41    -C36    -C42    -C44        -62.8(5) 
  
         O37    -C36    -C42    -C44       -172.8(4) 
  
         C34A   -C36    -C42    -C39        169.5(4) 
  
         O37    -C38    -C39    -C40         70.3(4) 
  
         O37    -C38    -C39    -C42        -35.0(4) 
  
         O37    -C38    -C39    -C45       -162.8(4) 
  
         O46    -C38    -C39    -C40       -109.3(6) 
  
         O46    -C38    -C39    -C42        145.4(6) 
  
         O46    -C38    -C39    -C45         17.6(8) 
  
         C38    -C39    -C40    -C41        -67.1(5) 
  
         C42    -C39    -C40    -C41         36.7(5) 
  
         C45    -C39    -C40    -C41        167.5(5) 
  
         C38    -C39    -C42    -C36         51.8(3) 
  
         C38    -C39    -C42    -C43        -64.6(4) 
  
         C38    -C39    -C42    -C44        169.2(4) 
  
         C40    -C39    -C42    -C36        -53.6(4) 
  
         C40    -C39    -C42    -C43       -170.1(4) 
  
         C40    -C39    -C42    -C44         63.8(5) 
  
         C45    -C39    -C42    -C36        176.8(4) 
  
         C45    -C39    -C42    -C43         60.3(5) 
  
         C45    -C39    -C42    -C44        -65.8(5) 
  
         C39    -C40    -C41    -C36         -0.6(6) 
  
Table 8 - Contact Distances(Angstrom) 
                    
        O23    .C1         3.253(4)     O25    .H18B         2.6400 
  
        O25    .C20        3.020(4)     O27    .H9           2.2500 
  
        O25    .C9         3.361(4)     O27    .H24C_d       2.8900 
  
        O25    .C18        3.304(4)     O29    .H17A         2.8300 
  
        O27    .C22_d      3.378(4)     O29    .H5           2.5500 
  
        O27    .C15_c      3.283(5)     O31    .H40B_e       2.9000 
  
        O27    .C24_d      3.266(4)     O31    .H41A_c       2.8600 
  
        O31    .C16_d      3.216(5)     O31    .H16B_d       2.8600 
  
        O33A   .O37        2.768(7)     O31    .H17A         2.9200 
  
        O33A   .C43        3.299(8)     O31    .H7           2.2800 
  
        O33B   .C16        3.313(9)     O33B   .H16C         2.7800 
  
        O35A   .C44        3.119(8)     O35A   .H32C_f       2.2800 
  
        O35A   .C14        3.302(6)     O35A   .H41B         2.3000 
  
        O35A   .C16        3.111(6)     O35A   .H44C         2.7200 
  
        O35A   .C32_f      3.153(6)     O35A   .H40A_g       2.7200 
  
        O35B   .C12_h      3.085(7)     O35A   .H16C         2.5300 
  
        O35B   .O37        2.597(7)     O35B   .H43C         2.5700 
  
        O35B   .C43        3.016(9)     O35B   .H14          2.7500 
  
        O35B   .C14        2.820(7)     O35B   .H1B_h        2.6300 
  
        O37    .O35B       2.597(7)     O35B   .H12B_h       2.4100 
  
        O37    .O33A       2.768(7)     O35B   .H12A_h       2.8700 
  
        O46    .C44_h      3.407(7)     O35B   .H43B         2.8300 
  
        O46    .C45_i      3.341(9)     O37    .H12A_h       2.8000 
  
        O23    .H1A          2.7800     O37    .H43C         2.4500 
  
        O23    .H2           2.4800     O37    .H16A_h       2.7200 
  
        O23    .H18C_a       2.6000     O46    .H17C_h       2.7700 
  
        O23    .H28B_b       2.7300     O46    .H44A_h       2.9000 
  
        O25    .H20A         2.3100     O46    .H45C_i       2.8600 
Table 8 - Contact Distances(Angstrom) (continued) 
                    
         O46    .H45A         2.7100     C1     .H11A         2.8000 
  
        C1     .C12        3.354(4)     C1     .H12B         2.7800 
  
        C1     .O23        3.253(4)     C2     .H20B         2.7200 
  
        C9     .O25        3.361(4)     C2     .H18A         2.8700 
  
        C12    .C17        3.430(5)     C2     .H5           3.0300 
  
        C12    .O35B_j     3.085(7)     C4     .H20B         3.0500 
  
        C12    .C1         3.354(4)     C6     .H19C         3.1000 
  
        C14    .O35B       2.820(7)     C6     .H19B         2.7900 
  
        C14    .O35A       3.302(6)     C6     .H18B         2.9400 
  
        C15    .O27_f      3.283(5)     C6     .H20A         2.9700 
  
        C16    .O35A       3.111(6)     C8     .H5           2.8300 
  
        C16    .O33B       3.313(9)     C8     .H12A         2.9700 
  
        C16    .O31_k      3.216(5)     C11    .H1A          2.6900 
  
        C17    .C12        3.430(5)     C11    .H17B         2.8900 
  
        C18    .O25        3.304(4)     C11    .H3A_h        3.0800 
  
        C18    .C20        3.248(4)     C11    .H20C         2.7100 
  
        C20    .O25        3.020(4)     C11    .H14          2.5100 
  
        C20    .C18        3.248(4)     C11    .H17C         2.9000 
  
        C22    .O27_k      3.378(4)     C12    .H17C         2.9300 
  
        C24    .O27_k      3.266(4)     C12    .H1B          3.0600 
  
        C24    .C28_l      3.580(5)     C12    .H1A          3.0100 
  
        C28    .C24_m      3.580(5)     C13    .H28C_k       2.9200 
  
        C32    .O35A_c     3.153(6)     C14    .H28C_k       2.9400 
  
        C43    .O33A       3.299(8)     C14    .H11A         2.9900 
  
        C43    .O35B       3.016(9)     C14    .H11B         2.7100 
  
        C44    .O35A       3.119(8)     C15    .H24C_h       3.0800 
  
        C44    .O46_j      3.407(7)     C15    .H16C         2.6000 
  
        C45    .O46_e      3.341(9)     C17    .H12A         2.9000 
Table 8 - Contact Distances(Angstrom) (continued) 
                   
        C17    .H11B         2.6500     C44    .H40B         2.7900 
  
        C18    .H24B_a       3.0500     C44    .H45B         3.0800 
  
        C18    .H20B         2.7300     C44    .H41B         2.8400 
  
        C18    .H2           3.0000     C45    .H44A         3.0200 
  
        C19    .H9           2.5600     C45    .H43A         2.9000 
  
        C20    .H2           2.8400     H1A    .H11A         2.2400 
  
        C20    .H18A         2.7200     H1A    .O23          2.7800 
  
        C20    .H11A         2.7500     H1A    .C11          2.6900 
  
        C22    .H1A          2.9100     H1A    .C12          3.0100 
  
        C24    .H28B_b       3.0700     H1A    .C22          2.9100 
  
        C26    .H16B_d       3.0400     H1A    .H12B         2.4200 
  
        C26    .H18B         2.8000     H1A    .H20C         2.5500 
  
        C26    .H7           3.1000     H1B    .C12          3.0600 
  
        C28    .H24A_a       3.0600     H1B    .O35B_j       2.6300 
  
        C30    .H17A         3.0700     H1B    .H5           2.3400 
  
        C32    .H43A_j       3.0100     H1B    .H12B         2.3800 
  
        C34A   .H44C         2.7900     H2     .C18          3.0000 
  
        C34A   .H32C_f       3.0200     H2     .O23          2.4800 
  
        C34A   .H43B         3.0400     H2     .H18A         2.3800 
  
        C34B   .H43B         2.6600     H2     .H20B         2.1900 
  
        C34B   .H43C         2.6600     H2     .C20          2.8400 
  
        C38    .H41A         3.0000     H3A    .H11B_j       2.4900 
  
        C38    .H43C         2.5200     H3A    .H19C         2.3900 
  
        C40    .H44B         2.5600     H3A    .C11_j        3.0800 
  
        C41    .H44B_n       2.9400     H3A    .H5           2.4100 
  
        C41    .H44B         2.5800     H3B    .H19A         2.4800 
  
        C43    .H32B_h       2.8000     H3B    .H20B_b       2.5400 
  
        C43    .H45C         2.8100     H3B    .H18C         2.5200 
Table 8 - Contact Distances(Angstrom) (continued) 
                    
        H5     .H3A          2.4100     H12A   .O35B_j       2.8700 
  
        H5     .H19C         2.3100     H12B   .O35B_j       2.4100 
  
        H5     .O29          2.5500     H12B   .C1           2.7800 
  
        H5     .C2           3.0300     H12B   .H1A          2.4200 
  
        H5     .C8           2.8300     H12B   .H16B         2.4400 
  
        H5     .H1B          2.3400     H12B   .H1B          2.3800 
  
        H7     .H17A         2.3000     H14    .O35B         2.7500 
  
        H7     .O31          2.2800     H14    .C11          2.5100 
  
        H7     .C26          3.1000     H14    .H11B         2.1300 
  
        H9     .H19B         2.1200     H14    .H11A         2.4600 
  
        H9     .O27          2.2500     H16A   .O37_j        2.7200 
  
        H9     .C19          2.5600     H16A   .H12A         2.5600 
  
        H11A   .C1           2.8000     H16B   .C26_k        3.0400 
  
        H11A   .H1A          2.2400     H16B   .O31_k        2.8600 
  
        H11A   .C14          2.9900     H16B   .H12B         2.4400 
  
        H11A   .C20          2.7500     H16C   .O33B         2.7800 
  
        H11A   .H14          2.4600     H16C   .O35A         2.5300 
  
        H11A   .H20C         2.1100     H16C   .C15          2.6000 
  
        H11B   .H3A_h        2.4900     H17A   .C30          3.0700 
  
        H11B   .C14          2.7100     H17A   .O29          2.8300 
  
        H11B   .C17          2.6500     H17A   .O31          2.9200 
  
        H11B   .H14          2.1300     H17A   .H7           2.3000 
  
        H11B   .H17B         2.2900     H17A   .H45B_e       2.5100 
  
        H12A   .C8           2.9700     H17B   .H11B         2.2900 
  
        H12A   .H17C         2.2100     H17B   .C11          2.8900 
  
        H12A   .C17          2.9000     H17C   .O46_j        2.7700 
  
        H12A   .H16A         2.5600     H17C   .C12          2.9300 
  
        H12A   .O37_j        2.8000     H17C   .H12A         2.2100 
Table 8 - Contact Distances(Angstrom) (continued) 
                   
        H17C   .C11          2.9000     H20B   .H18A         1.9900 
  
        H18A   .H2           2.3800     H20C   .C11          2.7100 
  
        H18A   .H20B         1.9900     H20C   .H1A          2.5500 
  
        H18A   .C2           2.8700     H20C   .H11A         2.1100 
  
        H18A   .C20          2.7200     H24A   .C28_b        3.0600 
  
        H18B   .C6           2.9400     H24B   .H18B_b       2.4900 
  
        H18B   .C26          2.8000     H24B   .C18_b        3.0500 
  
        H18B   .O25          2.6400     H24C   .O27_k        2.8900 
  
        H18B   .H24B_a       2.4900     H24C   .C15_j        3.0800 
  
        H18B   .H19B         2.5300     H28B   .O23_a        2.7300 
  
        H18C   .H19A         2.4000     H28B   .C24_a        3.0700 
  
        H18C   .O23_b        2.6000     H28C   .C14_d        2.9400 
  
        H18C   .H3B          2.5200     H28C   .C13_d        2.9200 
  
        H19A   .H3B          2.4800     H32A   .H44A_e       2.4900 
  
        H19A   .H18C         2.4000     H32B   .H43A_j       2.0700 
  
        H19B   .H9           2.1200     H32B   .C43_j        2.8000 
  
        H19B   .C6           2.7900     H32C   .C34A_c       3.0200 
  
        H19B   .H18B         2.5300     H32C   .O35A_c       2.2800 
  
        H19C   .H5           2.3100     H40A   .O35A_n       2.7200 
  
        H19C   .C6           3.1000     H40A   .H41B_n       2.5000 
  
        H19C   .H3A          2.3900     H40B   .C44          2.7900 
  
        H20A   .O25          2.3100     H40B   .O31_i        2.9000 
  
        H20A   .C6           2.9700     H40B   .H44B         2.2000 
  
        H20B   .H3B_a        2.5400     H40B   .H45B         2.5200 
  
        H20B   .C2           2.7200     H41A   .O31_f        2.8600 
  
        H20B   .C4           3.0500     H41A   .C38          3.0000 
  
        H20B   .C18          2.7300     H41A   .H44B_n       2.2400 
  
        H20B   .H2           2.1900     H41B   .O35A         2.3000 
Table 8 - Contact Distances(Angstrom) (continued) 
                   
        H41B   .H40A_g       2.5000     H44A   .O46_j        2.9000 
  
        H41B   .C44          2.8400     H44A   .C45          3.0200 
  
        H41B   .H44B         2.2300     H44B   .C40          2.5600 
  
        H43A   .C45          2.9000     H44B   .H41B         2.2300 
  
        H43A   .C32_h        3.0100     H44B   .C41          2.5800 
  
        H43A   .H44A         2.5200     H44B   .H40B         2.2000 
  
        H43A   .H45C         2.2900     H44B   .C41_g        2.9400 
  
        H43A   .H32B_h       2.0700     H44B   .H41A_g       2.2400 
  
        H43B   .O35B         2.8300     H44C   .C34A         2.7900 
  
        H43B   .C34B         2.6600     H44C   .O35A         2.7200 
  
        H43B   .C34A         3.0400     H44C   .H43B         2.3200 
  
        H43B   .H44C         2.3200     H45A   .O46          2.7100 
  
        H43C   .C38          2.5200     H45B   .C44          3.0800 
  
        H43C   .O35B         2.5700     H45B   .H40B         2.5200 
  
        H43C   .O37          2.4500     H45B   .H17A_i       2.5100 
  
        H43C   .C34B         2.6600     H45C   .O46_e        2.8600 
  
        H44A   .H32A_i       2.4900     H45C   .C43          2.8100 
  
        H44A   .H43A         2.5200     H45C   .H43A         2.2900 
  
                                 
 
Table 9 - Hydrogen Bonds (Angstrom, Deg) 
 
  
  
C5   -- H5   .. O29         1.0000     2.5500   3.021(4)     109.00     . 
  
C7   -- H7   .. O31         1.0000     2.2800   2.716(5)     105.00     . 
  
C6   -- H9   .. O27         1.0000     2.2500   2.701(4)     106.00     . 
  
C16  -- H16C .. O35A        0.9800     2.5300   3.111(6)     118.00     . 
  
C20  -- H20A .. O25         0.9800     2.3100   3.020(4)     129.00     . 
  
C32  -- H32C .. O35A        0.9800     2.2800   3.153(6)     148.00   1_645 
  
C41  -- H41B .. O35A        0.9900     2.3000   2.737(8)     106.00     . 
  
C43  -- H43C .. O37         0.9800     2.4500   2.856(7)     104.00     . 
 
 
                                  
  
  
Translation of Symmetry Code to Equiv.Pos 
  
  
a =[  2656.00 ]  = 1-x,1/2+y,1-z 
b =[  2646.00 ]  = 1-x,-1/2+y,1-z 
c =[  1645.00 ]  = 1+x,-1+y,z 
d =[  1655.00 ]  = 1+x,y,z 
e =[  2645.00 ]  = 1-x,-1/2+y,-z 
f =[  1465.00 ]  = -1+x,1+y,z 
g =[  2545.00 ]  = -x,-1/2+y,-z 
h =[  1565.00 ]  = x,1+y,z 
i =[  2655.00 ]  = 1-x,1/2+y,-z 
j =[  1545.00 ]  = x,-1+y,z 
k =[  1455.00 ]  = -1+x,y,z 
l =[  1445.00 ]  = -1+x,-1+y,z 
m =[  1665.00 ]  = 1+x,1+y,z 
n =[  2555.00 ]  = -x,1/2+y,-z 
Appendix II X-ray crystallographic data for 5.22 
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        Table 1 - Crystal Data and Details of the Structure Determination 
                     
  
                                   Crystal Data 
  
        Formula                                                 C18 H34 O2   
 
        Formula Weight                                              282.45   
 
        Crystal System                                        Orthorhombic   
 
        Space group                                  P212121      (No. 19)   
 
        a, b, c [Angstrom]             8.4923(2)    9.9407(2)   20.4323(4)   
 
        V [Ang**3]                                              1724.88(6)   
 
        Z                                                                4   
 
        D(obs), D(calc) [g/cm**3]                             1.040, 1.088   
 
        Mu(MoKa) [ /mm ]                                             0.068   
 
        F(000)                                                         632   
 
        Crystal Size [mm]                             0.20 x  0.25 x  0.25   
 
                               Data Collection 
  
        Temperature (K)                                                113   
 
        Radiation [Angstrom]                             MoKa      0.71073   
 
        Theta Min-Max [Deg]                                     3.6,  26.4   
 
        Dataset                                -10: 10 ; -12: 12 ; -25: 25   
 
        Tot., Uniq. Data, R(int)                      3520,   3520,  0.000   
 
        Observed data [I > 2.0 sigma(I)]                              2781   
 
                                  Refinement 
  
        Nref, Npar                                              3520,  195   
 
        R, wR2, S                                     0.0433, 0.1079, 1.04   
 
        w = 1/[\s^2^(Fo^2^)+(0.0593P)^2^+0.0176P] where P=(Fo^2^+2Fc^2^)/3   
 
        Max. and Av. Shift/Error                                0.00, 0.00   
 
        Flack x                                                   -1.8(12)   
 
        Min. and Max. Resd. Dens. [e/Ang^3]                    -0.16, 0.27 
                                  
        Table 2 - Final Coordinates and Equivalent Isotropic Displacement 
                   Parameters of the non-Hydrogen atoms 
                  
  
        Atom          x            y            z      U(eq) [Ang^2] 
         
  
        O19      0.10047(15)  0.63548(12)   0.45984(6)    0.0231(4) 
  
        O20      0.77002(14)  0.62257(14)   0.51153(6)    0.0244(4) 
  
        C1         0.4932(2)  0.52461(19)   0.31901(9)    0.0228(5) 
  
        C2         0.5107(2)    0.5458(2)   0.24519(9)    0.0278(6) 
  
        C3         0.3933(2)    0.4589(2)   0.20790(9)    0.0271(6) 
  
        C4         0.2208(2)  0.48060(19)   0.22757(9)    0.0249(6) 
  
        C5         0.2076(2)  0.46864(18)   0.30371(8)    0.0217(5) 
  
        C6         0.0404(2)  0.48409(19)   0.33077(9)    0.0226(5) 
  
        C7         0.0324(2)  0.43120(19)   0.40078(9)    0.0234(5) 
  
        C8         0.1510(2)  0.49825(17)   0.44706(8)    0.0202(5) 
  
        C9         0.3173(2)  0.50119(17)   0.41686(8)    0.0193(5) 
  
        C10        0.3264(2)  0.55369(17)   0.34482(8)    0.0189(5) 
  
        C11        0.4383(2)  0.56784(18)   0.46345(8)    0.0196(5) 
  
        C12        0.5500(2)  0.46940(17)   0.49627(9)    0.0215(5) 
  
        C13        0.6600(2)  0.53617(17)   0.54550(8)    0.0208(5) 
  
        C14        0.7498(2)    0.4356(2)   0.58636(9)    0.0273(6) 
  
        C15        0.1525(2)    0.4233(2)   0.51246(9)    0.0272(6) 
  
        C16        0.2956(2)  0.70576(17)   0.34160(9)    0.0225(6) 
  
        C17        0.1568(2)    0.6132(2)   0.19946(9)    0.0326(7) 
  
        C18        0.1262(2)    0.3649(2)  0.19635(10)    0.0343(7) 
  
  
          U(eq) = 1/3 of the trace of the orthogonalized U Tensor 
 
                                 
  
         
Table 3 - Hydrogen Atom Positions and Isotropic Displacement 
                   Parameters 
                     
  
        Atom          x            y            z     U(iso) [Ang^2] 
        
        H1A          0.56880      0.58390      0.34200       0.0270 
  
        H1B          0.52110      0.43040      0.32960       0.0270 
  
        H2A          0.49260      0.64170      0.23450       0.0330 
  
        H2B          0.61910      0.52220      0.23160       0.0330 
  
        H3A          0.42050      0.36320      0.21500       0.0320 
  
        H3B          0.40430      0.47780      0.16050       0.0320 
  
        H5           0.23640      0.37310      0.31330       0.0260 
  
        H6A          0.00960      0.58010      0.33000       0.0270 
  
        H6B         -0.03440      0.43350      0.30290       0.0270 
  
        H7A          0.05210      0.33300      0.40030       0.0280 
  
        H7B         -0.07520      0.44580      0.41800       0.0280 
  
        H9           0.35010      0.40470      0.41430       0.0230 
  
        H11A         0.50100      0.63390      0.43820       0.0240 
  
        H11B         0.38040      0.61780      0.49780       0.0240 
  
        H12A         0.61390      0.42420      0.46220       0.0260 
  
        H12B         0.48750      0.39950      0.51900       0.0260 
  
        H13          0.59520      0.59310      0.57550       0.0250 
  
        H13A         0.14830      0.36130      0.14930       0.0510 
  
        H13B         0.01340      0.38040      0.20320       0.0510 
  
        H13C         0.15660      0.27950      0.21670       0.0510 
  
        H14A         0.80460      0.37220      0.55750       0.0410 
  
        H14B         0.82690      0.48300      0.61360       0.0410 
  
        H14C         0.67630      0.38640      0.61450       0.0410 
  
        H15A         0.21870      0.47210      0.54380       0.0410 
  
        H15B         0.19480      0.33250      0.50600       0.0410 
  
        H15C         0.04490      0.41720      0.52950       0.0410 
  
 
        Table 3 - Hydrogen Atom Positions and Isotropic Displacement 
                   Parameters  (continued) 
                     
  
        Atom          x            y            z     U(iso) [Ang^2] 
         
        H16A         0.35830      0.75140      0.37520       0.0340 
  
        H16B         0.18350      0.72320      0.34930       0.0340 
  
        H16C         0.32520      0.73960      0.29830       0.0340 
  
        H17A         0.14960      0.60620      0.15170       0.0490 
  
        H17B         0.22800      0.68700      0.21110       0.0490 
  
        H17C         0.05210      0.63090      0.21760       0.0490 
  
        H19         0.006(3)     0.627(2)   0.4788(11)     0.037(6) 
  
        H20         0.724(3)     0.700(3)   0.5108(13)     0.058(8) 
  
  
            
  
         The Temperature Factor has the Form of Exp(-T) Where 
        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
 
                                    
    Table S4 - (An)isotropic  Displacement Parameters 
               
  
    Atom    U(1,1) or U  U(2,2)     U(3,3)     U(2,3)     U(1,3)     U(1,2) 
     
    O19      0.0225(7)  0.0207(7)  0.0261(7) -0.0042(6)  0.0028(6)  0.0002(6) 
  
    O20      0.0210(7)  0.0229(7)  0.0292(7) -0.0005(6)  0.0022(5) -0.0006(6) 
  
    C1       0.0206(9)  0.0247(9)  0.0232(9) -0.0023(8) -0.0010(7) -0.0006(8) 
  
    C2      0.0223(10) 0.0351(11) 0.0259(10) -0.0030(9)  0.0055(8) -0.0019(8) 
  
    C3      0.0282(11) 0.0347(12)  0.0183(9)  0.0000(8)  0.0039(7)  0.0029(9) 
  
    C4      0.0258(10) 0.0294(10)  0.0196(9) -0.0022(8) -0.0010(7)  0.0025(8) 
  
    C5       0.0207(9) 0.0214(10)  0.0229(9) -0.0008(8) -0.0011(7)  0.0009(8) 
  
    C6       0.0179(9) 0.0257(10)  0.0243(9) -0.0018(8) -0.0026(7) -0.0005(8) 
  
    C7       0.0210(9)  0.0232(9)  0.0259(9) -0.0034(8)  0.0018(8) -0.0020(8) 
  
    C8       0.0239(9)  0.0133(8)  0.0234(9) -0.0023(7) -0.0002(7) -0.0001(8) 
  
    C9       0.0188(9)  0.0172(9)  0.0218(9) -0.0023(8)  0.0007(7)  0.0011(8) 
  
    C10      0.0181(9)  0.0187(9)  0.0198(9) -0.0012(8)  0.0004(7)  0.0001(8) 
  
    C11      0.0217(9)  0.0188(9)  0.0184(9) -0.0005(8) -0.0005(7)  0.0002(8) 
  
    C12     0.0235(10)  0.0194(9)  0.0215(9) -0.0012(8) -0.0016(7)  0.0003(8) 
  
    C13      0.0192(9) 0.0235(10)  0.0198(9) -0.0001(8)  0.0001(7) -0.0022(8) 
  
    C14     0.0244(10) 0.0300(10) 0.0275(10)  0.0021(9) -0.0059(8) -0.0032(8) 
  
    C15     0.0291(11) 0.0297(10) 0.0228(10)  0.0005(8)  0.0015(8) -0.0013(9) 
  
    C16     0.0235(10) 0.0241(10)  0.0199(9) -0.0001(8)  0.0008(8) -0.0017(8) 
  
    C17     0.0336(11) 0.0443(13) 0.0198(10)  0.0008(9) -0.0013(8) 0.0081(10) 
  
    C18     0.0365(12) 0.0395(12) 0.0268(11)-0.0105(10) -0.0032(9)-0.0045(10) 
  
  
      
         The Temperature Factor has the Form of Exp(-T) Where 
        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
        T = 2*(Pi**2)*Sumij(h(i)*h(j)*U(i,j)*Astar(i)*Astar(j)), for 
      Anisotropic Atoms. Astar(i) are Reciprocal Axial Lengths and 
          h(i) are the Reflection Indices. 
 
                                 
  
         
Table 5 - Bond Distances (Angstrom)                 
   
        O19    -C8         1.454(2)     C3     -H3B          0.9900 
  
        O20    -C13        1.447(2)     C5     -H5           1.0000 
  
        O19    -H19         0.90(2)     C6     -H6A          0.9900 
  
        O20    -H20         0.86(3)     C6     -H6B          0.9900 
  
        C1     -C2         1.530(3)     C7     -H7A          0.9900 
  
        C1     -C10        1.539(2)     C7     -H7B          0.9900 
  
        C2     -C3         1.523(3)     C9     -H9           1.0000 
  
        C3     -C4         1.534(2)     C11    -H11A         0.9900 
  
        C4     -C18        1.541(3)     C11    -H11B         0.9900 
  
        C4     -C17        1.537(3)     C12    -H12A         0.9900 
  
        C4     -C5         1.564(2)     C12    -H12B         0.9900 
  
        C5     -C10        1.562(2)     C13    -H13          1.0000 
  
        C5     -C6         1.532(2)     C14    -H14A         0.9800 
  
        C6     -C7         1.526(3)     C14    -H14B         0.9800 
  
        C7     -C8         1.534(2)     C14    -H14C         0.9800 
  
        C8     -C9         1.542(2)     C15    -H15A         0.9800 
  
        C8     -C15        1.530(2)     C15    -H15B         0.9800 
  
        C9     -C11        1.550(2)     C15    -H15C         0.9800 
  
        C9     -C10        1.564(2)     C16    -H16A         0.9800 
  
        C10    -C16        1.536(2)     C16    -H16B         0.9800 
  
        C11    -C12        1.519(2)     C16    -H16C         0.9800 
  
        C12    -C13        1.525(2)     C17    -H17A         0.9800 
  
        C13    -C14        1.509(3)     C17    -H17B         0.9800 
  
        C1     -H1A          0.9900     C17    -H17C         0.9800 
  
        C1     -H1B          0.9900     C18    -H13A         0.9800 
  
        C2     -H2A          0.9900     C18    -H13B         0.9800 
  
        C2     -H2B          0.9900     C18    -H13C         0.9800 
  
        C3     -H3A          0.9900 
     Table 6 - Bond Angles    (Degrees)                
  
    C8     -O19    -H19       104.7(13)   C1     -C10    -C16      109.09(14) 
  
    C13    -O20    -H20       104.2(18)   C9     -C10    -C16      111.13(14) 
  
    C2     -C1     -C10      113.66(14)   C5     -C10    -C16      113.57(14) 
  
    C1     -C2     -C3       110.57(15)   C9     -C11    -C12      114.20(14) 
  
    C2     -C3     -C4       114.46(15)   C11    -C12    -C13      113.17(14) 
  
    C3     -C4     -C18      106.52(15)   C12    -C13    -C14      112.71(14) 
  
    C5     -C4     -C17      114.30(15)   O20    -C13    -C12      109.73(13) 
  
    C5     -C4     -C18      108.52(15)   O20    -C13    -C14      109.41(14) 
  
    C17    -C4     -C18      107.52(14)   C2     -C1     -H1A          109.00 
  
    C3     -C4     -C5       108.56(14)   C2     -C1     -H1B          109.00 
  
    C3     -C4     -C17      111.12(15)   C10    -C1     -H1A          109.00 
  
    C6     -C5     -C10      110.52(14)   C10    -C1     -H1B          109.00 
  
    C4     -C5     -C6       114.70(14)   H1A    -C1     -H1B          108.00 
  
    C4     -C5     -C10      116.59(14)   C1     -C2     -H2A          110.00 
  
    C5     -C6     -C7       110.20(14)   C1     -C2     -H2B          110.00 
  
    C6     -C7     -C8       113.52(15)   C3     -C2     -H2A          110.00 
  
    O19    -C8     -C9       108.94(13)   C3     -C2     -H2B          110.00 
  
    O19    -C8     -C7       108.95(14)   H2A    -C2     -H2B          108.00 
  
    C7     -C8     -C15      109.41(14)   C2     -C3     -H3A          109.00 
  
    O19    -C8     -C15      107.61(13)   C2     -C3     -H3B          109.00 
  
    C7     -C8     -C9       111.29(14)   C4     -C3     -H3A          109.00 
  
    C9     -C8     -C15      110.56(14)   C4     -C3     -H3B          109.00 
  
    C10    -C9     -C11      113.76(14)   H3A    -C3     -H3B          108.00 
  
    C8     -C9     -C11      111.70(13)   C4     -C5     -H5           104.00 
  
    C8     -C9     -C10      115.37(14)   C6     -C5     -H5           105.00 
  
    C1     -C10    -C5       107.98(14)   C10    -C5     -H5           105.00 
  
    C5     -C10    -C9       107.08(13)   C5     -C6     -H6A          110.00 
  
    C1     -C10    -C9       107.78(14)   C5     -C6     -H6B          110.00 
  
 
       Table 6 - Bond Angles    (Degrees)  (continued) 
               
    C7     -C6     -H6A          110.00   H14A   -C14    -H14B         109.00 
  
    C7     -C6     -H6B          110.00   H14A   -C14    -H14C         110.00 
  
    H6A    -C6     -H6B          108.00   H14B   -C14    -H14C         109.00 
  
    C6     -C7     -H7A          109.00   C8     -C15    -H15A         110.00 
  
    C6     -C7     -H7B          109.00   C8     -C15    -H15B         109.00 
  
    C8     -C7     -H7A          109.00   C8     -C15    -H15C         109.00 
  
    C8     -C7     -H7B          109.00   H15A   -C15    -H15B         109.00 
  
    H7A    -C7     -H7B          108.00   H15A   -C15    -H15C         109.00 
  
    C8     -C9     -H9           105.00   H15B   -C15    -H15C         109.00 
  
    C10    -C9     -H9           105.00   C10    -C16    -H16A         109.00 
  
    C11    -C9     -H9           105.00   C10    -C16    -H16B         109.00 
  
    C9     -C11    -H11A         109.00   C10    -C16    -H16C         109.00 
  
    C9     -C11    -H11B         109.00   H16A   -C16    -H16B         109.00 
  
    C12    -C11    -H11A         109.00   H16A   -C16    -H16C         110.00 
  
    C12    -C11    -H11B         109.00   H16B   -C16    -H16C         109.00 
  
    H11A   -C11    -H11B         108.00   C4     -C17    -H17A         109.00 
  
    C11    -C12    -H12A         109.00   C4     -C17    -H17B         109.00 
  
    C11    -C12    -H12B         109.00   C4     -C17    -H17C         109.00 
  
    C13    -C12    -H12A         109.00   H17A   -C17    -H17B         109.00 
  
    C13    -C12    -H12B         109.00   H17A   -C17    -H17C         109.00 
  
    H12A   -C12    -H12B         108.00   H17B   -C17    -H17C         110.00 
  
    O20    -C13    -H13          108.00   C4     -C18    -H13A         109.00 
  
    C12    -C13    -H13          108.00   C4     -C18    -H13B         109.00 
  
    C14    -C13    -H13          108.00   C4     -C18    -H13C         109.00 
  
    C13    -C14    -H14A         109.00   H13A   -C18    -H13B         109.00 
  
    C13    -C14    -H14B         109.00   H13A   -C18    -H13C         110.00 
  
    C13    -C14    -H14C         109.00   H13B   -C18    -H13C         109.00 
          Table 7 - Torsion Angles (Degrees) 
                      
         C10    -C1     -C2     -C3         -57.1(2) 
  
         C2     -C1     -C10    -C5        53.61(19) 
  
         C2     -C1     -C10    -C9       168.98(15) 
  
         C2     -C1     -C10    -C16      -70.25(19) 
  
         C1     -C2     -C3     -C4          56.0(2) 
  
         C2     -C3     -C4     -C5         -51.3(2) 
  
         C2     -C3     -C4     -C17         75.2(2) 
  
         C2     -C3     -C4     -C18     -168.01(16) 
  
         C3     -C4     -C5     -C6      -178.34(15) 
  
         C3     -C4     -C5     -C10         50.2(2) 
  
         C17    -C4     -C5     -C6          57.0(2) 
  
         C17    -C4     -C5     -C10      -74.41(19) 
  
         C18    -C4     -C5     -C6       -62.95(19) 
  
         C18    -C4     -C5     -C10      165.62(14) 
  
         C4     -C5     -C6     -C7       163.53(15) 
  
         C10    -C5     -C6     -C7       -62.19(19) 
  
         C4     -C5     -C10    -C1       -51.40(19) 
  
         C4     -C5     -C10    -C9      -167.23(14) 
  
         C4     -C5     -C10    -C16       69.71(19) 
  
         C6     -C5     -C10    -C1       175.26(14) 
  
         C6     -C5     -C10    -C9        59.44(17) 
  
         C6     -C5     -C10    -C16      -63.62(18) 
  
         C5     -C6     -C7     -C8          56.1(2) 
  
         C6     -C7     -C8     -O19       71.76(18) 
  
         C6     -C7     -C8     -C9       -48.37(19) 
  
         C6     -C7     -C8     -C15     -170.84(14) 
  
         O19    -C8     -C9     -C10      -71.68(17) 
  
         O19    -C8     -C9     -C11       60.27(17) 
  
                  
         Table 7 - Torsion Angles (Degrees)  (continued)  
  
         C7     -C8     -C9     -C10       48.45(19) 
  
         C7     -C8     -C9     -C11     -179.59(14) 
  
         C15    -C8     -C9     -C10      170.26(14) 
  
         C15    -C8     -C9     -C11      -57.79(18) 
  
         C8     -C9     -C10    -C1      -169.54(14) 
  
         C8     -C9     -C10    -C5       -53.58(18) 
  
         C8     -C9     -C10    -C16       70.98(18) 
  
         C11    -C9     -C10    -C1        59.48(18) 
  
         C11    -C9     -C10    -C5       175.44(14) 
  
         C11    -C9     -C10    -C16      -60.00(18) 
  
         C8     -C9     -C11    -C12      105.86(16) 
  
         C10    -C9     -C11    -C12     -121.37(16) 
  
         C9     -C11    -C12    -C13     -175.88(14) 
  
         C11    -C12    -C13    -O20      -68.03(18) 
  
         C11    -C12    -C13    -C14      169.77(14) 
  
 
                                  
 
  
        Table 8 - Contact Distances(Angstrom) 
                      
        O19    .O20_a    3.0012(17)     C6     .H13B         2.8100 
  
        O19    .C16        3.012(2)     C6     .H17C         2.7400 
  
        O19    .O20_b    2.8636(18)     C8     .H16B         3.0100 
  
        O19    .C13_b      3.305(2)     C8     .H5           3.0900 
  
        O20    .O19_d    2.8636(18)     C11    .H15A         2.6600 
  
        O20    .O19_c    3.0012(17)     C11    .H1A          2.7200 
  
        O19    .H11B         2.5100     C11    .H20         2.92(3) 
  
        O19    .H16B         2.5200     C11    .H20_b       2.99(3) 
  
        O19    .H20_b       2.03(3)     C11    .H16A         2.6500 
  
        O19    .H6A          2.8200     C12    .H15A         2.9800 
  
        O19    .H13_b        2.7900     C14    .H15C_c       2.7700 
  
        O20    .H11A         2.7300     C15    .H12B         2.8600 
  
        O20    .H19_c       2.11(3)     C15    .H11B         2.7500 
  
        O20    .H7B_c        2.9100     C16    .H2A          2.8300 
  
        O20    .H11B_d       2.7500     C16    .H6A          2.7400 
  
        O20    .H16A_d       2.7400     C16    .H17B         2.7300 
  
        C12    .C15        3.423(2)     C16    .H3A_f        3.1000 
  
        C13    .O19_d      3.305(2)     C16    .H11A         2.7300 
  
        C15    .C12        3.423(2)     C17    .H2A          2.9500 
  
        C16    .C17        3.267(3)     C17    .H6A          2.9600 
  
        C16    .O19        3.012(2)     C17    .H16C         2.7800 
  
        C17    .C16        3.267(3)     C18    .H6B          2.6600 
  
        C1     .H11A         2.6700     H1A    .C11          2.7200 
  
        C2     .H14B_e       3.0400     H1A    .H11A         2.1100 
  
        C2     .H16C         2.7100     H1A    .H16A         2.5400 
  
        C2     .H17B         2.8700     H1B    .H3A          2.5800 
  
        C4     .H16C         3.0800     H1B    .H5           2.5100 
  
        C6     .H16B         2.7000     H1B    .H9           2.2700                      
        Table 8 - Contact Distances(Angstrom) (continued) 
                     
        H2A    .C16          2.8300     H7A    .H5           2.4000 
  
        H2A    .C17          2.9500     H7A    .H15B         2.4800 
  
        H2A    .H16C         2.1600     H7A    .H14C_h       2.4400 
  
        H2A    .H17B         2.3400     H7B    .O20_a        2.9100 
  
        H2A    .H3A_f        2.5400     H7B    .H15C         2.5100 
  
        H2B    .H14B_e       2.4500     H7B    .H19          2.2900 
  
        H3A    .H1B          2.5800     H9     .H1B          2.2700 
  
        H3A    .H5           2.5500     H9     .H5           2.3000 
  
        H3A    .H13C         2.3900     H9     .H12A         2.4500 
  
        H3A    .C16_g        3.1000     H9     .H12B         2.4400 
  
        H3A    .H2A_g        2.5400     H9     .H15B         2.4000 
  
        H3A    .H16C_g       2.5000     H11A   .O20          2.7300 
  
        H3B    .H13A         2.4700     H11A   .C1           2.6700 
  
        H3B    .H17A         2.5200     H11A   .C16          2.7300 
  
        H3B    .H14B_e       2.5100     H11A   .H1A          2.1100 
  
        H5     .C8           3.0900     H11A   .H16A         2.1200 
  
        H5     .H1B          2.5100     H11A   .H20          2.4900 
  
        H5     .H3A          2.5500     H11B   .O19          2.5100 
  
        H5     .H7A          2.4000     H11B   .C15          2.7500 
  
        H5     .H9           2.3000     H11B   .H13          2.4300 
  
        H5     .H13C         2.2800     H11B   .H15A         2.2100 
  
        H6A    .O19          2.8200     H11B   .O20_b        2.7500 
  
        H6A    .C16          2.7400     H11B   .H20_b        2.2500 
  
        H6A    .C17          2.9600     H12A   .H9           2.4500 
  
        H6A    .H16B         2.0900     H12A   .H14A         2.5800 
  
        H6A    .H17C         2.3800     H12B   .C15          2.8600 
  
        H6B    .C18          2.6600     H12B   .H9           2.4400 
  
        H6B    .H13B         2.1400     H12B   .H14C         2.5300 
        Table 8 - Contact Distances(Angstrom) (continued)                  
  
        H12B   .H15A         2.4500     H15B   .H7A          2.4800 
  
        H12B   .H15B         2.5900     H15B   .H9           2.4000 
  
        H13    .H11B         2.4300     H15B   .H12B         2.5900 
  
        H13    .H13A_i       2.6000     H15B   .H14A_h       2.5900 
  
        H13    .O19_d        2.7900     H15C   .C14_a        2.7700 
  
        H13    .H16B_d       2.5000     H15C   .H7B          2.5100 
  
        H13A   .H3B          2.4700     H15C   .H14A_a       2.1700 
  
        H13A   .H17A         2.4300     H15C   .H19          2.3500 
  
        H13A   .H13_j        2.6000     H16A   .C11          2.6500 
  
        H13B   .C6           2.8100     H16A   .H1A          2.5400 
  
        H13B   .H6B          2.1400     H16A   .H11A         2.1200 
  
        H13B   .H17C         2.5300     H16A   .O20_b        2.7400 
  
        H13B   .H16B_k       2.5300     H16B   .O19          2.5200 
  
        H13C   .H3A          2.3900     H16B   .C6           2.7000 
  
        H13C   .H5           2.2800     H16B   .C8           3.0100 
  
        H14A   .H12A         2.5800     H16B   .H6A          2.0900 
  
        H14A   .H15C_c       2.1700     H16B   .H13_b        2.5000 
  
        H14A   .H15B_l       2.5900     H16B   .H13B_n       2.5300 
  
        H14B   .C2_m         3.0400     H16C   .C2           2.7100 
  
        H14B   .H2B_m        2.4500     H16C   .C4           3.0800 
  
        H14B   .H3B_m        2.5100     H16C   .C17          2.7800 
  
        H14C   .H12B         2.5300     H16C   .H2A          2.1600 
  
        H14C   .H7A_l        2.4400     H16C   .H17B         2.0300 
  
        H15A   .C11          2.6600     H16C   .H3A_f        2.5000 
  
        H15A   .C12          2.9800     H17A   .H3B          2.5200 
  
        H15A   .H11B         2.2100     H17A   .H13A         2.4300 
  
        H15A   .H12B         2.4500     H17A   .H15A_j       2.5900 
  
        H15A   .H17A_i       2.5900     H17B   .C2           2.8700 
                              
        Table 8 - Contact Distances(Angstrom) (continued) 
                     
   
        H17B   .C16          2.7300     H19    .H20_a       2.59(4) 
  
        H17B   .H2A          2.3400     H19    .H20_b       2.54(4) 
  
        H17B   .H16C         2.0300     H20    .C11         2.92(3) 
  
        H17C   .C6           2.7400     H20    .H11A         2.4900 
  
        H17C   .H6A          2.3800     H20    .H19_c       2.59(4) 
  
        H17C   .H13B         2.5300     H20    .O19_d       2.03(3) 
  
        H19    .O20_a       2.11(3)     H20    .C11_d       2.99(3) 
  
        H19    .H7B          2.2900     H20    .H11B_d       2.2500 
  
        H19    .H15C         2.3500     H20    .H19_d       2.54(4) 
  
 
                                  
  
        Table S9 - Hydrogen Bonds (Angstrom, Deg) 
                     
  
  
O19  -- H19  .. O20        0.90(2)    2.11(3) 3.0012(17)     172(2)   1_455 
  
O20  -- H20  .. O19        0.86(3)    2.03(3) 2.8636(18)     161(3)   3_566 
  
C11  -- H11B .. O19         0.9900     2.5100   2.948(2)     107.00     . 
  
C16  -- H16B .. O19         0.9800     2.5200   3.012(2)     111.00     . 
 
                                  
  
  
 Translation of Symmetry Code to Equiv.Pos 
  
  
a =[  1455.00 ]  = -1+x,y,z 
b =[  3466.00 ]  = -1/2+x,3/2-y,1-z 
c =[  1655.00 ]  = 1+x,y,z 
d =[  3566.00 ]  = 1/2+x,3/2-y,1-z 
e =[  2664.00 ]  = 3/2-x,1-y,-1/2+z 
f =[  4655.00 ]  = 1-x,1/2+y,1/2-z 
g =[  4645.00 ]  = 1-x,-1/2+y,1/2-z 
h =[  3456.00 ]  = -1/2+x,1/2-y,1-z 
i =[  2565.00 ]  = 1/2-x,1-y,1/2+z 
j =[  2564.00 ]  = 1/2-x,1-y,-1/2+z 
k =[  4545.00 ]  = -x,-1/2+y,1/2-z 
l =[  3556.00 ]  = 1/2+x,1/2-y,1-z 
m =[  2665.00 ]  = 3/2-x,1-y,1/2+z 
n =[  4555.00 ]  = -x,1/2+y,1/2-z 
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Figure 1.1 1H NMR spectrum of Compound 2.1 (600 MHz, C6D6) 
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Figure 1.2 13C NMR spectrum of Compound 2.1 (150 MHz, C6D6) 
 
ppm (f1)
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Figure 1.3 1H NMR spectrum of Compound 3.3 (600 MHz, CDCl3) 
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Figure 1.4 13C NMR spectrum of Compound 3.3 (150 MHz, CDCl3) 
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Figure 1.5 1H NMR spectrum of Compound 3.4 (600 MHz, CDCl3) 
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Figure 1.6 13C NMR spectrum of Compound 3.4 (150 MHz, CDCl3) 
 
 
ppm (t1)
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Figure 1.7 1H NMR spectrum of Compound 3.5 (600 MHz, CDCl3) 
 
 
ppm (t1)
0.330.671.001.331.672.002.332.673.003.333.674.004.334.675.005.335.676.006.336.677.007.33
HO OH
OH
 
 
Figure 1.8 13C NMR spectrum of Compound 3.5 (600 MHz, CDCl3) 
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Figure 1.9 1H NMR spectrum of Compound 4.1 (400 MHz, CDCl3) 
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Figure 1.10 13C NMR spectrum of Compound 4.1 (100 MHz, CDCl3) 
 
 
ppm (f1)
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Figure 1.11 1H NMR spectrum of Compound 4.2 (400 MHz, CDCl3) 
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Figure 1.12 13C NMR spectrum of Compound 4.2 (100 MHz, CDCl3) 
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Figure 1.13 1H NMR spectrum of Compound 4.3 (400 MHz, CDCl3) 
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Figure 1.14 13C NMR spectrum of Compound 4.3 (100 MHz, CDCl3) 
 
ppm (f1)
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Figure 1.15 1H NMR spectrum of Compound  5.1  (600 MHz, C6D6) 
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Figure 1.16 13C NMR of spectrum 5.1 (150 MHz, C6D6) 
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Figure 1.17 1H NMR spectrum of Compound 5.2  (600 MHz, C6D6) 
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Figure 1.18 13C NMR spectrum of Compound 5.2 (150 MHz, C6D6) 
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Figure 1.19 1H NMR spectrum of Compound 5.4 (600 MHz, CDCl3) 
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Figure 1.20 13C NMR spectrum of Compound 5.4 (150 MHz, CDCl3) 
 
 
ppm (f1)
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Figure 1.21 1H NMR spectrum of Compound 5.5 (600 MHz, CDCl3) 
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Figure 1.22 13C NMR spectrum of Compound 5.5 (150 MHz, CDCl3) 
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Figure 1.23 1H NMR spectrum of Compound 5.32 (400 MHz, CDCl3) 
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Figure 1.24 13C NMR spectrum of Compound 5.32 (100 MHz, CDCl3) 
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Figure 1.25 1H NMR spectrum of Compound 5.33 (400 MHz, CDCl3) 
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Figure 1.26 13C NMR spectrum of Compound 5.33 (100 MHz, CDCl3) 
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Figure 1.27 1H NMR spectrum of Compound 5.34 (400 MHz, CDCl3) 
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Figure 1.28 13C NMR spectrum of Compound 5.34 (100 MHz, CDCl3) 
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Figure 1.29 1H NMR spectrum of Compound 5.35 (400 MHz, CDCl3) 
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Figure 1.30 13C NMR spectrum of Compound 5.35 (100 MHz, CDCl3) 
 
ppm (f1)
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Figure 1.31 1H NMR spectrum of Compound 5.49 (400 MHz, CDCl3) 
ppm (t1)
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Figure 1.32 13C NMR spectrum of Compound 5.49 (100 MHz, CDCl3) 
 
ppm (t1)
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Figure 1.33 1H NMR spectrum of Compound 5.50 (400 MHz, CDCl3) 
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Figure 1.34 13C NMR spectrum of Compound 5.50 (100 MHz, CDCl3) 
 
ppm (f1)
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Figure 1.35 1H NMR spectrum of Compound 6.6 (600 MHz, CDCl3) 
ppm (f1)
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Figure 1.36 13C NMR spectrum of Compound 6.6 (150 MHz, CDCl3) 
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Figure 1.37 1H NMR spectrum of Compound 6.7 (600 MHz, C6D6) 
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Figure 1.38 13C NMR spectrum of Compound 6.7 (150 MHz, C6D6) 
 
ppm (t1)
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Figure 1.39 1H NMR spectrum of Compound 6.8 (600 MHz, C6D6) 
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Figure 1.40 13C NMR spectrum of Compound 6.8 (150 MHz, C6D6) 
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Figure 1.41 1H NMR spectrum of Compound 6.9 (400 MHz, CDCl3) 
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Figure 1.42 13 C NMR spectrum of Compound 6.9 (100 MHz, CDCl3) 
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